1	oR	NN	O	or	_	0	SENT_1	[p1l186t81r390b120],
2	|	CD	NUMBER	|	dep	1	SENT_1	[p1l186t81r390b120],
3	G	NN	O	g	dep	2	SENT_1	[p1l186t81r390b120],
4	|	CD	NUMBER	|	dobj	3	SENT_1	[p1l186t81r390b120],
5	NA	NNP	O	NA	dep	4	SENT_1	[p1l186t81r390b120],
6	|	SYM	O	|	dep	4	SENT_1	[p1l186t81r390b120],
7	-	:	O	-	_	0	SENT_1	[p1l186t81r390b120],
8	RESEARCH	NN	O	research	dep	2	SENT_1	[p1l408t82r613b120],
9	ART	NN	O	art	rcmod	8	SENT_1	[p1l630t82r792b120],
10	|	NN	O	|	nn	11	SENT_1	[p1l630t82r792b120],
11	C	NN	O	c	dep	9	SENT_1	[p1l630t82r792b120],
12	|	SYM	O	|	dep	9	SENT_1	[p1l630t82r792b120],
13	-	:	O	-	_	0	SENT_1	[p1l630t82r792b120],
14	E	NN	O	e	dep	2	SENT_1	[p1l630t82r792b120],
15	°	CD	NUMBER	°	num	14	SENT_1	[p1l1566t84r1966b128],
16	"	``	O	"	punct	14	SENT_1	[p1l1566t84r1966b128],
17	”	NN	O	”	nn	18	SENT_1	[p1l1566t84r1966b128],
18	P	NN	O	p	dep	14	SENT_1	[p1l1566t84r1966b128],
19	“	CD	MONEY	“	number	20	SENT_1	[p1l1566t84r1966b128],
20	3	CD	MONEY	3	dep	1	SENT_1	[p1l1566t84r1966b128],
21	£	NN	MONEY	£	nn	22	SENT_1	[p1l1566t84r1966b128],
22	T	NN	O	t	dep	20	SENT_1	[p1l1566t84r1966b128],
23	§	CD	NUMBER	§	number	24	SENT_1	[p1l1566t84r1966b128],
24	§	CD	NUMBER	§	dep	1	SENT_1	[p1l1566t84r1966b128],
25	3	CD	NUMBER	3	num	26	SENT_1	[p1l1566t84r1966b128],
26	§	NN	O	§	dep	24	SENT_1	[p1l1566t84r1966b128],
27	3	CD	PERCENT	3	num	28	SENT_1	[p1l1566t84r1966b128],
28	%	NN	PERCENT	%	dep	1	SENT_1	[p1l1566t84r1966b128],
29	2	CD	NUMBER	2	dep	28	SENT_1	[p1l1566t84r1966b128],
30	?	.	O	?	_	0	SENT_1	[p1l1566t84r1966b128],

1	3	CD	NUMBER	3	num	2	SENT_2	[p1l1566t84r1966b128],
2	§	NN	O	§	_	0	SENT_2	[p1l1566t84r1966b128],
3	§	CD	NUMBER	§	num	4	SENT_2	[p1l1566t84r1966b128],
4	éfEZéilsilfbﬁé	NN	O	éfezéilsilfbﬁé	dep	2	SENT_2	[p1l1566t84r1966b128],

1	Investigation	NN	O	investigation	_	0	SENT_3	[p1l194t256r742b346],
2	of	IN	O	of	dep	1	SENT_3	[p1l770t255r852b323],
3	the	DT	O	the	det	6	SENT_3	[p1l877t255r1004b323],
4	Mutual	JJ	O	mutual	amod	6	SENT_3	[p1l1033t255r1337b323],
5	Pharmacokinetic	JJ	O	pharmacokinetic	amod	6	SENT_3	[p1l194t354r889b422],
6	Interactions	NNS	O	interaction	pobj	2	SENT_3	[p1l917t355r1408b422],
7	Between	IN	O	between	dep	1	SENT_3	[p1l1437t358r1793b422],
8	Bosentan	NNP	O	Bosentan	pobj	7	SENT_3	[p1l194t457r597b535],
9	,	,	O	,	_	0	SENT_3	[p1l194t457r597b535],
10	a	DT	O	a	det	14	SENT_3	[p1l625t476r666b521],
11	Dual	JJ	O	dual	amod	14	SENT_3	[p1l693t453r895b521],
12	Endothelin	NN	O	endothelin	nn	14	SENT_3	[p1l925t453r1386b521],
13	Receptor	NN	O	receptor	nn	14	SENT_3	[p1l1414t457r1782b543],
14	Antagonist	NN	O	antagonist	conj_and	8	SENT_3	[p1l192t553r673b643],
15	,	,	O	,	_	0	SENT_3	[p1l192t553r673b643],
16	and	CC	O	and	_	0	SENT_3	[p1l702t552r853b620],
17	Simvastatin	NNP	O	Simvastatin	pobj	7	SENT_3	[p1l883t553r1374b620],

1	Iasper	NNP	O	Iasper	nn	2	SENT_4	[p1l189t706r302b751],
2	Dingemanse	NNP	O	Dingemanse	_	0	SENT_4	[p1l314t702r568b751],
3	,1	CD	NUMBER	,1	num	5	SENT_4	[p1l314t702r568b751],
4	Dieter	NNP	PERSON	Dieter	nn	5	SENT_4	[p1l584t706r699b739],
5	Schazzrschmidtz	NNP	PERSON	Schazzrschmidtz	dep	2	SENT_4	[p1l712t702r996b739],
6	and	CC	O	and	_	0	SENT_4	[p1l1010t705r1085b739],
7	Paul	NNP	PERSON	Paul	nn	12	SENT_4	[p1l1097t705r1182b739],
8	L.M.	NNP	PERSON	L.M.	nn	12	SENT_4	[p1l1195t706r1281b739],
9	van	NNP	PERSON	van	nn	12	SENT_4	[p1l1297t716r1363b739],
10	Giersbergenl	NNP	PERSON	Giersbergenl	nn	12	SENT_4	[p1l1378t702r1610b751],
11	1	CD	NUMBER	1	num	12	SENT_4	[p1l193t785r206b812],
12	Department	NNP	ORGANIZATION	Department	conj_and	5	SENT_4	[p1l241t785r442b823],
13	of	IN	ORGANIZATION	of	_	0	SENT_4	[p1l453t784r486b813],
14	Clinical	JJ	ORGANIZATION	clinical	amod	15	SENT_4	[p1l495t784r623b813],
15	Pharmacology	NN	ORGANIZATION	pharmacology	prep_of	12	SENT_4	[p1l633t784r882b823],
16	,	,	O	,	_	0	SENT_4	[p1l633t784r882b823],
17	Actelion	NNP	ORGANIZATION	Actelion	nn	25	SENT_4	[p1l893t784r1034b813],
18	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	nn	25	SENT_4	[p1l1044t784r1317b813],
19	Ltd	NNP	ORGANIZATION	Ltd	nn	25	SENT_4	[p1l1328t784r1394b818],
20	,	,	O	,	_	0	SENT_4	[p1l1328t784r1394b818],
21	Allschwil	NNP	O	Allschwil	appos	25	SENT_4	[p1l1405t784r1573b818],
22	,	,	O	,	_	0	SENT_4	[p1l1405t784r1573b818],
23	Switzerland	NNP	LOCATION	Switzerland	appos	25	SENT_4	[p1l1584t784r1784b813],
24	2	CD	NUMBER	2	num	25	SENT_4	[p1l191t834r208b861],
25	Pharos	NNP	O	Pharos	conj_and	5	SENT_4	[p1l241t833r355b861],
26	GmbH	NN	O	gmbh	dep	25	SENT_4	[p1l366t833r488b866],
27	,	,	O	,	_	0	SENT_4	[p1l366t833r488b866],
28	Ulm	NN	O	ulm	appos	26	SENT_4	[p1l499t833r580b866],
29	,	,	O	,	_	0	SENT_4	[p1l499t833r580b866],
30	Germany	NNP	LOCATION	Germany	dep	2	SENT_4	[p1l592t834r748b871],

1	AbSl	NN	O	absl	nsubjpass	14	SENT_5	[p1l191t1004r376b1039],
2	|	NN	O	|	dep	1	SENT_5	[p1l191t1004r376b1039],
3	'	''	O	'	_	0	SENT_5	[p1l191t1004r376b1039],
4	OCl	NN	O	ocl	nn	6	SENT_5	[p1l191t1004r376b1039],
5	'	''	O	'	_	0	SENT_5	[p1l191t1004r376b1039],
6	Background	NN	O	background	dep	1	SENT_5	[p1l641t1016r862b1051],
7	:	:	O	:	_	0	SENT_5	[p1l641t1016r862b1051],
8	In	FW	O	in	nn	9	SENT_5	[p1l877t1017r909b1044],
9	vitro	FW	O	vitro	dep	6	SENT_5	[p1l924t1017r1007b1049],
10	,	,	O	,	_	0	SENT_5	[p1l924t1017r1007b1049],
11	bosentan	NN	O	bosentan	appos	9	SENT_5	[p1l1021t1016r1163b1044],
12	has	VBZ	O	have	aux	14	SENT_5	[p1l1176t1016r1228b1044],
13	been	VBN	O	be	auxpass	14	SENT_5	[p1l1242t1016r1317b1044],
14	shown	VBN	O	show	_	0	SENT_5	[p1l1332t1016r1434b1044],
15	to	TO	O	to	aux	19	SENT_5	[p1l1447t1020r1477b1044],
16	be	VB	O	be	cop	19	SENT_5	[p1l1490t1016r1527b1044],
17	a	DT	O	a	det	19	SENT_5	[p1l1542t1024r1558b1044],
18	mild	JJ	O	mild	amod	19	SENT_5	[p1l1571t1016r1644b1044],
19	inducer	NN	O	inducer	xcomp	14	SENT_5	[p1l1657t1016r1777b1044],
20	of	IN	O	of	_	0	SENT_5	[p1l1790t1016r1824b1044],
21	cyto	JJ	O	cyto	amod	22	SENT_5	[p1l1835t1020r1915b1052],
22	—	NN	O	—	prep_of	19	SENT_5	[p1l1835t1020r1915b1052],

1	chrome	NN	O	chrome	nn	2	SENT_6	[p1l641t1061r759b1089],
2	P450	NN	O	p450	_	0	SENT_6	[p1l771t1061r851b1089],
3	(	CD	NUMBER	(	num	4	SENT_6	[p1l864t1061r965b1096],
4	CYP	NN	O	cyp	dep	2	SENT_6	[p1l864t1061r965b1096],
5	)	CD	NUMBER	)	num	6	SENT_6	[p1l864t1061r965b1096],
6	2C9	NN	O	2c9	dep	2	SENT_6	[p1l978t1061r1041b1090],
7	and	CC	O	and	_	0	SENT_6	[p1l1054t1061r1110b1089],
8	3A4	NN	O	3a4	dep	2	SENT_6	[p1l1122t1061r1197b1089],
9	.	.	O	.	_	0	SENT_6	[p1l1122t1061r1197b1089],

1	Purpose	NN	O	purpose	_	0	SENT_7	[p1l641t1133r790b1169],
2	:	:	O	:	_	0	SENT_7	[p1l641t1133r790b1169],
3	To	TO	O	to	aux	4	SENT_7	[p1l800t1134r843b1161],
4	investigate	VB	O	investigate	infmod	1	SENT_7	[p1l851t1133r1024b1169],
5	in	FW	O	in	nn	6	SENT_7	[p1l1033t1134r1061b1161],
6	vivo	FW	O	vivo	advmod	4	SENT_7	[p1l1070t1134r1134b1161],
7	the	DT	O	the	det	10	SENT_7	[p1l1143t1133r1190b1161],
8	mutual	JJ	O	mutual	amod	10	SENT_7	[p1l1199t1133r1308b1161],
9	pharmacokinetic	JJ	O	pharmacokinetic	amod	10	SENT_7	[p1l1316t1133r1581b1169],
10	interactions	NNS	O	interaction	dobj	4	SENT_7	[p1l1590t1133r1775b1161],
11	between	IN	O	between	_	0	SENT_7	[p1l1783t1133r1916b1161],
12	bosentan	NN	O	bosentan	prep_between	10	SENT_7	[p1l641t1178r782b1206],
13	and	CC	O	and	_	0	SENT_7	[p1l794t1178r850b1206],
14	simvastatin	NN	O	simvastatin	prep_between	10	SENT_7	[p1l862t1178r1051b1211],
15	,	,	O	,	_	0	SENT_7	[p1l862t1178r1051b1211],
16	a	DT	O	a	det	18	SENT_7	[p1l1064t1187r1081b1206],
17	CYP3A4	NN	O	cyp3a4	nn	18	SENT_7	[p1l1091t1178r1236b1206],
18	substrate	NN	O	substrate	appos	12	SENT_7	[p1l1249t1178r1396b1206],
19	.	.	O	.	_	0	SENT_7	[p1l1249t1178r1396b1206],

1	Methods	NNS	O	method	_	0	SENT_8	[p1l641t1249r799b1277],
2	:	:	O	:	_	0	SENT_8	[p1l641t1249r799b1277],
3	Nine	CD	NUMBER	nine	num	6	SENT_8	[p1l812t1249r889b1277],
4	healthy	JJ	O	healthy	amod	6	SENT_8	[p1l899t1249r1016b1285],
5	male	JJ	O	male	amod	6	SENT_8	[p1l1027t1249r1103b1277],
6	subjects	NNS	O	subject	nsubjpass	8	SENT_8	[p1l1115t1249r1241b1285],
7	were	VBD	O	be	auxpass	8	SENT_8	[p1l1253t1258r1329b1277],
8	treated	VBN	O	treat	dep	1	SENT_8	[p1l1339t1249r1448b1277],
9	in	IN	O	in	_	0	SENT_8	[p1l1458t1249r1488b1277],
10	a	DT	O	a	det	14	SENT_8	[p1l1499t1258r1516b1277],
11	three-period	JJ	O	three-period	amod	14	SENT_8	[p1l1525t1249r1720b1285],
12	randomised	JJ	O	randomised	amod	14	SENT_8	[p1l1730t1249r1916b1277],
13	crossover	NN	O	crossover	nn	14	SENT_8	[p1l641t1303r797b1322],
14	study	NN	O	study	prep_in	8	SENT_8	[p1l819t1294r904b1330],
15	with	IN	O	with	prep	14	SENT_8	[p1l927t1294r1006b1322],
16	:	:	O	:	_	0	SENT_8	[p1l927t1294r1006b1322],
17	(	CD	NUMBER	(	conj_and	14	SENT_8	[p1l1032t1294r1085b1328],
18	A	DT	O	a	det	21	SENT_8	[p1l1032t1294r1085b1328],
19	)	NN	O	)	nn	21	SENT_8	[p1l1032t1294r1085b1328],
20	bosentan	NN	O	bosentan	nn	21	SENT_8	[p1l1108t1294r1251b1322],
21	125mg	NN	O	125mg	tmod	17	SENT_8	[p1l1277t1294r1383b1330],
22	twice	RB	O	twice	advmod	23	SENT_8	[p1l1406t1294r1492b1322],
23	daily	RB	SET	daily	advmod	21	SENT_8	[p1l1515t1294r1594b1330],
24	for	IN	O	for	_	0	SENT_8	[p1l1617t1294r1664b1322],
25	5.5	CD	DURATION	5.5	num	26	SENT_8	[p1l1686t1294r1733b1322],
26	days	NNS	NUMBER	day	prep_for	23	SENT_8	[p1l1757t1294r1839b1330],
27	;	:	O	;	_	0	SENT_8	[p1l1757t1294r1839b1330],
28	(	NN	O	(	nn	29	SENT_8	[p1l1864t1295r1915b1328],
29	B	NN	O	b	conj_and	14	SENT_8	[p1l1864t1295r1915b1328],
30	)	CD	NUMBER	)	num	32	SENT_8	[p1l1864t1295r1915b1328],
31	simvastatin	NN	O	simvastatin	nn	32	SENT_8	[p1l642t1340r822b1368],
32	40mg	NN	O	40mg	npadvmod	33	SENT_8	[p1l832t1340r921b1376],
33	once	RB	DATE	once	advmod	29	SENT_8	[p1l931t1349r1005b1368],
34	daily	RB	SET	daily	advmod	29	SENT_8	[p1l1015t1340r1093b1376],
35	for	IN	O	for	_	0	SENT_8	[p1l1103t1340r1149b1368],
36	6	CD	DURATION	6	num	37	SENT_8	[p1l1159t1340r1176b1368],
37	days	NNS	NUMBER	day	prep_for	29	SENT_8	[p1l1187t1340r1268b1376],
38	;	:	O	;	_	0	SENT_8	[p1l1187t1340r1268b1376],
39	and	CC	O	and	_	0	SENT_8	[p1l1280t1340r1336b1368],
40	(	NN	O	(	nn	41	SENT_8	[p1l1346t1340r1396b1374],
41	C	NN	O	c	conj_and	14	SENT_8	[p1l1346t1340r1396b1374],
42	)	JJ	O	)	amod	44	SENT_8	[p1l1346t1340r1396b1374],
43	bosentan	NN	O	bosentan	nn	44	SENT_8	[p1l1406t1340r1548b1368],
44	125mg	NN	O	125mg	tmod	41	SENT_8	[p1l1561t1340r1666b1376],
45	twice	RB	O	twice	advmod	46	SENT_8	[p1l1676t1340r1761b1368],
46	daily	RB	SET	daily	advmod	44	SENT_8	[p1l1772t1340r1850b1376],
47	and	CC	O	and	_	0	SENT_8	[p1l1860t1340r1916b1368],
48	simvastatin	NN	O	simvastatin	nn	49	SENT_8	[p1l642t1385r822b1413],
49	40mg	NN	O	40mg	conj_and	14	SENT_8	[p1l832t1385r922b1421],
50	once	RB	DATE	once	advmod	51	SENT_8	[p1l933t1394r1007b1413],
51	daily	RB	SET	daily	advmod	49	SENT_8	[p1l1018t1385r1096b1421],
52	for	IN	O	for	_	0	SENT_8	[p1l1107t1385r1153b1413],
53	5.5	CD	NUMBER	5.5	nn	56	SENT_8	[p1l1163t1385r1210b1413],
54	and	CC	O	and	_	0	SENT_8	[p1l1223t1385r1279b1413],
55	6	CD	DURATION	6	nn	56	SENT_8	[p1l1290t1385r1307b1413],
56	days	NNS	NUMBER	day	prep_for	49	SENT_8	[p1l1319t1385r1399b1421],
57	,	,	O	,	_	0	SENT_8	[p1l1319t1385r1399b1421],
58	respectively	RB	O	respectively	advmod	56	SENT_8	[p1l1410t1385r1611b1421],
59	.	.	O	.	_	0	SENT_8	[p1l1410t1385r1611b1421],

1	Plasma	NN	O	plasma	nn	3	SENT_9	[p1l1624t1385r1739b1413],
2	concentration-time	NN	O	concentration-time	nn	3	SENT_9	[p1l1749t1389r1915b1413, p1l641t1430r789b1458],
3	profiles	NNS	O	profile	nsubj	9	SENT_9	[p1l806t1430r928b1466],
4	of	IN	O	of	_	0	SENT_9	[p1l947t1430r981b1458],
5	bosentan	NN	O	bosentan	prep_of	3	SENT_9	[p1l995t1430r1138b1458],
6	and	CC	O	and	_	0	SENT_9	[p1l1156t1430r1212b1458],
7	its	PRP$	O	its	poss	8	SENT_9	[p1l1229t1430r1265b1458],
8	metabolites	NNS	O	metabolite	prep_of	3	SENT_9	[p1l1283t1430r1468b1458],
9	(	VBP	O	(	_	0	SENT_9	[p1l1487t1431r1666b1464],
10	treatments	NNS	O	treatment	dobj	9	SENT_9	[p1l1487t1431r1666b1464],
11	A	DT	O	a	nsubjpass	28	SENT_9	[p1l1684t1431r1712b1458],
12	and	CC	O	and	_	0	SENT_9	[p1l1730t1430r1786b1458],
13	C	NN	O	c	nsubjpass	28	SENT_9	[p1l1803t1430r1841b1464],
14	)	NN	O	)	dep	11	SENT_9	[p1l1803t1430r1841b1464],
15	and	CC	O	and	_	0	SENT_9	[p1l1859t1430r1916b1458],
16	simvastatin	NN	O	simvastatin	dep	11	SENT_9	[p1l642t1476r822b1504],
17	and	CC	O	and	_	0	SENT_9	[p1l831t1476r887b1504],
18	[	NN	O	[	dep	11	SENT_9	[p1l895t1475r1128b1512],
19	3-hydroxyacid	JJ	O	3-hydroxyacid	amod	22	SENT_9	[p1l895t1475r1128b1512],
20	simvastatin	NN	O	simvastatin	nn	22	SENT_9	[p1l1136t1476r1316b1504],
21	(	NN	O	(	nn	22	SENT_9	[p1l1325t1476r1502b1510],
22	treatments	NNS	O	treatment	dep	11	SENT_9	[p1l1325t1476r1502b1510],
23	B	NN	O	b	nn	26	SENT_9	[p1l1510t1477r1534b1503],
24	and	CC	O	and	_	0	SENT_9	[p1l1544t1476r1600b1504],
25	C	NN	O	c	nn	26	SENT_9	[p1l1608t1476r1645b1510],
26	)	NN	O	)	dep	22	SENT_9	[p1l1608t1476r1645b1510],
27	were	VBD	O	be	auxpass	28	SENT_9	[p1l1653t1485r1729b1504],
28	determined	VBN	O	determine	rcmod	10	SENT_9	[p1l1738t1476r1916b1504],
29	on	IN	O	on	_	0	SENT_9	[p1l641t1530r680b1549],
30	day	NN	DURATION	day	prep_on	28	SENT_9	[p1l691t1521r747b1557],
31	6	CD	NUMBER	6	num	30	SENT_9	[p1l759t1521r786b1549],
32	.	.	O	.	_	0	SENT_9	[p1l759t1521r786b1549],

1	Results	NNS	O	result	_	0	SENT_10	[p1l641t1592r775b1620],
2	:	:	O	:	_	0	SENT_10	[p1l641t1592r775b1620],
3	Steady-state	JJ	O	steady-state	amod	4	SENT_10	[p1l791t1592r984b1628],
4	conditions	NNS	O	condition	nsubjpass	11	SENT_10	[p1l997t1592r1162b1620],
5	for	IN	O	for	_	0	SENT_10	[p1l1176t1592r1222b1620],
6	bosentan	NN	O	bosentan	prep_for	4	SENT_10	[p1l1233t1592r1375b1620],
7	and	CC	O	and	_	0	SENT_10	[p1l1388t1592r1444b1620],
8	its	PRP$	O	its	poss	9	SENT_10	[p1l1456t1592r1492b1620],
9	metabolites	NNS	O	metabolite	prep_for	4	SENT_10	[p1l1505t1592r1688b1620],
10	were	VBD	O	be	auxpass	11	SENT_10	[p1l1702t1601r1778b1620],
11	attained	VBN	O	attain	dep	1	SENT_10	[p1l1791t1592r1916b1620],
12	on	IN	O	on	_	0	SENT_10	[p1l641t1646r680b1665],
13	day	NN	DURATION	day	prep_on	11	SENT_10	[p1l692t1637r748b1673],
14	4	CD	NUMBER	4	num	13	SENT_10	[p1l760t1637r779b1665],
15	of	IN	O	of	_	0	SENT_10	[p1l791t1637r826b1665],
16	treatment	NN	O	treatment	prep_of	13	SENT_10	[p1l835t1642r993b1665],
17	.	.	O	.	_	0	SENT_10	[p1l835t1642r993b1665],

1	The	DT	O	the	det	3	SENT_11	[p1l1006t1637r1067b1665],
2	pharrnacokinetic	JJ	O	pharrnacokinetic	amod	3	SENT_11	[p1l1079t1637r1344b1673],
3	parameters	NNS	O	parameter	nsubjpass	11	SENT_11	[p1l1356t1641r1529b1673],
4	of	IN	O	of	_	0	SENT_11	[p1l1542t1637r1577b1665],
5	bosentan	NN	O	bosentan	prep_of	3	SENT_11	[p1l1585t1637r1727b1665],
6	and	CC	O	and	_	0	SENT_11	[p1l1739t1637r1795b1665],
7	its	PRP$	O	its	poss	8	SENT_11	[p1l1807t1637r1843b1665],
8	metabolites	NNS	O	metabolite	prep_of	3	SENT_11	[p1l1855t1646r1915b1665, p1l641t1682r775b1710],
9	were	VBD	O	be	auxpass	11	SENT_11	[p1l789t1691r865b1710],
10	not	RB	O	not	neg	11	SENT_11	[p1l878t1686r929b1710],
11	inﬂuenced	VBN	O	inﬂuenced	_	0	SENT_11	[p1l941t1682r1109b1710],
12	by	IN	O	by	_	0	SENT_11	[p1l1121t1682r1160b1718],
13	concomitant	JJ	O	concomitant	amod	14	SENT_11	[p1l1174t1682r1371b1710],
14	treatment	NN	O	treatment	agent	11	SENT_11	[p1l1383t1686r1534b1710],
15	with	IN	O	with	_	0	SENT_11	[p1l1547t1682r1616b1710],
16	simvastatin	NN	O	simvastatin	prep_with	11	SENT_11	[p1l1631t1682r1819b1710],
17	:	:	O	:	_	0	SENT_11	[p1l1631t1682r1819b1710],
18	areas	NNS	O	area	dep	37	SENT_11	[p1l1835t1691r1915b1710],
19	under	IN	O	under	_	0	SENT_11	[p1l641t1728r732b1756],
20	the	DT	O	the	det	23	SENT_11	[p1l740t1728r787b1756],
21	plasma	NN	O	plasma	nn	23	SENT_11	[p1l796t1728r909b1764],
22	concentration-time	NN	O	concentration-time	nn	23	SENT_11	[p1l917t1728r1218b1756],
23	curve	NN	O	curve	prep_under	18	SENT_11	[p1l1227t1737r1314b1756],
24	over	IN	O	over	_	0	SENT_11	[p1l1324t1737r1394b1756],
25	one	CD	NUMBER	one	num	27	SENT_11	[p1l1403t1737r1458b1756],
26	administration	NN	O	administration	nn	27	SENT_11	[p1l1468t1728r1698b1756],
27	interval	NN	O	interval	prep_over	23	SENT_11	[p1l1706t1728r1827b1756],
28	of	IN	O	of	_	0	SENT_11	[p1l1837t1728r1871b1756],
29	12	CD	DURATION	12	num	30	SENT_11	[p1l1881t1728r1915b1755],
30	hours	NNS	NUMBER	hour	prep_of	27	SENT_11	[p1l641t1773r728b1801],
31	(	CD	NUMBER	(	num	32	SENT_11	[p1l742t1773r862b1807],
32	AUC	NN	O	auc	dep	37	SENT_11	[p1l742t1773r862b1807],
33	¢	CD	NUMBER	¢	number	34	SENT_11	[p1l742t1773r862b1807],
34	)	CD	NUMBER	)	num	35	SENT_11	[p1l742t1773r862b1807],
35	[	NN	O	[	npadvmod	36	SENT_11	[p1l878t1773r1047b1809],
36	geometric	JJ	O	geometric	amod	37	SENT_11	[p1l878t1773r1047b1809],
37	mean	NN	O	mean	dep	45	SENT_11	[p1l1059t1782r1145b1801],
38	and	CC	O	and	_	0	SENT_11	[p1l1157t1773r1213b1801],
39	95	CD	PERCENT	95	number	40	SENT_11	[p1l1225t1773r1295b1801],
40	%	NN	PERCENT	%	amod	41	SENT_11	[p1l1225t1773r1295b1801],
41	CI	NN	O	ci	dep	45	SENT_11	[p1l1309t1773r1358b1806],
42	]	NN	O	]	nsubj	45	SENT_11	[p1l1309t1773r1358b1806],
43	were	VBD	O	be	cop	45	SENT_11	[p1l1373t1782r1449b1801],
44	4586	CD	NUMBER	4586	number	45	SENT_11	[p1l1461t1773r1539b1801],
45	(	CD	NUMBER	(	parataxis	11	SENT_11	[p1l1553t1773r1756b1807],
46	3719-5656	CD	DURATION	3719-5656	num	47	SENT_11	[p1l1553t1773r1756b1807],
47	)	NN	O	)	dep	45	SENT_11	[p1l1553t1773r1756b1807],
48	and	CC	O	and	_	0	SENT_11	[p1l1769t1773r1826b1801],
49	4928	CD	DATE	4928	number	50	SENT_11	[p1l1837t1773r1914b1801],
50	(	CD	NUMBER	(	parataxis	11	SENT_11	[p1l642t1818r845b1852],
51	3945-6156	CD	DURATION	3945-6156	num	52	SENT_11	[p1l642t1818r845b1852],
52	)	NN	O	)	dep	50	SENT_11	[p1l642t1818r845b1852],
53	pg	NN	O	pg	nn	55	SENT_11	[p1l861t1826r901b1854],
54	o	NN	O	o	nn	55	SENT_11	[p1l917t1826r932b1841],
55	h/L	NN	O	h/l	dep	50	SENT_11	[p1l948t1818r1011b1846],
56	.	.	O	.	_	0	SENT_11	[p1l948t1818r1011b1846],

1	In	IN	O	in	_	0	SENT_12	[p1l1027t1819r1058b1846],
2	contrast	NN	O	contrast	prep_in	6	SENT_12	[p1l1073t1822r1207b1851],
3	,	,	O	,	_	0	SENT_12	[p1l1073t1822r1207b1851],
4	bosentan	NN	O	bosentan	nsubj	6	SENT_12	[p1l1221t1818r1363b1846],
5	significantly	RB	O	significantly	advmod	6	SENT_12	[p1l1378t1818r1576b1854],
6	reduced	VBD	O	reduce	_	0	SENT_12	[p1l1589t1818r1716b1846],
7	exposure	NN	O	exposure	dobj	6	SENT_12	[p1l1729t1827r1872b1854],
8	to	TO	O	to	_	0	SENT_12	[p1l1886t1822r1915b1846],
9	simvastatin	NN	O	simvastatin	nn	13	SENT_12	[p1l642t1864r822b1892],
10	and	CC	O	and	_	0	SENT_12	[p1l835t1864r891b1892],
11	[	NN	O	[	conj_and	9	SENT_12	[p1l904t1863r1137b1900],
12	3-hydroxyacid	JJ	O	3-hydroxyacid	amod	13	SENT_12	[p1l904t1863r1137b1900],
13	simvastatin	NN	O	simvastatin	prep_to	6	SENT_12	[p1l1150t1864r1330b1892],
14	by	IN	O	by	_	0	SENT_12	[p1l1341t1864r1380b1900],
15	34	CD	NUMBER	34	prep_by	6	SENT_12	[p1l1393t1864r1431b1892],
16	and	CC	O	and	_	0	SENT_12	[p1l1444t1864r1500b1892],
17	46	CD	PERCENT	46	num	18	SENT_12	[p1l1511t1864r1592b1897],
18	%	NN	PERCENT	%	conj_and	15	SENT_12	[p1l1511t1864r1592b1897],
19	,	,	O	,	_	0	SENT_12	[p1l1511t1864r1592b1897],
20	respectively	RB	O	respectively	advmod	6	SENT_12	[p1l1605t1864r1806b1900],
21	.	.	O	.	_	0	SENT_12	[p1l1605t1864r1806b1900],

1	AUCT	NNP	O	AUCT	nn	2	SENT_13	[p1l1820t1864r1915b1896],
2	Values	NNS	O	value	nsubj	7	SENT_13	[p1l641t1909r741b1937],
3	for	IN	O	for	_	0	SENT_13	[p1l754t1909r800b1937],
4	simvastatin	NN	O	simvastatin	prep_for	2	SENT_13	[p1l811t1909r991b1937],
5	were	VBD	O	be	cop	7	SENT_13	[p1l1003t1918r1079b1937],
6	30.5	CD	NUMBER	30.5	number	7	SENT_13	[p1l1091t1909r1157b1937],
7	(	CD	NUMBER	(	_	0	SENT_13	[p1l1171t1909r1354b1943],
8	23.1	CD	NUMBER	23.1	num	9	SENT_13	[p1l1171t1909r1354b1943],
9	—	NN	O	—	dep	7	SENT_13	[p1l1171t1909r1354b1943],
10	40.2	CD	NUMBER	40.2	num	11	SENT_13	[p1l1171t1909r1354b1943],
11	)	NN	O	)	dep	7	SENT_13	[p1l1171t1909r1354b1943],
12	and	CC	O	and	_	0	SENT_13	[p1l1367t1909r1424b1937],
13	20.0	CD	NUMBER	20.0	number	14	SENT_13	[p1l1435t1909r1503b1937],
14	(	CD	NUMBER	(	conj_and	7	SENT_13	[p1l1516t1909r1699b1943],
15	l5	NN	O	l5	dep	14	SENT_13	[p1l1516t1909r1699b1943],
16	.9	CD	NUMBER	.9	num	15	SENT_13	[p1l1516t1909r1699b1943],
17	—	CD	NUMBER	—	number	18	SENT_13	[p1l1516t1909r1699b1943],
18	25.1	CD	NUMBER	25.1	num	22	SENT_13	[p1l1516t1909r1699b1943],
19	)	NN	O	)	nn	22	SENT_13	[p1l1516t1909r1699b1943],
20	ug	NN	O	ug	nn	22	SENT_13	[p1l1712t1917r1752b1945],
21	o	NN	O	o	nn	22	SENT_13	[p1l1765t1917r1780b1932],
22	hﬂ	NN	O	hﬂ	dep	14	SENT_13	[p1l1793t1909r1848b1937],
23	.	.	O	.	_	0	SENT_13	[p1l1793t1909r1848b1937],

1	and	CC	O	and	dep	8	SENT_14	[p1l1860t1909r1916b1937],
2	for	IN	O	for	mark	8	SENT_14	[p1l641t1954r687b1982],
3	[	CD	NUMBER	[	num	5	SENT_14	[p1l697t1953r930b1990],
4	3-hydroxyacid	JJ	O	3-hydroxyacid	amod	5	SENT_14	[p1l697t1953r930b1990],
5	simvastatin	NN	O	simvastatin	nsubj	8	SENT_14	[p1l940t1954r1120b1982],
6	43.0	CD	NUMBER	43.0	dep	5	SENT_14	[p1l1130t1954r1198b1982],
7	(	CD	NUMBER	(	num	8	SENT_14	[p1l1209t1954r1392b1988],
8	32.1	CD	NUMBER	32.1	_	0	SENT_14	[p1l1209t1954r1392b1988],
9	—	CD	NUMBER	—	number	10	SENT_14	[p1l1209t1954r1392b1988],
10	57.8	CD	NUMBER	57.8	num	11	SENT_14	[p1l1209t1954r1392b1988],
11	)	NN	O	)	dobj	8	SENT_14	[p1l1209t1954r1392b1988],
12	and	CC	O	and	_	0	SENT_14	[p1l1404t1954r1460b1982],
13	23.4	CD	NUMBER	23.4	number	14	SENT_14	[p1l1470t1954r1537b1982],
14	(	CD	NUMBER	(	num	15	SENT_14	[p1l1549t1954r1732b1988],
15	l6	NN	O	l6	conj_and	11	SENT_14	[p1l1549t1954r1732b1988],
16	.7	CD	NUMBER	.7	dep	11	SENT_14	[p1l1549t1954r1732b1988],
17	—	CD	NUMBER	—	number	18	SENT_14	[p1l1549t1954r1732b1988],
18	32.6	CD	NUMBER	32.6	num	22	SENT_14	[p1l1549t1954r1732b1988],
19	)	NN	O	)	nn	22	SENT_14	[p1l1549t1954r1732b1988],
20	ug	NN	O	ug	nn	22	SENT_14	[p1l1743t1962r1783b1990],
21	o	NN	O	o	nn	22	SENT_14	[p1l1795t1962r1809b1977],
22	h/L	NN	O	h/l	dep	16	SENT_14	[p1l1822t1954r1876b1982],
23	in	IN	O	in	_	0	SENT_14	[p1l1886t1954r1916b1982],
24	treatments	NNS	O	treatment	nn	25	SENT_14	[p1l641t2004r806b2028],
25	B	NN	O	b	prep_in	8	SENT_14	[p1l818t2001r841b2027],
26	and	CC	O	and	_	0	SENT_14	[p1l855t2000r911b2028],
27	C	NN	O	c	conj_and	25	SENT_14	[p1l922t2000r956b2033],
28	,	,	O	,	_	0	SENT_14	[p1l922t2000r956b2033],
29	respectively	RB	O	respectively	advmod	25	SENT_14	[p1l968t2000r1169b2036],
30	.	.	O	.	_	0	SENT_14	[p1l968t2000r1169b2036],

1	Conclusions	NNS	O	conclusion	_	0	SENT_15	[p1l642t2071r857b2100],
2	:	:	O	:	_	0	SENT_15	[p1l642t2071r857b2100],
3	Concomitant	JJ	O	concomitant	amod	4	SENT_15	[p1l877t2071r1086b2100],
4	treatment	NN	O	treatment	nsubj	7	SENT_15	[p1l1103t2076r1255b2100],
5	with	IN	O	with	_	0	SENT_15	[p1l1272t2071r1342b2100],
6	bosentan	NN	O	bosentan	prep_with	4	SENT_15	[p1l1359t2071r1502b2100],
7	reduces	VBZ	O	reduce	dep	1	SENT_15	[p1l1519t2071r1641b2100],
8	the	DT	O	the	det	9	SENT_15	[p1l1659t2072r1706b2100],
9	exposure	NN	O	exposure	dobj	7	SENT_15	[p1l1724t2080r1868b2108],
10	to	TO	O	to	_	0	SENT_15	[p1l1886t2076r1915b2100],
11	simvastatin	NN	O	simvastatin	nn	15	SENT_15	[p1l642t2117r822b2145],
12	and	CC	O	and	_	0	SENT_15	[p1l839t2117r895b2145],
13	[	NN	O	[	nn	15	SENT_15	[p1l913t2116r1145b2153],
14	3-hydroxyacid	JJ	O	3-hydroxyacid	amod	15	SENT_15	[p1l913t2116r1145b2153],
15	simvastatin	NN	O	simvastatin	prep_to	7	SENT_15	[p1l1162t2117r1342b2145],
16	by	IN	O	by	_	0	SENT_15	[p1l1358t2117r1397b2153],
17	approximately	RB	O	approximately	quantmod	18	SENT_15	[p1l1414t2117r1643b2153],
18	40	CD	PERCENT	40	num	19	SENT_15	[p1l1659t2117r1739b2150],
19	%	NN	PERCENT	%	prep_by	7	SENT_15	[p1l1659t2117r1739b2150],
20	,	,	O	,	_	0	SENT_15	[p1l1659t2117r1739b2150],
21	indicating	VBG	O	indicate	partmod	7	SENT_15	[p1l1757t2117r1915b2153],
22	that	IN	O	that	complm	30	SENT_15	[p1l641t2162r701b2190],
23	in	IN	O	in	_	0	SENT_15	[p1l713t2163r741b2190],
24	viva	FW	O	viva	nn	25	SENT_15	[p1l753t2163r817b2190],
25	bosentan	FW	O	bosentan	prep_in	30	SENT_15	[p1l829t2162r970b2190],
26	is	VBZ	O	be	cop	30	SENT_15	[p1l981t2162r1006b2190],
27	also	RB	O	also	advmod	30	SENT_15	[p1l1019t2162r1081b2190],
28	a	DT	O	a	det	30	SENT_15	[p1l1093t2171r1110b2190],
29	mild	JJ	O	mild	amod	30	SENT_15	[p1l1120t2162r1193b2190],
30	inducer	NN	O	inducer	ccomp	21	SENT_15	[p1l1204t2162r1323b2190],
31	of	IN	O	of	_	0	SENT_15	[p1l1334t2162r1368b2190],
32	CYP3A4	NN	O	cyp3a4	prep_of	30	SENT_15	[p1l1377t2162r1530b2190],
33	.	.	O	.	_	0	SENT_15	[p1l1377t2162r1530b2190],

1	294	CD	NUMBER	294	num	2	SENT_16	[p1l191t2399r241b2423],
2	Dingemrmse	NNP	O	Dingemrmse	_	0	SENT_16	[p1l1725t2398r1893b2432],
3	et	FW	O	et	nn	4	SENT_16	[p1l1902t2401r1925b2423],
4	al.	FW	O	al.	dep	2	SENT_16	[p1l1935t2398r1965b2423],
5	.	.	O	.	_	0	SENT_16	[p1l1935t2398r1965b2423],

1	Endothelin	JJ	O	endothelin	amod	2	SENT_17	[p1l136t2638r706b2722],
2	—	NN	O	—	nsubj	15	SENT_17	[p1l136t2638r706b2722],
3	1	CD	NUMBER	1	num	2	SENT_17	[p1l136t2638r706b2722],
4	,	,	O	,	_	0	SENT_17	[p1l136t2638r706b2722],
5	which	WDT	O	which	nsubjpass	7	SENT_17	[p1l755t2638r1007b2709],
6	is	VBZ	O	be	auxpass	7	SENT_17	[p1l1051t2638r1115b2708],
7	synthesised	VBN	O	synthesise	rcmod	2	SENT_17	[p1l1166t2638r1646b2730],
8	predominantly	RB	O	predominantly	advmod	7	SENT_17	[p1l1689t2638r2066b2730, p1l15t2759r269b2851],
9	by	IN	O	by	_	0	SENT_17	[p1l304t2759r404b2851],
10	the	DT	O	the	det	12	SENT_17	[p1l441t2759r562b2829],
11	Vascular	JJ	O	vascular	amod	12	SENT_17	[p1l599t2759r941b2830],
12	endothelium	NN	O	endothelium	agent	7	SENT_17	[p1l975t2759r1507b2843],
13	,	,	O	,	_	0	SENT_17	[p1l975t2759r1507b2843],
14	is	VBZ	O	be	cop	15	SENT_17	[p1l1546t2759r1609b2829],
15	one	CD	NUMBER	one	_	0	SENT_17	[p1l1649t2782r1792b2829],
16	of	IN	O	of	_	0	SENT_17	[p1l1829t2759r1917b2829],
17	the	DT	O	the	det	22	SENT_17	[p1l1946t2759r2067b2829],
18	most	RBS	O	most	advmod	19	SENT_17	[p1l15t2891r218b2950],
19	potent	JJ	O	potent	amod	22	SENT_17	[p1l278t2891r543b2972],
20	and	CC	O	and	_	0	SENT_17	[p1l607t2880r753b2950],
21	long	JJ	O	long	conj_and	19	SENT_17	[p1l816t2880r1319b2972],
22	—	NN	O	—	prep_of	15	SENT_17	[p1l816t2880r1319b2972],
23	lasting	VBG	O	last	partmod	22	SENT_17	[p1l816t2880r1319b2972],
24	vasoconstrictors	NNS	O	vasoconstrictor	dobj	23	SENT_17	[p1l1383t2880r2065b2951],
25	known	VBN	O	know	partmod	24	SENT_17	[p1l14t3000r311b3071],
26	.	.	O	.	_	0	SENT_17	[p1l14t3000r311b3071],

1	Since	IN	O	since	_	0	SENT_18	[p1l356t3000r577b3071],
2	its	PRP$	O	its	poss	3	SENT_18	[p1l614t3000r706b3071],
3	discovery	NN	O	discovery	prep_since	24	SENT_18	[p1l745t3000r1140b3092],
4	in	IN	O	in	_	0	SENT_18	[p1l1176t3000r1253b3070],
5	1988	CD	DATE	1988	prep_in	3	SENT_18	[p1l1298t2991r1596b3084],
6	,	,	O	,	_	0	SENT_18	[p1l1298t2991r1596b3084],
7	”	CD	NUMBER	”	number	8	SENT_18	[p1l1298t2991r1596b3084],
8	]	CD	NUMBER	]	num	10	SENT_18	[p1l1298t2991r1596b3084],
9	the	DT	O	the	det	10	SENT_18	[p1l1635t3001r1757b3071],
10	role	NN	O	role	nsubj	24	SENT_18	[p1l1792t3000r1949b3071],
11	of	IN	O	of	_	0	SENT_18	[p1l1987t3000r2075b3071],
12	endothelin	NN	O	endothelin	nn	13	SENT_18	[p1l17t3121r547b3191],
13	—	NN	O	—	prep_of	10	SENT_18	[p1l17t3121r547b3191],
14	1	CD	NUMBER	1	num	13	SENT_18	[p1l17t3121r547b3191],
15	in	IN	O	in	_	0	SENT_18	[p1l601t3121r680b3190],
16	(	CD	NUMBER	(	num	17	SENT_18	[p1l729t3121r1614b3213],
17	patho	NN	O	patho	prep_in	10	SENT_18	[p1l729t3121r1614b3213],
18	)	CD	NUMBER	)	num	20	SENT_18	[p1l729t3121r1614b3213],
19	physiological	JJ	O	physiological	amod	20	SENT_18	[p1l729t3121r1614b3213],
20	processes	NNS	O	process	dep	17	SENT_18	[p1l1658t3144r2064b3213],
21	has	VBZ	O	have	aux	24	SENT_18	[p1l15t3242r151b3312],
22	been	VBN	O	be	cop	24	SENT_18	[p1l182t3242r374b3312],
23	the	DT	O	the	det	24	SENT_18	[p1l404t3242r525b3312],
24	topic	NN	O	topic	_	0	SENT_18	[p1l555t3241r756b3332],
25	of	IN	O	of	_	0	SENT_18	[p1l788t3241r876b3312],
26	numerous	JJ	O	numerous	amod	27	SENT_18	[p1l898t3263r1297b3312],
27	investigations	NNS	O	investigation	prep_of	24	SENT_18	[p1l1328t3231r2064b3332],
28	.	.	O	.	_	0	SENT_18	[p1l1328t3231r2064b3332],

1	[	NN	O	[	nsubj	9	SENT_19	[p1l1328t3231r2064b3332],
2	2	CD	NUMBER	2	number	3	SENT_19	[p1l1328t3231r2064b3332],
3	‘	CD	NUMBER	‘	dep	1	SENT_19	[p1l1328t3231r2064b3332],
4	4	CD	NUMBER	4	num	8	SENT_19	[p1l1328t3231r2064b3332],
5	]	NN	O	]	nn	8	SENT_19	[p1l1328t3231r2064b3332],
6	Endothelin	NN	O	endothelin	nn	8	SENT_19	[p1l15t3361r478b3432],
7	receptor	NN	O	receptor	nn	8	SENT_19	[p1l521t3372r869b3453],
8	antagonists	NNS	O	antagonist	dep	1	SENT_19	[p1l914t3361r1384b3453],
9	display	VBP	O	display	_	0	SENT_19	[p1l1432t3361r1732b3453],
10	a	DT	O	a	det	12	SENT_19	[p1l1780t3384r1822b3432],
11	wide	JJ	O	wide	amod	12	SENT_19	[p1l1866t3361r2065b3432],
12	spectrum	NN	O	spectrum	dobj	9	SENT_19	[p1l19t3493r403b3574],
13	of	IN	O	of	_	0	SENT_19	[p1l446t3482r536b3553],
14	potential	JJ	O	potential	amod	15	SENT_19	[p1l571t3482r943b3574],
15	indications	NNS	O	indication	prep_of	12	SENT_19	[p1l987t3482r1451b3553],
16	such	JJ	O	such	_	0	SENT_19	[p1l1500t3483r1687b3553],
17	as	IN	O	as	_	0	SENT_19	[p1l1731t3505r1811b3553],
18	heart	NN	O	heart	nn	19	SENT_19	[p1l1855t3483r2067b3553],
19	failure	NN	O	failure	prep_such_as	15	SENT_19	[p2l16t22r316b105],
20	,	,	O	,	_	0	SENT_19	[p2l16t22r316b105],
21	pulmonary	JJ	O	pulmonary	amod	22	SENT_19	[p2l384t22r837b112],
22	hypertension	NN	O	hypertension	prep_such_as	15	SENT_19	[p2l903t22r1447b112],
23	and	CC	O	and	_	0	SENT_19	[p2l1515t22r1661b92],
24	diabetes	NN	O	diabetes	nn	25	SENT_19	[p2l1727t22r2067b92],
25	complications	NNS	O	complication	prep_such_as	15	SENT_19	[p2l16t130r766b233],
26	.	.	O	.	_	0	SENT_19	[p2l16t130r766b233],

1	[	NN	O	[	_	0	SENT_20	[p2l16t130r766b233],
2	5	CD	NUMBER	5	num	1	SENT_20	[p2l16t130r766b233],
3	’	NN	O	’	rcmod	1	SENT_20	[p2l16t130r766b233],
4	6	CD	NUMBER	6	num	3	SENT_20	[p2l16t130r766b233],
5	]	CD	NUMBER	]	num	8	SENT_20	[p2l16t130r766b233],
6	Bosentan	NNP	O	Bosentan	nn	8	SENT_20	[p2l802t143r1193b212],
7	(	CD	NUMBER	(	num	8	SENT_20	[p2l1228t130r1742b228],
8	Tracleerml	NNP	O	Tracleerml	dep	3	SENT_20	[p2l1228t130r1742b228],
9	;	:	O	;	_	0	SENT_20	[p2l1228t130r1742b228],
10	Ro	NN	O	ro	dep	3	SENT_20	[p2l1779t143r1895b212],
11	470203	CD	NUMBER	470203	num	10	SENT_20	[p2l1929t142r2063b212, p2l16t263r253b346],
12	;	:	O	;	_	0	SENT_20	[p2l1929t142r2063b212, p2l16t263r253b346],
13	4-tert-butyl-N	NN	O	4-tert-butyl-n	dep	10	SENT_20	[p2l303t262r1473b354],
14	-	:	O	-	_	0	SENT_20	[p2l303t262r1473b354],
15	[	NN	O	[	dep	3	SENT_20	[p2l303t262r1473b354],
16	6	CD	NUMBER	6	num	15	SENT_20	[p2l303t262r1473b354],
17	-	:	O	-	_	0	SENT_20	[p2l303t262r1473b354],
18	(	CD	NUMBER	(	num	19	SENT_20	[p2l303t262r1473b354],
19	2-hydroxy	NN	O	2-hydroxy	dep	15	SENT_20	[p2l303t262r1473b354],
20	-	:	O	-	_	0	SENT_20	[p2l303t262r1473b354],
21	ethoxy	NN	O	ethoxy	dep	3	SENT_20	[p2l1517t262r1917b354],
22	)	CD	NUMBER	)	num	23	SENT_20	[p2l1517t262r1917b354],
23	-5	CD	NUMBER	-5	dep	21	SENT_20	[p2l1517t262r1917b354],
24	-	:	O	-	_	0	SENT_20	[p2l1517t262r1917b354],
25	(	CD	NUMBER	(	num	27	SENT_20	[p2l1964t263r2068b350, p2l15t378r1472b475],
26	2methoxy-phenoxy	JJ	O	2methoxy-phenoxy	amod	27	SENT_20	[p2l1964t263r2068b350, p2l15t378r1472b475],
27	)	NN	O	)	dep	3	SENT_20	[p2l1964t263r2068b350, p2l15t378r1472b475],
28	-2,2	CD	NUMBER	-2,2	dep	27	SENT_20	[p2l1964t263r2068b350, p2l15t378r1472b475],
29	’	SYM	O	’	dep	3	SENT_20	[p2l1964t263r2068b350, p2l15t378r1472b475],
30	-	:	O	-	_	0	SENT_20	[p2l1964t263r2068b350, p2l15t378r1472b475],
31	bipyrimidin	NN	O	bipyrimidin	dep	1	SENT_20	[p2l1964t263r2068b350, p2l15t378r1472b475],
32	-4	CD	NUMBER	-4	num	31	SENT_20	[p2l1493t384r1706b475],
33	-	:	O	-	_	0	SENT_20	[p2l1493t384r1706b475],
34	yl	NN	O	yl	dep	31	SENT_20	[p2l1493t384r1706b475],
35	]	SYM	O	]	dep	38	SENT_20	[p2l1493t384r1706b475],
36	-	:	O	-	_	0	SENT_20	[p2l1731t384r2072b454],
37	benzene	NN	O	benzene	nn	38	SENT_20	[p2l1731t384r2072b454],
38	—	NN	O	—	dep	46	SENT_20	[p2l18t505r574b591],
39	sulfonamide	NN	O	sulfonamide	nn	40	SENT_20	[p2l18t505r574b591],
40	)	NN	O	)	nsubj	46	SENT_20	[p2l18t505r574b591],
41	is	VBZ	O	be	cop	46	SENT_20	[p2l616t505r679b575],
42	the	DT	O	the	det	46	SENT_20	[p2l720t505r841b575],
43	first	JJ	ORDINAL	first	amod	46	SENT_20	[p2l880t505r1045b575],
44	orally	RB	O	orally	advmod	45	SENT_20	[p2l1083t505r1317b595],
45	active	JJ	O	active	amod	46	SENT_20	[p2l1358t505r1598b575],
46	endothelin	NN	O	endothelin	rcmod	34	SENT_20	[p2l1638t505r2068b575],
47	receptor	NN	O	receptor	nn	48	SENT_20	[p2l14t636r352b717],
48	antagonist	NN	O	antagonist	dep	50	SENT_20	[p2l394t625r813b717],
49	to	TO	O	to	aux	50	SENT_20	[p2l853t636r929b695],
50	reach	VB	O	reach	dep	46	SENT_20	[p2l970t625r1191b695],
51	the	DT	O	the	det	52	SENT_20	[p2l1231t625r1353b695],
52	stage	NN	O	stage	dobj	50	SENT_20	[p2l1398t636r1602b717],
53	of	IN	O	of	_	0	SENT_20	[p2l1645t625r1733b695],
54	clinical	JJ	O	clinical	amod	55	SENT_20	[p2l1768t625r2068b695],
55	investigation	NN	O	investigation	prep_of	52	SENT_20	[p2l15t734r711b837],
56	.	.	O	.	_	0	SENT_20	[p2l15t734r711b837],

1	[	NN	O	[	nsubj	13	SENT_21	[p2l15t734r711b837],
2	7	CD	NUMBER	7	number	3	SENT_21	[p2l15t734r711b837],
3	‘	CD	NUMBER	‘	dep	1	SENT_21	[p2l15t734r711b837],
4	9	CD	NUMBER	9	num	6	SENT_21	[p2l15t734r711b837],
5	]	NN	O	]	nn	6	SENT_21	[p2l15t734r711b837],
6	Bosentan	NNP	O	Bosentan	dep	1	SENT_21	[p2l757t747r1137b815],
7	is	VBZ	O	be	cop	13	SENT_21	[p2l1178t745r1242b815],
8	a	DT	O	a	det	13	SENT_21	[p2l1288t768r1330b815],
9	competitive	JJ	O	competitive	amod	13	SENT_21	[p2l1371t745r1852b837],
10	dual	JJ	O	dual	amod	13	SENT_21	[p2l1895t745r2068b815],
11	endothelin	NN	O	endothelin	nn	13	SENT_21	[p2l16t867r447b937],
12	receptor	NN	O	receptor	nn	13	SENT_21	[p2l477t878r814b959],
13	antagonist	NN	O	antagonist	_	0	SENT_21	[p2l846t867r1281b959],
14	with	IN	O	with	_	0	SENT_21	[p2l1316t867r1501b938],
15	high	JJ	O	high	amod	16	SENT_21	[p2l1533t867r1719b959],
16	affinity	NN	O	affinity	prep_with	13	SENT_21	[p2l1755t867r2065b959],
17	for	IN	O	for	_	0	SENT_21	[p2l16t988r137b1058],
18	both	DT	O	both	det	20	SENT_21	[p2l165t988r352b1058],
19	endothelin	NN	O	endothelin	nn	20	SENT_21	[p2l383t988r829b1058],
20	A	NN	O	a	prep_for	16	SENT_21	[p2l860t989r930b1057],
21	and	CC	O	and	_	0	SENT_21	[p2l961t988r1105b1058],
22	B	NN	O	b	nn	23	SENT_21	[p2l1131t990r1191b1057],
23	receptors	NNS	O	receptor	prep_for	16	SENT_21	[p2l1222t999r1619b1080],
24	.	.	O	.	_	0	SENT_21	[p2l1222t999r1619b1080],

1	Currently	RB	DATE	currently	advmod	6	SENT_22	[p2l1652t988r2064b1080],
2	,	,	O	,	_	0	SENT_22	[p2l1652t988r2064b1080],
3	bosentan	NN	O	bosentan	nsubjpass	30	SENT_22	[p2l14t1109r378b1179],
4	has	VBZ	O	have	aux	6	SENT_22	[p2l408t1109r540b1179],
5	been	VBN	O	be	auxpass	6	SENT_22	[p2l573t1109r765b1179],
6	approved	VBN	O	approve	_	0	SENT_22	[p2l798t1109r1175b1201],
7	by	IN	O	by	_	0	SENT_22	[p2l1205t1109r1304b1201],
8	the	DT	O	the	det	10	SENT_22	[p2l1336t1109r1458b1179],
9	regulatory	JJ	O	regulatory	amod	10	SENT_22	[p2l1488t1109r1909b1201],
10	authorities	NNS	O	authority	agent	6	SENT_22	[p2l1943t1132r2066b1179, p2l15t1230r348b1300],
11	of	IN	O	of	_	0	SENT_22	[p2l378t1230r466b1300],
12	the	DT	O	the	det	13	SENT_22	[p2l485t1230r607b1300],
13	US	NNP	LOCATION	US	prep_of	10	SENT_22	[p2l634t1231r783b1313],
14	,	,	O	,	_	0	SENT_22	[p2l634t1231r783b1313],
15	Canada	NNP	LOCATION	Canada	prep_of	10	SENT_22	[p2l814t1230r1151b1313],
16	,	,	O	,	_	0	SENT_22	[p2l814t1230r1151b1313],
17	EU	NNP	ORGANIZATION	EU	conj_and	13	SENT_22	[p2l1184t1232r1319b1301],
18	and	CC	O	and	_	0	SENT_22	[p2l1351t1230r1498b1300],
19	Australia	NNP	LOCATION	Australia	conj_and	13	SENT_22	[p2l1527t1230r1917b1300],
20	for	IN	O	for	_	0	SENT_22	[p2l1946t1230r2068b1300],
21	the	DT	O	the	det	22	SENT_22	[p2l15t1349r141b1420],
22	treatment	NN	O	treatment	prep_for	13	SENT_22	[p2l184t1360r585b1420],
23	of	IN	O	of	_	0	SENT_22	[p2l627t1349r717b1420],
24	pulmonary	JJ	O	pulmonary	amod	26	SENT_22	[p2l751t1349r1198b1441],
25	hypertensionm	NN	O	hypertensionm	nn	26	SENT_22	[p2l1236t1338r1881b1441],
26	]	NN	O	]	prep_of	22	SENT_22	[p2l1236t1338r1881b1441],
27	and	CC	O	and	_	0	SENT_22	[p2l1925t1349r2069b1419],
28	is	VBZ	O	be	aux	30	SENT_22	[p2l15t1471r78b1541],
29	being	VBG	O	be	auxpass	30	SENT_22	[p2l114t1471r339b1563],
30	investigated	VBN	O	investigate	conj_and	6	SENT_22	[p2l375t1471r870b1563],
31	in	IN	O	in	_	0	SENT_22	[p2l903t1471r981b1540],
32	chronic	JJ	O	chronic	amod	34	SENT_22	[p2l1015t1471r1318b1541],
33	heart	NN	O	heart	nn	34	SENT_22	[p2l1353t1471r1558b1541],
34	failure	NN	O	failure	prep_in	30	SENT_22	[p2l1590t1460r2064b1541],
35	[	CD	NUMBER	[	number	36	SENT_22	[p2l1590t1460r2064b1541],
36	“’	CD	NUMBER	“’	dep	34	SENT_22	[p2l1590t1460r2064b1541],
37	12	CD	NUMBER	12	num	38	SENT_22	[p2l1590t1460r2064b1541],
38	]	NN	O	]	dep	36	SENT_22	[p2l1590t1460r2064b1541],
39	at	IN	O	at	_	0	SENT_22	[p2l18t1602r88b1662],
40	oral	JJ	O	oral	amod	41	SENT_22	[p2l118t1591r272b1662],
41	doses	NNS	O	dose	prep_at	30	SENT_22	[p2l304t1592r525b1662],
42	of	IN	O	of	_	0	SENT_22	[p2l558t1591r645b1662],
43	62.5	CD	NUMBER	62.5	num	44	SENT_22	[p2l670t1591r1179b1683],
44	—	CD	NUMBER	—	prep_of	41	SENT_22	[p2l670t1591r1179b1683],
45	l25mg	NN	O	l25mg	dobj	6	SENT_22	[p2l670t1591r1179b1683],
46	twice	RB	O	twice	advmod	47	SENT_22	[p2l1210t1591r1428b1663],
47	daily	RB	SET	daily	advmod	6	SENT_22	[p2l1459t1591r1682b1683],
48	.	.	O	.	_	0	SENT_22	[p2l1459t1591r1682b1683],

1	After	IN	O	after	_	0	SENT_23	[p2l136t1712r352b1783],
2	prolonged	JJ	O	prolonged	amod	3	SENT_23	[p2l379t1712r794b1804],
3	administration	NN	O	administration	prep_after	6	SENT_23	[p2l826t1712r1437b1796],
4	,	,	O	,	_	0	SENT_23	[p2l826t1712r1437b1796],
5	bosentan	NN	O	bosentan	nsubj	6	SENT_23	[p2l1469t1712r1833b1783],
6	has	VBZ	O	have	_	0	SENT_23	[p2l1862t1712r1994b1783],
7	a	DT	O	a	det	10	SENT_23	[p2l2028t1735r2069b1783],
8	systemic	JJ	O	systemic	amod	10	SENT_23	[p2l19t1834r376b1924],
9	plasma	NN	O	plasma	nn	10	SENT_23	[p2l422t1834r717b1924],
10	clearance	NN	O	clearance	dobj	6	SENT_23	[p2l761t1834r1152b1904],
11	of	IN	O	of	_	0	SENT_23	[p2l1199t1834r1287b1904],
12	approximately	RB	O	approximately	quantmod	13	SENT_23	[p2l1327t1834r1924b1924],
13	12	CD	NUMBER	12	num	14	SENT_23	[p2l1978t1834r2068b1903],
14	L/h	NN	O	l/h	prep_of	10	SENT_23	[p2l15t1954r155b2024],
15	and	CC	O	and	_	0	SENT_23	[p2l185t1954r328b2024],
16	a	DT	O	a	det	17	SENT_23	[p2l358t1976r399b2024],
17	volume	NN	O	volume	conj_and	14	SENT_23	[p2l427t1954r730b2024],
18	of	IN	O	of	_	0	SENT_23	[p2l760t1954r847b2024],
19	distribution	NN	O	distribution	prep_of	17	SENT_23	[p2l869t1954r1340b2024],
20	of	IN	O	of	_	0	SENT_23	[p2l1369t1954r1457b2024],
21	approximately	RB	O	approximately	quantmod	22	SENT_23	[p2l1480t1954r2068b2044],
22	0.5	CD	NUMBER	0.5	num	23	SENT_23	[p2l16t2073r140b2144],
23	L/l	NN	O	l/l	npadvmod	24	SENT_23	[p2l197t2063r537b2164],
24	<	JJR	O	<	prep_of	19	SENT_23	[p2l197t2063r537b2164],
25	g.	CD	NUMBER	g.	num	26	SENT_23	[p2l197t2063r537b2164],
26	[	NN	O	[	dep	17	SENT_23	[p2l197t2063r537b2164],
27	13	CD	NUMBER	13	number	28	SENT_23	[p2l197t2063r537b2164],
28	]	CD	NUMBER	]	dep	26	SENT_23	[p2l197t2063r537b2164],
29	Bosentan	NNP	O	Bosentan	nsubj	33	SENT_23	[p2l593t2075r984b2143],
30	is	VBZ	O	be	cop	33	SENT_23	[p2l1038t2073r1103b2143],
31	extensively	RB	O	extensively	advmod	33	SENT_23	[p2l1160t2073r1642b2164],
32	biotrans	JJ	O	biotrans	amod	33	SENT_23	[p2l1695t2073r2066b2143],
33	—	NN	O	—	rcmod	10	SENT_23	[p2l1695t2073r2066b2143],
34	formed	VBN	O	form	partmod	33	SENT_23	[p2l16t2193r310b2264],
35	to	TO	O	to	_	0	SENT_23	[p2l342t2204r417b2264],
36	several	JJ	O	several	amod	37	SENT_23	[p2l455t2193r739b2265],
37	metabolites	NNS	O	metabolite	prep_to	34	SENT_23	[p2l773t2193r1241b2264],
38	via	IN	O	via	_	0	SENT_23	[p2l1277t2193r1400b2264],
39	the	DT	O	the	det	41	SENT_23	[p2l1432t2194r1553b2264],
40	cytochrome	NN	O	cytochrome	nn	41	SENT_23	[p2l1587t2194r2067b2285],
41	P450	NN	O	p450	prep_via	37	SENT_23	[p2l16t2316r222b2387],
42	(	CD	NUMBER	(	num	45	SENT_23	[p2l252t2317r509b2403],
43	CYP	NN	O	cyp	nn	45	SENT_23	[p2l252t2317r509b2403],
44	)	NN	O	)	nn	45	SENT_23	[p2l252t2317r509b2403],
45	isoenzymes	NNS	O	isoenzyme	tmod	34	SENT_23	[p2l537t2316r1010b2407],
46	2C9	NN	O	2c9	dep	45	SENT_23	[p2l1039t2317r1203b2388],
47	and	CC	O	and	_	0	SENT_23	[p2l1231t2316r1375b2387],
48	3A4	NN	O	3a4	dep	45	SENT_23	[p2l1401t2306r1714b2387],
49	.	.	O	.	_	0	SENT_23	[p2l1401t2306r1714b2387],

1	[	RB	O	[	dep	3	SENT_24	[p2l1401t2306r1714b2387],
2	14	CD	NUMBER	14	number	3	SENT_24	[p2l1401t2306r1714b2387],
3	]	CD	NUMBER	]	_	0	SENT_24	[p2l1401t2306r1714b2387],
4	In	FW	O	in	nn	5	SENT_24	[p2l1741t2319r1824b2386],
5	vitro	FW	O	vitro	dep	3	SENT_24	[p2l1851t2319r2058b2398],
6	,	,	O	,	_	0	SENT_24	[p2l1851t2319r2058b2398],
7	bosentan	NN	O	bosentan	appos	3	SENT_24	[p2l14t2436r387b2507],
8	has	VBZ	O	have	aux	10	SENT_24	[p2l440t2437r573b2507],
9	been	VBN	O	be	auxpass	10	SENT_24	[p2l627t2437r822b2507],
10	shown	VBN	O	show	rcmod	7	SENT_24	[p2l878t2436r1144b2507],
11	to	TO	O	to	aux	14	SENT_24	[p2l1196t2447r1273b2507],
12	be	VB	O	be	cop	14	SENT_24	[p2l1325t2437r1421b2507],
13	an	DT	O	a	det	14	SENT_24	[p2l1476t2459r1568b2507],
14	inducer	NN	O	inducer	xcomp	10	SENT_24	[p2l1620t2436r1934b2507],
15	of	IN	O	of	prep	14	SENT_24	[p2l1985t2436r2074b2507],

1	CYP2C9	NN	O	cyp2c9	_	0	SENT_25	[p2l17t2558r379b2629],
2	and	CC	O	and	_	0	SENT_25	[p2l406t2558r549b2628],
3	3A4	NN	O	3a4	conj_and	1	SENT_25	[p2l573t2558r764b2628],
4	.	.	O	.	_	0	SENT_25	[p2l573t2558r764b2628],

1	These	DT	O	these	det	2	SENT_26	[p2l791t2558r1033b2628],
2	experiments	NNS	O	experiment	nsubj	13	SENT_26	[p2l1056t2558r1576b2648],
3	,	,	O	,	_	0	SENT_26	[p2l1056t2558r1576b2648],
4	which	WDT	O	which	nsubjpass	6	SENT_26	[p2l1603t2558r1850b2628],
5	were	VBD	O	be	auxpass	6	SENT_26	[p2l1872t2580r2067b2628],
6	conducted	VBN	O	conduct	rcmod	2	SENT_26	[p2l16t2678r435b2748],
7	with	IN	O	with	_	0	SENT_26	[p2l461t2678r640b2749],
8	cultures	NNS	O	culture	prep_with	6	SENT_26	[p2l667t2678r986b2748],
9	of	IN	O	of	_	0	SENT_26	[p2l1015t2678r1103b2748],
10	human	JJ	O	human	amod	11	SENT_26	[p2l1121t2678r1398b2748],
11	hepatocytes	NNS	O	hepatocyte	prep_of	8	SENT_26	[p2l1423t2678r1928b2770],
12	,	,	O	,	_	0	SENT_26	[p2l1423t2678r1928b2770],
13	indicated	VBD	O	indicate	_	0	SENT_26	[p2l1958t2678r2065b2747, p2l17t2799r321b2869],
14	that	IN	O	that	complm	24	SENT_26	[p2l383t2799r542b2869],
15	the	DT	O	the	det	17	SENT_26	[p2l603t2799r729b2869],
16	enzyme	NN	O	enzyme	nn	17	SENT_26	[p2l793t2799r1526b2891],
17	—	NN	O	—	nsubj	24	SENT_26	[p2l793t2799r1526b2891],
18	inducing	VBG	O	induce	partmod	17	SENT_26	[p2l793t2799r1526b2891],
19	potency	NN	O	potency	dobj	18	SENT_26	[p2l1589t2810r1921b2891],
20	of	IN	O	of	_	0	SENT_26	[p2l1985t2799r2074b2869],
21	bosentan	NN	O	bosentan	prep_of	19	SENT_26	[p2l14t2919r378b2990],
22	is	VBZ	O	be	cop	24	SENT_26	[p2l404t2919r467b2990],
23	markedly	RB	O	markedly	advmod	24	SENT_26	[p2l494t2919r878b3011],
24	lower	JJR	O	lower	ccomp	13	SENT_26	[p2l904t2919r1136b2990],
25	than	IN	O	than	_	0	SENT_26	[p2l1160t2919r1333b2990],
26	that	DT	O	that	prep_than	24	SENT_26	[p2l1358t2919r1511b2990],
27	of	IN	O	of	_	0	SENT_26	[p2l1536t2919r1624b2990],
28	rifampicin	NN	O	rifampicin	nn	30	SENT_26	[p2l1641t2919r2068b3011],
29	(	CD	NUMBER	(	num	30	SENT_26	[p2l19t3040r432b3132],
30	rifampin	NN	O	rifampin	prep_of	26	SENT_26	[p2l19t3040r432b3132],
31	)	CD	NUMBER	)	number	32	SENT_26	[p2l19t3040r432b3132],
32	[	CD	NUMBER	[	dep	26	SENT_26	[p2l471t3040r849b3126],
33	Actelion	NNP	ORGANIZATION	Actelion	nn	35	SENT_26	[p2l471t3040r849b3126],
34	Pharmaceuticals	NNPS	ORGANIZATION	Pharmaceuticals	nn	35	SENT_26	[p2l878t3040r1546b3111],
35	Ltd	NNP	ORGANIZATION	Ltd	dep	32	SENT_26	[p2l1577t3040r1738b3124],
36	,	,	O	,	_	0	SENT_26	[p2l1577t3040r1738b3124],
37	data	NNS	O	datum	appos	26	SENT_26	[p2l1773t3040r1941b3111],
38	on	IN	O	on	_	0	SENT_26	[p2l1970t3063r2068b3111],
39	file	NN	O	file	nn	40	SENT_26	[p2l16t3161r205b3247],
40	]	NN	O	]	prep_on	37	SENT_26	[p2l16t3161r205b3247],
41	.	.	O	.	_	0	SENT_26	[p2l16t3161r205b3247],

1	However	RB	O	however	advmod	16	SENT_27	[p2l252t3163r646b3245],
2	,	,	O	,	_	0	SENT_27	[p2l252t3163r646b3245],
3	the	DT	O	the	det	4	SENT_27	[p2l691t3161r813b3232],
4	use	NN	O	use	nsubjpass	16	SENT_27	[p2l853t3184r987b3232],
5	of	IN	O	of	_	0	SENT_27	[p2l1030t3161r1117b3232],
6	human	JJ	O	human	amod	7	SENT_27	[p2l1151t3161r1427b3232],
7	hepatocytes	NNS	O	hepatocyte	prep_of	4	SENT_27	[p2l1467t3161r1948b3253],
8	in	IN	O	in	_	0	SENT_27	[p2l1991t3161r2068b3231],
9	screening	VBG	O	screen	prepc_in	7	SENT_27	[p2l19t3282r405b3374],
10	the	DT	O	the	det	12	SENT_27	[p2l436t3282r558b3353],
11	induction	NN	O	induction	nn	12	SENT_27	[p2l589t3282r975b3353],
12	potential	NN	O	potential	dobj	9	SENT_27	[p2l1003t3282r1361b3374],
13	of	IN	O	of	_	0	SENT_27	[p2l1393t3282r1481b3353],
14	compounds	NNS	O	compound	prep_of	12	SENT_27	[p2l1504t3282r1970b3374],
15	is	VBZ	O	be	auxpass	16	SENT_27	[p2l2002t3282r2065b3353],
16	limited	VBN	O	limit	_	0	SENT_27	[p2l15t3403r314b3474],
17	because	IN	O	because	_	0	SENT_27	[p2l357t3403r689b3474],
18	of	IN	O	of	prepc_because_of	16	SENT_27	[p2l736t3403r825b3474],
19	the	DT	O	the	det	21	SENT_27	[p2l863t3403r988b3474],
20	variable	JJ	O	variable	amod	21	SENT_27	[p2l1034t3403r1372b3474],
21	response	NN	O	response	pobj	16	SENT_27	[p2l1416t3392r1928b3495],
22	.	.	O	.	_	0	SENT_27	[p2l1416t3392r1928b3495],

1	[	RB	O	[	dep	3	SENT_28	[p2l1416t3392r1928b3495],
2	15	CD	NUMBER	15	number	3	SENT_28	[p2l1416t3392r1928b3495],
3	]	CD	NUMBER	]	_	0	SENT_28	[p2l1416t3392r1928b3495],
4	In	FW	O	in	nn	5	SENT_28	[p2l1983t3406r2067b3473],
5	vivo	FW	O	vivo	dep	3	SENT_28	[p2l16t3528r200b3607],
6	,	,	O	,	_	0	SENT_28	[p2l16t3528r200b3607],
7	the	DT	O	the	det	10	SENT_28	[p2l243t3525r364b3595],
8	CYP3A4	NN	O	cyp3a4	nn	10	SENT_28	[p2l400t3525r769b3596],
9	enzyme	NN	O	enzyme	nn	10	SENT_28	[p2l803t3525r1511b3617],
10	—	NN	O	—	appos	3	SENT_28	[p2l803t3525r1511b3617],
11	inducing	VBG	O	induce	partmod	10	SENT_28	[p2l803t3525r1511b3617],
12	properties	NNS	O	property	nsubjpass	16	SENT_28	[p2l1544t3525r1951b3617],
13	of	IN	O	of	_	0	SENT_28	[p2l1987t3525r2075b3595],
14	bosentan	NN	O	bosentan	prep_of	12	SENT_28	[p2l14t3646r378b3716],
15	were	VBD	O	be	auxpass	16	SENT_28	[p2l415t3668r609b3716],
16	reﬂected	VBN	O	reﬂected	ccomp	11	SENT_28	[p2l645t3646r1004b3716],
17	in	IN	O	in	_	0	SENT_28	[p2l1040t3646r1116b3715],
18	an	DT	O	a	det	21	SENT_28	[p2l1154t3668r1246b3716],
19	approximately	RB	O	approximately	quantmod	20	SENT_28	[p2l1284t3646r1872b3736],
20	1.7	CD	NUMBER	1.7	num	21	SENT_28	[p2l1918t3646r2064b3716, p3l16t25r183b95],
21	fold	NN	O	fold	prep_in	16	SENT_28	[p2l1918t3646r2064b3716, p3l16t25r183b95],

1	increase	NN	O	increase	_	0	SENT_29	[p3l235t25r579b95],
2	in	IN	O	in	_	0	SENT_29	[p3l632t25r711b94],
3	the	DT	O	the	det	6	SENT_29	[p3l763t25r888b95],
4	6B	NN	O	6b	nn	6	SENT_29	[p3l942t19r2067b117],
5	—	CD	NUMBER	—	num	6	SENT_29	[p3l942t19r2067b117],
6	hydroXycortisol/cortisol	NN	O	hydroxycortisol/cortisol	prep_in	1	SENT_29	[p3l942t19r2067b117],
7	urinary	JJ	O	urinary	amod	9	SENT_29	[p3l15t146r309b236],
8	excretion	NN	O	excretion	nn	9	SENT_29	[p3l332t146r711b216],
9	ratio	NN	O	ratio	dep	6	SENT_29	[p3l732t146r917b216],
10	following	VBG	O	follow	_	0	SENT_29	[p3l941t146r1335b236],
11	multiple	JJ	O	multiple	amod	14	SENT_29	[p3l1358t146r1919b236],
12	—	NN	O	—	nn	14	SENT_29	[p3l1358t146r1919b236],
13	dose	NN	O	dose	nn	14	SENT_29	[p3l1358t146r1919b236],
14	administration	NN	O	administration	prep_following	9	SENT_29	[p3l1943t146r2066b216, p3l16t265r510b336],
15	to	TO	O	to	_	0	SENT_29	[p3l543t276r618b336],
16	healthy	JJ	O	healthy	amod	17	SENT_29	[p3l652t266r951b356],
17	subjects	NNS	O	subject	prep_to	14	SENT_29	[p3l989t255r1456b356],
18	.	.	O	.	_	0	SENT_29	[p3l989t255r1456b356],

1	[	RB	O	[	dep	2	SENT_30	[p3l989t255r1456b356],
2	13	CD	NUMBER	13	dep	3	SENT_30	[p3l989t255r1456b356],
3	]	CD	NUMBER	]	_	0	SENT_30	[p3l989t255r1456b356],
4	An	DT	O	a	dep	3	SENT_30	[p3l1493t266r1615b334],
5	in	FW	O	in	nn	6	SENT_30	[p3l1651t268r1723b335],
6	vivo	FW	O	vivo	advmod	8	SENT_30	[p3l1758t268r1924b336],
7	interaction	NN	O	interaction	nn	8	SENT_30	[p3l1958t265r2066b334, p3l15t385r373b456],
8	study	NN	O	study	dep	4	SENT_30	[p3l398t385r613b477],
9	between	IN	O	between	_	0	SENT_30	[p3l633t385r973b457],
10	bosentan	NN	O	bosentan	nn	13	SENT_30	[p3l992t385r1356b456],
11	and	CC	O	and	_	0	SENT_30	[p3l1379t385r1522b456],
12	racemic	JJ	O	racemic	conj_and	10	SENT_30	[p3l1540t385r1861b456],
13	war1	NN	O	war1	prep_between	8	SENT_30	[p3l1884t408r2065b457, p3l13t610r46b669],

1	Use	NN	O	use	nsubj	5	SENT_31	[p3l71t612r201b670],
2	of	IN	O	of	_	0	SENT_31	[p3l225t610r298b669],
3	tradenames	NNS	O	tradename	prep_of	1	SENT_31	[p3l314t610r701b669],
4	is	VBZ	O	be	aux	5	SENT_31	[p3l725t610r777b669],
5	for	IN	O	for	_	0	SENT_31	[p3l801t610r900b669],
6	product	NN	O	product	nn	7	SENT_31	[p3l919t610r1181b687],
7	identification	NN	O	identification	pobj	5	SENT_31	[p3l1201t610r1657b669],
8	only	RB	O	only	advmod	5	SENT_31	[p3l1680t610r1828b687],
9	and	CC	O	and	_	0	SENT_31	[p3l1852t610r1972b669],
10	does	VBZ	O	do	aux	12	SENT_31	[p3l1994t610r2146b669],
11	not	RB	O	not	neg	12	SENT_31	[p3l9t724r117b774],
12	imply	VB	O	imply	conj_and	5	SENT_31	[p3l141t715r338b792],
13	endorsement	NN	O	endorsement	dobj	12	SENT_31	[p3l364t715r817b775],
14	.	.	O	.	_	0	SENT_31	[p3l364t715r817b775],

1	©	NN	O	©	_	0	SENT_32	[p3l18t978r60b1019],
2	Adis	NNP	O	Adis	nn	4	SENT_32	[p3l80t973r199b1019],
3	International	NNP	O	International	nn	4	SENT_32	[p3l220t973r579b1019],
4	Limited	NNP	O	Limited	dep	1	SENT_32	[p3l603t973r818b1019],
5	.	.	O	.	_	0	SENT_32	[p3l603t973r818b1019],

1	All	DT	O	all	det	2	SENT_33	[p3l840t973r905b1019],
2	rights	NNS	O	rights	nsubj	3	SENT_33	[p3l928t973r1074b1031],
3	reserved	VBN	O	reserve	_	0	SENT_33	[p3l1095t973r1353b1019],
4	.	.	O	.	_	0	SENT_33	[p3l1095t973r1353b1019],

1	farin	NN	PERSON	farin	nsubj	2	SENT_34	[p3l7t1220r206b1293],
2	confirmed	VBD	O	confirm	_	0	SENT_34	[p3l233t1220r670b1293],
3	the	DT	O	the	det	4	SENT_34	[p3l694t1220r822b1293],
4	potential	NN	O	potential	dobj	2	SENT_34	[p3l847t1220r1221b1316],
5	of	IN	O	of	_	0	SENT_34	[p3l1248t1220r1339b1293],
6	bosentan	NN	O	bosentan	prep_of	4	SENT_34	[p3l1356t1220r1735b1293],
7	to	TO	O	to	aux	8	SENT_34	[p3l1760t1231r1839b1293],
8	induce	VB	O	induce	xcomp	2	SENT_34	[p3l1865t1220r2147b1293],
9	metabolising	NN	O	metabolising	nn	10	SENT_34	[p3l7t1345r556b1441],
10	enzymes	NNS	O	enzyme	dobj	8	SENT_34	[p3l593t1369r985b1441],
11	:	:	O	:	_	0	SENT_34	[p3l593t1369r985b1441],
12	exposures	NNS	O	exposure	dep	10	SENT_34	[p3l1028t1369r1449b1441],
13	to	TO	O	to	_	0	SENT_34	[p3l1485t1356r1564b1418],
14	(	CD	NUMBER	(	num	16	SENT_34	[p3l1603t1345r2144b1436],
15	S	NN	O	s	nn	16	SENT_34	[p3l1603t1345r2144b1436],
16	)	NN	O	)	prep_to	12	SENT_34	[p3l1603t1345r2144b1436],
17	.	.	O	.	_	0	SENT_34	[p3l1603t1345r2144b1436],

1	—	NN	O	—	_	0	SENT_35	[p3l1603t1345r2144b1436],
2	.	.	O	.	_	0	SENT_35	[p3l1603t1345r2144b1436],

1	warfarin	NN	O	warfarin	_	0	SENT_36	[p3l1603t1345r2144b1436],
2	,	,	O	,	_	0	SENT_36	[p3l1603t1345r2144b1436],
3	a	DT	O	a	det	5	SENT_36	[p3l9t1494r53b1544],
4	CYPZC9	NN	O	cypzc9	nn	5	SENT_36	[p3l86t1471r464b1545],
5	substrate	NN	O	substrate	appos	1	SENT_36	[p3l504t1470r902b1557],
6	,	,	O	,	_	0	SENT_36	[p3l504t1470r902b1557],
7	and	CC	O	and	_	0	SENT_36	[p3l942t1470r1091b1544],
8	to	TO	O	to	aux	9	SENT_36	[p3l1124t1481r1203b1544],
9	(	VB	O	(	conj_and	5	SENT_36	[p3l1242t1470r1793b1561],
10	R	NN	O	r	nn	11	SENT_36	[p3l1242t1470r1793b1561],
11	)	NN	O	)	dobj	9	SENT_36	[p3l1242t1470r1793b1561],
12	.	.	O	.	_	0	SENT_36	[p3l1242t1470r1793b1561],

1	—	NN	O	—	_	0	SENT_37	[p3l1242t1470r1793b1561],
2	.	.	O	.	_	0	SENT_37	[p3l1242t1470r1793b1561],

1	warfarin	NN	O	warfarin	nsubjpass	8	SENT_38	[p3l1242t1470r1793b1561],
2	,	,	O	,	_	0	SENT_38	[p3l1242t1470r1793b1561],
3	a	DT	O	a	det	5	SENT_38	[p3l1834t1494r1877b1544],
4	CYP3A4	NN	O	cyp3a4	nn	5	SENT_38	[p3l1911t1471r2145b1544, p3l10t1595r186b1669],
5	substrate	NN	O	substrate	appos	1	SENT_38	[p3l231t1594r629b1681],
6	,	,	O	,	_	0	SENT_38	[p3l231t1594r629b1681],
7	were	VBD	O	be	auxpass	8	SENT_38	[p3l675t1618r878b1669],
8	reduced	VBN	O	reduce	_	0	SENT_38	[p3l918t1594r1256b1668],
9	by	IN	O	by	_	0	SENT_38	[p3l1294t1594r1398b1690],
10	29	CD	NUMBER	29	agent	8	SENT_38	[p3l1440t1595r1540b1669],
11	and	CC	O	and	_	0	SENT_38	[p3l1585t1594r1734b1668],
12	38	CD	PERCENT	38	num	13	SENT_38	[p3l1776t1595r1988b1681],
13	%	NN	PERCENT	%	agent	8	SENT_38	[p3l1776t1595r1988b1681],
14	,	,	O	,	_	0	SENT_38	[p3l1776t1595r1988b1681],
15	respectively	RB	O	respectively	advmod	8	SENT_38	[p3l2032t1618r2145b1668, p3l11t1709r588b1816],
16	.	.	O	.	_	0	SENT_38	[p3l2032t1618r2145b1668, p3l11t1709r588b1816],

1	[	RB	O	[	advmod	3	SENT_39	[p3l2032t1618r2145b1668, p3l11t1709r588b1816],
2	16	CD	NUMBER	16	num	3	SENT_39	[p3l2032t1618r2145b1668, p3l11t1709r588b1816],
3	]	CD	NUMBER	]	ccomp	10	SENT_39	[p3l2032t1618r2145b1668, p3l11t1709r588b1816],
4	However	RB	O	however	advmod	3	SENT_39	[p3l620t1723r1032b1807],
5	,	,	O	,	_	0	SENT_39	[p3l620t1723r1032b1807],
6	this	DT	O	this	det	8	SENT_39	[p3l1064t1720r1213b1794],
7	interaction	NN	O	interaction	nn	8	SENT_39	[p3l1244t1720r1701b1794],
8	study	NN	O	study	nsubjpass	10	SENT_39	[p3l1732t1720r1957b1816],
9	was	VBD	O	be	auxpass	10	SENT_39	[p3l1986t1744r2145b1794],
10	conducted	VBN	O	conduct	_	0	SENT_39	[p3l8t1845r457b1918],
11	with	IN	O	with	_	0	SENT_39	[p3l511t1845r703b1919],
12	a	DT	O	a	det	14	SENT_39	[p3l759t1869r802b1918],
13	bosentan	NN	O	bosentan	nn	14	SENT_39	[p3l853t1845r1243b1918],
14	regimen	NN	O	regimen	prep_with	10	SENT_39	[p3l1296t1845r1654b1941],
15	of	IN	O	of	_	0	SENT_39	[p3l1709t1845r1802b1918],
16	500mg	CD	NUMBER	500mg	prep_of	14	SENT_39	[p3l1850t1845r2147b1941],
17	twice	RB	O	twice	advmod	16	SENT_39	[p3l7t1970r235b2044],
18	daily	RB	SET	daily	advmod	10	SENT_39	[p3l268t1970r500b2066],
19	.	.	O	.	_	0	SENT_39	[p3l268t1970r500b2066],

1	The	DT	O	the	det	3	SENT_40	[p3l133t2095r294b2168],
2	present	JJ	DATE	present	amod	3	SENT_40	[p3l323t2105r633b2189],
3	study	NN	O	study	nsubjpass	5	SENT_40	[p3l664t2095r888b2189],
4	was	VBD	O	be	auxpass	5	SENT_40	[p3l919t2118r1079b2168],
5	conducted	VBN	O	conduct	_	0	SENT_40	[p3l1112t2095r1548b2168],
6	to	TO	O	to	aux	7	SENT_40	[p3l1576t2106r1655b2168],
7	investigate	VB	O	investigate	xcomp	5	SENT_40	[p3l1685t2095r2146b2189],
8	the	DT	O	the	det	11	SENT_40	[p3l7t2219r134b2292],
9	mutual	JJ	O	mutual	amod	11	SENT_40	[p3l173t2219r467b2292],
10	pharmacokinetic	JJ	O	pharmacokinetic	amod	11	SENT_40	[p3l505t2219r1217b2313],
11	interactions	NNS	O	interaction	dobj	7	SENT_40	[p3l1258t2219r1753b2292],
12	between	IN	O	between	_	0	SENT_40	[p3l1793t2219r2148b2292],
13	bosentan	NN	O	bosentan	prep_between	11	SENT_40	[p3l6t2344r385b2417],
14	and	CC	O	and	_	0	SENT_40	[p3l434t2344r583b2417],
15	the	DT	O	the	det	19	SENT_40	[p3l630t2344r756b2417],
16	HMG-CoA	NN	O	hmg-coa	nn	19	SENT_40	[p3l804t2344r1286b2417],
17	reductase	NN	O	reductase	nn	19	SENT_40	[p3l1331t2344r1733b2417],
18	inhibitor	NN	O	inhibitor	nn	19	SENT_40	[p3l1780t2344r2149b2417],
19	simvastatin	NN	O	simvastatin	prep_between	11	SENT_40	[p3l11t2468r493b2541],
20	as	IN	O	as	_	0	SENT_40	[p3l541t2491r622b2541],
21	a	DT	O	a	det	22	SENT_40	[p3l672t2491r716b2541],
22	representative	NN	O	representative	prep_as	7	SENT_40	[p3l758t2468r1359b2562],
23	of	IN	O	of	_	0	SENT_40	[p3l1406t2468r1497b2541],
24	drugs	NNS	O	drug	prep_of	22	SENT_40	[p3l1538t2468r1769b2562],
25	that	WDT	O	that	nsubj	27	SENT_40	[p3l1817t2468r1977b2541],
26	are	VBP	O	be	cop	27	SENT_40	[p3l2023t2491r2147b2541],
27	substrates	NNS	O	substrate	rcmod	24	SENT_40	[p3l11t2592r440b2665],
28	of	IN	O	of	_	0	SENT_40	[p3l497t2592r590b2665],
29	CYP3A4	NN	O	cyp3a4	prep_of	27	SENT_40	[p3l637t2581r1181b2665],
30	.	.	O	.	_	0	SENT_40	[p3l637t2581r1181b2665],

1	[	NN	O	[	nsubjpass	11	SENT_41	[p3l637t2581r1181b2665],
2	17	CD	NUMBER	17	number	3	SENT_41	[p3l637t2581r1181b2665],
3	]	CD	NUMBER	]	num	6	SENT_41	[p3l637t2581r1181b2665],
4	Inactive	JJ	O	inactive	amod	6	SENT_41	[p3l1237t2591r1592b2665],
5	simvastatin	NN	O	simvastatin	nn	6	SENT_41	[p3l1649t2591r2148b2665],
6	(	NN	O	(	dep	1	SENT_41	[p3l10t2715r348b2806],
7	lactone	NN	O	lactone	nn	9	SENT_41	[p3l10t2715r348b2806],
8	prodrug	NN	O	prodrug	nn	9	SENT_41	[p3l387t2716r756b2811],
9	)	NN	O	)	dep	1	SENT_41	[p3l387t2716r756b2811],
10	is	VBZ	O	be	auxpass	11	SENT_41	[p3l798t2715r863b2789],
11	biotransformed	VBN	O	biotransform	_	0	SENT_41	[p3l903t2715r1557b2789],
12	via	IN	O	via	_	0	SENT_41	[p3l1594t2715r1724b2790],
13	CYP3A4	NN	O	cyp3a4	prep_via	11	SENT_41	[p3l1761t2716r2146b2790],
14	into	IN	O	into	_	0	SENT_41	[p3l7t2841r169b2915],
15	several	JJ	O	several	amod	16	SENT_41	[p3l213t2841r510b2915],
16	metabolites	NNS	O	metabolite	prep_into	11	SENT_41	[p3l550t2830r1190b2915],
17	.	.	O	.	_	0	SENT_41	[p3l550t2830r1190b2915],

1	[	NN	O	[	nsubj	8	SENT_42	[p3l550t2830r1190b2915],
2	18	CD	NUMBER	18	number	3	SENT_42	[p3l550t2830r1190b2915],
3	]	CD	NUMBER	]	dep	1	SENT_42	[p3l550t2830r1190b2915],
4	The	DT	O	the	det	6	SENT_42	[p3l1234t2841r1396b2914],
5	pharmacological	JJ	O	pharmacological	amod	6	SENT_42	[p3l1434t2840r2147b2936],
6	activity	NN	O	activity	dep	1	SENT_42	[p3l9t2965r330b3061],
7	mainly	RB	O	mainly	advmod	8	SENT_42	[p3l377t2965r672b3061],
8	resides	VBZ	O	reside	_	0	SENT_42	[p3l717t2965r1011b3039],
9	with	IN	O	with	_	0	SENT_42	[p3l1059t2965r1246b3040],
10	[	CD	NUMBER	[	num	12	SENT_42	[p3l1295t2960r1918b3061],
11	3-hydroxyacid	JJ	O	3-hydroxyacid	amod	12	SENT_42	[p3l1295t2960r1918b3061],
12	simvastatin	NN	O	simvastatin	prep_with	8	SENT_42	[p3l1965t2965r2145b3039, p3l7t3091r361b3178],
13	,	,	O	,	_	0	SENT_42	[p3l1965t2965r2145b3039, p3l7t3091r361b3178],
14	the	DT	O	the	det	17	SENT_42	[p3l408t3091r535b3165],
15	open	JJ	O	open	amod	17	SENT_42	[p3l581t3114r784b3186],
16	ring	NN	O	ring	nn	17	SENT_42	[p3l825t3091r995b3186],
17	form	NN	O	form	appos	12	SENT_42	[p3l1040t3080r1393b3165],
18	.	.	O	.	_	0	SENT_42	[p3l1040t3080r1393b3165],

1	[	NN	O	[	nsubjpass	21	SENT_43	[p3l1040t3080r1393b3165],
2	19	CD	NUMBER	19	number	3	SENT_43	[p3l1040t3080r1393b3165],
3	]	CD	NUMBER	]	num	4	SENT_43	[p3l1040t3080r1393b3165],
4	Simvastatin	NNP	O	Simvastatin	nsubjpass	6	SENT_43	[p3l1442t3090r1943b3165],
5	was	VBD	O	be	auxpass	6	SENT_43	[p3l1986t3114r2145b3165],
6	selected	VBN	O	select	rcmod	1	SENT_43	[p3l11t3215r350b3289],
7	as	IN	O	as	_	0	SENT_43	[p3l381t3239r462b3289],
8	a	DT	O	a	det	10	SENT_43	[p3l495t3239r538b3289],
9	model	NN	O	model	nn	10	SENT_43	[p3l566t3215r829b3289],
10	substrate	NN	O	substrate	prep_as	6	SENT_43	[p3l862t3216r1236b3289],
11	in	IN	O	in	_	0	SENT_43	[p3l1266t3215r1346b3288],
12	this	DT	O	this	det	13	SENT_43	[p3l1374t3215r1524b3289],
13	study	NN	O	study	prep_in	10	SENT_43	[p3l1559t3216r1783b3311],
14	because	IN	O	because	_	0	SENT_43	[p3l1810t3215r2147b3289],
15	systemic	JJ	O	systemic	amod	16	SENT_43	[p3l11t3341r376b3435],
16	exposure	NN	O	exposure	prep_because	6	SENT_43	[p3l415t3364r796b3435],
17	to	TO	O	to	_	0	SENT_43	[p3l831t3352r910b3414],
18	simvastatin	NN	O	simvastatin	prep_to	6	SENT_43	[p3l949t3341r1431b3414],
19	has	VBZ	O	have	aux	21	SENT_43	[p3l1465t3341r1602b3414],
20	been	VBN	O	be	auxpass	21	SENT_43	[p3l1638t3341r1837b3414],
21	shown	VBN	O	show	_	0	SENT_43	[p3l1876t3341r2148b3414],
22	to	TO	O	to	aux	25	SENT_43	[p3l7t3476r85b3538],
23	be	VB	O	be	cop	25	SENT_43	[p3l127t3465r225b3538],
24	very	RB	O	very	advmod	25	SENT_43	[p3l268t3488r453b3559],
25	sensitive	JJ	O	sensitive	xcomp	21	SENT_43	[p3l499t3465r867b3538],
26	to	TO	O	to	_	0	SENT_43	[p3l909t3475r988b3538],
27	changes	NNS	O	change	prep_to	25	SENT_43	[p3l1030t3465r1369b3559],
28	in	IN	O	in	_	0	SENT_43	[p3l1412t3465r1492b3537],
29	the	DT	O	the	det	30	SENT_43	[p3l1533t3465r1660b3538],
30	activity	NN	O	activity	prep_in	27	SENT_43	[p3l1703t3465r2020b3559],
31	of	IN	O	of	_	0	SENT_43	[p3l2063t3465r2154b3538],
32	intestinal	JJ	O	intestinal	amod	35	SENT_43	[p3l7t3589r398b3663],
33	and	CC	O	and	_	0	SENT_43	[p3l431t3589r581b3663],
34	hepatic	JJ	O	hepatic	conj_and	32	SENT_43	[p3l610t3589r915b3684],
35	CYP3A4	NN	O	cyp3a4	prep_of	30	SENT_43	[p3l949t3578r1485b3663],
36	.	.	O	.	_	0	SENT_43	[p3l949t3578r1485b3663],

1	[	NN	O	[	_	0	SENT_44	[p3l949t3578r1485b3663],
2	2	CD	NUMBER	2	number	3	SENT_44	[p3l949t3578r1485b3663],
3	°	CD	NUMBER	°	dep	1	SENT_44	[p3l949t3578r1485b3663],
4	]	NN	O	]	dep	3	SENT_44	[p3l949t3578r1485b3663],

1	Subjects	NNS	O	subject	_	0	SENT_45	[p4l133t96r554b194],
2	and	CC	O	and	_	0	SENT_45	[p4l587t97r781b177],
3	Methods	NNS	O	method	conj_and	1	SENT_45	[p4l821t97r1250b177],

1	Subjects	NNS	O	subject	_	0	SENT_46	[p4l133t372r506b461],

1	Nine	CD	NUMBER	nine	num	4	SENT_47	[p4l132t584r338b658],
2	healthy	JJ	O	healthy	amod	4	SENT_47	[p4l383t584r698b680],
3	male	JJ	O	male	amod	4	SENT_47	[p4l745t584r950b658],
4	subjects	NNS	O	subject	nsubjpass	6	SENT_47	[p4l1000t584r1339b680],
5	were	VBD	O	be	auxpass	6	SENT_47	[p4l1388t608r1592b659],
6	recruited	VBN	O	recruit	_	0	SENT_47	[p4l1637t584r2021b658],
7	to	TO	O	to	aux	8	SENT_47	[p4l2066t595r2144b658],
8	participate	VB	O	participate	xcomp	6	SENT_47	[p4l6t709r457b805],
9	in	IN	O	in	_	0	SENT_47	[p4l503t709r583b782],
10	this	DT	O	this	det	11	SENT_47	[p4l628t709r778b783],
11	study	NN	O	study	prep_in	8	SENT_47	[p4l829t709r1076b805],
12	.	.	O	.	_	0	SENT_47	[p4l829t709r1076b805],

1	All	DT	O	all	det	2	SENT_48	[p4l1126t710r1259b782],
2	subjects	NNS	O	subject	nsubj	5	SENT_48	[p4l1309t709r1645b805],
3	were	VBD	O	be	cop	5	SENT_48	[p4l1693t733r1896b784],
4	male	JJ	O	male	amod	5	SENT_48	[p4l1942t709r2146b783],
5	Caucasians	NNPS	MISC	Caucasians	_	0	SENT_48	[p4l8t835r517b909],
6	in	IN	O	in	_	0	SENT_48	[p4l568t835r652b907],
7	the	DT	O	the	det	9	SENT_48	[p4l699t835r833b909],
8	age	NN	O	age	nn	9	SENT_48	[p4l884t858r1032b930],
9	range	NN	O	range	prep_in	5	SENT_48	[p4l1080t858r1328b930],
10	24-45	CD	NUMBER	24-45	num	11	SENT_48	[p4l1379t834r1648b909],
11	years	NNS	NUMBER	year	tmod	9	SENT_48	[p4l1702t858r1962b930],
12	.	.	O	.	_	0	SENT_48	[p4l1702t858r1962b930],

1	An	DT	O	a	det	3	SENT_49	[p4l2016t835r2146b907],
2	Ethics	NNPS	O	Ethics	nn	3	SENT_49	[p4l6t960r278b1033],
3	Committee	NNP	ORGANIZATION	Committee	nsubj	12	SENT_49	[p4l329t960r813b1034],
4	(	CD	NUMBER	(	num	6	SENT_49	[p4l864t960r1790b1050],
5	Landesarztekammer	NN	PERSON	landesarztekammer	nn	6	SENT_49	[p4l864t960r1790b1050],
6	BadenWurttemberg	NN	PERSON	badenwurttemberg	dep	3	SENT_49	[p4l1835t960r2144b1033, p4l6t1085r603b1179],
7	,	,	O	,	_	0	SENT_49	[p4l1835t960r2144b1033, p4l6t1085r603b1179],
8	Stuttgart	NNP	LOCATION	Stuttgart	nn	10	SENT_49	[p4l656t1085r1048b1179],
9	,	,	O	,	_	0	SENT_49	[p4l656t1085r1048b1179],
10	Germany	NNP	LOCATION	Germany	appos	3	SENT_49	[p4l1100t1085r1529b1179],
11	)	CD	NUMBER	)	num	10	SENT_49	[p4l1100t1085r1529b1179],
12	approved	VBD	O	approve	_	0	SENT_49	[p4l1580t1085r1974b1179],
13	the	DT	O	the	det	15	SENT_49	[p4l2018t1085r2145b1158],
14	study	NN	O	study	nn	15	SENT_49	[p4l11t1209r238b1303],
15	protocol	NN	O	protocol	nsubj	19	SENT_49	[p4l284t1209r644b1303],
16	and	CC	O	and	_	0	SENT_49	[p4l693t1209r843b1282],
17	all	DT	O	all	det	18	SENT_49	[p4l891t1209r994b1282],
18	subjects	NNS	O	subject	nsubj	19	SENT_49	[p4l1044t1209r1385b1303],
19	gave	VBD	O	give	ccomp	12	SENT_49	[p4l1435t1232r1634b1303],
20	written	VBN	O	write	amod	22	SENT_49	[p4l1682t1209r1987b1282],
21	informed	VBN	O	inform	amod	22	SENT_49	[p4l2032t1209r2145b1281, p4l7t1333r313b1406],
22	consent	NN	O	consent	dobj	19	SENT_49	[p4l357t1343r682b1406],
23	before	IN	O	before	mark	28	SENT_49	[p4l722t1333r993b1406],
24	any	DT	O	any	det	26	SENT_49	[p4l1039t1356r1187b1427],
25	screening	JJ	O	screening	amod	26	SENT_49	[p4l1234t1333r1637b1427],
26	procedures	NNS	O	procedure	nsubjpass	28	SENT_49	[p4l1679t1333r2145b1427],
27	were	VBD	O	be	auxpass	28	SENT_49	[p4l7t1480r210b1530],
28	performed	VBN	O	perform	advcl	19	SENT_49	[p4l245t1457r711b1551],
29	.	.	O	.	_	0	SENT_49	[p4l245t1457r711b1551],

1	The	DT	O	the	det	2	SENT_50	[p4l752t1457r914b1530],
2	study	NN	O	study	nsubjpass	4	SENT_50	[p4l955t1457r1179b1551],
3	was	VBD	O	be	auxpass	4	SENT_50	[p4l1215t1480r1375b1530],
4	conducted	VBN	O	conduct	_	0	SENT_50	[p4l1414t1457r1851b1530],
5	in	IN	O	in	_	0	SENT_50	[p4l1886t1457r1966b1529],
6	full	JJ	O	full	amod	7	SENT_50	[p4l2001t1457r2146b1530],
7	conformity	NN	O	conformity	prep_in	4	SENT_50	[p4l8t1581r479b1675],
8	with	IN	O	with	_	0	SENT_50	[p4l518t1581r705b1654],
9	the	DT	O	the	det	10	SENT_50	[p4l741t1581r868b1654],
10	principles	NNS	O	principle	prep_with	4	SENT_50	[p4l904t1581r1324b1675],
11	of	IN	O	of	_	0	SENT_50	[p4l1365t1581r1456b1654],
12	the	DT	O	the	det	13	SENT_50	[p4l1486t1581r1613b1654],
13	Declaration	NN	O	declaration	prep_of	10	SENT_50	[p4l1650t1581r2148b1654],
14	of	IN	O	of	_	0	SENT_50	[p4l8t1705r99b1778],
15	Helsinki	NNP	LOCATION	Helsinki	prep_of	13	SENT_50	[p4l121t1705r479b1778],
16	and	CC	O	and	_	0	SENT_50	[p4l511t1705r660b1778],
17	its	PRP$	O	its	poss	18	SENT_50	[p4l688t1705r784b1778],
18	amendments	NNS	O	amendment	prep_of	13	SENT_50	[p4l816t1705r1373b1778],
19	.	.	O	.	_	0	SENT_50	[p4l816t1705r1373b1778],

1	Subjects	NNS	O	subject	nsubjpass	3	SENT_51	[p4l1409t1705r1764b1799],
2	were	VBD	O	be	auxpass	3	SENT_51	[p4l1795t1728r1998b1778],
3	assessed	VBN	O	assess	_	0	SENT_51	[p4l2029t1728r2145b1778, p4l11t1829r287b1902],
4	to	TO	O	to	aux	6	SENT_51	[p4l333t1840r414b1902],
5	be	VB	O	be	cop	6	SENT_51	[p4l461t1829r561b1902],
6	healthy	JJ	O	healthy	xcomp	3	SENT_51	[p4l608t1829r931b1923],
7	on	IN	O	on	_	0	SENT_51	[p4l980t1852r1084b1902],
8	the	DT	O	the	det	9	SENT_51	[p4l1131t1829r1262b1902],
9	basis	NN	O	basis	prep_on	6	SENT_51	[p4l1308t1829r1525b1902],
10	of	IN	O	of	_	0	SENT_51	[p4l1576t1829r1670b1902],
11	a	DT	O	a	det	13	SENT_51	[p4l1712t1852r1755b1902],
12	medical	JJ	O	medical	amod	13	SENT_51	[p4l1800t1829r2147b1902],
13	screen	NN	O	screen	prep_of	9	SENT_51	[p4l11t1976r301b2040],
14	,	,	O	,	_	0	SENT_51	[p4l11t1976r301b2040],
15	which	WDT	O	which	nsubj	16	SENT_51	[p4l344t1953r603b2026],
16	included	VBD	O	include	rcmod	13	SENT_51	[p4l641t1953r1009b2026],
17	physical	JJ	O	physical	amod	18	SENT_51	[p4l1045t1953r1400b2047],
18	examination	NN	O	examination	dobj	16	SENT_51	[p4l1441t1953r1989b2039],
19	,	,	O	,	_	0	SENT_51	[p4l1441t1953r1989b2039],
20	recording	NN	O	recording	appos	18	SENT_51	[p4l2032t1976r2145b2026, p4l8t2077r330b2171],
21	of	IN	O	of	_	0	SENT_51	[p4l371t2077r462b2150],
22	medical	JJ	O	medical	amod	23	SENT_51	[p4l494t2077r829b2150],
23	history	NN	O	history	prep_of	20	SENT_51	[p4l868t2077r1187b2171],
24	,	,	O	,	_	0	SENT_51	[p4l868t2077r1187b2171],
25	measurement	NN	O	measurement	appos	23	SENT_51	[p4l1230t2088r1799b2150],
26	of	IN	O	of	_	0	SENT_51	[p4l1837t2077r1928b2150],
27	vital	JJ	O	vital	amod	28	SENT_51	[p4l1960t2077r2147b2150],
28	signs	NNS	O	sign	prep_of	25	SENT_51	[p4l11t2201r221b2295],
29	(	IN	O	(	_	0	SENT_51	[p4l251t2201r684b2295],
30	including	VBG	O	include	prepc_(	16	SENT_51	[p4l251t2201r684b2295],
31	ECG	NN	O	ecg	nn	32	SENT_51	[p4l709t2201r978b2291],
32	)	NN	O	)	dobj	30	SENT_51	[p4l709t2201r978b2291],
33	,	,	O	,	_	0	SENT_51	[p4l709t2201r978b2291],
34	and	CC	O	and	_	0	SENT_51	[p4l1008t2201r1157b2274],
35	conduct	NN	O	conduct	nsubj	40	SENT_51	[p4l1181t2201r1518b2274],
36	of	IN	O	of	_	0	SENT_51	[p4l1541t2201r1632b2274],
37	clinical	JJ	O	clinical	amod	39	SENT_51	[p4l1649t2201r1961b2274],
38	laboratory	NN	O	laboratory	nn	39	SENT_51	[p4l1985t2201r2145b2274, p4l8t2336r312b2421],
39	tests	NNS	O	test	prep_of	35	SENT_51	[p4l352t2336r538b2398],
40	(	VBP	O	(	conj_and	3	SENT_51	[p4l583t2325r1189b2421],
41	haematology	NN	O	haematology	nn	50	SENT_51	[p4l583t2325r1189b2421],
42	,	,	O	,	_	0	SENT_51	[p4l583t2325r1189b2421],
43	blood	NN	O	blood	dep	50	SENT_51	[p4l1230t2325r1473b2398],
44	chemistry	NN	O	chemistry	nn	50	SENT_51	[p4l1512t2325r1954b2421],
45	,	,	O	,	_	0	SENT_51	[p4l1512t2325r1954b2421],
46	urinalysis	NN	O	urinalysis	dep	50	SENT_51	[p4l1996t2325r2145b2398, p4l7t2450r325b2546],
47	,	,	O	,	_	0	SENT_51	[p4l1996t2325r2145b2398, p4l7t2450r325b2546],
48	drug	NN	O	drug	dep	50	SENT_51	[p4l365t2450r555b2546],
49	screen	NN	O	screen	nn	50	SENT_51	[p4l595t2451r895b2541],
50	)	NN	O	)	dobj	40	SENT_51	[p4l595t2451r895b2541],
51	within	IN	O	within	_	0	SENT_51	[p4l933t2450r1204b2524],
52	3	CD	DURATION	3	num	53	SENT_51	[p4l1242t2451r1283b2524],
53	weeks	NNS	NUMBER	week	prep_within	50	SENT_51	[p4l1324t2450r1584b2524],
54	prior	RB	O	prior	_	0	SENT_51	[p4l1621t2450r1830b2546],
55	to	TO	O	to	_	0	SENT_51	[p4l1862t2461r1941b2523],
56	first	JJ	ORDINAL	first	amod	58	SENT_51	[p4l1978t2450r2149b2523],
57	drug	NN	O	drug	nn	58	SENT_51	[p4l8t2575r198b2671],
58	administration	NN	O	administration	prep_prior_to	53	SENT_51	[p4l227t2575r863b2648],
59	.	.	O	.	_	0	SENT_51	[p4l227t2575r863b2648],

1	During	IN	O	during	_	0	SENT_52	[p4l893t2575r1192b2671],
2	the	DT	O	the	det	3	SENT_52	[p4l1218t2575r1345b2648],
3	study	NN	O	study	prep_during	9	SENT_52	[p4l1374t2575r1622b2671],
4	,	,	O	,	_	0	SENT_52	[p4l1374t2575r1622b2671],
5	no	DT	O	no	det	7	SENT_52	[p4l1650t2599r1752b2648],
6	concomitant	JJ	O	concomitant	amod	7	SENT_52	[p4l1779t2599r2145b2648, p4l7t2700r196b2773],
7	medication	NN	O	medication	nsubjpass	9	SENT_52	[p4l218t2700r692b2773],
8	was	VBD	O	be	auxpass	9	SENT_52	[p4l716t2724r876b2774],
9	allowed	VBN	O	allow	_	0	SENT_52	[p4l904t2700r1239b2774],
10	with	IN	O	with	_	0	SENT_52	[p4l1262t2700r1450b2774],
11	the	DT	O	the	det	12	SENT_52	[p4l1472t2700r1599b2773],
12	exception	NN	O	exception	prep_with	9	SENT_52	[p4l1625t2700r2038b2796],
13	of	IN	O	of	_	0	SENT_52	[p4l2062t2700r2154b2773],
14	medications	NNS	O	medication	prep_of	12	SENT_52	[p4l7t2826r519b2899],
15	to	TO	O	to	aux	16	SENT_52	[p4l567t2837r645b2899],
16	treat	VB	O	treat	xcomp	9	SENT_52	[p4l692t2837r882b2899],
17	adverse	JJ	O	adverse	amod	18	SENT_52	[p4l928t2826r1248b2899],
18	events	NNS	O	event	dobj	16	SENT_52	[p4l1296t2837r1587b2899],
19	.	.	O	.	_	0	SENT_52	[p4l1296t2837r1587b2899],

1	Restrictions	NNS	O	restriction	nsubjpass	3	SENT_53	[p4l1638t2826r2145b2899],
2	were	VBD	O	be	auxpass	3	SENT_53	[p4l7t2974r210b3024],
3	applied	VBN	O	apply	_	0	SENT_53	[p4l256t2950r568b3046],
4	regarding	VBG	O	regard	xcomp	3	SENT_53	[p4l609t2950r1017b3046],
5	the	DT	O	the	det	6	SENT_53	[p4l1062t2950r1189b3023],
6	intake	NN	O	intake	dobj	4	SENT_53	[p4l1233t2950r1491b3023],
7	of	IN	O	of	_	0	SENT_53	[p4l1536t2950r1628b3023],
8	methylXan	NN	O	methylxan	prep_of	6	SENT_53	[p4l1663t2950r2145b3046],
9	—	CD	NUMBER	—	num	8	SENT_53	[p4l1663t2950r2145b3046],
10	thine	PRP$	O	thine	poss	11	SENT_53	[p4l7t3074r730b3170],
11	—	NN	O	—	tmod	4	SENT_53	[p4l7t3074r730b3170],
12	containing	VBG	O	contain	partmod	11	SENT_53	[p4l7t3074r730b3170],
13	beverages	NNS	O	beverage	dobj	12	SENT_53	[p4l781t3074r1215b3170],
14	as	IN	O	as	_	0	SENT_53	[p4l1271t3098r1353b3148],
15	Well	NNP	O	Well	prep_as	12	SENT_53	[p4l1406t3074r1590b3148],
16	as	IN	O	as	_	0	SENT_53	[p4l1643t3098r1726b3148],
17	the	DT	O	the	det	18	SENT_53	[p4l1779t3074r1908b3148],
18	conClin	NN	O	conclin	prep_as	15	SENT_53	[p4l1960t3098r2145b3148, p4l1208t3359r1316b3407],

1	Phormocokinet	NNP	O	Phormocokinet	_	0	SENT_54	[p4l1341t3359r1800b3407],
2	2003	CD	DATE	2003	num	1	SENT_54	[p4l1818t3359r1969b3410],
3	;	:	O	;	_	0	SENT_54	[p4l1818t3359r1969b3410],
4	42	CD	NUMBER	42	number	5	SENT_54	[p4l1990t3359r2056b3407],
5	(	CD	NUMBER	(	dep	1	SENT_54	[p4l2079t3359r2153b3414],
6	3	CD	NUMBER	3	num	7	SENT_54	[p4l2079t3359r2153b3414],
7	)	NN	O	)	dep	5	SENT_54	[p4l2079t3359r2153b3414],

1	Bosentan	NNP	O	Bosentan	_	0	SENT_55	[p4l192t3489r518b3514],
2	.	.	O	.	_	0	SENT_55	[p4l192t3489r518b3514],

1	—	NN	O	—	_	0	SENT_56	[p4l192t3489r518b3514],
2	.	.	O	.	_	0	SENT_56	[p4l192t3489r518b3514],

1	Simvastatin	NNP	O	Simvastatin	_	0	SENT_57	[p4l192t3489r518b3514],
2	Interactions	NNS	O	interaction	dep	1	SENT_57	[p4l527t3489r702b3514],
3	295	CD	NUMBER	295	dep	1	SENT_57	[p4l1918t3490r1967b3514],

1	sumption	NN	O	sumption	nsubj	4	SENT_58	[p5l24t100r416b194],
2	of	IN	O	of	_	0	SENT_58	[p5l463t100r554b173],
3	grapefruit	NN	O	grapefruit	prep_of	1	SENT_58	[p5l594t100r1016b194],
4	juice	NN	O	juice	_	0	SENT_58	[p5l1050t100r1287b194],
5	.	.	O	.	_	0	SENT_58	[p5l1050t100r1287b194],

1	The	DT	O	the	det	2	SENT_59	[p5l1338t100r1500b173],
2	subjects	NNS	O	subject	nsubjpass	4	SENT_59	[p5l1549t100r1885b194],
3	were	VBD	O	be	auxpass	4	SENT_59	[p5l1932t123r2133b173],
4	hospitalised	VBN	O	hospitalise	_	0	SENT_59	[p5l20t224r526b318],
5	from	IN	O	from	_	0	SENT_59	[p5l565t224r768b297],
6	approximately	RB	O	approximately	quantmod	7	SENT_59	[p5l807t224r1415b318],
7	12	CD	DURATION	12	num	8	SENT_59	[p5l1463t224r1555b296],
8	hours	NNS	NUMBER	hour	prep_from	4	SENT_59	[p5l1594t224r1824b297],
9	before	IN	O	before	dep	4	SENT_59	[p5l1864t224r2132b297],
10	until	IN	O	until	_	0	SENT_59	[p5l20t348r212b421],
11	12	CD	DURATION	12	num	12	SENT_59	[p5l260t348r351b420],
12	hours	NNS	NUMBER	hour	prep_until	4	SENT_59	[p5l389t348r619b421],
13	after	IN	O	after	_	0	SENT_59	[p5l662t348r854b421],
14	drug	NN	O	drug	nn	15	SENT_59	[p5l890t348r1078b442],
15	intake	NN	O	intake	prep_after	12	SENT_59	[p5l1117t348r1372b421],
16	on	IN	O	on	_	0	SENT_59	[p5l1411t371r1512b421],
17	day	NN	DURATION	day	prep_on	4	SENT_59	[p5l1550t348r1698b442],
18	6	CD	NUMBER	6	num	17	SENT_59	[p5l1737t348r1783b421],
19	of	IN	O	of	_	0	SENT_59	[p5l1823t348r1914b421],
20	each	DT	O	each	det	22	SENT_59	[p5l1944t348r2134b421],
21	treatment	NN	O	treatment	nn	22	SENT_59	[p5l21t483r435b545],
22	period	NN	O	period	prep_of	17	SENT_59	[p5l478t472r776b566],
23	.	.	O	.	_	0	SENT_59	[p5l478t472r776b566],

1	An	DT	O	a	det	3	SENT_60	[p5l827t473r955b544],
2	end-of-study	JJ	O	end-of-study	amod	3	SENT_60	[p5l1002t472r1553b566],
3	examination	NN	O	examination	nsubjpass	5	SENT_60	[p5l1602t472r2135b545],
4	was	VBD	O	be	auxpass	5	SENT_60	[p5l21t619r179b669],
5	performed	VBN	O	perform	_	0	SENT_60	[p5l208t596r648b690],
6	2-4	CD	NUMBER	2-4	num	7	SENT_60	[p5l676t596r829b668],
7	days	NNS	NUMBER	day	tmod	5	SENT_60	[p5l858t596r1046b690],
8	after	IN	O	after	_	0	SENT_60	[p5l1078t596r1269b669],
9	the	DT	O	the	det	12	SENT_60	[p5l1295t596r1421b669],
10	last	JJ	O	last	amod	12	SENT_60	[p5l1449t596r1595b669],
11	drug	NN	O	drug	nn	12	SENT_60	[p5l1622t596r1810b690],
12	administration	NN	O	administration	prep_after	5	SENT_60	[p5l1840t596r2132b669, p5l21t720r367b793],
13	in	IN	O	in	_	0	SENT_60	[p5l397t720r477b792],
14	the	DT	O	the	det	16	SENT_60	[p5l507t720r633b793],
15	third	JJ	ORDINAL	third	amod	16	SENT_60	[p5l664t720r863b793],
16	period	NN	O	period	prep_in	12	SENT_60	[p5l891t720r1182b814],
17	.	.	O	.	_	0	SENT_60	[p5l891t720r1182b814],

1	Dedgn	NN	O	dedgn	_	0	SENT_61	[p5l150t1001r444b1091],

1	This	DT	O	this	nsubj	6	SENT_62	[p5l145t1260r328b1333],
2	was	VBD	O	be	cop	6	SENT_62	[p5l370t1283r528b1333],
3	a	DT	O	a	det	6	SENT_62	[p5l572t1283r614b1333],
4	single	JJ	O	single	amod	6	SENT_62	[p5l655t1260r1221b1354],
5	—	NN	O	—	nn	6	SENT_62	[p5l655t1260r1221b1354],
6	centre	NN	O	centre	_	0	SENT_62	[p5l655t1260r1221b1354],
7	,	,	O	,	_	0	SENT_62	[p5l655t1260r1221b1354],
8	open	JJ	O	open	amod	10	SENT_62	[p5l1265t1260r1732b1354],
9	—	NN	O	—	nn	10	SENT_62	[p5l1265t1260r1732b1354],
10	label	NN	O	label	appos	6	SENT_62	[p5l1265t1260r1732b1354],
11	,	,	O	,	_	0	SENT_62	[p5l1265t1260r1732b1354],
12	randomised	VBN	O	randomise	partmod	6	SENT_62	[p5l1773t1260r2132b1333, p5l21t1384r219b1470],
13	,	,	O	,	_	0	SENT_62	[p5l1773t1260r2132b1333, p5l21t1384r219b1470],
14	three	CD	NUMBER	three	num	17	SENT_62	[p5l271t1384r707b1478],
15	—	JJ	O	—	amod	17	SENT_62	[p5l271t1384r707b1478],
16	way	NN	O	way	nn	17	SENT_62	[p5l271t1384r707b1478],
17	crossover	NN	O	crossover	conj_and	6	SENT_62	[p5l758t1407r1177b1457],
18	study	NN	O	study	rel	23	SENT_62	[p5l1228t1384r1458b1478],
19	in	IN	O	in	_	0	SENT_62	[p5l1508t1384r1589b1456],
20	which	WDT	O	which	prep_in	18	SENT_62	[p5l1639t1384r1901b1457],
21	subjects	NNS	O	subject	nsubjpass	23	SENT_62	[p5l1954t1384r2132b1457, p5l12t1508r210b1602],
22	were	VBD	O	be	auxpass	23	SENT_62	[p5l239t1531r440b1581],
23	treated	VBN	O	treat	rcmod	17	SENT_62	[p5l467t1508r754b1581],
24	with	IN	O	with	prep	23	SENT_62	[p5l780t1508r987b1581],
25	:	:	O	:	_	0	SENT_62	[p5l780t1508r987b1581],
26	(	CD	NUMBER	(	conj_and	6	SENT_62	[p5l1024t1508r1161b1597],
27	A	DT	O	a	det	30	SENT_62	[p5l1024t1508r1161b1597],
28	)	NN	O	)	nn	30	SENT_62	[p5l1024t1508r1161b1597],
29	bosentan	NN	O	bosentan	nn	30	SENT_62	[p5l1189t1508r1565b1581],
30	125mg	NN	O	125mg	tmod	26	SENT_62	[p5l1601t1507r1880b1602],
31	twice	RB	O	twice	advmod	32	SENT_62	[p5l1907t1508r2133b1581],
32	daily	RB	SET	daily	advmod	30	SENT_62	[p5l22t1632r229b1726],
33	for	IN	O	for	_	0	SENT_62	[p5l260t1632r382b1705],
34	5.5	CD	DURATION	5.5	num	35	SENT_62	[p5l412t1632r534b1705],
35	days	NNS	NUMBER	day	prep_for	32	SENT_62	[p5l570t1632r785b1726],
36	;	:	O	;	_	0	SENT_62	[p5l570t1632r785b1726],
37	(	NN	O	(	nn	38	SENT_62	[p5l824t1633r955b1722],
38	B	NN	O	b	conj_and	6	SENT_62	[p5l824t1633r955b1722],
39	)	CD	NUMBER	)	num	40	SENT_62	[p5l824t1633r955b1722],
40	simvastatin	NN	O	simvastatin	dep	38	SENT_62	[p5l992t1632r1469b1705],
41	40mg	JJ	O	40mg	amod	49	SENT_62	[p5l1498t1632r1734b1726],
42	(	NN	O	(	nn	49	SENT_62	[p5l1769t1621r2130b1722],
43	Zocor	NNP	O	Zocor	nn	49	SENT_62	[p5l1769t1621r2130b1722],
44	®	NNP	O	®	nn	49	SENT_62	[p5l1769t1621r2130b1722],
45	,	,	O	,	_	0	SENT_62	[p5l1769t1621r2130b1722],
46	Merck	NNP	ORGANIZATION	Merck	conj_and	44	SENT_62	[p5l20t1756r302b1829],
47	&	CC	ORGANIZATION	&	_	0	SENT_62	[p5l354t1756r429b1829],
48	Co.	NNP	ORGANIZATION	Co.	conj_and	44	SENT_62	[p5l482t1756r665b1845],
49	)	NN	O	)	dep	40	SENT_62	[p5l482t1756r665b1845],
50	once	RB	DATE	once	advmod	51	SENT_62	[p5l721t1779r921b1829],
51	daily	RB	SET	daily	advmod	40	SENT_62	[p5l973t1756r1187b1850],
52	for	IN	O	for	_	0	SENT_62	[p5l1239t1756r1364b1829],
53	6	CD	DURATION	6	num	54	SENT_62	[p5l1415t1756r1461b1829],
54	days	NNS	NUMBER	day	prep_for	51	SENT_62	[p5l1514t1756r1735b1850],
55	;	:	O	;	_	0	SENT_62	[p5l1514t1756r1735b1850],
56	and	CC	O	and	_	0	SENT_62	[p5l1793t1756r1944b1829],
57	(	NN	O	(	nn	58	SENT_62	[p5l1997t1756r2131b1846],
58	C	NN	O	c	conj_and	6	SENT_62	[p5l1997t1756r2131b1846],
59	)	JJ	O	)	amod	61	SENT_62	[p5l1997t1756r2131b1846],
60	bosentan	NN	O	bosentan	nn	61	SENT_62	[p5l19t1880r395b1953],
61	125mg	NN	O	125mg	tmod	58	SENT_62	[p5l429t1879r708b1974],
62	twice	RB	O	twice	advmod	63	SENT_62	[p5l733t1880r959b1953],
63	daily	RB	SET	daily	advmod	61	SENT_62	[p5l986t1880r1193b1974],
64	and	CC	O	and	_	0	SENT_62	[p5l1220t1880r1368b1953],
65	simvastatin	NN	O	simvastatin	nn	66	SENT_62	[p5l1395t1880r1873b1953],
66	40mg	NN	O	40mg	conj_and	6	SENT_62	[p5l1896t1880r2133b1974],
67	once	RB	DATE	once	advmod	68	SENT_62	[p5l22t2027r217b2077],
68	daily	RB	SET	daily	advmod	66	SENT_62	[p5l250t2004r458b2098],
69	for	IN	O	for	_	0	SENT_62	[p5l492t2004r613b2077],
70	5.5	CD	NUMBER	5.5	nn	73	SENT_62	[p5l645t2004r769b2077],
71	and	CC	O	and	_	0	SENT_62	[p5l808t2004r956b2077],
72	6	CD	DURATION	6	conj_and	70	SENT_62	[p5l989t2004r1036b2077],
73	days	NNS	NUMBER	day	prep_for	66	SENT_62	[p5l1070t2004r1283b2098],
74	,	,	O	,	_	0	SENT_62	[p5l1070t2004r1283b2098],
75	respectively	RB	O	respectively	advmod	73	SENT_62	[p5l1319t2004r1852b2098],
76	.	.	O	.	_	0	SENT_62	[p5l1319t2004r1852b2098],

1	Three	CD	NUMBER	three	num	4	SENT_63	[p5l1890t2004r2133b2077],
2	different	JJ	O	different	amod	4	SENT_63	[p5l22t2128r385b2201],
3	treatment	NN	O	treatment	nn	4	SENT_63	[p5l408t2139r808b2201],
4	sequences	NNS	O	sequence	nsubjpass	6	SENT_63	[p5l834t2151r1255b2222],
5	were	VBD	O	be	auxpass	6	SENT_63	[p5l1281t2151r1482b2201],
6	employed	VBN	O	employ	_	0	SENT_63	[p5l1508t2128r1943b2222],
7	.	.	O	.	_	0	SENT_63	[p5l1508t2128r1943b2222],

1	The	DT	O	the	det	3	SENT_64	[p5l1972t2128r2133b2201],
2	washout	NN	O	washout	nn	3	SENT_64	[p5l21t2252r374b2325],
3	period	NN	O	period	nsubj	10	SENT_64	[p5l417t2252r689b2346],
4	between	IN	O	between	_	0	SENT_64	[p5l732t2252r1086b2325],
5	the	DT	O	the	det	7	SENT_64	[p5l1131t2252r1257b2325],
6	separate	JJ	O	separate	amod	7	SENT_64	[p5l1307t2263r1648b2346],
7	treatments	NNS	O	treatment	prep_between	3	SENT_64	[p5l1693t2263r2131b2325],
8	was	VBD	O	be	cop	10	SENT_64	[p5l21t2399r179b2449],
9	2	CD	DURATION	2	num	10	SENT_64	[p5l224t2376r271b2448],
10	weeks	NNS	NUMBER	week	_	0	SENT_64	[p5l315t2376r597b2449],
11	.	.	O	.	_	0	SENT_64	[p5l315t2376r597b2449],

1	Drug	NN	O	drug	nsubjpass	3	SENT_65	[p5l643t2378r856b2470],
2	was	VBD	O	be	auxpass	3	SENT_65	[p5l899t2399r1057b2449],
3	administered	VBN	O	administer	_	0	SENT_65	[p5l1103t2376r1646b2449],
4	at	IN	O	at	_	0	SENT_65	[p5l1689t2387r1762b2449],
5	12-hour	JJ	DURATION	12-hour	amod	6	SENT_65	[p5l1811t2376r2136b2449],
6	intervals	NNS	O	interval	prep_at	3	SENT_65	[p5l21t2500r381b2573],
7	in	IN	O	in	_	0	SENT_65	[p5l408t2500r488b2572],
8	the	DT	O	the	det	9	SENT_65	[p5l512t2500r638b2573],
9	morning	NN	TIME	morning	prep_in	6	SENT_65	[p5l663t2500r1017b2594],
10	and	CC	O	and	_	0	SENT_65	[p5l1045t2500r1193b2573],
11	the	DT	O	the	det	12	SENT_65	[p5l1216t2500r1343b2573],
12	evening	NN	TIME	evening	prep_at	3	SENT_65	[p5l1368t2500r1699b2594],
13	following	VBG	O	follow	_	0	SENT_65	[p5l1725t2500r2133b2594],
14	consumption	NN	O	consumption	prep_following	12	SENT_65	[p5l22t2624r566b2718],
15	of	IN	O	of	_	0	SENT_65	[p5l590t2624r680b2697],
16	breakfast	NN	O	breakfast	prep_of	14	SENT_65	[p5l695t2624r1085b2697],
17	and	CC	O	and	_	0	SENT_65	[p5l1108t2624r1257b2697],
18	dinner	NN	O	dinner	prep_of	14	SENT_65	[p5l1280t2624r1570b2710],
19	,	,	O	,	_	0	SENT_65	[p5l1280t2624r1570b2710],
20	respectively	RB	O	respectively	advmod	14	SENT_65	[p5l1596t2624r2129b2718],
21	.	.	O	.	_	0	SENT_65	[p5l1596t2624r2129b2718],

1	On	IN	O	on	_	0	SENT_66	[p5l22t2749r146b2821],
2	day	NN	DURATION	day	prep_on	8	SENT_66	[p5l178t2748r326b2843],
3	6	CD	NUMBER	6	num	2	SENT_66	[p5l360t2748r430b2834],
4	,	,	O	,	_	0	SENT_66	[p5l360t2748r430b2834],
5	no	DT	O	no	det	6	SENT_66	[p5l465t2771r566b2821],
6	food	NN	O	food	nsubjpass	8	SENT_66	[p5l599t2748r790b2821],
7	was	VBD	O	be	auxpass	8	SENT_66	[p5l821t2771r980b2821],
8	allowed	VBN	O	allow	_	0	SENT_66	[p5l1016t2748r1347b2821],
9	until	IN	O	until	_	0	SENT_66	[p5l1376t2748r1568b2821],
10	4	CD	DURATION	4	num	11	SENT_66	[p5l1599t2748r1648b2820],
11	hours	NNS	NUMBER	hour	prep_until	8	SENT_66	[p5l1679t2748r1910b2821],
12	after	IN	O	after	_	0	SENT_66	[p5l1946t2748r2137b2821],
13	drug	NN	O	drug	nn	14	SENT_66	[p5l22t2872r214b2967],
14	intake	NN	O	intake	prep_after	8	SENT_66	[p5l261t2872r679b2945],
15	.	.	O	.	_	0	SENT_66	[p5l261t2872r679b2945],

1	On	IN	O	on	_	0	SENT_67	[p5l261t2872r679b2945],
2	days	NNS	DURATION	day	prep_on	6	SENT_67	[p5l729t2872r920b2967],
3	1-5	CD	NUMBER	1-5	dep	2	SENT_67	[p5l982t2872r1154b2958],
4	,	,	O	,	_	0	SENT_67	[p5l982t2872r1154b2958],
5	subjects	NNS	O	subject	nsubj	6	SENT_67	[p5l1210t2872r1552b2967],
6	came	VBD	O	come	_	0	SENT_67	[p5l1604t2895r1827b2945],
7	to	TO	O	to	_	0	SENT_67	[p5l1876t2883r1955b2945],
8	the	DT	O	the	det	9	SENT_67	[p5l2005t2872r2133b2945],
9	clinic	NN	O	clinic	prep_to	6	SENT_67	[p5l22t2996r252b3069],
10	for	IN	O	for	_	0	SENT_67	[p5l296t2996r418b3069],
11	drug	NN	O	drug	nn	12	SENT_67	[p5l459t2996r648b3091],
12	administration	NN	O	administration	prep_for	6	SENT_67	[p5l693t2996r1302b3069],
13	and	CC	O	and	_	0	SENT_67	[p5l1345t2996r1493b3069],
14	withdrawal	NN	O	withdrawal	conj_and	12	SENT_67	[p5l1534t2996r2007b3069],
15	of	IN	O	of	_	0	SENT_67	[p5l2051t2996r2141b3069],
16	morning	NN	TIME	morning	nn	19	SENT_67	[p5l20t3120r375b3215],
17	trough	NN	O	trough	nn	19	SENT_67	[p5l406t3120r681b3215],
18	blood	NN	O	blood	nn	19	SENT_67	[p5l709t3120r950b3193],
19	samples	NNS	O	sample	prep_of	12	SENT_67	[p5l983t3120r1339b3215],
20	.	.	O	.	_	0	SENT_67	[p5l983t3120r1339b3215],

1	250	CD	NUMBER	250	_	0	SENT_68	[p6l276t101r393b155],
2	I	PRP	O	I	dep	1	SENT_68	[p6l1311t101r1369b159],
3	No	DT	O	no	det	4	SENT_68	[p6l1439t100r1524b154],
4	simvastatin	NN	O	simvastatin	dep	1	SENT_68	[p6l1548t100r1902b154],

1	o	NN	O	o	_	0	SENT_69	[p6l1311t210r1369b267],
2	With	IN	O	with	dep	1	SENT_69	[p6l1435t204r1574b257],
3	simvastatin	NN	O	simvastatin	pobj	2	SENT_69	[p6l1601t204r1954b258],

1	Q	NNP	O	Q	_	0	SENT_70	[p6l135t287r204b368],
2	33	CD	NUMBER	33	num	1	SENT_70	[p6l135t370r205b467],
3	200	CD	NUMBER	200	num	6	SENT_70	[p6l276t402r393b455],
4	C	NN	O	c	nn	6	SENT_70	[p6l149t495r189b527],
5	.2	NN	NUMBER	.2	nn	6	SENT_70	[p6l137t534r190b583],
6	E	NN	O	e	dep	1	SENT_70	[p6l140t589r190b666],
7	5	CD	NUMBER	5	number	8	SENT_70	[p6l149t696r190b770],
8	150	CD	NUMBER	150	num	12	SENT_70	[p6l281t702r393b755],
9	O	NN	O	o	nn	12	SENT_70	[p6l149t773r190b806],
10	C	NN	O	c	nn	12	SENT_70	[p6l149t812r189b844],
11	O	NN	O	o	nn	12	SENT_70	[p6l149t851r190b886],
12	O	NN	O	o	dep	6	SENT_70	[p6l149t890r190b923],
13	.	.	O	.	_	0	SENT_70	[p6l137t949r189b981],

1	C	NN	O	c	nn	3	SENT_71	[p6l137t949r189b981],
2	3	CD	NUMBER	3	num	3	SENT_71	[p6l149t989r205b1061],
3	’	NN	O	’	_	0	SENT_71	[p6l149t989r205b1061],
4	100	CD	NUMBER	100	number	5	SENT_71	[p6l281t1004r393b1057],
5	2	CD	NUMBER	2	dep	3	SENT_71	[p6l149t1068r190b1125],
6	‘	CD	NUMBER	‘	num	7	SENT_71	[p6l140t1131r189b1206],
7	E	NN	O	e	dep	5	SENT_71	[p6l140t1131r189b1206],
8	:2	CD	NUMBER	:2	num	9	SENT_71	[p6l140t1212r190b1270],
9	C	NN	O	c	dep	3	SENT_71	[p6l149t1275r189b1306],
10	3	CD	NUMBER	3	number	11	SENT_71	[p6l149t1313r190b1385],
11	50	CD	NUMBER	50	num	13	SENT_71	[p6l317t1305r393b1357],
12	o	NN	O	o	nn	13	SENT_71	[p6l149t1390r190b1426],
13	ED	NN	O	ed	dep	9	SENT_71	[p6l137t1430r189b1471],

1	Day	NN	DURATION	day	_	0	SENT_72	[p6l968t1805r1088b1874],
2	of	IN	O	of	_	0	SENT_72	[p6l1112t1805r1169b1859],
3	treatment	NN	O	treatment	prep_of	1	SENT_72	[p6l1190t1809r1494b1859],

1	Fig	NN	O	fig	_	0	SENT_73	[p6l13t1976r133b2045],
2	.	.	O	.	_	0	SENT_73	[p6l13t1976r133b2045],

1	1	LS	NUMBER	1	_	0	SENT_74	[p6l171t1977r223b2030],
2	.	.	O	.	_	0	SENT_74	[p6l171t1977r223b2030],

1	Trough	NN	O	trough	nn	3	SENT_75	[p6l259t1972r498b2046],
2	plasma	NN	O	plasma	nn	3	SENT_75	[p6l538t1972r782b2046],
3	concentrations	NNS	O	concentration	_	0	SENT_75	[p6l817t1972r1314b2031],
4	of	IN	O	of	_	0	SENT_75	[p6l1350t1972r1411b2030],
5	bosentan	NN	O	bosentan	prep_of	3	SENT_75	[p6l1446t1972r1775b2041],
6	,	,	O	,	_	0	SENT_75	[p6l1446t1972r1775b2041],
7	measured	VBN	O	measure	partmod	3	SENT_75	[p6l1816t1972r2152b2031],
8	just	RB	O	just	advmod	7	SENT_75	[p6l7t2065r127b2139],
9	before	IN	O	before	_	0	SENT_75	[p6l158t2065r370b2124],
10	intake	NN	O	intake	prep_before	7	SENT_75	[p6l403t2065r602b2124],
11	of	IN	O	of	_	0	SENT_75	[p6l632t2065r693b2123],
12	the	DT	O	the	det	14	SENT_75	[p6l720t2065r824b2124],
13	morning	NN	TIME	morning	nn	14	SENT_75	[p6l857t2065r1128b2139],
14	dose	NN	O	dose	prep_of	10	SENT_75	[p6l1159t2065r1323b2124],
15	on	IN	O	on	_	0	SENT_75	[p6l1353t2080r1432b2123],
16	days	NNS	DURATION	day	prep_on	7	SENT_75	[p6l1464t2065r1623b2139],
17	2-6	CD	NUMBER	2-6	dep	16	SENT_75	[p6l1653t2066r1795b2134],
18	,	,	O	,	_	0	SENT_75	[p6l1653t2066r1795b2134],
19	in	IN	O	in	_	0	SENT_75	[p6l1831t2065r1882b2123],
20	the	DT	O	the	det	25	SENT_75	[p6l1912t2065r2017b2123],
21	absence	NN	O	absence	nn	25	SENT_75	[p6l2047t2065r2153b2123, p6l11t2172r212b2216],
22	(	NN	O	(	nn	25	SENT_75	[p6l240t2156r586b2231],
23	treatment	NN	O	treatment	nn	25	SENT_75	[p6l240t2156r586b2231],
24	A	NN	O	a	nn	25	SENT_75	[p6l608t2156r680b2231],
25	)	NN	O	)	prep_in	3	SENT_75	[p6l608t2156r680b2231],
26	and	CC	O	and	_	0	SENT_75	[p6l707t2157r830b2216],
27	presence	NN	O	presence	nn	31	SENT_75	[p6l857t2172r1168b2231],
28	(	NN	O	(	nn	31	SENT_75	[p6l1196t2156r1542b2231],
29	treatment	NN	O	treatment	nn	31	SENT_75	[p6l1196t2156r1542b2231],
30	C	NN	O	c	nn	31	SENT_75	[p6l1566t2156r1639b2231],
31	)	NN	O	)	prep_in	3	SENT_75	[p6l1566t2156r1639b2231],
32	of	IN	O	of	_	0	SENT_75	[p6l1667t2157r1728b2215],
33	simvastatin	NN	O	simvastatin	prep_of	31	SENT_75	[p6l1750t2157r2150b2216],
34	.	.	O	.	_	0	SENT_75	[p6l1750t2157r2150b2216],

1	Data	NNS	O	datum	nsubjpass	3	SENT_76	[p6l14t2250r171b2309],
2	are	VBP	O	be	auxpass	3	SENT_76	[p6l195t2265r303b2309],
3	presented	VBN	O	present	_	0	SENT_76	[p6l330t2250r666b2324],
4	as	IN	O	as	_	0	SENT_76	[p6l693t2265r770b2309],
5	mean	JJ	O	mean	amod	6	SENT_76	[p6l798t2265r983b2309],
6	values	NNS	O	value	prep_as	3	SENT_76	[p6l1009t2250r1229b2309],
7	i	FW	O	i	nn	8	SENT_76	[p6l1254t2256r1295b2308],
8	SEM	NN	O	sem	dobj	3	SENT_76	[p6l1320t2249r1480b2309],
9	for	IN	O	for	_	0	SENT_76	[p6l1507t2250r1597b2308],
10	n	NN	O	n	prep_for	8	SENT_76	[p6l1622t2265r1656b2308],
11	=	JJ	O	=	amod	10	SENT_76	[p6l1684t2276r1724b2298],
12	9	CD	NUMBER	9	tmod	11	SENT_76	[p6l1751t2252r1806b2309],
13	.	.	O	.	_	0	SENT_76	[p6l1751t2252r1806b2309],

1	©	NN	O	©	_	0	SENT_77	[p6l21t2515r65b2559],
2	Adis	NNP	O	Adis	nn	4	SENT_77	[p6l84t2511r208b2559],
3	International	NNP	O	International	nn	4	SENT_77	[p6l229t2511r600b2559],
4	Limited	NNP	O	Limited	dep	1	SENT_77	[p6l625t2511r847b2559],
5	.	.	O	.	_	0	SENT_77	[p6l625t2511r847b2559],

1	All	DT	O	all	det	2	SENT_78	[p6l870t2511r937b2558],
2	rights	NNS	O	rights	nsubj	3	SENT_78	[p6l961t2511r1112b2571],
3	reserved	VBN	O	reserve	_	0	SENT_78	[p6l1133t2511r1401b2559],
4	.	.	O	.	_	0	SENT_78	[p6l1133t2511r1401b2559],

1	1200	CD	DATE	1200	_	0	SENT_79	[p7l175t101r327b154],
2	I	PRP	O	I	dep	1	SENT_79	[p7l1473t101r1531b159],
3	No	DT	O	no	det	4	SENT_79	[p7l1600t100r1686b154],
4	simvastatin	NN	O	simvastatin	dep	1	SENT_79	[p7l1710t100r2063b154],

1	o	NN	O	o	_	0	SENT_80	[p7l1473t210r1531b267],
2	With	IN	O	with	dep	1	SENT_80	[p7l1596t204r1736b257],
3	simvastatin	NN	O	simvastatin	pobj	2	SENT_80	[p7l1762t204r2115b258],

1	Q	NNP	O	Q	nn	3	SENT_81	[p7l35t494r104b576],
2	900	CD	NUMBER	900	num	3	SENT_81	[p7l211t525r327b577],
3	C7	NN	O	c7	dep	11	SENT_81	[p7l50t578r105b612],
4	3	CD	NUMBER	3	num	7	SENT_81	[p7l35t619r104b674],
5	C	NN	O	c	nn	7	SENT_81	[p7l50t703r89b735],
6	.2	NN	NUMBER	.2	nn	7	SENT_81	[p7l36t741r90b791],
7	E	NN	O	e	dep	3	SENT_81	[p7l40t796r90b874],
8	E	NN	O	e	dep	11	SENT_81	[p7l40t880r90b935],
9	’	CD	NUMBER	’	num	8	SENT_81	[p7l40t880r90b935],
10	8	CD	NUMBER	8	num	11	SENT_81	[p7l50t941r90b1014],
11	600	CD	NUMBER	600	dep	23	SENT_81	[p7l211t948r327b1001],
12	C	NN	O	c	nn	20	SENT_81	[p7l50t1020r89b1051],
13	O	NN	O	o	nn	20	SENT_81	[p7l50t1058r90b1094],
14	O	NN	O	o	nn	20	SENT_81	[p7l50t1097r90b1130],
15	C	NN	O	c	nn	20	SENT_81	[p7l50t1156r89b1188],
16	(	CD	NUMBER	(	num	20	SENT_81	[p7l50t1194r90b1230],
17	U	NNP	O	U	nn	20	SENT_81	[p7l50t1194r90b1230],
18	E	NNP	O	E	nn	20	SENT_81	[p7l40t1234r90b1288],
19	(	NN	O	(	nn	20	SENT_81	[p7l50t1295r90b1330],
20	D	NN	O	d	dep	11	SENT_81	[p7l50t1295r90b1330],
21	3	CD	NUMBER	3	number	22	SENT_81	[p7l50t1335r90b1407],
22	300	CD	NUMBER	300	dep	20	SENT_81	[p7l210t1371r327b1424],
23	CD	NNP	O	CD	_	0	SENT_81	[p7l36t1412r89b1453],

1	O	NN	O	o	_	0	SENT_82	[p7l427t1882r463b1935],
2	2	CD	NUMBER	2	number	3	SENT_82	[p7l699t1882r734b1934],
3	4	CD	NUMBER	4	num	5	SENT_82	[p7l971t1882r1008b1934],
4	6	CD	NUMBER	6	number	5	SENT_82	[p7l1245t1882r1280b1935],
5	8	CD	NUMBER	8	dep	1	SENT_82	[p7l1517t1882r1552b1935],
6	10	CD	NUMBER	10	number	7	SENT_82	[p7l1774t1882r1845b1935],
7	12	CD	NUMBER	12	amod	5	SENT_82	[p7l2046t1882r2117b1934],

1	Time	NNP	O	Time	_	0	SENT_83	[p7l811t1992r969b2046],
2	after	IN	O	after	dep	1	SENT_83	[p7l994t1992r1136b2046],
3	administration	NN	O	administration	nn	5	SENT_83	[p7l1159t1992r1601b2046],
4	(	CD	NUMBER	(	num	5	SENT_83	[p7l1630t1991r1710b2060],
5	h	NN	O	h	pobj	2	SENT_83	[p7l1630t1991r1710b2060],
6	)	CD	NUMBER	)	num	5	SENT_83	[p7l1630t1991r1710b2060],

1	Fig	NN	O	fig	_	0	SENT_84	[p7l11t2104r131b2173],
2	.	.	O	.	_	0	SENT_84	[p7l11t2104r131b2173],

1	2	LS	NUMBER	2	_	0	SENT_85	[p7l155t2105r209b2158],
2	.	.	O	.	_	0	SENT_85	[p7l155t2105r209b2158],

1	Plasma	NN	O	plasma	nn	3	SENT_86	[p7l239t2100r491b2159],
2	concentration-time	NN	O	concentration-time	nn	3	SENT_86	[p7l514t2100r1147b2159],
3	profiles	NNS	O	profile	_	0	SENT_86	[p7l1174t2100r1417b2174],
4	of	IN	O	of	_	0	SENT_86	[p7l1440t2100r1502b2158],
5	bosentan	NN	O	bosentan	prep_of	3	SENT_86	[p7l1526t2100r1836b2159],
6	on	IN	O	on	_	0	SENT_86	[p7l1862t2115r1942b2158],
7	day	NN	DURATION	day	prep_on	3	SENT_86	[p7l1968t2100r2090b2174],
8	6	CD	NUMBER	6	num	7	SENT_86	[p7l2113t2101r2151b2159],
9	following	VBG	O	follow	_	0	SENT_86	[p7l6t2193r303b2267],
10	administration	NN	O	administration	prep_following	3	SENT_86	[p7l339t2193r815b2252],
11	of	IN	O	of	_	0	SENT_86	[p7l851t2193r913b2251],
12	bosentan	NN	O	bosentan	nn	13	SENT_86	[p7l947t2193r1258b2252],
13	125mg	NN	O	125mg	prep_of	10	SENT_86	[p7l1300t2194r1527b2267],
14	twice	RB	O	twice	advmod	15	SENT_86	[p7l1561t2193r1734b2252],
15	daily	RB	SET	daily	advmod	13	SENT_86	[p7l1769t2193r1925b2267],
16	in	IN	O	in	_	0	SENT_86	[p7l1961t2193r2012b2251],
17	the	DT	O	the	det	22	SENT_86	[p7l2047t2193r2152b2251],
18	absence	NN	O	absence	nn	22	SENT_86	[p7l8t2285r300b2344],
19	(	NN	O	(	nn	22	SENT_86	[p7l336t2284r689b2359],
20	treatment	NN	O	treatment	nn	22	SENT_86	[p7l336t2284r689b2359],
21	A	NN	O	a	nn	22	SENT_86	[p7l719t2284r792b2359],
22	)	NN	O	)	prep_in	15	SENT_86	[p7l719t2284r792b2359],
23	and	CC	O	and	_	0	SENT_86	[p7l826t2285r951b2344],
24	presence	NN	O	presence	nn	28	SENT_86	[p7l986t2300r1303b2359],
25	(	NN	O	(	nn	28	SENT_86	[p7l1338t2284r1691b2359],
26	treatment	NN	O	treatment	nn	28	SENT_86	[p7l1338t2284r1691b2359],
27	C	NN	O	c	nn	28	SENT_86	[p7l1723t2284r1797b2359],
28	)	NN	O	)	prep_in	15	SENT_86	[p7l1723t2284r1797b2359],
29	of	IN	O	of	_	0	SENT_86	[p7l1832t2285r1894b2343],
30	simvastatin	NN	O	simvastatin	nn	31	SENT_86	[p7l1925t2285r2151b2344, p7l8t2379r190b2438],
31	40mg	NN	O	40mg	prep_of	28	SENT_86	[p7l214t2380r405b2453],
32	once	RB	DATE	once	advmod	33	SENT_86	[p7l430t2394r595b2438],
33	daily	RB	SET	daily	advmod	15	SENT_86	[p7l618t2379r794b2453],
34	.	.	O	.	_	0	SENT_86	[p7l618t2379r794b2453],

1	Data	NNS	O	datum	nsubjpass	3	SENT_87	[p7l823t2379r982b2438],
2	are	VBP	O	be	auxpass	3	SENT_87	[p7l1004t2394r1113b2437],
3	presented	VBN	O	present	_	0	SENT_87	[p7l1137t2379r1479b2453],
4	as	IN	O	as	_	0	SENT_87	[p7l1503t2394r1582b2437],
5	mean	JJ	O	mean	amod	6	SENT_87	[p7l1607t2394r1794b2438],
6	values	NNS	O	value	prep_as	3	SENT_87	[p7l1817t2379r2041b2438],
7	for	IN	O	for	_	0	SENT_87	[p7l2062t2379r2154b2437],
8	n	NN	O	n	prep_for	6	SENT_87	[p7l11t2487r45b2530],
9	=	JJ	O	=	amod	8	SENT_87	[p7l74t2498r115b2520],
10	9	CD	NUMBER	9	tmod	9	SENT_87	[p7l142t2473r199b2531],
11	.	.	O	.	_	0	SENT_87	[p7l142t2473r199b2531],

1	Assessments	NNS	O	assessment	_	0	SENT_88	[p7l147t2719r692b2790],

1	Blood	NN	O	blood	nn	2	SENT_89	[p7l147t2931r404b3004],
2	samples	NNS	O	sample	nsubjpass	19	SENT_89	[p7l446t2931r780b3025],
3	of	IN	O	of	_	0	SENT_89	[p7l822t2931r913b3004],
4	4.5	CD	NUMBER	4.5	num	7	SENT_89	[p7l944t2930r1186b3004],
5	ml	NN	O	ml	nn	7	SENT_89	[p7l944t2930r1186b3004],
6	(	NN	O	(	nn	7	SENT_89	[p7l1229t2931r1700b3021],
7	treatments	NNS	O	treatment	prep_of	2	SENT_89	[p7l1229t2931r1700b3021],
8	A	DT	O	a	dep	7	SENT_89	[p7l1741t2931r1814b3003],
9	and	CC	O	and	_	0	SENT_89	[p7l1855t2931r2003b3004],
10	B	NN	O	b	dep	7	SENT_89	[p7l2041t2931r2140b3021],
11	)	CD	NUMBER	)	num	17	SENT_89	[p7l2041t2931r2140b3021],
12	or	CC	O	or	_	0	SENT_89	[p7l23t3081r109b3132],
13	10ml	CD	NUMBER	10ml	num	17	SENT_89	[p7l149t3059r354b3132],
14	(	NN	O	(	nn	17	SENT_89	[p7l390t3060r824b3148],
15	treatment	NN	O	treatment	nn	17	SENT_89	[p7l390t3060r824b3148],
16	C	NN	O	c	nn	17	SENT_89	[p7l856t3059r954b3149],
17	)	NN	O	)	dep	8	SENT_89	[p7l856t3059r954b3149],
18	were	VBD	O	be	auxpass	19	SENT_89	[p7l989t3081r1191b3132],
19	collected	VBN	O	collect	_	0	SENT_89	[p7l1224t3059r1606b3132],
20	into	IN	O	into	_	0	SENT_89	[p7l1637t3059r1798b3132],
21	EDTAcontaining	JJ	O	edtacontaining	amod	65	SENT_89	[p7l1831t3059r2143b3130, p7l23t3187r468b3281],
22	tubes	NNS	O	tube	npadvmod	21	SENT_89	[p7l496t3187r716b3260],
23	from	IN	O	from	_	0	SENT_89	[p7l746t3187r950b3260],
24	an	DT	O	a	det	26	SENT_89	[p7l977t3210r1072b3260],
25	indwelling	NN	O	indwelling	nn	26	SENT_89	[p7l1099t3187r1551b3281],
26	catheter	NN	O	catheter	prep_from	22	SENT_89	[p7l1579t3187r1915b3260],
27	in	IN	O	in	_	0	SENT_89	[p7l1941t3187r2020b3259],
28	an	DT	O	a	det	30	SENT_89	[p7l2049t3210r2143b3260],
29	antecubital	JJ	O	antecubital	amod	30	SENT_89	[p7l25t3314r487b3388],
30	Vein	NN	O	vein	prep_in	21	SENT_89	[p7l524t3314r704b3388],
31	just	RB	O	just	advmod	32	SENT_89	[p7l730t3314r891b3409],
32	before	RB	O	before	advmod	30	SENT_89	[p7l925t3314r1194b3388],
33	and	CC	O	and	_	0	SENT_89	[p7l1233t3314r1382b3388],
34	at	IN	O	at	_	0	SENT_89	[p7l1419t3325r1492b3388],
35	15	CD	NUMBER	15	prep_at	21	SENT_89	[p7l1536t3314r1651b3400],
36	,	,	O	,	_	0	SENT_89	[p7l1536t3314r1651b3400],
37	30	CD	NUMBER	30	appos	35	SENT_89	[p7l1693t3315r1816b3401],
38	,	,	O	,	_	0	SENT_89	[p7l1693t3315r1816b3401],
39	45	CD	NUMBER	45	nn	42	SENT_89	[p7l1855t3314r1953b3388],
40	and	CC	O	and	_	0	SENT_89	[p7l1995t3314r2144b3388],
41	60	CD	DURATION	60	conj_and	39	SENT_89	[p7l24t3441r124b3515],
42	minutes	NNS	NUMBER	minute	appos	35	SENT_89	[p7l151t3441r483b3514],
43	and	CC	O	and	_	0	SENT_89	[p7l514t3442r662b3514],
44	1.5	CD	NUMBER	1.5	conj_and	37	SENT_89	[p7l698t3441r841b3527],
45	,	,	O	,	_	0	SENT_89	[p7l698t3441r841b3527],
46	2	CD	NUMBER	2	tmod	21	SENT_89	[p7l873t3442r945b3527],
47	,	,	O	,	_	0	SENT_89	[p7l873t3442r945b3527],
48	2.5	CD	NUMBER	2.5	num	46	SENT_89	[p7l977t3441r1128b3527],
49	,	,	O	,	_	0	SENT_89	[p7l977t3441r1128b3527],
50	3	CD	NUMBER	3	num	46	SENT_89	[p7l1162t3442r1232b3527],
51	,	,	O	,	_	0	SENT_89	[p7l1162t3442r1232b3527],
52	3.5	CD	NUMBER	3.5	num	46	SENT_89	[p7l1265t3441r1415b3527],
53	,	,	O	,	_	0	SENT_89	[p7l1265t3441r1415b3527],
54	4	CD	NUMBER	4	num	46	SENT_89	[p7l1445t3442r1518b3527],
55	,	,	O	,	_	0	SENT_89	[p7l1445t3442r1518b3527],
56	4.5	CD	NUMBER	4.5	num	46	SENT_89	[p7l1548t3441r1702b3527],
57	,	,	O	,	_	0	SENT_89	[p7l1548t3441r1702b3527],
58	5	CD	NUMBER	5	num	46	SENT_89	[p7l1734t3441r1805b3527],
59	,	,	O	,	_	0	SENT_89	[p7l1734t3441r1805b3527],
60	6	CD	NUMBER	6	num	46	SENT_89	[p7l1838t3441r1909b3527],
61	,	,	O	,	_	0	SENT_89	[p7l1838t3441r1909b3527],
62	8,10	CD	NUMBER	8,10	num	46	SENT_89	[p7l1942t3442r2143b3527],
63	and	CC	O	and	_	0	SENT_89	[p7l25t3569r173b3643],
64	12	CD	DURATION	12	conj_and	46	SENT_89	[p7l214t3570r305b3642],
65	hours	NNS	NUMBER	hour	prep_into	19	SENT_89	[p7l336t3570r568b3643],
66	after	IN	O	after	_	0	SENT_89	[p7l603t3569r796b3643],
67	administration	NN	O	administration	prep_after	19	SENT_89	[p7l826t3569r1437b3643],
68	of	IN	O	of	_	0	SENT_89	[p7l1469t3569r1560b3643],
69	study	NN	O	study	nn	70	SENT_89	[p7l1587t3569r1811b3664],
70	drug	NN	O	drug	prep_of	67	SENT_89	[p7l1843t3569r2032b3664],
71	in	IN	O	in	_	0	SENT_89	[p7l2064t3569r2144b3642],
72	the	DT	O	the	det	73	SENT_89	[p7l22t3698r148b3771],
73	morning	NN	TIME	morning	prep_in	19	SENT_89	[p7l181t3698r537b3792],
74	of	IN	O	of	_	0	SENT_89	[p7l571t3698r662b3771],
75	day	NN	DURATION	day	prep_of	73	SENT_89	[p7l688t3698r836b3792],
76	6	CD	NUMBER	6	num	75	SENT_89	[p7l871t3698r940b3771],
77	.	.	O	.	_	0	SENT_89	[p7l871t3698r940b3771],

1	On	IN	O	on	_	0	SENT_90	[p7l980t3698r1104b3771],
2	study	NN	O	study	nn	3	SENT_90	[p7l1139t3698r1362b3792],
3	days	NNS	DURATION	day	prep_on	10	SENT_90	[p7l1395t3698r1583b3792],
4	1-5	CD	NUMBER	1-5	dep	3	SENT_90	[p7l1627t3698r1796b3784],
5	,	,	O	,	_	0	SENT_90	[p7l1627t3698r1796b3784],
6	a	DT	O	a	det	8	SENT_90	[p7l1833t3721r1876b3771],
7	blood	NN	O	blood	nn	8	SENT_90	[p7l1905t3698r2146b3771],
8	sample	NN	O	sample	nsubjpass	10	SENT_90	[p8l26t24r319b118],
9	was	VBD	O	be	auxpass	10	SENT_90	[p8l348t47r506b97],
10	collected	VBN	O	collect	_	0	SENT_90	[p8l537t24r919b97],
11	just	RB	O	just	advmod	10	SENT_90	[p8l936t24r1098b118],
12	before	IN	O	before	_	0	SENT_90	[p8l1121t24r1391b97],
13	administration	NN	O	administration	prep_before	10	SENT_90	[p8l1420t24r2032b97],
14	of	IN	O	of	_	0	SENT_90	[p8l2060t24r2150b97],
15	the	DT	O	the	det	17	SENT_90	[p8l22t152r148b225],
16	morning	NN	TIME	morning	nn	17	SENT_90	[p8l170t152r526b246],
17	dose	NN	O	dose	prep_of	13	SENT_90	[p8l549t152r762b225],
18	.	.	O	.	_	0	SENT_90	[p8l549t152r762b225],

1	Plasma	NN	O	plasma	nsubjpass	3	SENT_91	[p8l788t152r1094b225],
2	was	VBD	O	be	auxpass	3	SENT_91	[p8l1114t175r1273b225],
3	separated	VBN	O	separate	_	0	SENT_91	[p8l1299t152r1696b246],
4	and	CC	O	and	_	0	SENT_91	[p8l1718t152r1866b225],
5	stored	VBN	O	store	conj_and	3	SENT_91	[p8l1890t152r2144b225],
6	at	IN	O	at	_	0	SENT_91	[p8l25t291r98b353],
7	-20	CD	NUMBER	-20	number	8	SENT_91	[p8l129t280r285b353],
8	°	CD	NUMBER	°	num	9	SENT_91	[p8l326t280r429b353],
9	C	NN	O	c	npadvmod	10	SENT_91	[p8l326t280r429b353],
10	pending	JJ	O	pending	amod	11	SENT_91	[p8l465t280r805b374],
11	analysis	NN	O	analysis	prep_at	3	SENT_91	[p8l843t280r1203b374],
12	.	.	O	.	_	0	SENT_91	[p8l843t280r1203b374],

1	After	IN	O	after	_	0	SENT_92	[p8l1244t280r1467b353],
2	solid	JJ	O	solid	amod	4	SENT_92	[p8l1504t280r1705b353],
3	phase	NN	O	phase	nn	4	SENT_92	[p8l1737t280r1977b374],
4	extraction	NN	O	extraction	prep_after	25	SENT_92	[p8l2013t303r2142b353, p8l22t408r368b494],
5	,	,	O	,	_	0	SENT_92	[p8l2013t303r2142b353, p8l22t408r368b494],
6	plasma	NN	O	plasma	nn	7	SENT_92	[p8l395t408r697b502],
7	concentrations	NNS	O	concentration	prep_after	25	SENT_92	[p8l720t408r1336b481],
8	of	IN	O	of	_	0	SENT_92	[p8l1364t408r1456b481],
9	bosentan	NN	O	bosentan	prep_of	7	SENT_92	[p8l1472t408r1849b481],
10	and	CC	O	and	_	0	SENT_92	[p8l1875t408r2023b481],
11	its	PRP$	O	its	poss	13	SENT_92	[p8l2046t408r2142b481],
12	three	CD	NUMBER	three	num	13	SENT_92	[p8l22t536r231b609],
13	metabolites	NNS	O	metabolite	conj_and	4	SENT_92	[p8l253t536r740b609],
14	(	CD	NUMBER	(	num	15	SENT_92	[p8l767t537r917b625],
15	Ro	NN	O	ro	dep	13	SENT_92	[p8l767t537r917b625],
16	47-8634	CD	NUMBER	47-8634	dep	13	SENT_92	[p8l940t536r1314b622],
17	,	,	O	,	_	0	SENT_92	[p8l940t536r1314b622],
18	Ro	NN	O	ro	nsubjpass	25	SENT_92	[p8l1340t538r1458b609],
19	48-5033	CD	NUMBER	48-5033	num	18	SENT_92	[p8l1480t535r1826b609],
20	and	CC	O	and	_	0	SENT_92	[p8l1855t536r2004b609],
21	Ro	NN	O	ro	nn	23	SENT_92	[p8l2024t537r2142b609],
22	64-1056	CD	NUMBER	64-1056	num	23	SENT_92	[p8l24t664r406b754],
23	)	NN	O	)	conj_and	18	SENT_92	[p8l24t664r406b754],
24	were	VBD	O	be	auxpass	25	SENT_92	[p8l430t687r633b737],
25	determined	VBN	O	determine	_	0	SENT_92	[p8l656t664r1132b737],
26	with	IN	O	with	_	0	SENT_92	[p8l1152t664r1338b737],
27	a	DT	O	a	det	31	SENT_92	[p8l1361t687r1404b737],
28	slightly	RB	O	slightly	advmod	31	SENT_92	[p8l1428t664r1741b759],
29	modified	VBN	O	modify	amod	31	SENT_92	[p8l1762t664r2144b737],
30	liquid	JJ	O	liquid	amod	31	SENT_92	[p8l22t792r269b887],
31	chromatography	NN	O	chromatography	prep_with	25	SENT_92	[p8l298t792r990b887],
32	assay	NN	O	assay	nn	33	SENT_92	[p8l1022t815r1247b887],
33	method	NN	O	method	nsubjpass	45	SENT_92	[p8l1276t792r1592b865],
34	with	IN	O	with	_	0	SENT_92	[p8l1620t792r1806b865],
35	tandem	JJ	O	tandem	amod	38	SENT_92	[p8l1834t792r2145b865],
36	mass	NN	O	mass	nn	38	SENT_92	[p8l22t943r229b993],
37	spectrometry	NN	O	spectrometry	nn	38	SENT_92	[p8l256t931r806b1015],
38	detection	NN	O	detection	prep_with	33	SENT_92	[p8l829t920r1239b1006],
39	,	,	O	,	_	0	SENT_92	[p8l829t920r1239b1006],
40	details	NNS	O	detail	appos	38	SENT_92	[p8l1266t920r1538b993],
41	of	IN	O	of	_	0	SENT_92	[p8l1563t920r1654b993],
42	which	WDT	O	which	prep_of	33	SENT_92	[p8l1668t920r1925b993],
43	have	VBP	O	have	aux	45	SENT_92	[p8l1945t920r2143b993],
44	been	VBN	O	be	auxpass	45	SENT_92	[p8l21t1047r220b1120],
45	provided	VBN	O	provide	rcmod	31	SENT_92	[p8l252t1047r630b1142],
46	preViously	RB	DATE	previously	advmod	45	SENT_92	[p8l662t1037r1259b1142],
47	.	.	O	.	_	0	SENT_92	[p8l662t1037r1259b1142],

1	[	NN	O	[	nsubj	10	SENT_93	[p8l662t1037r1259b1142],
2	21	CD	NUMBER	21	number	3	SENT_93	[p8l662t1037r1259b1142],
3	]	CD	NUMBER	]	num	5	SENT_93	[p8l662t1037r1259b1142],
4	The	DT	O	the	det	5	SENT_93	[p8l1298t1048r1458b1121],
5	limit	NN	O	limit	dep	1	SENT_93	[p8l1494t1048r1694b1121],
6	of	IN	O	of	_	0	SENT_93	[p8l1728t1048r1819b1121],
7	quantification	NN	O	quantification	prep_of	1	SENT_93	[p8l1847t1048r2142b1142, p8l22t1176r345b1249],
8	was	VBD	O	be	cop	10	SENT_93	[p8l386t1198r545b1249],
9	1	CD	NUMBER	1	num	10	SENT_93	[p8l598t1176r628b1247],
10	ug/L	NN	O	ug/l	_	0	SENT_93	[p8l680t1176r882b1271],
11	for	IN	O	for	_	0	SENT_93	[p8l923t1176r1045b1249],
12	bosentan	NN	O	bosentan	prep_for	10	SENT_93	[p8l1083t1176r1460b1249],
13	and	CC	O	and	_	0	SENT_93	[p8l1502t1176r1651b1249],
14	2	CD	NUMBER	2	num	15	SENT_93	[p8l1691t1176r1738b1247],
15	ug/L	NN	O	ug/l	conj_and	10	SENT_93	[p8l1781t1176r1983b1271],
16	for	IN	O	for	_	0	SENT_93	[p8l2023t1176r2145b1249],
17	each	DT	O	each	prep_for	15	SENT_93	[p8l23t1304r214b1377],
18	of	IN	O	of	_	0	SENT_93	[p8l255t1304r345b1377],
19	the	DT	O	the	det	21	SENT_93	[p8l378t1304r504b1377],
20	three	CD	NUMBER	three	num	21	SENT_93	[p8l544t1304r753b1377],
21	metabolites	NNS	O	metabolite	prep_of	17	SENT_93	[p8l793t1304r1303b1377],
22	.	.	O	.	_	0	SENT_93	[p8l793t1304r1303b1377],

1	Imprecision	NN	O	imprecision	nsubj	5	SENT_94	[p8l1348t1304r1854b1398],
2	of	IN	O	of	_	0	SENT_94	[p8l1894t1304r1985b1377],
3	the	DT	O	the	det	4	SENT_94	[p8l2017t1304r2143b1377],
4	assay	NN	O	assay	prep_of	1	SENT_94	[p8l25t1455r249b1527],
5	was	VBD	O	be	_	0	SENT_94	[p8l277t1455r436b1505],
6	up	RB	O	up	advmod	5	SENT_94	[p8l465t1455r567b1527],
7	to	TO	O	to	_	0	SENT_94	[p8l596t1443r674b1505],
8	7.7	CD	PERCENT	7.7	num	9	SENT_94	[p8l704t1432r916b1505],
9	%	NN	PERCENT	%	prep_to	6	SENT_94	[p8l704t1432r916b1505],
10	for	IN	O	for	_	0	SENT_94	[p8l948t1432r1071b1505],
11	bosentan	NN	O	bosentan	prep_for	5	SENT_94	[p8l1095t1432r1472b1505],
12	and	CC	O	and	_	0	SENT_94	[p8l1500t1432r1649b1505],
13	its	PRP$	O	its	poss	14	SENT_94	[p8l1675t1432r1770b1505],
14	metabolites	NNS	O	metabolite	nsubj	18	SENT_94	[p8l1799t1432r2142b1505, p8l22t1560r195b1633],
15	and	CC	O	and	_	0	SENT_94	[p8l239t1560r388b1633],
16	inaccuracy	NN	O	inaccuracy	nsubj	18	SENT_94	[p8l426t1560r884b1655],
17	was	VBD	O	be	cop	18	SENT_94	[p8l925t1583r1083b1633],
18	<	JJR	O	<	conj_and	5	SENT_94	[p8l1126t1561r1423b1633],
19	8.0	CD	PERCENT	8.0	num	20	SENT_94	[p8l1126t1561r1423b1633],
20	%	NN	PERCENT	%	dep	18	SENT_94	[p8l1126t1561r1423b1633],
21	.	.	O	.	_	0	SENT_94	[p8l1126t1561r1423b1633],

1	Plasma	NN	O	plasma	nn	2	SENT_95	[p8l1468t1560r1774b1633],
2	concentrations	NNS	O	concentration	_	0	SENT_95	[p8l1811t1583r2142b1633, p8l22t1687r347b1760],
3	of	IN	O	of	_	0	SENT_95	[p8l401t1687r493b1760],
4	simvastatin	NN	O	simvastatin	prep_of	2	SENT_95	[p8l539t1687r1031b1760],
5	and	CC	O	and	_	0	SENT_95	[p8l1084t1687r1234b1760],
6	B	NN	O	b	conj_and	4	SENT_95	[p8l1286t1681r1913b1782],
7	—	CD	NUMBER	—	num	9	SENT_95	[p8l1286t1681r1913b1782],
8	hydroXyacid	NN	O	hydroxyacid	nn	9	SENT_95	[p8l1286t1681r1913b1782],
9	simClin	NN	O	simclin	dep	2	SENT_95	[p8l1962t1687r2142b1760, p8l1211t1970r1319b2018],

1	Phormocokinet	NNP	O	Phormocokinet	_	0	SENT_96	[p8l1344t1970r1800b2018],
2	2003	CD	DATE	2003	num	1	SENT_96	[p8l1818t1970r1969b2021],
3	;	:	O	;	_	0	SENT_96	[p8l1818t1970r1969b2021],
4	42	CD	NUMBER	42	number	5	SENT_96	[p8l1989t1970r2055b2017],
5	(	CD	NUMBER	(	dep	1	SENT_96	[p8l2078t1970r2152b2025],
6	3	CD	NUMBER	3	num	7	SENT_96	[p8l2078t1970r2152b2025],
7	)	NN	O	)	dep	5	SENT_96	[p8l2078t1970r2152b2025],

1	296	CD	NUMBER	296	num	2	SENT_97	[p8l191t2101r240b2126],
2	Dingemanse	NNP	O	Dingemanse	_	0	SENT_97	[p8l1725t2100r1893b2134],
3	et	FW	O	et	nn	4	SENT_97	[p8l1903t2103r1926b2125],
4	ul	FW	O	ul	dep	2	SENT_97	[p8l1935t2100r1965b2125],
5	.	.	O	.	_	0	SENT_97	[p8l1935t2100r1965b2125],

1	Vastatin	NNP	O	Vastatin	nsubjpass	3	SENT_98	[p8l8t2348r353b2422],
2	were	VBD	O	be	auxpass	3	SENT_98	[p8l400t2372r610b2422],
3	determined	VBN	O	determine	_	0	SENT_98	[p8l658t2348r1155b2421],
4	by	IN	O	by	_	0	SENT_98	[p8l1200t2348r1305b2444],
5	a	DT	O	a	det	9	SENT_98	[p8l1356t2372r1399b2421],
6	Validated	NNP	O	Validated	nn	9	SENT_98	[p8l1445t2348r1852b2422],
7	liquid	NN	O	liquid	nn	9	SENT_98	[p8l1897t2348r2152b2444],
8	chromatography	NN	O	chromatography	nn	9	SENT_98	[p8l9t2473r730b2569],
9	method	NN	O	method	agent	3	SENT_98	[p8l778t2473r1129b2546],
10	.	.	O	.	_	0	SENT_98	[p8l778t2473r1129b2546],

1	The	DT	O	the	det	3	SENT_99	[p8l1182t2473r1348b2546],
2	detection	NN	O	detection	nn	3	SENT_99	[p8l1397t2473r1802b2546],
3	system	NN	O	system	nsubj	4	SENT_99	[p8l1852t2484r2153b2569],
4	consisted	VBD	O	consist	_	0	SENT_99	[p8l9t2598r405b2671],
5	of	IN	O	of	_	0	SENT_99	[p8l438t2598r530b2671],
6	tandem	JJ	O	tandem	amod	8	SENT_99	[p8l554t2598r868b2671],
7	mass	NN	O	mass	nn	8	SENT_99	[p8l898t2622r1106b2671],
8	spectrometry	NN	O	spectrometry	prep_of	4	SENT_99	[p8l1144t2609r1697b2694],
9	with	IN	O	with	_	0	SENT_99	[p8l1729t2598r1916b2672],
10	electrospray	NN	O	electrospray	nn	11	SENT_99	[p8l1949t2598r2150b2671, p8l8t2734r356b2819],
11	ionisation	NN	O	ionisation	prep_with	8	SENT_99	[p8l384t2723r806b2796],
12	(	CD	NUMBER	(	num	13	SENT_99	[p8l836t2724r1058b2814],
13	ESI	NNP	ORGANIZATION	ESI	dobj	4	SENT_99	[p8l836t2724r1058b2814],
14	)	CD	NUMBER	)	num	13	SENT_99	[p8l836t2724r1058b2814],
15	Working	VBG	O	work	partmod	13	SENT_99	[p8l1090t2723r1441b2819],
16	in	IN	O	in	_	0	SENT_99	[p8l1470t2723r1551b2795],
17	the	DT	O	the	det	20	SENT_99	[p8l1578t2723r1706b2796],
18	combined	JJ	O	combined	amod	20	SENT_99	[p8l1734t2723r2153b2796],
19	ESI	NNP	ORGANIZATION	ESI	nn	20	SENT_99	[p8l8t2848r611b2939],
20	(	NN	O	(	prep_in	15	SENT_99	[p8l8t2848r611b2939],
21	.	.	O	.	_	0	SENT_99	[p8l8t2848r611b2939],

1	—	NN	O	—	_	0	SENT_100	[p8l8t2848r611b2939],
2	.	.	O	.	_	0	SENT_100	[p8l8t2848r611b2939],
3	)	SYM	O	)	dep	1	SENT_100	[p8l8t2848r611b2939],

1	/	:	O	/	punct	23	SENT_101	[p8l8t2848r611b2939],
2	ESI	NNP	O	ESI	dep	15	SENT_101	[p8l8t2848r611b2939],
3	(	CD	NUMBER	(	num	2	SENT_101	[p8l8t2848r611b2939],
4	+	CC	O	+	_	0	SENT_101	[p8l8t2848r611b2939],
5	)	CD	NUMBER	)	num	6	SENT_101	[p8l8t2848r611b2939],
6	mode	NN	O	mode	dep	15	SENT_101	[p8l655t2848r888b2921],
7	and	CC	O	and	_	0	SENT_101	[p8l932t2848r1082b2921],
8	multiple	JJ	O	multiple	amod	10	SENT_101	[p8l1122t2848r1476b2944],
9	reaction	NN	O	reaction	nn	10	SENT_101	[p8l1516t2848r1861b2921],
10	monitoring	NN	O	monitoring	conj_and	2	SENT_101	[p8l1901t2848r2151b2921, p8l8t2972r269b3068],
11	of	IN	O	of	_	0	SENT_101	[p8l315t2972r408b3046],
12	indicative	JJ	O	indicative	amod	13	SENT_101	[p8l444t2972r881b3046],
13	precursor/product	NN	O	precursor/product	prep_of	10	SENT_101	[p8l923t2972r1717b3068],
14	ion	NN	O	ion	dep	15	SENT_101	[p8l1757t2972r1895b3046],
15	pairs	NNS	O	pair	dep	21	SENT_101	[p8l1936t2972r2148b3068],
16	of	IN	O	of	_	0	SENT_101	[p8l9t3097r103b3171],
17	simvastatin	NN	O	simvastatin	prep_of	15	SENT_101	[p8l163t3097r664b3172],
18	and	CC	O	and	_	0	SENT_101	[p8l729t3097r882b3171],
19	[	NN	O	[	conj_and	17	SENT_101	[p8l948t3091r1581b3193],
20	3	CD	NUMBER	3	num	21	SENT_101	[p8l948t3091r1581b3193],
21	—	NN	O	—	dep	23	SENT_101	[p8l948t3091r1581b3193],
22	hydroXyacid	NN	O	hydroxyacid	nn	23	SENT_101	[p8l948t3091r1581b3193],
23	simvastatin	NN	O	simvastatin	_	0	SENT_101	[p8l1631t3097r2146b3171],
24	.	.	O	.	_	0	SENT_101	[p8l1631t3097r2146b3171],

1	Lovastatin	NN	MISC	lovastatin	nsubjpass	9	SENT_102	[p8l8t3222r473b3296],
2	and	CC	O	and	_	0	SENT_102	[p8l541t3222r694b3296],
3	[	NN	O	[	nsubjpass	9	SENT_102	[p8l763t3216r1404b3318],
4	3	CD	NUMBER	3	num	7	SENT_102	[p8l763t3216r1404b3318],
5	—	NN	O	—	nn	7	SENT_102	[p8l763t3216r1404b3318],
6	hydroXyacid	NN	O	hydroxyacid	nn	7	SENT_102	[p8l763t3216r1404b3318],
7	lovastatin	NN	O	lovastatin	dep	1	SENT_102	[p8l1459t3222r1889b3297],
8	were	VBD	O	be	auxpass	9	SENT_102	[p8l1943t3246r2151b3297],
9	used	VBN	O	use	_	0	SENT_102	[p8l7t3347r202b3421],
10	as	IN	O	as	_	0	SENT_102	[p8l232t3371r313b3421],
11	internal	JJ	O	internal	amod	12	SENT_102	[p8l345t3347r670b3421],
12	standards	NNS	O	standard	prep_as	9	SENT_102	[p8l703t3347r1123b3421],
13	.	.	O	.	_	0	SENT_102	[p8l703t3347r1123b3421],

1	The	DT	O	the	det	2	SENT_103	[p8l1157t3347r1319b3421],
2	limit	NN	O	limit	nsubj	7	SENT_103	[p8l1349t3347r1550b3421],
3	of	IN	O	of	_	0	SENT_103	[p8l1578t3347r1669b3421],
4	quantification	NN	O	quantification	prep_of	2	SENT_103	[p8l1692t3347r2150b3443, p8l8t3472r172b3546],
5	was	VBD	O	be	cop	7	SENT_103	[p8l202t3496r361b3547],
6	0.2	CD	NUMBER	0.2	num	7	SENT_103	[p8l394t3473r523b3547],
7	ug/L	NN	O	ug/l	_	0	SENT_103	[p8l555t3473r759b3568],
8	for	IN	O	for	_	0	SENT_103	[p8l789t3472r912b3546],
9	simvastatin	NN	O	simvastatin	prep_for	7	SENT_103	[p8l943t3472r1426b3546],
10	and	CC	O	and	_	0	SENT_103	[p8l1457t3472r1606b3546],
11	0.1	CD	NUMBER	0.1	num	12	SENT_103	[p8l1636t3473r1756b3547],
12	ug/L	NN	O	ug/l	conj_and	7	SENT_103	[p8l1797t3473r2001b3568],
13	for	IN	O	for	_	0	SENT_103	[p8l2030t3472r2153b3546],
14	[	CD	NUMBER	[	number	15	SENT_103	[p8l13t3591r635b3693],
15	3	CD	NUMBER	3	prep_for	12	SENT_103	[p8l13t3591r635b3693],
16	—	NN	O	—	nn	18	SENT_103	[p8l13t3591r635b3693],
17	hydroXyacid	NN	O	hydroxyacid	nn	18	SENT_103	[p8l13t3591r635b3693],
18	simvastatin	NN	O	simvastatin	dep	15	SENT_103	[p8l670t3597r1174b3671],
19	.	.	O	.	_	0	SENT_103	[p8l670t3597r1174b3671],

1	Imprecision	NN	O	imprecision	_	0	SENT_104	[p8l1213t3597r1722b3693],
2	of	IN	O	of	_	0	SENT_104	[p8l1755t3597r1846b3671],
3	the	DT	O	the	det	4	SENT_104	[p8l1872t3597r1998b3671],
4	assay	NN	O	assay	prep_of	1	SENT_104	[p8l2033t3621r2150b3671, p9l12t48r148b120],

1	was	VBD	O	be	cop	13	SENT_105	[p9l196t48r359b99],
2	up	RB	O	up	advmod	13	SENT_105	[p9l406t48r510b120],
3	to	TO	O	to	_	0	SENT_105	[p9l557t36r636b98],
4	7.7	CD	PERCENT	7.7	num	5	SENT_105	[p9l684t25r900b99],
5	%	NN	PERCENT	%	prep_to	2	SENT_105	[p9l684t25r900b99],
6	for	IN	O	for	_	0	SENT_105	[p9l951t24r1076b98],
7	(	CD	NUMBER	(	prep_for	5	SENT_105	[p9l1122t19r1816b120],
8	[	CD	NUMBER	[	number	9	SENT_105	[p9l1122t19r1816b120],
9	3	CD	NUMBER	3	num	13	SENT_105	[p9l1122t19r1816b120],
10	—	NN	O	—	nn	13	SENT_105	[p9l1122t19r1816b120],
11	hydroXyacid	NN	O	hydroxyacid	nn	13	SENT_105	[p9l1122t19r1816b120],
12	)	CD	NUMBER	)	num	13	SENT_105	[p9l1122t19r1816b120],
13	simvastatin	NN	O	simvastatin	csubj	17	SENT_105	[p9l1868t24r2150b99, p9l12t149r238b223],
14	and	CC	O	and	_	0	SENT_105	[p9l266t150r416b223],
15	inaccuracy	NN	O	inaccuracy	csubj	17	SENT_105	[p9l441t149r901b245],
16	was	VBD	O	be	cop	17	SENT_105	[p9l928t173r1087b224],
17	<	JJR	O	<	_	0	SENT_105	[p9l1116t168r1170b223],
18	7.0	CD	PERCENT	7.0	num	19	SENT_105	[p9l1197t150r1437b224],
19	%	NN	PERCENT	%	dep	17	SENT_105	[p9l1197t150r1437b224],
20	.	.	O	.	_	0	SENT_105	[p9l1197t150r1437b224],

1	Vital	JJ	O	vital	amod	2	SENT_106	[p9l1468t149r1679b223],
2	signs	NNS	O	sign	nsubjpass	15	SENT_106	[p9l1708t149r1920b245],
3	(	IN	O	(	_	0	SENT_106	[p9l1950t150r2149b245, p9l8t274r195b348],
4	systolic	JJ	O	systolic	amod	8	SENT_106	[p9l1950t150r2149b245, p9l8t274r195b348],
5	and	CC	O	and	_	0	SENT_106	[p9l235t274r385b348],
6	diastolic	JJ	O	diastolic	amod	8	SENT_106	[p9l421t274r780b348],
7	blood	NN	O	blood	nn	8	SENT_106	[p9l816t275r1059b348],
8	pressure	NN	O	pressure	prep_(	2	SENT_106	[p9l1093t298r1472b370],
9	,	,	O	,	_	0	SENT_106	[p9l1093t298r1472b370],
10	and	CC	O	and	_	0	SENT_106	[p9l1514t275r1663b348],
11	pulse	NN	O	pulse	nn	12	SENT_106	[p9l1697t275r1921b370],
12	rate	NN	O	rate	prep_(	2	SENT_106	[p9l1956t275r2148b365],
13	)	CD	NUMBER	)	dep	12	SENT_106	[p9l1956t275r2148b365],
14	were	VBD	O	be	auxpass	15	SENT_106	[p9l8t423r212b474],
15	measured	VBN	O	measure	_	0	SENT_106	[p9l259t399r667b473],
16	at	IN	O	at	_	0	SENT_106	[p9l715t410r789b473],
17	several	JJ	O	several	amod	19	SENT_106	[p9l837t400r1134b474],
18	time	NN	O	time	nn	19	SENT_106	[p9l1180t399r1367b473],
19	points	NNS	O	point	prep_at	15	SENT_106	[p9l1412t399r1670b495],
20	after	IN	O	after	_	0	SENT_106	[p9l1721t399r1914b473],
21	drug	NN	O	drug	nn	22	SENT_106	[p9l1959t399r2150b495],
22	intake	NN	O	intake	prep_after	15	SENT_106	[p9l8t524r267b598],
23	with	IN	O	with	_	0	SENT_106	[p9l309t524r496b598],
24	subjects	NNS	O	subject	prep_with	22	SENT_106	[p9l540t524r878b620],
25	in	IN	O	in	_	0	SENT_106	[p9l921t524r1001b597],
26	a	DT	O	a	det	28	SENT_106	[p9l1044t548r1087b598],
27	sitting	VBG	O	sit	amod	28	SENT_106	[p9l1131t524r1392b620],
28	position	NN	O	position	prep_in	24	SENT_106	[p9l1432t524r1799b620],
29	.	.	O	.	_	0	SENT_106	[p9l1432t524r1799b620],

1	All	DT	O	all	det	3	SENT_107	[p9l1845t524r1978b597],
2	adverse	JJ	O	adverse	amod	3	SENT_107	[p9l2022t524r2150b598, p9l8t673r234b723],
3	events	NNS	O	event	nsubjpass	11	SENT_107	[p9l281t661r552b724],
4	reported	VBN	O	report	partmod	3	SENT_107	[p9l599t649r960b745],
5	during	IN	O	during	_	0	SENT_107	[p9l1006t649r1284b745],
6	the	DT	O	the	det	7	SENT_107	[p9l1331t649r1460b723],
7	study	NN	O	study	prep_during	4	SENT_107	[p9l1510t649r1737b745],
8	Were	VBD	O	be	auxpass	9	SENT_107	[p9l1784t673r1989b724],
9	recorded	VBN	O	record	_	0	SENT_107	[p9l2035t673r2150b723, p9l9t775r297b848],
10	and	CC	O	and	_	0	SENT_107	[p9l329t775r479b848],
11	rated	VBN	O	rate	conj_and	9	SENT_107	[p9l508t775r722b848],
12	as	IN	O	as	_	0	SENT_107	[p9l754t798r835b848],
13	mild	JJ	O	mild	prep_as	9	SENT_107	[p9l868t775r1084b862],
14	,	,	O	,	_	0	SENT_107	[p9l868t775r1084b862],
15	moderate	JJ	O	moderate	prep_as	9	SENT_107	[p9l1119t775r1514b848],
16	or	CC	O	or	_	0	SENT_107	[p9l1547t798r1633b848],
17	severe	JJ	O	severe	conj_or	13	SENT_107	[p9l1666t798r1954b848],
18	.	.	O	.	_	0	SENT_107	[p9l1666t798r1954b848],

1	Evoluotion	NN	O	evoluotion	_	0	SENT_108	[p9l139t1051r604b1122],

1	The	DT	O	the	det	3	SENT_109	[p9l134t1285r297b1358],
2	pharmacokinetic	JJ	O	pharmacokinetic	amod	3	SENT_109	[p9l343t1285r1063b1381],
3	evaluation	NN	O	evaluation	nsubjpass	19	SENT_109	[p9l1112t1285r1561b1359],
4	for	IN	O	for	_	0	SENT_109	[p9l1606t1285r1730b1358],
5	bosentan	NN	O	bosentan	prep_for	3	SENT_109	[p9l1771t1285r2152b1358],
6	and	CC	O	and	_	0	SENT_109	[p9l11t1411r160b1484],
7	its	PRP$	O	its	poss	8	SENT_109	[p9l196t1411r292b1484],
8	metabolites	NNS	O	metabolite	prep_for	3	SENT_109	[p9l331t1411r820b1484],
9	as	RB	O	as	_	0	SENT_109	[p9l861t1435r942b1484],
10	well	RB	O	well	_	0	SENT_109	[p9l982t1411r1162b1484],
11	as	IN	O	as	_	0	SENT_109	[p9l1201t1435r1282b1484],
12	for	IN	O	for	_	0	SENT_109	[p9l1321t1411r1444b1484],
13	simvastatin	NN	O	simvastatin	nn	17	SENT_109	[p9l1482t1411r1964b1484],
14	and	CC	O	and	_	0	SENT_109	[p9l2003t1411r2152b1484],
15	[	NN	O	[	nn	17	SENT_109	[p9l13t1529r653b1631],
16	3-hydroxyacid	JJ	O	3-hydroxyacid	amod	17	SENT_109	[p9l13t1529r653b1631],
17	simvastatin	NN	O	simvastatin	conj_and	5	SENT_109	[p9l703t1535r1201b1609],
18	was	VBD	O	be	auxpass	19	SENT_109	[p9l1248t1559r1411b1609],
19	performed	VBN	O	perform	_	0	SENT_109	[p9l1458t1535r1914b1631],
20	with	IN	O	with	_	0	SENT_109	[p9l1960t1535r2151b1609],
21	model	NN	O	model	npadvmod	23	SENT_109	[p9l8t1660r835b1756],
22	—	CD	NUMBER	—	num	21	SENT_109	[p9l8t1660r835b1756],
23	independent	JJ	O	independent	amod	24	SENT_109	[p9l8t1660r835b1756],
24	methods	NNS	O	method	prep_with	19	SENT_109	[p9l869t1649r1378b1734],
25	.	.	O	.	_	0	SENT_109	[p9l869t1649r1378b1734],

1	[	NN	O	[	nsubjpass	20	SENT_110	[p9l869t1649r1378b1734],
2	22	CD	NUMBER	22	number	3	SENT_110	[p9l869t1649r1378b1734],
3	]	CD	NUMBER	]	dep	1	SENT_110	[p9l869t1649r1378b1734],
4	The	DT	O	the	det	10	SENT_110	[p9l1418t1660r1580b1734],
5	peak	NN	O	peak	nn	10	SENT_110	[p9l1616t1660r1818b1756],
6	plasma	NN	O	plasma	nn	10	SENT_110	[p9l1850t1660r2153b1756],
7	concentration	NN	O	concentration	nn	10	SENT_110	[p9l9t1785r591b1859],
8	(	CD	NUMBER	(	num	10	SENT_110	[p9l640t1785r902b1876],
9	Cmax	NN	O	cmax	nn	10	SENT_110	[p9l640t1785r902b1876],
10	)	NN	O	)	dep	3	SENT_110	[p9l640t1785r902b1876],
11	and	CC	O	and	_	0	SENT_110	[p9l953t1785r1103b1859],
12	the	DT	O	the	det	13	SENT_110	[p9l1148t1785r1276b1859],
13	time	NN	O	time	conj_and	1	SENT_110	[p9l1322t1785r1509b1859],
14	to	TO	O	to	_	0	SENT_110	[p9l1555t1796r1634b1859],
15	Cmax	NNP	O	Cmax	prep_to	13	SENT_110	[p9l1683t1786r1878b1874],
16	(	CD	NUMBER	(	num	15	SENT_110	[p9l1927t1786r2148b1876],
17	tmax	NN	O	tmax	nn	18	SENT_110	[p9l1927t1786r2148b1876],
18	)	NN	O	)	dep	13	SENT_110	[p9l1927t1786r2148b1876],
19	were	VBD	O	be	auxpass	20	SENT_110	[p9l9t1935r217b1985],
20	read	VBN	O	read	_	0	SENT_110	[p9l263t1911r451b1985],
21	directly	RB	O	directly	advmod	20	SENT_110	[p9l498t1911r833b2006],
22	from	IN	O	from	_	0	SENT_110	[p9l881t1911r1092b1985],
23	the	DT	O	the	det	27	SENT_110	[p9l1137t1911r1268b1985],
24	concentration	NN	O	concentration	nn	27	SENT_110	[p9l1316t1911r2150b1985],
25	—	CD	NUMBER	—	num	27	SENT_110	[p9l1316t1911r2150b1985],
26	time	NN	O	time	nn	27	SENT_110	[p9l1316t1911r2150b1985],
27	data	NNS	O	datum	prep_from	20	SENT_110	[p9l9t2042r209b2115],
28	.	.	O	.	_	0	SENT_110	[p9l9t2042r209b2115],

1	Area	NN	O	area	nsubj	16	SENT_111	[p9l261t2043r469b2115],
2	under	IN	O	under	_	0	SENT_111	[p9l513t2042r759b2115],
3	the	DT	O	the	det	8	SENT_111	[p9l803t2042r932b2115],
4	plasma	NN	O	plasma	nn	8	SENT_111	[p9l977t2042r1282b2137],
5	concentration	NN	O	concentration	nn	8	SENT_111	[p9l1327t2042r2145b2115],
6	—	CD	NUMBER	—	num	8	SENT_111	[p9l1327t2042r2145b2115],
7	time	NN	O	time	nn	8	SENT_111	[p9l1327t2042r2145b2115],
8	curve	NN	O	curve	prep_under	1	SENT_111	[p9l9t2196r241b2246],
9	over	IN	O	over	_	0	SENT_111	[p9l273t2196r461b2246],
10	one	CD	NUMBER	one	num	12	SENT_111	[p9l488t2196r637b2246],
11	administration	NN	O	administration	nn	12	SENT_111	[p9l669t2173r1283b2246],
12	interval	NN	O	interval	prep_over	8	SENT_111	[p9l1312t2173r1636b2246],
13	of	IN	O	of	_	0	SENT_111	[p9l1667t2173r1758b2246],
14	12	CD	DURATION	12	num	15	SENT_111	[p9l1790t2173r1882b2245],
15	hours	NNS	NUMBER	hour	prep_of	12	SENT_111	[p9l1911t2173r2143b2246],
16	(	VBP	O	(	_	0	SENT_111	[p9l12t2303r329b2392],
17	AUCT	NN	O	auct	nn	18	SENT_111	[p9l12t2303r329b2392],
18	)	NN	O	)	nsubjpass	20	SENT_111	[p9l12t2303r329b2392],
19	was	VBD	O	be	auxpass	20	SENT_111	[p9l366t2326r525b2376],
20	estimated	VBN	O	estimate	ccomp	16	SENT_111	[p9l562t2302r969b2376],
21	with	IN	O	with	_	0	SENT_111	[p9l1002t2302r1188b2376],
22	use	NN	O	use	prep_with	20	SENT_111	[p9l1220t2326r1360b2376],
23	of	IN	O	of	_	0	SENT_111	[p9l1395t2302r1486b2376],
24	the	DT	O	the	det	27	SENT_111	[p9l1512t2303r1639b2376],
25	linear	JJ	O	linear	amod	27	SENT_111	[p9l1673t2302r1916b2376],
26	trapezoidal	JJ	O	trapezoidal	amod	27	SENT_111	[p9l1947t2313r2143b2397, p9l9t2434r314b2507],
27	rule	NN	O	rule	prep_of	22	SENT_111	[p9l335t2434r521b2507],
28	.	.	O	.	_	0	SENT_111	[p9l335t2434r521b2507],

1	The	DT	O	the	det	6	SENT_112	[p9l547t2434r709b2507],
2	terminal	JJ	O	terminal	amod	6	SENT_112	[p9l731t2434r1084b2507],
3	elimination	NN	O	elimination	nn	6	SENT_112	[p9l1107t2434r1592b2507],
4	rate	NN	O	rate	nn	6	SENT_112	[p9l1611t2445r1770b2507],
5	constant	JJ	O	constant	amod	6	SENT_112	[p9l1792t2445r2147b2507],
6	ll	NN	O	ll	nsubjpass	13	SENT_112	[p9l9t2559r95b2652],
7	of	IN	O	of	_	0	SENT_112	[p9l134t2564r226b2638],
8	simvastatin	NN	O	simvastatin	nn	11	SENT_112	[p9l268t2564r749b2639],
9	and	CC	O	and	_	0	SENT_112	[p9l797t2564r947b2638],
10	B-hydroxyacid	JJ	MISC	b-hydroxyacid	nn	11	SENT_112	[p9l996t2559r1617b2660],
11	simvastatin	NN	O	simvastatin	prep_of	6	SENT_112	[p9l1664t2564r2146b2639],
12	was	VBD	O	be	auxpass	13	SENT_112	[p9l8t2719r168b2769],
13	determined	VBN	O	determine	_	0	SENT_112	[p9l212t2695r690b2769],
14	by	IN	O	by	_	0	SENT_112	[p9l728t2695r831b2790],
15	log	NN	O	log	nn	19	SENT_112	[p9l873t2695r1288b2790],
16	—	CD	NUMBER	—	num	19	SENT_112	[p9l873t2695r1288b2790],
17	linear	JJ	O	linear	amod	19	SENT_112	[p9l873t2695r1288b2790],
18	regression	NN	O	regression	nn	19	SENT_112	[p9l1325t2695r1764b2790],
19	analysis	NN	O	analysis	agent	13	SENT_112	[p9l1806t2695r2143b2790],
20	of	IN	O	of	_	0	SENT_112	[p9l9t2826r100b2899],
21	the	DT	O	the	det	23	SENT_112	[p9l121t2826r248b2899],
22	terminal	JJ	O	terminal	amod	23	SENT_112	[p9l276t2826r629b2899],
23	phase	NN	O	phase	prep_of	13	SENT_112	[p9l656t2826r919b2921],
24	.	.	O	.	_	0	SENT_112	[p9l656t2826r919b2921],

1	The	DT	O	the	det	6	SENT_113	[p9l951t2826r1113b2899],
2	elimination	NN	O	elimination	nn	6	SENT_113	[p9l1141t2826r1626b2899],
3	half	NN	O	half	nn	6	SENT_113	[p9l1652t2826r1995b2899],
4	—	CD	NUMBER	—	num	6	SENT_113	[p9l1652t2826r1995b2899],
5	life	NN	O	life	nn	6	SENT_113	[p9l1652t2826r1995b2899],
6	t1/ZZ	NN	O	t1/zz	nsubjpass	8	SENT_113	[p9l2022t2837r2145b2923],
7	was	VBD	O	be	auxpass	8	SENT_113	[p9l8t2981r168b3032],
8	calculated	VBN	O	calculate	_	0	SENT_113	[p9l209t2957r641b3031],
9	by	IN	O	by	_	0	SENT_113	[p9l676t2958r780b3053],
10	dividing	VBG	O	divide	agent	8	SENT_113	[p9l820t2957r1171b3053],
11	ln	NN	O	ln	dobj	10	SENT_113	[p9l1210t2958r1290b3030],
12	2	CD	NUMBER	2	num	11	SENT_113	[p9l1347t2958r1394b3030],
13	by	IN	O	by	_	0	SENT_113	[p9l1432t2957r1535b3053],
14	M.	NN	O	m.	prep_by	11	SENT_113	[p9l1575t2952r1682b3046],
15	The	DT	O	the	det	17	SENT_113	[p9l1725t2957r1887b3031],
16	pharmacokinetic	JJ	O	pharmacokinetic	amod	17	SENT_113	[p9l1923t2958r2143b3053, p9l8t3089r526b3162],
17	parameters	NNS	O	parameter	nsubjpass	24	SENT_113	[p9l572t3100r1037b3184],
18	of	IN	O	of	_	0	SENT_113	[p9l1086t3089r1177b3162],
19	the	DT	O	the	det	21	SENT_113	[p9l1214t3089r1342b3162],
20	different	JJ	O	different	amod	21	SENT_113	[p9l1388t3089r1755b3162],
21	analytes	NNS	O	analyte	prep_of	17	SENT_113	[p9l1800t3089r2143b3184],
22	were	VBD	O	be	auxpass	24	SENT_113	[p9l8t3242r212b3292],
23	descriptively	RB	O	descriptively	advmod	24	SENT_113	[p9l253t3219r802b3314],
24	presented	VBN	O	present	rcmod	11	SENT_113	[p9l841t3219r1250b3314],
25	as	IN	O	as	_	0	SENT_113	[p9l1291t3242r1372b3292],
26	geometric	JJ	O	geometric	amod	27	SENT_113	[p9l1414t3219r1835b3314],
27	means	NNS	O	means	prep_as	24	SENT_113	[p9l1876t3242r2143b3292],
28	with	IN	O	with	_	0	SENT_113	[p9l8t3349r195b3422],
29	95	CD	PERCENT	95	number	30	SENT_113	[p9l224t3348r409b3423],
30	%	NN	PERCENT	%	amod	31	SENT_113	[p9l224t3348r409b3423],
31	CIs	NNS	O	ci	prep_with	24	SENT_113	[p9l443t3349r608b3422],
32	.	.	O	.	_	0	SENT_113	[p9l443t3349r608b3422],

1	The	DT	O	the	det	3	SENT_114	[p9l641t3349r803b3422],
2	pharmacokinetic	JJ	O	pharmacokinetic	amod	3	SENT_114	[p9l829t3349r1538b3443],
3	parameters	NNS	O	parameter	nsubjpass	8	SENT_114	[p9l1566t3360r2030b3443],
4	of	IN	O	of	_	0	SENT_114	[p9l2061t3349r2153b3422],
5	the	DT	O	the	det	6	SENT_114	[p9l8t3478r135b3551],
6	treatments	NNS	O	treatment	prep_of	3	SENT_114	[p9l167t3489r607b3551],
7	were	VBD	O	be	auxpass	8	SENT_114	[p9l641t3502r844b3552],
8	compared	VBN	O	compare	_	0	SENT_114	[p9l876t3478r1294b3573],
9	by	IN	O	by	_	0	SENT_114	[p9l1322t3478r1426b3573],
10	analysis	NN	O	analysis	agent	8	SENT_114	[p9l1460t3478r1797b3573],
11	of	IN	O	of	_	0	SENT_114	[p9l1832t3478r1923b3551],
12	variance	NN	O	variance	prep_of	10	SENT_114	[p9l1947t3478r2143b3552, p9l11t3631r200b3681],
13	(	CD	NUMBER	(	num	12	SENT_114	[p9l232t3609r676b3698],
14	ANOVA	NNP	ORGANIZATION	ANOVA	tmod	8	SENT_114	[p9l232t3609r676b3698],
15	)	CD	NUMBER	)	num	14	SENT_114	[p9l232t3609r676b3698],
16	with	IN	O	with	_	0	SENT_114	[p9l708t3608r894b3682],
17	the	DT	O	the	det	19	SENT_114	[p9l921t3608r1049b3681],
18	factors	NNS	O	factor	nn	19	SENT_114	[p9l1076t3608r1362b3681],
19	treatment	NN	O	treatment	prep_with	8	SENT_114	[p9l1392t3619r1816b3694],
20	,	,	O	,	_	0	SENT_114	[p9l1392t3619r1816b3694],
21	period	NN	O	period	appos	19	SENT_114	[p9l1846t3608r2141b3703],
22	,	,	O	,	_	0	SENT_114	[p9l1846t3608r2141b3703],

1	sequence	NN	O	sequence	_	0	SENT_115	[p10l12t48r419b119],
2	,	,	O	,	_	0	SENT_115	[p10l12t48r419b119],
3	and	CC	O	and	dep	1	SENT_115	[p10l448t25r596b98],
4	subject	JJ	O	subject	amod	6	SENT_115	[p10l620t25r918b119],
5	(	NN	O	(	nn	6	SENT_115	[p10l940t26r1419b119],
6	sequence	NN	O	sequence	dep	1	SENT_115	[p10l940t26r1419b119],
7	)	NN	O	)	dep	6	SENT_115	[p10l940t26r1419b119],
8	.	.	O	.	_	0	SENT_115	[p10l940t26r1419b119],

1	For	IN	O	for	_	0	SENT_116	[p10l1444t27r1592b98],
2	this	DT	O	this	det	3	SENT_116	[p10l1611t25r1760b98],
3	purpose	NN	O	purpose	prep_for	12	SENT_116	[p10l1782t48r2142b119],
4	,	,	O	,	_	0	SENT_116	[p10l1782t48r2142b119],
5	Cmax	NN	PERSON	cmax	nn	8	SENT_116	[p10l9t156r204b243],
6	and	CC	O	and	_	0	SENT_116	[p10l236t155r385b228],
7	AUC	NN	O	auc	conj_and	5	SENT_116	[p10l421t156r639b228],
8	Values	NNS	O	value	nsubj	12	SENT_116	[p10l679t155r946b228],
9	were	VBD	O	be	cop	12	SENT_116	[p10l986t178r1188b228],
10	first	JJ	ORDINAL	first	amod	12	SENT_116	[p10l1226t155r1397b228],
11	log	NN	O	log	nn	12	SENT_116	[p10l1432t155r2140b250],
12	—	NN	O	—	_	0	SENT_116	[p10l1432t155r2140b250],
13	transformed	VBN	O	transform	partmod	12	SENT_116	[p10l1432t155r2140b250],
14	.	.	O	.	_	0	SENT_116	[p10l1432t155r2140b250],

1	The	DT	O	the	det	2	SENT_117	[p10l8t285r170b358],
2	Values	NNS	O	value	nsubj	6	SENT_117	[p10l194t285r462b358],
3	of	IN	O	of	_	0	SENT_117	[p10l489t285r580b358],
4	tmax	NN	O	tmax	prep_of	2	SENT_117	[p10l597t296r752b373],
5	were	VBD	O	be	cop	6	SENT_117	[p10l777t308r981b358],
6	statistically	RB	O	statistically	dep	11	SENT_117	[p10l1009t285r1492b380],
7	compared	VBN	O	compare	_	0	SENT_117	[p10l1518t285r1936b380],
8	with	IN	O	with	prepc_compared_with	6	SENT_117	[p10l1959t285r2146b358],
9	the	DT	O	the	det	10	SENT_117	[p10l8t415r135b488],
10	Wilcoxon	NNP	O	Wilcoxon	pobj	6	SENT_117	[p10l159t414r579b488],
11	Signed	VBD	O	sign	_	0	SENT_117	[p10l606t414r898b509],
12	Rank	NNP	O	Rank	nn	13	SENT_117	[p10l923t414r1146b488],
13	test	NN	O	test	nsubj	11	SENT_117	[p10l1169t425r1337b488],
14	.	.	O	.	_	0	SENT_117	[p10l1169t425r1337b488],

1	A	DT	O	a	det	2	SENT_118	[p10l1367t415r1441b487],
2	level	NN	O	level	nsubjpass	8	SENT_118	[p10l1466t414r1670b488],
3	of	IN	O	of	_	0	SENT_118	[p10l1697t414r1788b488],
4	p	NN	O	p	prep_of	2	SENT_118	[p10l1805t438r1854b509],
5	<	JJR	O	<	dep	4	SENT_118	[p10l1883t433r1937b487],
6	0.05	CD	NUMBER	0.05	dep	5	SENT_118	[p10l1963t414r2141b488],
7	was	VBD	O	be	auxpass	8	SENT_118	[p10l8t568r168b618],
8	considered	VBN	O	consider	_	0	SENT_118	[p10l202t545r662b618],
9	as	IN	O	as	_	0	SENT_118	[p10l694t568r775b618],
10	statistically	RB	O	statistically	advmod	11	SENT_118	[p10l812t545r1294b640],
11	significant	JJ	O	significant	prep_as	8	SENT_118	[p10l1329t545r1797b640],
12	.	.	O	.	_	0	SENT_118	[p10l1329t545r1797b640],

1	Safety	NNP	O	Safety	nn	2	SENT_119	[p10l136t674r403b769],
2	data	NNS	O	datum	nsubjpass	4	SENT_119	[p10l438t675r614b748],
3	were	VBD	O	be	auxpass	4	SENT_119	[p10l646t698r849b748],
4	evaluated	VBN	O	evaluate	_	0	SENT_119	[p10l884t675r1291b748],
5	descriptively	RB	O	descriptively	advmod	4	SENT_119	[p10l1324t674r1896b769],
6	.	.	O	.	_	0	SENT_119	[p10l1324t674r1896b769],

1	Vital	JJ	O	vital	amod	2	SENT_120	[p10l1934t674r2145b748],
2	signs	NNS	O	sign	nsubjpass	4	SENT_120	[p10l12t805r222b900],
3	were	VBD	O	be	auxpass	4	SENT_120	[p10l247t828r450b878],
4	screened	VBN	O	screen	_	0	SENT_120	[p10l475t805r843b878],
5	for	IN	O	for	_	0	SENT_120	[p10l864t805r987b878],
6	Values	NNS	O	value	prep_for	4	SENT_120	[p10l1007t805r1274b878],
7	outside	IN	O	outside	_	0	SENT_120	[p10l1300t805r1604b878],
8	prespecified	JJ	O	prespecified	amod	9	SENT_120	[p10l1624t805r2146b900],
9	ranges	NNS	O	range	prep_outside	6	SENT_120	[p10l7t958r317b1030],
10	,	,	O	,	_	0	SENT_120	[p10l7t958r317b1030],
11	defined	VBN	O	define	partmod	6	SENT_120	[p10l369t936r696b1009],
12	as	IN	O	as	_	0	SENT_120	[p10l743t959r825b1009],
13	lOO	NN	O	loo	prep_as	11	SENT_120	[p10l884t936r1422b1009],
14	—	CD	NUMBER	—	num	13	SENT_120	[p10l884t936r1422b1009],
15	160mm	CD	NUMBER	160mm	num	16	SENT_120	[p10l884t936r1422b1009],
16	Hg	NN	O	hg	dep	13	SENT_120	[p10l1467t937r1593b1030],
17	for	IN	O	for	_	0	SENT_120	[p10l1641t936r1766b1009],
18	systolic	JJ	O	systolic	amod	20	SENT_120	[p10l1815t936r2143b1030],
19	blood	NN	O	blood	nn	20	SENT_120	[p10l7t1066r249b1139],
20	pressure	NN	O	pressure	prep_for	16	SENT_120	[p10l278t1089r656b1160],
21	,	,	O	,	_	0	SENT_120	[p10l278t1089r656b1160],
22	45-100mm	JJ	O	45-100mm	amod	23	SENT_120	[p10l690t1065r1174b1139],
23	Hg	NN	O	hg	prep_as	11	SENT_120	[p10l1204t1067r1329b1160],
24	for	IN	O	for	_	0	SENT_120	[p10l1362t1066r1485b1139],
25	diastolic	JJ	O	diastolic	amod	27	SENT_120	[p10l1516t1066r1873b1139],
26	blood	NN	O	blood	nn	27	SENT_120	[p10l1904t1066r2146b1139],
27	pressure	NN	O	pressure	prep_for	23	SENT_120	[p10l7t1219r365b1290],
28	and	CC	O	and	_	0	SENT_120	[p10l414t1195r564b1268],
29	45-100	CD	NUMBER	45-100	num	30	SENT_120	[p10l609t1195r928b1269],
30	beats	NNS	O	beat	prep_as	11	SENT_120	[p10l973t1195r1191b1268],
31	per	IN	O	per	_	0	SENT_120	[p10l1237t1219r1374b1290],
32	minute	NN	DURATION	minute	prep_per	30	SENT_120	[p10l1417t1195r1710b1268],
33	for	IN	O	for	_	0	SENT_120	[p10l1756t1195r1879b1268],
34	pulse	NN	O	pulse	nn	35	SENT_120	[p10l1921t1195r2144b1290],
35	rate	NN	O	rate	prep_for	32	SENT_120	[p10l7t1338r193b1400],
36	.	.	O	.	_	0	SENT_120	[p10l7t1338r193b1400],

1	Clinical	JJ	O	clinical	amod	3	SENT_121	[p10l247t1327r593b1400],
2	laboratory	NN	O	laboratory	nn	3	SENT_121	[p10l640t1327r1090b1421],
3	Values	NNS	O	value	nsubjpass	5	SENT_121	[p10l1138t1327r1413b1400],
4	were	VBD	O	be	auxpass	5	SENT_121	[p10l1463t1350r1669b1400],
5	compared	VBN	O	compare	_	0	SENT_121	[p10l1717t1327r2144b1421],
6	with	IN	O	with	_	0	SENT_121	[p10l8t1458r195b1531],
7	the	DT	O	the	det	9	SENT_121	[p10l237t1458r364b1531],
8	normal	JJ	O	normal	amod	9	SENT_121	[p10l406t1458r705b1531],
9	range	NN	O	range	prep_with	5	SENT_121	[p10l747t1481r981b1552],
10	supplied	VBN	O	supply	partmod	9	SENT_121	[p10l1027t1458r1384b1552],
11	by	IN	O	by	_	0	SENT_121	[p10l1423t1458r1527b1552],
12	the	DT	O	the	det	14	SENT_121	[p10l1569t1458r1696b1531],
13	analysing	VBG	O	analyse	amod	14	SENT_121	[p10l1741t1458r2144b1552],
14	laboratory	NN	O	laboratory	agent	10	SENT_121	[p10l8t1587r467b1682],
15	.	.	O	.	_	0	SENT_121	[p10l8t1587r467b1682],

1	Table	NNP	O	Table	nn	4	SENT_122	[p10l197t1757r272b1779],
2	I.	NNP	O	I.	nn	4	SENT_122	[p10l281t1757r294b1779],
3	Pharmacokinetic	JJ	O	pharmacokinetic	amod	4	SENT_122	[p10l311t1757r522b1779],
4	parameters	NNS	O	parameter	_	0	SENT_122	[p10l530t1758r674b1785],
5	of	IN	O	of	_	0	SENT_122	[p10l683t1757r706b1779],
6	bosentan	NN	O	bosentan	prep_of	4	SENT_122	[p10l714t1757r830b1779],
7	and	CC	O	and	_	0	SENT_122	[p10l839t1757r885b1779],
8	its	PRP$	O	its	poss	9	SENT_122	[p10l895t1757r921b1779],
9	metabolites	NNS	O	metabolite	conj_and	4	SENT_122	[p10l931t1757r1075b1779],
10	on	IN	O	on	_	0	SENT_122	[p10l1084t1762r1113b1779],
11	day	NN	DURATION	day	prep_on	9	SENT_122	[p10l1123t1757r1168b1785],
12	6	CD	NUMBER	6	num	11	SENT_122	[p10l1176t1758r1190b1779],
13	following	VBG	O	follow	dep	4	SENT_122	[p10l1198t1757r1308b1785],
14	administration	NN	O	administration	pobj	13	SENT_122	[p10l1317t1757r1494b1779],
15	of	IN	O	of	_	0	SENT_122	[p10l1503t1757r1526b1779],
16	bosentan	NN	O	bosentan	nn	17	SENT_122	[p10l1535t1757r1650b1779],
17	125mg	NN	O	125mg	prep_of	14	SENT_122	[p10l1661t1757r1746b1785],
18	twice	RB	O	twice	advmod	14	SENT_122	[p10l1754t1757r1819b1779],
19	daily	RB	SET	daily	advmod	14	SENT_122	[p10l1827t1757r1886b1785],
20	in	IN	O	in	amod	14	SENT_122	[p10l1894t1757r1913b1779],
21	the	DT	O	the	det	26	SENT_122	[p10l1922t1757r1961b1779],
22	absence	NN	O	absence	nn	26	SENT_122	[p10l198t1794r305b1816],
23	(	NN	O	(	nn	26	SENT_122	[p10l316t1794r445b1822],
24	treatment	NN	O	treatment	nn	26	SENT_122	[p10l316t1794r445b1822],
25	A	NN	O	a	nn	26	SENT_122	[p10l454t1794r481b1822],
26	)	NN	O	)	dep	14	SENT_122	[p10l454t1794r481b1822],
27	and	CC	O	and	_	0	SENT_122	[p10l491t1794r537b1816],
28	presence	NN	O	presence	nn	32	SENT_122	[p10l548t1799r664b1822],
29	(	NN	O	(	nn	32	SENT_122	[p10l675t1794r804b1822],
30	treatment	NN	O	treatment	nn	32	SENT_122	[p10l675t1794r804b1822],
31	C	NN	O	c	nn	32	SENT_122	[p10l813t1794r841b1822],
32	)	NN	O	)	dep	14	SENT_122	[p10l813t1794r841b1822],
33	of	IN	O	of	_	0	SENT_122	[p10l851t1794r875b1816],
34	simvastatin	NN	O	simvastatin	nn	37	SENT_122	[p10l883t1794r1025b1816],
35	40mg	CD	NUMBER	40mg	num	37	SENT_122	[p10l1035t1794r1106b1822],
36	once	RB	DATE	once	advmod	37	SENT_122	[p10l1116t1799r1177b1816],
37	dailya	NN	O	dailya	prep_of	32	SENT_122	[p10l1186t1793r1256b1822],

1	Bosentan	NNP	O	Bosentan	nn	2	SENT_123	[p10l12t1978r502b2060],
2	A	NNP	O	A	dep	9	SENT_123	[p10l6t2131r77b2212],
3	3.5	CD	NUMBER	3.5	number	4	SENT_123	[p10l1540t2133r1686b2215],
4	(	CD	NUMBER	(	dep	2	SENT_123	[p10l1726t2129r1797b2236],
5	1	CD	NUMBER	1	dep	4	SENT_123	[p10l1726t2129r1797b2236],
6	.5	CD	NUMBER	.5	num	7	SENT_123	[p10l1826t2129r2153b2236],
7	—	NN	O	—	dep	9	SENT_123	[p10l1826t2129r2153b2236],
8	5.0	CD	NUMBER	5.0	num	9	SENT_123	[p10l1826t2129r2153b2236],
9	)	NN	O	)	dep	17	SENT_123	[p10l1826t2129r2153b2236],
10	C	NN	O	c	num	14	SENT_123	[p10l9t2297r81b2383],
11	3.5	CD	NUMBER	3.5	number	10	SENT_123	[p10l1540t2301r1686b2383],
12	(	CD	NUMBER	(	number	10	SENT_123	[p10l1726t2297r2153b2404],
13	2.0	CD	NUMBER	2.0	number	10	SENT_123	[p10l1726t2297r2153b2404],
14	—	NN	O	—	dep	9	SENT_123	[p10l1726t2297r2153b2404],
15	5.0	CD	NUMBER	5.0	num	16	SENT_123	[p10l1726t2297r2153b2404],
16	)	CD	NUMBER	)	dep	14	SENT_123	[p10l1726t2297r2153b2404],
17	Ro	NN	O	ro	dep	21	SENT_123	[p10l12t2473r150b2555],
18	47-8634	CD	NUMBER	47-8634	num	17	SENT_123	[p10l186t2473r586b2557],
19	A	DT	O	a	det	21	SENT_123	[p10l6t2626r77b2707],
20	3.5	CD	NUMBER	3.5	num	21	SENT_123	[p10l1540t2628r1686b2710],
21	(	NN	O	(	dep	25	SENT_123	[p10l1726t2624r2153b2731],
22	2.0	CD	NUMBER	2.0	num	23	SENT_123	[p10l1726t2624r2153b2731],
23	—	NN	O	—	dep	21	SENT_123	[p10l1726t2624r2153b2731],
24	4.5	CD	NUMBER	4.5	num	25	SENT_123	[p10l1726t2624r2153b2731],
25	)	NN	O	)	dep	33	SENT_123	[p10l1726t2624r2153b2731],
26	C	NN	O	c	num	30	SENT_123	[p10l9t2792r81b2878],
27	2.5	CD	NUMBER	2.5	number	26	SENT_123	[p10l1538t2796r1686b2878],
28	(	CD	NUMBER	(	number	26	SENT_123	[p10l1726t2792r2153b2899],
29	2.0	CD	NUMBER	2.0	number	26	SENT_123	[p10l1726t2792r2153b2899],
30	—	NN	O	—	dep	25	SENT_123	[p10l1726t2792r2153b2899],
31	5.0	CD	NUMBER	5.0	num	32	SENT_123	[p10l1726t2792r2153b2899],
32	)	CD	NUMBER	)	dep	30	SENT_123	[p10l1726t2792r2153b2899],
33	Ro	NN	O	ro	dep	37	SENT_123	[p10l13t2968r150b3050],
34	48-5033	CD	NUMBER	48-5033	num	33	SENT_123	[p10l186t2968r585b3052],
35	A	DT	O	a	det	37	SENT_123	[p10l6t3121r79b3202],
36	4.0	CD	NUMBER	4.0	num	37	SENT_123	[p10l1538t3123r1686b3205],
37	(	NN	O	(	dep	41	SENT_123	[p10l1727t3119r2153b3226],
38	3.0	CD	NUMBER	3.0	num	39	SENT_123	[p10l1727t3119r2153b3226],
39	—	CD	NUMBER	—	dep	37	SENT_123	[p10l1727t3119r2153b3226],
40	5.0	CD	NUMBER	5.0	num	41	SENT_123	[p10l1727t3119r2153b3226],
41	)	NN	O	)	dep	49	SENT_123	[p10l1727t3119r2153b3226],
42	C	NN	O	c	num	46	SENT_123	[p10l10t3287r81b3371],
43	4.0	CD	NUMBER	4.0	number	42	SENT_123	[p10l1538t3291r1686b3371],
44	(	CD	NUMBER	(	number	42	SENT_123	[p10l1727t3287r2153b3392],
45	2.5	CD	NUMBER	2.5	number	42	SENT_123	[p10l1727t3287r2153b3392],
46	—	NN	O	—	dep	41	SENT_123	[p10l1727t3287r2153b3392],
47	6.0	CD	NUMBER	6.0	num	48	SENT_123	[p10l1727t3287r2153b3392],
48	)	CD	NUMBER	)	dep	46	SENT_123	[p10l1727t3287r2153b3392],
49	Ro	NN	O	ro	dep	53	SENT_123	[p10l13t3461r150b3543],
50	64-1056	CD	NUMBER	64-1056	num	49	SENT_123	[p10l186t3461r585b3545],
51	A	DT	O	a	det	53	SENT_123	[p10l6t3612r79b3694],
52	4.5	CD	NUMBER	4.5	num	53	SENT_123	[p10l1538t3614r1686b3696],
53	(	NN	O	(	_	0	SENT_123	[p10l1727t3610r2153b3717],
54	3.5	CD	NUMBER	3.5	number	55	SENT_123	[p10l1727t3610r2153b3717],
55	—	CD	NUMBER	—	dep	53	SENT_123	[p10l1727t3610r2153b3717],
56	5.0	CD	NUMBER	5.0	num	57	SENT_123	[p10l1727t3610r2153b3717],
57	)	NN	O	)	dep	55	SENT_123	[p10l1727t3610r2153b3717],

1	C	NN	O	c	_	0	SENT_124	[p11l10t38r81b124],
2	3.5	CD	NUMBER	3.5	number	3	SENT_124	[p11l1540t42r1686b124],
3	(	CD	NUMBER	(	dep	1	SENT_124	[p11l1727t38r2153b145],
4	2.5	CD	NUMBER	2.5	num	5	SENT_124	[p11l1727t38r2153b145],
5	—	NN	O	—	dep	3	SENT_124	[p11l1727t38r2153b145],
6	6.0	CD	NUMBER	6.0	num	7	SENT_124	[p11l1727t38r2153b145],
7	)	NN	O	)	dep	1	SENT_124	[p11l1727t38r2153b145],

1	a	DT	O	a	det	2	SENT_125	[p11l198t1849r213b1866],
2	Data	NNS	O	datum	nsubjpass	4	SENT_125	[p11l247t1844r305b1866],
3	are	VBP	O	be	auxpass	4	SENT_125	[p11l315t1849r355b1866],
4	presented	VBN	O	present	_	0	SENT_125	[p11l365t1844r490b1872],
5	as	IN	O	as	mark	8	SENT_125	[p11l500t1849r529b1866],
6	geometric	JJ	O	geometric	amod	7	SENT_125	[p11l539t1844r664b1872],
7	means	NNS	O	means	nsubj	8	SENT_125	[p11l674t1849r759b1866],
8	(	VBP	O	(	advcl	4	SENT_125	[p11l769t1843r834b1872],
9	95	CD	PERCENT	95	number	10	SENT_125	[p11l769t1843r834b1872],
10	%	NN	PERCENT	%	amod	11	SENT_125	[p11l769t1843r834b1872],
11	Cls	NNS	O	cl	nsubj	12	SENT_125	[p11l844t1843r894b1872],
12	)	VBP	O	)	ccomp	8	SENT_125	[p11l844t1843r894b1872],
13	for	IN	O	for	_	0	SENT_125	[p11l904t1843r937b1866],
14	Cmax	NN	O	cmax	prep_for	12	SENT_125	[p11l946t1843r1004b1869],
15	and	CC	O	and	_	0	SENT_125	[p11l1013t1844r1060b1866],
16	AUCT	NN	O	auct	prep_for	12	SENT_125	[p11l1069t1843r1139b1869],
17	and	CC	O	and	_	0	SENT_125	[p11l1148t1844r1194b1866],
18	as	IN	O	as	_	0	SENT_125	[p11l1204t1849r1233b1866],
19	median	JJ	O	median	amod	22	SENT_125	[p11l1243t1844r1334b1866],
20	(	NN	O	(	nn	22	SENT_125	[p11l1346t1843r1435b1872],
21	range	NN	O	range	nn	22	SENT_125	[p11l1346t1843r1435b1872],
22	)	NN	O	)	prep_as	12	SENT_125	[p11l1346t1843r1435b1872],
23	for	IN	O	for	_	0	SENT_125	[p11l1445t1843r1479b1866],
24	tmax	NN	O	tmax	nn	26	SENT_125	[p11l1486t1845r1533b1869],
25	(	NN	O	(	nn	26	SENT_125	[p11l1543t1843r1565b1872],
26	n	NN	O	n	prep_for	22	SENT_125	[p11l1543t1843r1565b1872],
27	=	JJ	O	=	amod	29	SENT_125	[p11l1575t1853r1591b1862],
28	9	CD	NUMBER	9	num	29	SENT_125	[p11l1601t1843r1631b1872],
29	)	NN	O	)	dep	12	SENT_125	[p11l1601t1843r1631b1872],
30	.	.	O	.	_	0	SENT_125	[p11l1601t1843r1631b1872],

1	AUCT	NN	O	auct	nn	3	SENT_126	[p11l198t1887r269b1913],
2	=	JJ	O	=	amod	3	SENT_126	[p11l278t1897r293b1906],
3	area	NN	O	area	_	0	SENT_126	[p11l303t1893r359b1910],
4	under	IN	O	under	_	0	SENT_126	[p11l369t1888r441b1910],
5	the	DT	O	the	det	7	SENT_126	[p11l448t1888r487b1910],
6	concentration-time	JJ	O	concentration-time	amod	7	SENT_126	[p11l497t1888r731b1910],
7	curve	NN	O	curve	prep_under	3	SENT_126	[p11l741t1893r809b1910],
8	during	IN	O	during	_	0	SENT_126	[p11l819t1888r897b1916],
9	a	DT	O	a	det	14	SENT_126	[p11l906t1893r921b1910],
10	dosage	NN	O	dosage	nn	14	SENT_126	[p11l930t1888r1023b1916],
11	interval	NN	O	interval	nn	14	SENT_126	[p11l1033t1888r1122b1910],
12	(	NN	O	(	nn	14	SENT_126	[p11l1133t1887r1163b1916],
13	1	CD	NUMBER	1	num	14	SENT_126	[p11l1133t1887r1163b1916],
14	)	NN	O	)	prep_during	7	SENT_126	[p11l1133t1887r1163b1916],
15	at	IN	O	at	_	0	SENT_126	[p11l1173t1889r1196b1910],
16	steady	JJ	O	steady	amod	17	SENT_126	[p11l1204t1888r1288b1916],
17	state	NN	O	state	prep_at	3	SENT_126	[p11l1297t1889r1364b1914],
18	;	:	O	;	_	0	SENT_126	[p11l1297t1889r1364b1914],
19	Cmax	NN	O	cmax	dep	3	SENT_126	[p11l1376t1887r1437b1913],
20	=	JJ	O	=	amod	22	SENT_126	[p11l1446t1897r1461b1906],
21	maximum	NN	O	maximum	nn	22	SENT_126	[p11l1472t1888r1594b1910],
22	concentration	NN	O	concentration	dep	19	SENT_126	[p11l1604t1888r1782b1914],
23	;	:	O	;	_	0	SENT_126	[p11l1604t1888r1782b1914],
24	tmax	NN	O	tmax	nn	26	SENT_126	[p11l1792t1889r1842b1913],
25	=	JJ	O	=	amod	26	SENT_126	[p11l1851t1897r1867b1906],
26	time	NN	O	time	dep	3	SENT_126	[p11l1876t1888r1929b1910],
27	to	TO	O	to	aux	28	SENT_126	[p11l1938t1889r1962b1910],
28	reach	VB	O	reach	infmod	26	SENT_126	[p11l199t1924r268b1946],
29	maximum	NN	O	maximum	nn	30	SENT_126	[p11l279t1924r401b1946],
30	concentration	NN	O	concentration	dobj	28	SENT_126	[p11l411t1924r589b1946],
31	.	.	O	.	_	0	SENT_126	[p11l411t1924r589b1946],

1	©	NN	O	©	_	0	SENT_127	[p11l196t2037r214b2055],
2	Adis	NNP	O	Adis	nn	4	SENT_127	[p11l222t2035r272b2055],
3	International	NNP	O	International	nn	4	SENT_127	[p11l280t2035r429b2055],
4	Limited	NNP	O	Limited	dep	1	SENT_127	[p11l439t2035r528b2055],
5	.	.	O	.	_	0	SENT_127	[p11l439t2035r528b2055],

1	All	DT	O	all	det	2	SENT_128	[p11l537t2035r564b2055],
2	rights	NNS	O	rights	nsubj	3	SENT_128	[p11l573t2035r634b2060],
3	reserved	VBN	O	reserve	_	0	SENT_128	[p11l643t2035r750b2055],
4	.	.	O	.	_	0	SENT_128	[p11l643t2035r750b2055],

1	Clin	NNP	O	Clin	nn	2	SENT_129	[p11l1595t2035r1639b2055],
2	Phormocokinet	NNP	O	Phormocokinet	_	0	SENT_129	[p11l1648t2035r1831b2055],
3	2003	CD	DATE	2003	num	2	SENT_129	[p11l1838t2035r1898b2056],
4	;	:	O	;	_	0	SENT_129	[p11l1838t2035r1898b2056],
5	42	CD	NUMBER	42	number	6	SENT_129	[p11l1906t2035r1933b2054],
6	(	CD	NUMBER	(	dep	2	SENT_129	[p11l1942t2035r1971b2057],
7	3	CD	NUMBER	3	num	9	SENT_129	[p11l1942t2035r1971b2057],
8	)	NN	O	)	nn	9	SENT_129	[p11l1942t2035r1971b2057],
9	Bosentan	NNP	O	Bosentan	dep	6	SENT_129	[p11l192t2073r518b2098],
10	.	.	O	.	_	0	SENT_129	[p11l192t2073r518b2098],

1	—	NN	O	—	_	0	SENT_130	[p11l192t2073r518b2098],
2	.	.	O	.	_	0	SENT_130	[p11l192t2073r518b2098],

1	Simvastatin	NNP	O	Simvastatin	_	0	SENT_131	[p11l192t2073r518b2098],
2	Interactions	NNS	O	interaction	dep	1	SENT_131	[p11l528t2073r702b2098],
3	297	CD	NUMBER	297	dep	1	SENT_131	[p11l1918t2073r1968b2098],

1	a	DT	O	a	det	2	SENT_132	[p11l370t2340r412b2387],
2	I	PRP	O	I	_	0	SENT_132	[p11l1482t2321r1539b2380],
3	No	DT	O	no	det	4	SENT_132	[p11l1609t2320r1695b2375],
4	bosentan	NN	O	bosentan	dep	2	SENT_132	[p11l1721t2320r2011b2375],

1	o	NN	O	o	_	0	SENT_133	[p12l1482t36r1539b93],
2	With	IN	O	with	dep	1	SENT_133	[p12l1605t29r1745b83],
3	bosentan	NN	O	bosentan	pobj	2	SENT_133	[p12l1773t29r2064b84],

1	3	CD	NUMBER	3	_	0	SENT_134	[p12l91t376r161b556],
2	&	CC	O	&	cc	1	SENT_134	[p12l91t376r161b556],
3	3	CD	NUMBER	3	num	6	SENT_134	[p12l91t376r161b556],
4	cozmzcmocoo	NN	O	cozmzcmocoo	nn	6	SENT_134	[p12l92t586r146b1014],
5	c	NN	O	c	nn	6	SENT_134	[p12l91t1041r147b1406],
6	_	NN	O	_	dep	1	SENT_134	[p12l91t1041r147b1406],
7	.	.	O	.	_	0	SENT_134	[p12l91t1041r147b1406],

1	.	.	O	.	_	0	SENT_135	[p12l91t1041r147b1406],

1	m.	NN	O	m.	_	0	SENT_136	[p12l91t1041r147b1406],
2	.	.	O	.	_	0	SENT_136	[p12l91t1041r147b1406],

1	wm	NN	O	wm	_	0	SENT_137	[p12l91t1041r147b1406],
2	>	JJR	O	>	amod	3	SENT_137	[p12l91t1041r147b1406],
3	E_m	NN	O	e_m	dep	1	SENT_137	[p12l91t1041r147b1406],

1	3	CD	NUMBER	3	_	0	SENT_138	[p12l91t2114r161b2295],
2	&	CC	O	&	_	0	SENT_138	[p12l91t2114r161b2295],
3	3	CD	NUMBER	3	num	4	SENT_138	[p12l91t2114r161b2295],
4	cozmbcmocoo	NN	O	cozmbcmocoo	conj_and	1	SENT_138	[p12l92t2323r146b2752],
5	:	:	O	:	_	0	SENT_138	[p12l92t2779r146b3134],
6	_	CD	NUMBER	_	num	7	SENT_138	[p12l92t2779r146b3134],
7	§	NN	O	§	dep	1	SENT_138	[p12l92t2779r146b3134],
8	.	.	O	.	_	0	SENT_138	[p12l92t2779r146b3134],

1	mm	NN	O	mm	_	0	SENT_139	[p12l92t2779r146b3134],
2	>	JJR	O	>	amod	3	SENT_139	[p12l92t2779r146b3134],
3	E_w	NN	O	e_w	dep	1	SENT_139	[p12l92t2779r146b3134],
4	_	CD	NUMBER	_	num	5	SENT_139	[p12l91t3160r162b3611],
5	u_om	NN	O	u_om	dep	3	SENT_139	[p12l91t3160r162b3611],
6	>	JJR	O	>	amod	9	SENT_139	[p12l91t3160r162b3611],
7	xo	NN	O	xo	nn	9	SENT_139	[p12l91t3160r162b3611],
8	__	NN	O	__	nn	9	SENT_139	[p12l91t3160r162b3611],
9	u	NN	O	u	dep	10	SENT_139	[p12l91t3160r162b3611],
10	>	JJR	O	>	dep	1	SENT_139	[p12l91t3160r162b3611],
11	_	CD	NUMBER	_	dep	10	SENT_139	[p12l91t3160r162b3611],
12	.	.	O	.	_	0	SENT_139	[p12l91t3160r162b3611],

1	_	SYM	O	_	dep	3	SENT_140	[p12l91t3160r162b3611],
2	-	:	O	-	_	0	SENT_140	[p12l91t3160r162b3611],
3	n	NN	O	n	_	0	SENT_140	[p12l91t3160r162b3611],

1	O	NN	O	o	_	0	SENT_141	[p13l421t27r457b80],
2	2	CD	NUMBER	2	number	3	SENT_141	[p13l685t27r721b79],
3	4	CD	NUMBER	4	num	5	SENT_141	[p13l950t27r987b79],
4	6	CD	NUMBER	6	number	5	SENT_141	[p13l1216t27r1251b80],
5	8	CD	NUMBER	8	dep	1	SENT_141	[p13l1481t27r1516b80],
6	10	CD	NUMBER	10	number	7	SENT_141	[p13l1730t27r1801b80],
7	12	CD	NUMBER	12	amod	5	SENT_141	[p13l1994t27r2065b79],

1	Time	NNP	O	Time	_	0	SENT_142	[p13l781t143r938b197],
2	after	IN	O	after	dep	1	SENT_142	[p13l964t143r1107b197],
3	administration	NN	O	administration	nn	5	SENT_142	[p13l1129t143r1574b197],
4	(	CD	NUMBER	(	num	5	SENT_142	[p13l1603t142r1682b211],
5	h	NN	O	h	pobj	2	SENT_142	[p13l1603t142r1682b211],
6	)	CD	NUMBER	)	num	5	SENT_142	[p13l1603t142r1682b211],

1	Fig	NN	O	fig	_	0	SENT_143	[p13l9t254r130b323],
2	.	.	O	.	_	0	SENT_143	[p13l9t254r130b323],

1	3	LS	NUMBER	3	_	0	SENT_144	[p13l149t255r204b309],
2	.	.	O	.	_	0	SENT_144	[p13l149t255r204b309],

1	Plasma	NN	O	plasma	nn	3	SENT_145	[p13l230t250r482b309],
2	concentration-time	NN	O	concentration-time	nn	3	SENT_145	[p13l502t250r1136b309],
3	profiles	NNS	O	profile	nsubj	8	SENT_145	[p13l1159t250r1402b324],
4	of	IN	O	of	_	0	SENT_145	[p13l1423t250r1484b308],
5	simvastatin	NN	O	simvastatin	prep_of	3	SENT_145	[p13l1502t250r1885b309],
6	(	CD	NUMBER	(	num	5	SENT_145	[p13l1909t249r1995b324],
7	a	DT	O	a	det	8	SENT_145	[p13l1909t249r1995b324],
8	)	NN	O	)	_	0	SENT_145	[p13l1909t249r1995b324],
9	and	CC	O	and	_	0	SENT_145	[p13l2018t250r2142b309],
10	[	NN	O	[	conj_and	8	SENT_145	[p13l9t343r484b417],
11	3-hydroxyacid	JJ	O	3-hydroxyacid	amod	15	SENT_145	[p13l9t343r484b417],
12	simvastatin	NN	O	simvastatin	nn	15	SENT_145	[p13l508t343r891b402],
13	(	NN	O	(	nn	15	SENT_145	[p13l918t342r1008b417],
14	b	NN	O	b	nn	15	SENT_145	[p13l918t342r1008b417],
15	)	NN	O	)	nsubj	37	SENT_145	[p13l918t342r1008b417],
16	on	IN	O	on	_	0	SENT_145	[p13l1033t358r1113b401],
17	day	NN	DURATION	day	prep_on	15	SENT_145	[p13l1138t343r1261b417],
18	6	CD	NUMBER	6	num	17	SENT_145	[p13l1282t345r1320b402],
19	following	VBG	O	follow	_	0	SENT_145	[p13l1342t343r1639b417],
20	administration	NN	O	administration	prep_following	17	SENT_145	[p13l1664t343r2141b402],
21	of	IN	O	of	_	0	SENT_145	[p13l7t436r69b494],
22	simvastatin	NN	O	simvastatin	nn	23	SENT_145	[p13l85t436r468b495],
23	40mg	NN	O	40mg	prep_of	20	SENT_145	[p13l488t437r678b510],
24	once	RB	DATE	once	advmod	25	SENT_145	[p13l698t451r862b495],
25	daily	RB	SET	daily	advmod	23	SENT_145	[p13l880t436r1037b510],
26	in	IN	O	in	_	0	SENT_145	[p13l1056t436r1108b494],
27	the	DT	O	the	det	32	SENT_145	[p13l1126t436r1231b495],
28	absence	NN	O	absence	nn	32	SENT_145	[p13l1250t436r1539b495],
29	(	NN	O	(	nn	32	SENT_145	[p13l1560t435r1909b510],
30	treatment	NN	O	treatment	nn	32	SENT_145	[p13l1560t435r1909b510],
31	B	NN	O	b	nn	32	SENT_145	[p13l1929t435r1997b510],
32	)	NN	O	)	prep_in	25	SENT_145	[p13l1929t435r1997b510],
33	and	CC	O	and	_	0	SENT_145	[p13l2018t436r2142b495],
34	presence	NN	O	presence	nn	36	SENT_145	[p13l8t544r322b603],
35	(	NN	O	(	nn	36	SENT_145	[p13l347t528r696b603],
36	treatment	NN	O	treatment	prep_in	25	SENT_145	[p13l347t528r696b603],
37	C	NN	O	c	rcmod	8	SENT_145	[p13l718t528r792b603],
38	)	NN	O	)	dobj	37	SENT_145	[p13l718t528r792b603],
39	of	IN	O	of	_	0	SENT_145	[p13l817t529r879b587],
40	bosentan	NN	O	bosentan	nn	41	SENT_145	[p13l901t529r1212b588],
41	125mg	NN	O	125mg	prep_of	38	SENT_145	[p13l1242t530r1464b603],
42	twice	RB	O	twice	dep	8	SENT_145	[p13l1484t529r1653b588],
43	daily	RB	SET	daily	dep	42	SENT_145	[p13l1673t529r1840b603],
44	.	.	O	.	_	0	SENT_145	[p13l1673t529r1840b603],

1	Data	NNS	O	datum	nsubjpass	3	SENT_146	[p13l1867t529r2020b588],
2	are	VBP	O	be	auxpass	3	SENT_146	[p13l2039t544r2144b588],
3	presented	VBN	O	present	_	0	SENT_146	[p13l8t623r337b697],
4	as	IN	O	as	_	0	SENT_146	[p13l362t638r438b682],
5	mean	JJ	O	mean	amod	6	SENT_146	[p13l464t638r647b681],
6	values	NNS	O	value	prep_as	3	SENT_146	[p13l670t623r887b682],
7	for	IN	O	for	_	0	SENT_146	[p13l908t623r996b681],
8	n	NN	O	n	prep_for	6	SENT_146	[p13l1019t638r1054b681],
9	=	JJ	O	=	amod	8	SENT_146	[p13l1080t649r1120b671],
10	9	CD	NUMBER	9	tmod	9	SENT_146	[p13l1144t624r1198b682],
11	.	.	O	.	_	0	SENT_146	[p13l1144t624r1198b682],

1	Results	NNS	O	result	_	0	SENT_147	[p13l147t886r477b966],

1	All	DT	O	all	det	2	SENT_148	[p13l142t1121r275b1193],
2	subjects	NNS	O	subject	nsubj	13	SENT_148	[p13l308t1121r644b1215],
3	completed	VBD	O	complete	_	0	SENT_148	[p13l676t1121r1118b1215],
4	the	DT	O	the	det	5	SENT_148	[p13l1146t1121r1273b1194],
5	study	NN	O	study	dobj	3	SENT_148	[p13l1306t1121r1530b1215],
6	in	IN	O	in	_	0	SENT_148	[p13l1560t1121r1640b1193],
7	accordance	NN	O	accordance	prep_in	3	SENT_148	[p13l1670t1121r2145b1194],
8	with	IN	O	with	_	0	SENT_148	[p13l17t1245r203b1318],
9	the	DT	O	the	det	10	SENT_148	[p13l236t1245r363b1318],
10	protocol	NN	O	protocol	prep_with	3	SENT_148	[p13l395t1245r750b1339],
11	and	CC	O	and	_	0	SENT_148	[p13l785t1245r934b1318],
12	were	VBD	O	be	cop	13	SENT_148	[p13l966t1268r1169b1318],
13	evaluable	JJ	O	evaluable	conj_and	3	SENT_148	[p13l1203t1245r1608b1318],
14	for	IN	O	for	_	0	SENT_148	[p13l1641t1245r1764b1318],
15	pharmacokinetics	NNS	O	pharmacokinetic	prep_for	13	SENT_148	[p13l1793t1245r2144b1339, p13l17t1369r470b1442],
16	.	.	O	.	_	0	SENT_148	[p13l1793t1245r2144b1339, p13l17t1369r470b1442],

1	Figure	NNP	O	Figure	nsubj	3	SENT_149	[p13l499t1369r775b1463],
2	1	CD	NUMBER	1	num	1	SENT_149	[p13l810t1369r840b1441],
3	displays	VBZ	O	display	ccomp	10	SENT_149	[p13l875t1369r1220b1463],
4	the	DT	O	the	det	6	SENT_149	[p13l1247t1369r1374b1442],
5	trough	NN	O	trough	nn	6	SENT_149	[p13l1399t1369r1676b1463],
6	concentrations	NNS	O	concentration	dobj	3	SENT_149	[p13l1700t1380r2145b1442, p13l16t1493r219b1566],
7	of	IN	O	of	_	0	SENT_149	[p13l251t1493r341b1566],
8	bosentan	NN	O	bosentan	prep_of	6	SENT_149	[p13l361t1493r762b1579],
9	,	,	O	,	_	0	SENT_149	[p13l361t1493r762b1579],
10	determined	VBD	O	determine	_	0	SENT_149	[p13l795t1493r1273b1566],
11	just	RB	O	just	advmod	10	SENT_149	[p13l1291t1493r1453b1588],
12	before	IN	O	before	_	0	SENT_149	[p13l1477t1493r1748b1566],
13	intake	NN	O	intake	prep_before	10	SENT_149	[p13l1775t1493r2034b1566],
14	of	IN	O	of	_	0	SENT_149	[p13l2062t1493r2153b1566],
15	the	DT	O	the	det	17	SENT_149	[p13l16t1617r143b1690],
16	morning	NN	TIME	morning	nn	17	SENT_149	[p13l171t1617r529b1712],
17	dose	NN	O	dose	prep_of	13	SENT_149	[p13l558t1617r749b1690],
18	on	IN	O	on	_	0	SENT_149	[p13l777t1640r880b1690],
19	days	NNS	DURATION	day	prep_on	17	SENT_149	[p13l908t1617r1096b1712],
20	2-6	CD	NUMBER	2-6	nsubj	10	SENT_149	[p13l1127t1617r1305b1703],
21	,	,	O	,	_	0	SENT_149	[p13l1127t1617r1305b1703],
22	in	IN	O	in	_	0	SENT_149	[p13l1336t1617r1417b1689],
23	the	DT	O	the	det	24	SENT_149	[p13l1443t1617r1570b1690],
24	presence	NN	O	presence	prep_in	20	SENT_149	[p13l1596t1640r1968b1712],
25	and	CC	O	and	cc	24	SENT_149	[p13l1998t1617r2147b1690],

1	©	NN	O	©	_	0	SENT_150	[p13l17t1905r61b1949],
2	Adis	NNP	O	Adis	nn	4	SENT_150	[p13l81t1901r205b1949],
3	International	NNP	O	International	nn	4	SENT_150	[p13l227t1901r601b1949],
4	Limited	NNP	O	Limited	dep	1	SENT_150	[p13l625t1901r849b1949],
5	.	.	O	.	_	0	SENT_150	[p13l625t1901r849b1949],

1	All	DT	O	all	det	2	SENT_151	[p13l872t1901r940b1947],
2	rights	NNS	O	rights	nsubj	3	SENT_151	[p13l964t1901r1116b1961],
3	reserved	VBN	O	reserve	_	0	SENT_151	[p13l1138t1901r1407b1949],
4	.	.	O	.	_	0	SENT_151	[p13l1138t1901r1407b1949],

1	absence	NN	O	absence	_	0	SENT_152	[p13l11t2150r344b2224],
2	of	IN	O	of	_	0	SENT_152	[p13l367t2150r459b2224],
3	simvastatin	NN	O	simvastatin	prep_of	1	SENT_152	[p13l477t2150r981b2225],
4	.	.	O	.	_	0	SENT_152	[p13l477t2150r981b2225],

1	The	DT	O	the	det	4	SENT_153	[p13l1009t2150r1170b2224],
2	trough	NN	O	trough	nn	4	SENT_153	[p13l1192t2151r1469b2246],
3	plasma	NN	O	plasma	nn	4	SENT_153	[p13l1489t2150r1791b2246],
4	concentrations	NNS	O	concentration	nsubj	9	SENT_153	[p13l1811t2174r2143b2224, p13l9t2282r335b2356],
5	of	IN	O	of	_	0	SENT_153	[p13l385t2282r478b2356],
6	the	DT	O	the	det	8	SENT_153	[p13l517t2282r647b2356],
7	bosentan	NN	O	bosentan	nn	8	SENT_153	[p13l692t2282r1081b2356],
8	metabolites	NNS	O	metabolite	prep_of	4	SENT_153	[p13l1128t2282r1624b2356],
9	followed	VBD	O	follow	_	0	SENT_153	[p13l1673t2282r2055b2356],
10	a	DT	O	a	det	14	SENT_153	[p13l2103t2306r2146b2356],
11	Very	RB	O	very	advmod	12	SENT_153	[p13l9t2438r195b2510],
12	similar	JJ	O	similar	amod	14	SENT_153	[p13l240t2414r534b2487],
13	time	NN	O	time	nn	14	SENT_153	[p13l573t2414r759b2487],
14	course	NN	O	course	dobj	9	SENT_153	[p13l802t2438r1099b2488],
15	.	.	O	.	_	0	SENT_153	[p13l802t2438r1099b2488],

1	The	DT	O	the	det	3	SENT_154	[p13l1146t2414r1308b2487],
2	mean	NN	O	mean	nn	3	SENT_154	[p13l1349t2438r1577b2487],
3	plasma	NN	O	plasma	nsubjpass	17	SENT_154	[p13l1617t2414r1920b2510],
4	concentration-time	JJ	O	concentration-time	amod	5	SENT_154	[p13l1960t2438r2143b2487, p13l10t2546r680b2620],
5	curves	NNS	O	curve	dep	3	SENT_154	[p13l729t2569r1005b2620],
6	of	IN	O	of	_	0	SENT_154	[p13l1055t2546r1147b2620],
7	bosentan	NN	O	bosentan	prep_of	5	SENT_154	[p13l1185t2546r1569b2620],
8	on	IN	O	on	_	0	SENT_154	[p13l1616t2569r1719b2620],
9	day	NN	DURATION	day	prep_on	7	SENT_154	[p13l1765t2546r1916b2641],
10	6	CD	NUMBER	6	num	9	SENT_154	[p13l1964t2546r2011b2620],
11	of	IN	O	of	_	0	SENT_154	[p13l2060t2546r2152b2620],
12	treatments	NNS	O	treatment	prep_of	9	SENT_154	[p13l9t2688r451b2751],
13	A	DT	O	a	dep	3	SENT_154	[p13l486t2678r559b2750],
14	and	CC	O	and	_	0	SENT_154	[p13l594t2678r744b2751],
15	C	NN	O	c	dep	3	SENT_154	[p13l777t2678r841b2752],
16	are	VBP	O	be	auxpass	17	SENT_154	[p13l877t2701r1002b2751],
17	presented	VBN	O	present	_	0	SENT_154	[p13l1034t2677r1444b2773],
18	in	IN	O	in	_	0	SENT_154	[p13l1475t2677r1556b2750],
19	figure	NN	O	figure	prep_in	17	SENT_154	[p13l1588t2677r1840b2773],
20	2	CD	NUMBER	2	num	19	SENT_154	[p13l1874t2678r1944b2751],
21	.	.	O	.	_	0	SENT_154	[p13l1874t2678r1944b2751],

1	The	DT	O	the	det	4	SENT_155	[p13l1982t2677r2144b2751],
2	derived	VBN	O	derive	amod	4	SENT_155	[p13l10t2809r328b2884],
3	pharmacokinetic	JJ	O	pharmacokinetic	amod	4	SENT_155	[p13l370t2809r1081b2905],
4	parameters	NNS	O	parameter	nsubjpass	11	SENT_155	[p13l1125t2821r1591b2905],
5	of	IN	O	of	_	0	SENT_155	[p13l1639t2809r1730b2883],
6	bosentan	NN	O	bosentan	prep_of	4	SENT_155	[p13l1765t2810r2144b2883],
7	and	CC	O	and	_	0	SENT_155	[p13l11t2942r161b3016],
8	its	PRP$	O	its	poss	9	SENT_155	[p13l201t2942r297b3016],
9	metabolites	NNS	O	metabolite	prep_of	4	SENT_155	[p13l341t2942r830b3016],
10	are	VBP	O	be	auxpass	11	SENT_155	[p13l876t2965r1001b3016],
11	presented	VBN	O	present	_	0	SENT_155	[p13l1041t2942r1451b3037],
12	in	IN	O	in	_	0	SENT_155	[p13l1491t2942r1572b3014],
13	table	NN	O	table	prep_in	11	SENT_155	[p13l1612t2942r1818b3016],
14	1	CD	NUMBER	1	num	13	SENT_155	[p13l1859t2944r1913b3016],
15	.	.	O	.	_	0	SENT_155	[p13l1859t2944r1913b3016],

1	ANOVA	NNP	ORGANIZATION	ANOVA	nsubj	4	SENT_156	[p13l1959t2943r2143b3016, p13l11t3074r236b3148],
2	did	VBD	O	do	aux	4	SENT_156	[p13l264t3074r398b3148],
3	not	RB	O	not	neg	4	SENT_156	[p13l424t3085r559b3148],
4	yield	VB	O	yield	_	0	SENT_156	[p13l584t3074r797b3169],
5	any	DT	O	any	det	8	SENT_156	[p13l825t3097r973b3169],
6	statistically	RB	O	statistically	advmod	7	SENT_156	[p13l1005t3074r1489b3169],
7	significant	JJ	O	significant	amod	8	SENT_156	[p13l1520t3074r1969b3169],
8	differences	NNS	O	difference	dobj	4	SENT_156	[p13l1995t3074r2143b3148, p13l9t3205r361b3278],
9	between	IN	O	between	_	0	SENT_156	[p13l408t3205r763b3279],
10	the	DT	O	the	det	12	SENT_156	[p13l809t3205r936b3278],
11	two	CD	NUMBER	two	num	12	SENT_156	[p13l982t3216r1138b3279],
12	treatments	NNS	O	treatment	prep_between	8	SENT_156	[p13l1185t3216r1652b3278],
13	.	.	O	.	_	0	SENT_156	[p13l1185t3216r1652b3278],

1	Maximum	NNP	O	Maximum	nn	3	SENT_157	[p13l1703t3205r2146b3278],
2	plasma	NN	O	plasma	nn	3	SENT_157	[p13l8t3336r311b3432],
3	concentrations	NNS	O	concentration	nsubjpass	7	SENT_157	[p13l352t3336r971b3410],
4	of	IN	O	of	_	0	SENT_157	[p13l1017t3336r1108b3410],
5	bosentan	NN	O	bosentan	prep_of	3	SENT_157	[p13l1141t3336r1521b3410],
6	were	VBD	O	be	auxpass	7	SENT_157	[p13l1562t3360r1765b3410],
7	attained	VBN	O	attain	_	0	SENT_157	[p13l1809t3336r2144b3410],
8	after	IN	O	after	_	0	SENT_157	[p13l11t3469r205b3543],
9	approximately	RB	O	approximately	quantmod	10	SENT_157	[p13l239t3469r852b3564],
10	3.5	CD	DURATION	3.5	num	11	SENT_157	[p13l889t3468r1012b3543],
11	hours	NNS	NUMBER	hour	prep_after	7	SENT_157	[p13l1049t3469r1307b3543],
12	.	.	O	.	_	0	SENT_157	[p13l1049t3469r1307b3543],

1	The	DT	O	the	det	3	SENT_158	[p13l1345t3469r1507b3543],
2	total	JJ	O	total	amod	3	SENT_158	[p13l1540t3469r1728b3543],
3	exposure	NN	O	exposure	_	0	SENT_158	[p13l1762t3492r2144b3564],
4	to	TO	O	to	_	0	SENT_158	[p13l8t3611r88b3673],
5	the	DT	O	the	det	7	SENT_158	[p13l129t3600r256b3673],
6	metabolites	NNS	O	metabolite	nn	7	SENT_158	[p13l297t3600r787b3673],
7	Ro	NN	O	ro	prep_to	3	SENT_158	[p13l830t3602r949b3673],
8	47-8634	CD	NUMBER	47-8634	dep	3	SENT_158	[p13l991t3599r1368b3686],
9	,	,	O	,	_	0	SENT_158	[p13l991t3599r1368b3686],
10	Ro	NN	O	ro	appos	8	SENT_158	[p13l1412t3602r1532b3673],
11	48-5033	CD	NUMBER	48-5033	num	10	SENT_158	[p13l1573t3599r1950b3686],
12	,	,	O	,	_	0	SENT_158	[p13l1573t3599r1950b3686],
13	and	CC	O	and	advmod	10	SENT_158	[p13l1996t3600r2146b3673],

1	Ro	NN	O	ro	nsubj	14	SENT_159	[p14l9t31r130b103],
2	64-1056	CD	NUMBER	64-1056	num	1	SENT_159	[p14l180t29r566b116],
3	,	,	O	,	_	0	SENT_159	[p14l180t29r566b116],
4	in	IN	O	in	_	0	SENT_159	[p14l617t29r699b102],
5	comparison	NN	O	comparison	prep_in	1	SENT_159	[p14l746t29r1254b125],
6	to	TO	O	to	_	0	SENT_159	[p14l1301t40r1381b103],
7	the	DT	O	the	det	9	SENT_159	[p14l1429t29r1560b103],
8	parent	NN	O	parent	nn	9	SENT_159	[p14l1606t40r1880b125],
9	compound	NN	O	compound	prep_to	5	SENT_159	[p14l1927t53r2142b103, p14l8t162r301b258],
10	,	,	O	,	_	0	SENT_159	[p14l1927t53r2142b103, p14l8t162r301b258],
11	Was	VBD	O	be	cop	14	SENT_159	[p14l352t186r514b236],
12	approximately	RB	O	approximately	quantmod	14	SENT_159	[p14l565t162r1189b258],
13	20	CD	PERCENT	20	number	14	SENT_159	[p14l1238t162r1454b249],
14	%	NN	PERCENT	%	_	0	SENT_159	[p14l1238t162r1454b249],
15	,	,	O	,	_	0	SENT_159	[p14l1238t162r1454b249],
16	irrespective	RB	O	irrespective	_	0	SENT_159	[p14l1505t162r2011b258],
17	of	IN	O	of	_	0	SENT_159	[p14l2059t162r2151b235],
18	concomitant	JJ	O	concomitant	amod	19	SENT_159	[p14l10t294r538b367],
19	treatment	NN	O	treatment	prep_irrespective_of	14	SENT_159	[p14l566t304r971b367],
20	with	IN	O	with	_	0	SENT_159	[p14l1000t294r1187b367],
21	simvastatin	NN	O	simvastatin	prep_with	19	SENT_159	[p14l1222t294r1726b367],
22	.	.	O	.	_	0	SENT_159	[p14l1222t294r1726b367],

1	The	DT	O	the	det	4	SENT_160	[p14l135t425r300b499],
2	plasma	NN	O	plasma	nn	4	SENT_160	[p14l369t425r681b520],
3	concentration-time	JJ	O	concentration-time	amod	4	SENT_160	[p14l750t425r1584b499],
4	profiles	NNS	O	profile	nsubjpass	21	SENT_160	[p14l1652t425r1986b520],
5	of	IN	O	of	_	0	SENT_160	[p14l2060t425r2152b499],
6	simvastatin	NN	O	simvastatin	prep_of	4	SENT_160	[p14l12t556r495b629],
7	and	CC	O	and	_	0	SENT_160	[p14l523t556r674b629],
8	B	NN	O	b	nn	11	SENT_160	[p14l704t550r1326b652],
9	—	CD	NUMBER	—	num	11	SENT_160	[p14l704t550r1326b652],
10	hydroxyacid	NN	O	hydroxyacid	nn	11	SENT_160	[p14l704t550r1326b652],
11	simvastatin	NN	O	simvastatin	conj_and	4	SENT_160	[p14l1355t556r1838b629],
12	on	IN	O	on	_	0	SENT_160	[p14l1865t579r1968b629],
13	day	NN	DURATION	day	prep_on	11	SENT_160	[p14l1995t556r2144b651],
14	6	CD	NUMBER	6	num	13	SENT_160	[p14l11t688r57b762],
15	of	IN	O	of	_	0	SENT_160	[p14l93t688r184b761],
16	treatments	NNS	O	treatment	nn	17	SENT_160	[p14l210t699r652b761],
17	B	NN	O	b	prep_of	13	SENT_160	[p14l687t690r748b760],
18	and	CC	O	and	_	0	SENT_160	[p14l789t688r939b761],
19	C	NN	O	c	prep_of	13	SENT_160	[p14l972t689r1036b762],
20	are	VBP	O	be	auxpass	21	SENT_160	[p14l1073t712r1197b761],
21	presented	VBN	O	present	_	0	SENT_160	[p14l1229t688r1639b784],
22	in	IN	O	in	_	0	SENT_160	[p14l1670t688r1751b760],
23	figure	NN	O	figure	prep_in	21	SENT_160	[p14l1782t688r2035b784],
24	3	CD	NUMBER	3	num	23	SENT_160	[p14l2071t689r2139b762],
25	.	.	O	.	_	0	SENT_160	[p14l2071t689r2139b762],

1	The	DT	O	the	det	4	SENT_161	[p14l9t827r174b900],
2	corresponding	JJ	O	corresponding	amod	4	SENT_161	[p14l221t827r845b923],
3	pharmacokinetic	JJ	O	pharmacokinetic	amod	4	SENT_161	[p14l891t827r1620b923],
4	parameters	NNS	O	parameter	nsubjpass	6	SENT_161	[p14l1668t838r2142b923],
5	are	VBP	O	be	auxpass	6	SENT_161	[p14l11t982r136b1032],
6	given	VBN	O	give	_	0	SENT_161	[p14l172t958r406b1054],
7	in	IN	O	in	_	0	SENT_161	[p14l440t958r521b1031],
8	table	NN	O	table	prep_in	6	SENT_161	[p14l555t958r761b1032],
9	II	CD	NUMBER	ii	num	8	SENT_161	[p14l796t960r886b1032],
10	.	.	O	.	_	0	SENT_161	[p14l796t960r886b1032],

1	Simvastatin	NNP	O	Simvastatin	nsubjpass	4	SENT_162	[p14l928t958r1430b1033],
2	was	VBD	O	be	auxpass	4	SENT_162	[p14l1464t982r1624b1033],
3	quickly	RB	O	quickly	advmod	4	SENT_162	[p14l1661t958r1978b1054],
4	absorbed	VBN	O	absorb	conj_or	4	SENT_162	[p14l2015t958r2143b1032, p14l13t1090r292b1164],
5	with	IN	O	with	_	0	SENT_162	[p14l314t1090r501b1164],
6	or	CC	O	or	_	0	SENT_162	[p14l525t1114r612b1164],
7	without	IN	O	without	_	0	SENT_162	[p14l632t1090r957b1164],
8	concomitant	JJ	O	concomitant	amod	9	SENT_162	[p14l979t1090r1507b1164],
9	administration	NN	O	administration	prep_with	4	SENT_162	[p14l1529t1090r2145b1164],
10	of	IN	O	of	_	0	SENT_162	[p14l10t1221r102b1294],
11	bosentan	NN	O	bosentan	nn	13	SENT_162	[p14l120t1221r500b1294],
12	(	CD	NUMBER	(	num	13	SENT_162	[p14l530t1222r718b1312],
13	tmax	NN	O	tmax	prep_of	9	SENT_162	[p14l530t1222r718b1312],
14	approximately	RB	O	approximately	advmod	9	SENT_162	[p14l748t1221r1362b1317],
15	1	CD	DURATION	1	num	17	SENT_162	[p14l1400t1222r1431b1294],
16	hour	NN	NUMBER	hour	nn	17	SENT_162	[p14l1467t1221r1718b1312],
17	)	NN	O	)	pobj	14	SENT_162	[p14l1467t1221r1718b1312],
18	.	.	O	.	_	0	SENT_162	[p14l1467t1221r1718b1312],

1	Concomitant	JJ	O	concomitant	amod	2	SENT_163	[p14l1753t1222r2143b1296, p14l9t1353r199b1427],
2	administration	NN	O	administration	nsubj	5	SENT_163	[p14l226t1353r843b1427],
3	of	IN	O	of	_	0	SENT_163	[p14l870t1353r962b1427],
4	bosentan	NN	O	bosentan	prep_of	2	SENT_163	[p14l981t1353r1361b1427],
5	reduced	VBD	O	reduce	_	0	SENT_163	[p14l1387t1353r1725b1427],
6	the	DT	O	the	det	7	SENT_163	[p14l1751t1353r1878b1427],
7	exposure	NN	O	exposure	dobj	5	SENT_163	[p14l1907t1377r2143b1449, p14l12t1508r184b1558],
8	to	TO	O	to	_	0	SENT_163	[p14l211t1496r289b1558],
9	simvastatin	NN	O	simvastatin	nn	12	SENT_163	[p14l321t1485r804b1559],
10	and	CC	O	and	_	0	SENT_163	[p14l832t1485r981b1558],
11	B-hydroxyacid	JJ	MISC	b-hydroxyacid	nn	12	SENT_163	[p14l1011t1479r1633b1581],
12	simvastatin	NN	O	simvastatin	prep_to	5	SENT_163	[p14l1663t1485r2146b1559],
13	by	IN	O	by	_	0	SENT_163	[p14l7t1617r112b1712],
14	34	CD	NUMBER	34	prep_by	5	SENT_163	[p14l142t1617r242b1691],
15	and	CC	O	and	_	0	SENT_163	[p14l272t1617r422b1691],
16	46	CD	PERCENT	46	num	17	SENT_163	[p14l448t1617r663b1704],
17	%	NN	PERCENT	%	conj_and	14	SENT_163	[p14l448t1617r663b1704],
18	,	,	O	,	_	0	SENT_163	[p14l448t1617r663b1704],
19	respectively	RB	O	respectively	advmod	5	SENT_163	[p14l693t1617r1233b1712],
20	,	,	O	,	_	0	SENT_163	[p14l693t1617r1233b1712],
21	both	DT	O	both	dobj	5	SENT_163	[p14l1263t1617r1452b1691],
22	to	TO	O	to	_	0	SENT_163	[p14l1479t1627r1557b1691],
23	a	DT	O	a	det	26	SENT_163	[p14l1588t1640r1632b1691],
24	statistically	RB	O	statistically	advmod	25	SENT_163	[p14l1660t1617r2143b1712],
25	significant	JJ	O	significant	amod	26	SENT_163	[p14l12t1749r481b1844],
26	extent	NN	O	extent	prep_to	21	SENT_163	[p14l527t1759r819b1823],
27	.	.	O	.	_	0	SENT_163	[p14l527t1759r819b1823],

1	In	IN	O	in	_	0	SENT_164	[p14l872t1750r960b1821],
2	the	DT	O	the	det	3	SENT_164	[p14l1006t1749r1138b1823],
3	presence	NN	O	presence	prep_in	7	SENT_164	[p14l1184t1772r1570b1844],
4	of	IN	O	of	_	0	SENT_164	[p14l1620t1749r1713b1823],
5	bosentan	NN	O	bosentan	prep_of	3	SENT_164	[p14l1752t1749r2145b1823],
6	there	EX	O	there	expl	7	SENT_164	[p14l9t1879r221b1952],
7	was	VBD	O	be	_	0	SENT_164	[p14l257t1903r417b1953],
8	a	DT	O	a	det	9	SENT_164	[p14l457t1903r500b1952],
9	trend	NN	O	trend	nsubj	7	SENT_164	[p14l533t1879r752b1952],
10	for	IN	O	for	_	0	SENT_164	[p14l785t1879r909b1952],
11	a	DT	O	a	det	12	SENT_164	[p14l943t1903r986b1952],
12	decrease	NN	O	decrease	prep_for	9	SENT_164	[p14l1020t1879r1385b1952],
13	in	IN	O	in	_	0	SENT_164	[p14l1420t1879r1500b1952],
14	t1/ZZ	NN	O	t1/zz	prep_in	12	SENT_164	[p14l1534t1890r1681b1977],
15	,	,	O	,	_	0	SENT_164	[p14l1534t1890r1681b1977],
16	which	WDT	O	which	nsubj	19	SENT_164	[p14l1719t1879r1978b1953],
17	did	VBD	O	do	aux	19	SENT_164	[p14l2012t1879r2146b1952],
18	not	RB	O	not	neg	19	SENT_164	[p14l9t2022r144b2085],
19	reach	VB	O	reach	rcmod	14	SENT_164	[p14l167t2011r397b2085],
20	statistical	JJ	O	statistical	amod	21	SENT_164	[p14l425t2011r826b2085],
21	significance	NN	O	significance	dobj	19	SENT_164	[p14l855t2011r1390b2107],
22	.	.	O	.	_	0	SENT_164	[p14l855t2011r1390b2107],

1	Figure	NNP	O	Figure	nsubj	3	SENT_165	[p14l1420t2011r1697b2107],
2	4	CD	NUMBER	4	num	1	SENT_165	[p14l1722t2012r1770b2084],
3	displays	VBZ	O	display	_	0	SENT_165	[p14l1797t2011r2143b2107],
4	the	DT	O	the	det	6	SENT_165	[p14l8t2144r136b2218],
5	individual	JJ	O	individual	amod	6	SENT_165	[p14l171t2144r603b2218],
6	changes	NNS	O	change	dobj	3	SENT_165	[p14l638t2144r977b2239],
7	in	IN	O	in	_	0	SENT_165	[p14l1014t2144r1094b2216],
8	exposure	NN	O	exposure	prep_in	6	SENT_165	[p14l1128t2167r1511b2239],
9	to	TO	O	to	_	0	SENT_165	[p14l1545t2155r1624b2218],
10	simvastatin	NN	O	simvastatin	nn	13	SENT_165	[p14l1663t2144r2146b2218],
11	and	CC	O	and	_	0	SENT_165	[p14l11t2275r161b2348],
12	B-hydroxyacid	JJ	MISC	b-hydroxyacid	conj_and	10	SENT_165	[p14l188t2269r811b2371],
13	simvastatin	NN	O	simvastatin	prep_to	3	SENT_165	[p14l837t2275r1320b2349],
14	due	JJ	O	due	_	0	SENT_165	[p14l1345t2275r1494b2348],
15	to	TO	O	to	_	0	SENT_165	[p14l1518t2286r1597b2348],
16	the	DT	O	the	det	17	SENT_165	[p14l1621t2275r1749b2348],
17	presence	NN	O	presence	prep_due_to	13	SENT_165	[p14l1771t2298r2144b2370],
18	of	IN	O	of	_	0	SENT_165	[p14l10t2406r104b2480],
19	bosentan	NN	O	bosentan	prep_of	17	SENT_165	[p14l119t2406r520b2480],
20	.	.	O	.	_	0	SENT_165	[p14l119t2406r520b2480],

1	The	DT	O	the	det	2	SENT_166	[p14l550t2406r712b2480],
2	decrease	NN	O	decrease	nsubj	5	SENT_166	[p14l738t2406r1102b2480],
3	in	IN	O	in	_	0	SENT_166	[p14l1126t2406r1206b2479],
4	exposure	NN	O	exposure	prep_in	2	SENT_166	[p14l1230t2430r1613b2502],
5	ranged	VBD	O	range	conj_and	5	SENT_166	[p14l1635t2406r1926b2502],
6	from	IN	O	from	_	0	SENT_166	[p14l1949t2406r2148b2480],
7	a	DT	O	a	det	8	SENT_166	[p14l11t2562r54b2611],
8	factor	NN	O	factor	prep_from	5	SENT_166	[p14l77t2538r317b2611],
9	of	IN	O	of	_	0	SENT_166	[p14l340t2538r429b2611],
10	0.36	CD	NUMBER	0.36	prep_of	8	SENT_166	[p14l447t2538r852b2612],
11	—	CD	NUMBER	—	number	12	SENT_166	[p14l447t2538r852b2612],
12	1.45	CD	NUMBER	1.45	npadvmod	5	SENT_166	[p14l447t2538r852b2612],
13	for	IN	O	for	_	0	SENT_166	[p14l881t2538r1000b2611],
14	simvastatin	NN	O	simvastatin	prep_for	5	SENT_166	[p14l1025t2538r1489b2612],
15	and	CC	O	and	_	0	SENT_166	[p14l1514t2538r1660b2611],
16	from	IN	O	from	_	0	SENT_166	[p14l1683t2538r1883b2611],
17	0.31	CD	NUMBER	0.31	prep_from	5	SENT_166	[p14l1908t2539r2147b2612],
18	—	CD	NUMBER	—	num	19	SENT_166	[p14l1908t2539r2147b2612],
19	1.04	CD	NUMBER	1.04	dep	5	SENT_166	[p14l19t2669r192b2743],
20	for	IN	O	for	_	0	SENT_166	[p14l224t2669r347b2742],
21	B-hydroxyacid	JJ	MISC	b-hydroxyacid	amod	22	SENT_166	[p14l381t2663r1003b2765],
22	simvastatin	NN	O	simvastatin	prep_for	5	SENT_166	[p14l1037t2669r1541b2743],
23	.	.	O	.	_	0	SENT_166	[p14l1037t2669r1541b2743],

1	Of	IN	O	of	_	0	SENT_167	[p14l137t2801r251b2875],
2	the	DT	O	the	det	3	SENT_167	[p14l275t2801r403b2875],
3	38	CD	NUMBER	38	prep_of	4	SENT_167	[p14l437t2801r534b2875],
4	reported	VBD	O	report	_	0	SENT_167	[p14l568t2801r924b2896],
5	adverse	JJ	O	adverse	amod	6	SENT_167	[p14l957t2801r1278b2875],
6	events	NNS	O	event	nsubj	9	SENT_167	[p14l1310t2812r1604b2888],
7	,	,	O	,	_	0	SENT_167	[p14l1310t2812r1604b2888],
8	12	CD	NUMBER	12	appos	6	SENT_167	[p14l1649t2801r1741b2873],
9	occurred	VBD	O	occur	dep	4	SENT_167	[p14l1775t2801r2146b2875],
10	during	IN	O	during	_	0	SENT_167	[p14l10t2933r284b3029],
11	treatment	NN	O	treatment	nn	12	SENT_167	[p14l323t2944r728b3006],
12	A	NN	O	a	prep_during	9	SENT_167	[p14l764t2934r861b3020],
13	,	,	O	,	_	0	SENT_167	[p14l764t2934r861b3020],
14	5	CD	NUMBER	5	appos	12	SENT_167	[p14l905t2933r949b3007],
15	during	IN	O	during	_	0	SENT_167	[p14l993t2933r1267b3029],
16	treatment	NN	O	treatment	nn	17	SENT_167	[p14l1307t2944r1711b3006],
17	B	NN	O	b	prep_during	9	SENT_167	[p14l1747t2935r1809b3005],
18	and	CC	O	and	_	0	SENT_167	[p14l1854t2933r2004b3006],
19	21	CD	NUMBER	21	nsubj	33	SENT_167	[p14l2042t2934r2136b3005],
20	during	IN	O	during	_	0	SENT_167	[p14l10t3065r286b3161],
21	treatment	NN	O	treatment	nn	23	SENT_167	[p14l333t3076r739b3138],
22	C.	NNP	O	C.	nn	23	SENT_167	[p14l784t3065r868b3139],
23	Mild	NNP	O	Mild	prep_during	19	SENT_167	[p14l923t3065r1131b3138],
24	to	TO	O	to	_	0	SENT_167	[p14l1175t3076r1255b3138],
25	moderate	JJ	O	moderate	amod	26	SENT_167	[p14l1301t3065r1700b3138],
26	headache	NN	O	headache	prep_to	23	SENT_167	[p14l1745t3065r2144b3138],
27	was	VBD	O	be	cop	33	SENT_167	[p14l9t3220r169b3271],
28	the	DT	O	the	det	33	SENT_167	[p14l194t3196r322b3270],
29	most	RBS	O	most	advmod	30	SENT_167	[p14l344t3207r550b3270],
30	frequently	RB	O	frequently	advmod	31	SENT_167	[p14l571t3196r1009b3292],
31	reported	VBN	O	report	amod	33	SENT_167	[p14l1030t3196r1387b3292],
32	adverse	JJ	O	adverse	amod	33	SENT_167	[p14l1410t3196r1732b3271],
33	event	NN	O	event	conj_and	9	SENT_167	[p14l1756t3207r1985b3271],
34	(	NN	O	(	nsubj	4	SENT_167	[p14l2009t3197r2082b3287],
35	1	CD	NUMBER	1	number	36	SENT_167	[p14l2009t3197r2082b3287],
36	1	CD	NUMBER	1	num	37	SENT_167	[p14l2105t3197r2135b3269],
37	cases	NNS	O	case	dep	34	SENT_167	[p14l10t3329r297b3419],
38	)	CD	NUMBER	)	dep	37	SENT_167	[p14l10t3329r297b3419],
39	.	.	O	.	_	0	SENT_167	[p14l10t3329r297b3419],

1	All	DT	O	all	det	2	SENT_168	[p14l349t3328r485b3401],
2	events	NNS	O	event	nsubj	3	SENT_168	[p14l533t3339r806b3403],
3	resolved	VBN	O	resolve	_	0	SENT_168	[p14l855t3328r1226b3403],
4	quickly	RB	O	quickly	advmod	3	SENT_168	[p14l1272t3328r1596b3424],
5	without	IN	O	without	_	0	SENT_168	[p14l1645t3328r1978b3403],
6	sequelae	NNS	O	sequela	prep_without	3	SENT_168	[p14l2027t3352r2143b3402, p14l9t3461r307b3557],
7	.	.	O	.	_	0	SENT_168	[p14l2027t3352r2143b3402, p14l9t3461r307b3557],

1	No	DT	O	no	det	2	SENT_169	[p14l348t3463r475b3535],
2	pattern	NN	O	pattern	nsubjpass	11	SENT_169	[p14l511t3472r807b3557],
3	of	IN	O	of	_	0	SENT_169	[p14l844t3461r935b3534],
4	abnormal	JJ	O	abnormal	amod	6	SENT_169	[p14l966t3461r1365b3534],
5	laboratory	NN	O	laboratory	nn	6	SENT_169	[p14l1401t3461r1838b3557],
6	values	NNS	O	value	prep_of	2	SENT_169	[p14l1875t3461r2143b3535],
7	or	CC	O	or	_	0	SENT_169	[p14l10t3616r97b3667],
8	vital	JJ	O	vital	amod	9	SENT_169	[p14l122t3593r309b3667],
9	signs	NNS	O	sign	prep_of	2	SENT_169	[p14l339t3593r550b3688],
10	was	VBD	O	be	auxpass	11	SENT_169	[p14l580t3616r740b3667],
11	detected	VBN	O	detect	_	0	SENT_169	[p14l769t3593r1124b3667],
12	during	IN	O	during	_	0	SENT_169	[p14l1150t3593r1424b3688],
13	the	DT	O	the	det	14	SENT_169	[p14l1451t3593r1578b3667],
14	study	NN	O	study	prep_during	11	SENT_169	[p14l1608t3593r1833b3688],
15	to	TO	O	to	aux	16	SENT_169	[p14l1859t3604r1938b3667],
16	suggest	VB	O	suggest	xcomp	11	SENT_169	[p14l1969t3616r2143b3688, p15l10t36r180b121],

1	a	DT	O	a	det	3	SENT_170	[p15l214t49r258b99],
2	treatment	NN	O	treatment	nn	3	SENT_170	[p15l289t36r694b99],
3	effect	NN	O	effect	nsubjpass	11	SENT_170	[p15l726t25r990b112],
4	,	,	O	,	_	0	SENT_170	[p15l726t25r990b112],
5	and	CC	O	and	_	0	SENT_170	[p15l1030t26r1180b99],
6	the	DT	O	the	det	8	SENT_170	[p15l1212t26r1339b99],
7	few	JJ	O	few	amod	8	SENT_170	[p15l1374t25r1529b100],
8	abnormalities	NNS	O	abnormality	conj_and	3	SENT_170	[p15l1566t25r2143b99],
9	observed	VBN	O	observe	partmod	3	SENT_170	[p15l10t157r394b232],
10	were	VBD	O	be	auxpass	11	SENT_170	[p15l419t181r623b232],
11	judged	VBN	O	judge	_	0	SENT_170	[p15l640t157r939b253],
12	to	TO	O	to	aux	16	SENT_170	[p15l963t168r1043b231],
13	be	VB	O	be	cop	16	SENT_170	[p15l1068t157r1167b231],
14	clinically	RB	O	clinically	advmod	16	SENT_170	[p15l1194t157r1590b253],
15	not	RB	O	not	neg	16	SENT_170	[p15l1615t168r1751b231],
16	relevant	JJ	O	relevant	xcomp	11	SENT_170	[p15l1773t157r2139b231],
17	.	.	O	.	_	0	SENT_170	[p15l1773t157r2139b231],

1	Clin	NNP	O	Clin	nn	2	SENT_171	[p15l1206t442r1314b491],
2	Phclrmclcokinet	NNP	O	Phclrmclcokinet	_	0	SENT_171	[p15l1339t443r1799b491],
3	2003	CD	DATE	2003	num	2	SENT_171	[p15l1818t442r1968b494],
4	;	:	O	;	_	0	SENT_171	[p15l1818t442r1968b494],
5	42	CD	NUMBER	42	number	6	SENT_171	[p15l1989t442r2056b490],
6	(	CD	NUMBER	(	dep	2	SENT_171	[p15l2079t442r2153b497],
7	3	CD	NUMBER	3	num	8	SENT_171	[p15l2079t442r2153b497],
8	)	NN	O	)	dep	6	SENT_171	[p15l2079t442r2153b497],

1	298	CD	NUMBER	298	num	2	SENT_172	[p15l191t573r240b597],
2	Dingemanse	NNP	O	Dingemanse	_	0	SENT_172	[p15l1725t572r1893b606],
3	et	FW	O	et	nn	4	SENT_172	[p15l1902t575r1925b597],
4	al.	FW	O	al.	dep	2	SENT_172	[p15l1935t572r1965b597],
5	.	.	O	.	_	0	SENT_172	[p15l1935t572r1965b597],

1	Table	NNP	O	Table	nn	2	SENT_173	[p15l196t705r271b728],
2	II	NNP	O	II	_	0	SENT_173	[p15l281t705r302b727],
3	.	.	O	.	_	0	SENT_173	[p15l281t705r302b727],

1	Pharmacokinetic	JJ	O	pharmacokinetic	dep	194	SENT_174	[p15l323t705r533b728],
2	parameters	NNS	O	parameter	dep	194	SENT_174	[p15l543t707r687b733],
3	of	IN	O	of	dep	194	SENT_174	[p15l697t705r720b728],
4	simvastatin	NN	O	simvastatin	dep	194	SENT_174	[p15l730t705r871b728],
5	and	CC	O	and	dep	194	SENT_174	[p15l882t705r928b728],
6	|	NN	O	|	dep	194	SENT_174	[p15l940t705r1116b734],
7	3-hydroxyacid	JJ	O	3-hydroxyacid	dep	194	SENT_174	[p15l940t705r1116b734],
8	simvastatin	NN	O	simvastatin	dep	194	SENT_174	[p15l1126t705r1268b728],
9	on	IN	O	on	dep	194	SENT_174	[p15l1279t711r1309b728],
10	day	NN	DURATION	day	dep	194	SENT_174	[p15l1320t705r1365b734],
11	6	CD	NUMBER	6	dep	194	SENT_174	[p15l1375t706r1389b728],
12	following	VBG	O	follow	dep	194	SENT_174	[p15l1399t705r1509b734],
13	administration	NN	O	administration	dep	194	SENT_174	[p15l1520t705r1696b728],
14	of	IN	O	of	dep	194	SENT_174	[p15l1707t705r1730b728],
15	simvastatin	NN	O	simvastatin	dep	194	SENT_174	[p15l1740t705r1882b728],
16	40mg	NN	O	40mg	dep	194	SENT_174	[p15l1892t706r1962b734],
17	once	RB	DATE	once	dep	194	SENT_174	[p15l196t748r257b765],
18	daily	RB	SET	daily	dep	194	SENT_174	[p15l267t743r325b771],
19	in	IN	O	in	dep	194	SENT_174	[p15l335t743r354b765],
20	the	DT	O	the	dep	194	SENT_174	[p15l364t743r403b765],
21	absence	NN	O	absence	dep	194	SENT_174	[p15l412t743r520b765],
22	(	NN	O	(	dep	194	SENT_174	[p15l530t742r659b771],
23	treatment	NN	O	treatment	dep	194	SENT_174	[p15l530t742r659b771],
24	B	NN	O	b	dep	194	SENT_174	[p15l670t742r695b771],
25	)	NN	O	)	dep	194	SENT_174	[p15l670t742r695b771],
26	and	CC	O	and	dep	194	SENT_174	[p15l705t743r751b765],
27	presence	NN	O	presence	dep	194	SENT_174	[p15l762t748r878b771],
28	(	NN	O	(	dep	194	SENT_174	[p15l889t743r1018b771],
29	treatment	NN	O	treatment	dep	194	SENT_174	[p15l889t743r1018b771],
30	C	NN	O	c	dep	194	SENT_174	[p15l1027t742r1055b771],
31	)	NN	O	)	dep	194	SENT_174	[p15l1027t742r1055b771],
32	of	IN	O	of	dep	194	SENT_174	[p15l1066t743r1089b765],
33	bosentan	NN	O	bosentan	dep	194	SENT_174	[p15l1098t743r1214b765],
34	125mg	NN	O	125mg	dep	194	SENT_174	[p15l1226t743r1310b771],
35	twice	RB	O	twice	dep	194	SENT_174	[p15l1320t743r1384b765],
36	daily	RB	SET	daily	dep	194	SENT_174	[p15l1394t742r1463b771],
37	“	CD	NUMBER	“	dep	194	SENT_174	[p15l1394t742r1463b771],
38	Treatment	NN	O	treatment	dep	194	SENT_174	[p15l196t799r327b822],
39	tmax	NN	O	tmax	dep	194	SENT_174	[p15l637t801r684b825],
40	(	CD	NUMBER	(	dep	194	SENT_174	[p15l692t799r723b828],
41	h	NN	O	h	dep	194	SENT_174	[p15l692t799r723b828],
42	)	CD	NUMBER	)	dep	194	SENT_174	[p15l692t799r723b828],
43	Cmax	NN	O	cmax	dep	194	SENT_174	[p15l999t799r1138b828],
44	(	CD	NUMBER	(	dep	194	SENT_174	[p15l999t799r1138b828],
45	ug/L	NN	O	ug/l	dep	194	SENT_174	[p15l999t799r1138b828],
46	)	CD	NUMBER	)	dep	194	SENT_174	[p15l999t799r1138b828],
47	AUC	NN	ORGANIZATION	auc	dep	194	SENT_174	[p15l1338t799r1407b825],
48	,	,	O	,	_	0	SENT_174	[p15l1338t799r1407b825],
49	(	CD	NUMBER	(	dep	194	SENT_174	[p15l1417t799r1457b828],
50	pg	NN	O	pg	dep	194	SENT_174	[p15l1417t799r1457b828],
51	o	NN	O	o	dep	194	SENT_174	[p15l1467t807r1478b818],
52	h/L	NN	O	h/l	dep	194	SENT_174	[p15l1491t799r1538b828],
53	)	CD	NUMBER	)	dep	194	SENT_174	[p15l1491t799r1538b828],
54	t1/22	NN	O	t1/22	dep	194	SENT_174	[p15l1758t801r1801b827],
55	(	CD	NUMBER	(	dep	194	SENT_174	[p15l1812t799r1844b828],
56	h	NN	O	h	dep	194	SENT_174	[p15l1812t799r1844b828],
57	)	CD	NUMBER	)	dep	194	SENT_174	[p15l1812t799r1844b828],
58	simvastatin	NN	O	simvastatin	dep	194	SENT_174	[p15l196t862r356b885],
59	B	NN	O	b	dep	194	SENT_174	[p15l197t902r214b924],
60	1.5	CD	NUMBER	1.5	dep	194	SENT_174	[p15l640t903r676b925],
61	(	CD	NUMBER	(	dep	194	SENT_174	[p15l687t902r815b930],
62	0.50	CD	NUMBER	0.50	dep	194	SENT_174	[p15l687t902r815b930],
63	—	NN	O	—	dep	194	SENT_174	[p15l687t902r815b930],
64	3.5	CD	NUMBER	3.5	dep	194	SENT_174	[p15l687t902r815b930],
65	)	NN	O	)	dep	194	SENT_174	[p15l687t902r815b930],
66	12.9	CD	NUMBER	12.9	dep	194	SENT_174	[p15l1001t903r1053b925],
67	(	NN	O	(	dep	194	SENT_174	[p15l1064t902r1117b930],
68	8.1	CD	NUMBER	8.1	dep	194	SENT_174	[p15l1064t902r1117b930],
69	,	,	O	,	_	0	SENT_174	[p15l1064t902r1117b930],
70	20.5	CD	NUMBER	20.5	dep	194	SENT_174	[p15l1128t902r1191b930],
71	)	CD	NUMBER	)	dep	194	SENT_174	[p15l1128t902r1191b930],
72	30.5	CD	NUMBER	30.5	dep	194	SENT_174	[p15l1338t903r1393b925],
73	(	NN	O	(	dep	194	SENT_174	[p15l1403t902r1473b930],
74	23.1	CD	NUMBER	23.1	dep	194	SENT_174	[p15l1403t902r1473b930],
75	,	,	O	,	_	0	SENT_174	[p15l1403t902r1473b930],
76	40.2	CD	NUMBER	40.2	dep	194	SENT_174	[p15l1483t902r1547b930],
77	)	NN	O	)	dep	194	SENT_174	[p15l1483t902r1547b930],
78	3.2	CD	NUMBER	3.2	dep	194	SENT_174	[p15l1759t903r1797b925],
79	(	NN	O	(	dep	194	SENT_174	[p15l1808t902r1861b930],
80	2.6	CD	NUMBER	2.6	dep	194	SENT_174	[p15l1808t902r1861b930],
81	,	,	O	,	_	0	SENT_174	[p15l1808t902r1861b930],
82	3.8	CD	NUMBER	3.8	dep	194	SENT_174	[p15l1872t902r1919b930],
83	)	NN	O	)	dep	194	SENT_174	[p15l1872t902r1919b930],
84	C	NN	O	c	dep	194	SENT_174	[p15l197t943r216b965],
85	1.0	CD	NUMBER	1.0	dep	194	SENT_174	[p15l640t943r677b965],
86	(	CD	NUMBER	(	dep	194	SENT_174	[p15l687t943r815b971],
87	0.75	CD	NUMBER	0.75	dep	194	SENT_174	[p15l687t943r815b971],
88	—	NN	O	—	dep	194	SENT_174	[p15l687t943r815b971],
89	3.5	CD	NUMBER	3.5	dep	194	SENT_174	[p15l687t943r815b971],
90	)	CD	NUMBER	)	dep	194	SENT_174	[p15l687t943r815b971],
91	10.7	CD	NUMBER	10.7	dep	194	SENT_174	[p15l1001t943r1053b965],
92	(	NN	O	(	dep	194	SENT_174	[p15l1064t943r1117b971],
93	7.2	CD	NUMBER	7.2	dep	194	SENT_174	[p15l1064t943r1117b971],
94	,	,	O	,	_	0	SENT_174	[p15l1064t943r1117b971],
95	15.9	CD	NUMBER	15.9	dep	194	SENT_174	[p15l1130t943r1191b971],
96	)	CD	NUMBER	)	dep	194	SENT_174	[p15l1130t943r1191b971],
97	20.0	CD	NUMBER	20.0	dep	194	SENT_174	[p15l1338t938r1404b965],
98	“	NN	O	“	dep	194	SENT_174	[p15l1338t938r1404b965],
99	(	CD	NUMBER	(	dep	194	SENT_174	[p15l1415t943r1484b971],
100	15.9	CD	NUMBER	15.9	dep	194	SENT_174	[p15l1415t943r1484b971],
101	,	,	O	,	_	0	SENT_174	[p15l1415t943r1484b971],
102	25.1	CD	NUMBER	25.1	dep	194	SENT_174	[p15l1495t943r1558b971],
103	)	NN	O	)	dep	194	SENT_174	[p15l1495t943r1558b971],
104	2.1	CD	NUMBER	2.1	dep	194	SENT_174	[p15l1759t943r1793b965],
105	(	CD	NUMBER	(	dep	194	SENT_174	[p15l1808t943r1861b971],
106	1.6	CD	NUMBER	1.6	dep	194	SENT_174	[p15l1808t943r1861b971],
107	,	,	O	,	_	0	SENT_174	[p15l1808t943r1861b971],
108	2.9	CD	NUMBER	2.9	dep	194	SENT_174	[p15l1872t943r1919b971],
109	)	CD	NUMBER	)	dep	194	SENT_174	[p15l1872t943r1919b971],
110	[	NN	O	[	dep	194	SENT_174	[p15l197t1003r390b1032],
111	3-hydroxyacid	JJ	O	3-hydroxyacid	dep	194	SENT_174	[p15l197t1003r390b1032],
112	simvastatin	NN	O	simvastatin	dep	194	SENT_174	[p15l400t1003r556b1026],
113	B	NN	O	b	dep	194	SENT_174	[p15l197t1043r214b1065],
114	4.5	CD	NUMBER	4.5	dep	194	SENT_174	[p15l638t1044r676b1066],
115	(	CD	NUMBER	(	dep	194	SENT_174	[p15l687t1043r815b1071],
116	0.75	CD	NUMBER	0.75	dep	194	SENT_174	[p15l687t1043r815b1071],
117	—	CD	NUMBER	—	dep	194	SENT_174	[p15l687t1043r815b1071],
118	6.0	CD	NUMBER	6.0	dep	194	SENT_174	[p15l687t1043r815b1071],
119	)	NN	O	)	dep	194	SENT_174	[p15l687t1043r815b1071],
120	7.3	CD	NUMBER	7.3	dep	194	SENT_174	[p15l999t1044r1037b1066],
121	(	NN	O	(	dep	194	SENT_174	[p15l1048t1043r1101b1071],
122	5.4	CD	NUMBER	5.4	dep	194	SENT_174	[p15l1048t1043r1101b1071],
123	,	,	O	,	_	0	SENT_174	[p15l1048t1043r1101b1071],
124	9.7	CD	NUMBER	9.7	dep	194	SENT_174	[p15l1112t1043r1159b1071],
125	)	CD	NUMBER	)	dep	194	SENT_174	[p15l1112t1043r1159b1071],
126	43.0	CD	NUMBER	43.0	dep	194	SENT_174	[p15l1338t1044r1393b1066],
127	(	NN	O	(	dep	194	SENT_174	[p15l1403t1043r1473b1071],
128	32.1	CD	NUMBER	32.1	dep	194	SENT_174	[p15l1403t1043r1473b1071],
129	,	,	O	,	_	0	SENT_174	[p15l1403t1043r1473b1071],
130	57.8	CD	NUMBER	57.8	dep	194	SENT_174	[p15l1484t1043r1547b1071],
131	)	CD	NUMBER	)	dep	194	SENT_174	[p15l1484t1043r1547b1071],
132	4.0	CD	NUMBER	4.0	dep	194	SENT_174	[p15l1758t1044r1797b1066],
133	(	NN	O	(	dep	194	SENT_174	[p15l1808t1043r1861b1071],
134	3.3	CD	NUMBER	3.3	dep	194	SENT_174	[p15l1808t1043r1861b1071],
135	,	,	O	,	_	0	SENT_174	[p15l1808t1043r1861b1071],
136	5.0	CD	NUMBER	5.0	dep	194	SENT_174	[p15l1872t1043r1919b1071],
137	)	NN	O	)	dep	194	SENT_174	[p15l1872t1043r1919b1071],
138	C	NN	O	c	dep	194	SENT_174	[p15l197t1083r216b1106],
139	4.5	CD	NUMBER	4.5	dep	194	SENT_174	[p15l638t1084r676b1106],
140	(	CD	NUMBER	(	dep	194	SENT_174	[p15l687t1084r799b1112],
141	1.0	CD	NUMBER	1.0	dep	194	SENT_174	[p15l687t1084r799b1112],
142	—	NN	O	—	dep	194	SENT_174	[p15l687t1084r799b1112],
143	4.5	CD	NUMBER	4.5	dep	194	SENT_174	[p15l687t1084r799b1112],
144	)	CD	NUMBER	)	dep	194	SENT_174	[p15l687t1084r799b1112],
145	6.0	CD	NUMBER	6.0	dep	194	SENT_174	[p15l999t1084r1037b1106],
146	(	NN	O	(	dep	194	SENT_174	[p15l1047t1084r1101b1112],
147	4.2	CD	NUMBER	4.2	dep	194	SENT_174	[p15l1047t1084r1101b1112],
148	,	,	O	,	_	0	SENT_174	[p15l1047t1084r1101b1112],
149	8.7	CD	NUMBER	8.7	dep	194	SENT_174	[p15l1112t1084r1159b1112],
150	)	CD	NUMBER	)	dep	194	SENT_174	[p15l1112t1084r1159b1112],
151	23.4	CD	NUMBER	23.4	dep	194	SENT_174	[p15l1338t1079r1404b1106],
152	“	NN	O	“	dep	194	SENT_174	[p15l1338t1079r1404b1106],
153	(	CD	NUMBER	(	dep	194	SENT_174	[p15l1415t1084r1484b1112],
154	16.7	CD	NUMBER	16.7	dep	194	SENT_174	[p15l1415t1084r1484b1112],
155	,	,	O	,	_	0	SENT_174	[p15l1415t1084r1484b1112],
156	32.6	CD	NUMBER	32.6	dep	194	SENT_174	[p15l1495t1084r1558b1112],
157	)	NN	O	)	dep	194	SENT_174	[p15l1495t1084r1558b1112],
158	2.9	CD	NUMBER	2.9	dep	194	SENT_174	[p15l1759t1084r1797b1106],
159	(	CD	NUMBER	(	dep	194	SENT_174	[p15l1808t1084r1861b1112],
160	2.4	CD	NUMBER	2.4	dep	194	SENT_174	[p15l1808t1084r1861b1112],
161	,	,	O	,	_	0	SENT_174	[p15l1808t1084r1861b1112],
162	3.6	CD	NUMBER	3.6	dep	194	SENT_174	[p15l1872t1084r1919b1112],
163	)	CD	NUMBER	)	dep	194	SENT_174	[p15l1872t1084r1919b1112],
164	a	DT	O	a	dep	194	SENT_174	[p15l196t1134r211b1150],
165	Data	NN	O	datum	dep	194	SENT_174	[p15l245t1128r304b1150],
166	are	VBP	O	be	dep	194	SENT_174	[p15l313t1134r353b1150],
167	presented	VBN	O	present	dep	194	SENT_174	[p15l363t1128r489b1156],
168	as	IN	O	as	dep	194	SENT_174	[p15l499t1134r528b1150],
169	geometric	JJ	O	geometric	dep	194	SENT_174	[p15l537t1128r662b1156],
170	means	NNS	O	means	dep	194	SENT_174	[p15l672t1134r757b1150],
171	(	VBP	O	(	dep	194	SENT_174	[p15l767t1128r832b1156],
172	95	CD	PERCENT	95	dep	194	SENT_174	[p15l767t1128r832b1156],
173	%	NN	PERCENT	%	dep	194	SENT_174	[p15l767t1128r832b1156],
174	Cls	NNS	O	cl	dep	194	SENT_174	[p15l842t1128r892b1156],
175	)	VBP	O	)	dep	194	SENT_174	[p15l842t1128r892b1156],
176	for	IN	O	for	dep	194	SENT_174	[p15l902t1128r936b1150],
177	Cmax	NNP	O	Cmax	dep	194	SENT_174	[p15l944t1128r1009b1154],
178	,	,	O	,	_	0	SENT_174	[p15l944t1128r1009b1154],
179	AUC1	NN	O	auc1	dep	194	SENT_174	[p15l1019t1128r1089b1153],
180	and	CC	O	and	dep	194	SENT_174	[p15l1098t1128r1144b1150],
181	t1/zz	NN	O	t1/zz	dep	194	SENT_174	[p15l1154t1130r1197b1155],
182	and	CC	O	and	dep	194	SENT_174	[p15l1206t1128r1252b1150],
183	as	IN	O	as	dep	194	SENT_174	[p15l1262t1134r1291b1150],
184	median	JJ	O	median	dep	194	SENT_174	[p15l1302t1128r1393b1150],
185	(	NN	O	(	dep	194	SENT_174	[p15l1404t1128r1494b1156],
186	range	NN	O	range	dep	194	SENT_174	[p15l1404t1128r1494b1156],
187	)	NN	O	)	dep	194	SENT_174	[p15l1404t1128r1494b1156],
188	for	IN	O	for	dep	194	SENT_174	[p15l1503t1128r1537b1150],
189	tmax	NN	O	tmax	dep	194	SENT_174	[p15l1545t1130r1592b1153],
190	(	NN	O	(	dep	194	SENT_174	[p15l1601t1128r1624b1156],
191	n	NN	O	n	dep	194	SENT_174	[p15l1601t1128r1624b1156],
192	=	JJ	O	=	dep	194	SENT_174	[p15l1634t1138r1649b1147],
193	9	CD	NUMBER	9	dep	194	SENT_174	[p15l1659t1128r1690b1156],
194	)	NN	O	)	_	0	SENT_174	[p15l1659t1128r1690b1156],
195	.	.	O	.	_	0	SENT_174	[p15l1659t1128r1690b1156],

1	b	NN	O	b	nn	2	SENT_175	[p15l197t1173r211b1195],
2	p	NN	O	p	dep	3	SENT_175	[p15l245t1178r258b1200],
3	<	JJR	O	<	_	0	SENT_175	[p15l268t1179r283b1194],
4	0.05	CD	NUMBER	0.05	nsubj	38	SENT_175	[p15l293t1173r347b1195],
5	in	IN	O	in	_	0	SENT_175	[p15l358t1173r377b1194],
6	comparison	NN	O	comparison	prep_in	4	SENT_175	[p15l387t1173r534b1200],
7	with	IN	O	with	_	0	SENT_175	[p15l544t1173r593b1194],
8	treatment	NN	O	treatment	nn	10	SENT_175	[p15l603t1174r724b1195],
9	B.	NNP	O	B.	nn	10	SENT_175	[p15l734t1173r758b1194],
10	AUC	NN	O	auc	prep_with	6	SENT_175	[p15l196t1212r267b1238],
11	,	,	O	,	_	0	SENT_175	[p15l196t1212r267b1238],
12	=	JJ	O	=	amod	13	SENT_175	[p15l276t1222r292b1231],
13	area	NN	O	area	appos	10	SENT_175	[p15l301t1218r358b1235],
14	under	IN	O	under	_	0	SENT_175	[p15l368t1213r440b1235],
15	the	DT	O	the	det	17	SENT_175	[p15l448t1213r487b1235],
16	concentration-time	JJ	O	concentration-time	amod	17	SENT_175	[p15l496t1213r731b1235],
17	curve	NN	O	curve	prep_under	13	SENT_175	[p15l741t1218r810b1235],
18	during	IN	O	during	_	0	SENT_175	[p15l819t1213r897b1241],
19	a	DT	O	a	det	24	SENT_175	[p15l907t1218r922b1235],
20	dosage	NN	O	dosage	nn	24	SENT_175	[p15l931t1213r1024b1241],
21	interval	NN	O	interval	nn	24	SENT_175	[p15l1035t1213r1124b1235],
22	(	NN	O	(	nn	24	SENT_175	[p15l1135t1212r1163b1241],
23	1	CD	NUMBER	1	num	24	SENT_175	[p15l1135t1212r1163b1241],
24	)	NN	O	)	prep_during	17	SENT_175	[p15l1135t1212r1163b1241],
25	at	IN	O	at	_	0	SENT_175	[p15l1174t1214r1197b1235],
26	steady	JJ	O	steady	amod	27	SENT_175	[p15l1206t1213r1290b1241],
27	state	NN	O	state	prep_at	13	SENT_175	[p15l1299t1214r1366b1239],
28	;	:	O	;	_	0	SENT_175	[p15l1299t1214r1366b1239],
29	Cmax	NN	O	cmax	dep	13	SENT_175	[p15l1378t1212r1438b1238],
30	=	JJ	O	=	amod	32	SENT_175	[p15l1448t1222r1463b1231],
31	maximum	NN	O	maximum	nn	32	SENT_175	[p15l1474t1213r1596b1235],
32	concentration	NN	O	concentration	dep	29	SENT_175	[p15l1606t1213r1784b1239],
33	;	:	O	;	_	0	SENT_175	[p15l1606t1213r1784b1239],
34	tmax	NN	O	tmax	dep	13	SENT_175	[p15l1794t1214r1844b1238],
35	=	JJ	O	=	amod	36	SENT_175	[p15l1853t1222r1868b1231],
36	time	NN	O	time	tmod	34	SENT_175	[p15l1877t1213r1931b1235],
37	to	TO	O	to	aux	38	SENT_175	[p15l1940t1214r1963b1235],
38	reach	VB	O	reach	infmod	3	SENT_175	[p15l197t1250r266b1272],
39	maximum	NN	O	maximum	nn	40	SENT_175	[p15l277t1250r399b1272],
40	concentration	NN	O	concentration	dobj	38	SENT_175	[p15l410t1250r588b1276],
41	;	:	O	;	_	0	SENT_175	[p15l410t1250r588b1276],
42	t1/2	NN	O	t1/2	dep	3	SENT_175	[p15l598t1251r639b1277],
43	;	:	O	;	_	0	SENT_175	[p15l598t1251r639b1277],
44	=	JJ	O	=	amod	46	SENT_175	[p15l648t1260r664b1268],
45	elimination	NN	O	elimination	nn	46	SENT_175	[p15l673t1250r808b1272],
46	half-life	NN	O	half-life	dep	42	SENT_175	[p15l819t1250r916b1272],
47	.	.	O	.	_	0	SENT_175	[p15l819t1250r916b1272],

1	Discussion	NN	O	discussion	_	0	SENT_176	[p15l139t1475r647b1554],

1	The	DT	O	the	det	2	SENT_177	[p15l134t1705r296b1778],
2	objective	NN	O	objective	nsubj	6	SENT_177	[p15l344t1705r731b1800],
3	of	IN	O	of	_	0	SENT_177	[p15l779t1705r870b1778],
4	this	DT	O	this	det	5	SENT_177	[p15l909t1705r1058b1778],
5	study	NN	O	study	prep_of	2	SENT_177	[p15l1110t1705r1334b1800],
6	was	VBD	O	be	_	0	SENT_177	[p15l1381t1729r1540b1779],
7	to	TO	O	to	aux	8	SENT_177	[p15l1589t1716r1667b1778],
8	assess	VB	O	assess	xcomp	6	SENT_177	[p15l1717t1729r1970b1778],
9	the	DT	O	the	det	10	SENT_177	[p15l2018t1705r2145b1778],
10	inﬂuence	NN	O	inﬂuence	dobj	8	SENT_177	[p15l8t1829r403b1902],
11	of	IN	O	of	_	0	SENT_177	[p15l438t1829r530b1902],
12	concomitant	JJ	O	concomitant	amod	13	SENT_177	[p15l557t1829r1083b1902],
13	treatment	NN	O	treatment	prep_of	10	SENT_177	[p15l1115t1840r1518b1902],
14	with	IN	O	with	_	0	SENT_177	[p15l1550t1829r1736b1903],
15	bosentan	NN	O	bosentan	prep_with	8	SENT_177	[p15l1767t1829r2146b1902],
16	and	CC	O	and	_	0	SENT_177	[p15l11t1953r160b2026],
17	simvastatin	NN	O	simvastatin	conj_and	15	SENT_177	[p15l198t1953r679b2027],
18	on	IN	O	on	_	0	SENT_177	[p15l715t1977r817b2026],
19	the	DT	O	the	det	20	SENT_177	[p15l851t1953r978b2026],
20	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	8	SENT_177	[p15l1012t1953r1762b2048],
21	and	CC	O	and	_	0	SENT_177	[p15l1801t1953r1951b2026],
22	metabolism	NN	O	metabolism	conj_and	20	SENT_177	[p15l1984t1977r2143b2026, p15l8t2077r375b2150],
23	of	IN	O	of	prep	8	SENT_177	[p15l409t2077r501b2150],
24	both	CC	O	both	dep	23	SENT_177	[p15l527t2077r716b2150],
25	compounds	NNS	O	compound	conj	23	SENT_177	[p15l751t2077r1260b2172],
26	.	.	O	.	_	0	SENT_177	[p15l751t2077r1260b2172],

1	The	DT	O	the	det	3	SENT_178	[p15l1300t2077r1461b2150],
2	mutual	JJ	O	mutual	amod	3	SENT_178	[p15l1496t2077r1789b2150],
3	interactions	NNS	O	interaction	nsubjpass	5	SENT_178	[p15l1823t2077r2144b2150, p15l8t2201r211b2274],
4	were	VBD	O	be	auxpass	5	SENT_178	[p15l239t2225r442b2275],
5	explored	VBN	O	explore	_	0	SENT_178	[p15l469t2201r840b2296],
6	in	IN	O	in	_	0	SENT_178	[p15l864t2201r944b2273],
7	a	DT	O	a	det	13	SENT_178	[p15l971t2225r1014b2274],
8	three	CD	NUMBER	three	number	9	SENT_178	[p15l1037t2201r1461b2296],
9	—	CD	NUMBER	—	num	13	SENT_178	[p15l1037t2201r1461b2296],
10	way	NN	O	way	nn	13	SENT_178	[p15l1037t2201r1461b2296],
11	crossover	NN	O	crossover	nn	13	SENT_178	[p15l1487t2225r1895b2275],
12	study	NN	O	study	nn	13	SENT_178	[p15l1921t2201r2145b2296],
13	design	NN	O	design	prep_in	5	SENT_178	[p15l9t2325r307b2420],
14	,	,	O	,	_	0	SENT_178	[p15l9t2325r307b2420],
15	which	WDT	O	which	nsubj	16	SENT_178	[p15l342t2325r600b2399],
16	allowed	VBD	O	allow	rcmod	13	SENT_178	[p15l631t2325r965b2399],
17	each	DT	O	each	det	18	SENT_178	[p15l995t2326r1187b2399],
18	subject	NN	O	subject	dobj	16	SENT_178	[p15l1220t2325r1518b2420],
19	to	TO	O	to	aux	20	SENT_178	[p15l1546t2336r1624b2399],
20	serve	VB	O	serve	infmod	18	SENT_178	[p15l1659t2349r1878b2399],
21	as	IN	O	as	_	0	SENT_178	[p15l1910t2349r1991b2399],
22	his	PRP$	O	he	poss	24	SENT_178	[p15l2022t2325r2143b2399],
23	own	JJ	O	own	amod	24	SENT_178	[p15l10t2473r188b2523],
24	control	NN	O	control	prep_as	20	SENT_178	[p15l234t2450r555b2523],
25	.	.	O	.	_	0	SENT_178	[p15l234t2450r555b2523],

1	The	DT	O	the	det	2	SENT_179	[p15l606t2450r768b2523],
2	duration	NN	O	duration	nsubj	10	SENT_179	[p15l815t2449r1167b2523],
3	of	IN	O	of	_	0	SENT_179	[p15l1213t2449r1304b2523],
4	treatment	NN	O	treatment	dep	8	SENT_179	[p15l1342t2460r1745b2523],
5	(	CD	NUMBER	(	num	4	SENT_179	[p15l1791t2449r1872b2539],
6	6	CD	DURATION	6	num	7	SENT_179	[p15l1791t2449r1872b2539],
7	days	NNS	NUMBER	day	dep	4	SENT_179	[p15l1919t2449r2143b2544],
8	)	NN	O	)	prep_of	2	SENT_179	[p15l1919t2449r2143b2544],
9	was	VBD	O	be	cop	10	SENT_179	[p15l9t2597r168b2647],
10	sufficient	JJ	O	sufficient	_	0	SENT_179	[p15l212t2573r612b2647],
11	to	TO	O	to	aux	12	SENT_179	[p15l648t2584r727b2647],
12	attain	VB	O	attain	xcomp	10	SENT_179	[p15l768t2573r1001b2647],
13	steady	JJ	O	steady	amod	16	SENT_179	[p15l1042t2573r1541b2668],
14	—	JJ	O	—	amod	16	SENT_179	[p15l1042t2573r1541b2668],
15	state	NN	O	state	nn	16	SENT_179	[p15l1042t2573r1541b2668],
16	conditions	NNS	O	condition	dobj	12	SENT_179	[p15l1580t2573r2020b2647],
17	of	IN	O	of	_	0	SENT_179	[p15l2061t2573r2153b2647],
18	bosentan	NN	O	bosentan	prep_of	16	SENT_179	[p15l7t2697r385b2771],
19	and	CC	O	and	_	0	SENT_179	[p15l423t2697r572b2771],
20	its	PRP$	O	its	poss	21	SENT_179	[p15l607t2697r703b2771],
21	metabolites	NNS	O	metabolite	dobj	12	SENT_179	[p15l741t2697r1229b2771],
22	(	CD	NUMBER	(	num	23	SENT_179	[p15l1271t2697r1555b2792],
23	figure	NN	O	figure	dep	21	SENT_179	[p15l1271t2697r1555b2792],
24	1	CD	NUMBER	1	num	25	SENT_179	[p15l1601t2698r1698b2787],
25	)	NN	O	)	dep	21	SENT_179	[p15l1601t2698r1698b2787],
26	.	.	O	.	_	0	SENT_179	[p15l1601t2698r1698b2787],

1	This	DT	O	this	nsubj	2	SENT_180	[p15l1740t2697r1923b2771],
2	is	VBZ	O	be	_	0	SENT_180	[p15l1962t2697r2028b2771],
3	in	IN	O	in	_	0	SENT_180	[p15l2066t2697r2146b2770],
4	line	NN	O	line	prep_in	2	SENT_180	[p15l8t2821r171b2895],
5	with	IN	O	with	_	0	SENT_180	[p15l234t2821r427b2895],
6	previous	JJ	O	previous	amod	7	SENT_180	[p15l487t2821r861b2916],
7	observations	NNS	O	observation	prep_with	2	SENT_180	[p15l925t2821r1474b2895],
8	that	WDT	O	that	nsubj	9	SENT_180	[p15l1537t2821r1700b2895],
9	bosentan	VBP	O	bosentan	rcmod	7	SENT_180	[p15l1758t2822r2146b2895],
10	trough	NN	O	trough	nn	11	SENT_180	[p15l8t2946r285b3040],
11	concentrations	NNS	O	concentration	nsubj	13	SENT_180	[p15l308t2945r927b3019],
12	are	VBP	O	be	cop	13	SENT_180	[p15l955t2969r1079b3019],
13	constant	JJ	O	constant	ccomp	9	SENT_180	[p15l1104t2956r1458b3019],
14	Within	IN	O	within	_	0	SENT_180	[p15l1481t2945r1751b3019],
15	3-5	CD	NUMBER	3-5	num	16	SENT_180	[p15l1777t2945r1925b3019],
16	days	NNS	NUMBER	day	prep_within	9	SENT_180	[p15l1954t2945r2143b3040],
17	of	IN	O	of	_	0	SENT_180	[p15l10t3070r101b3144],
18	initiation	NN	O	initiation	prep_of	16	SENT_180	[p15l140t3070r531b3144],
19	of	IN	O	of	_	0	SENT_180	[p15l579t3070r670b3144],
20	treatment	NN	O	treatment	prep_of	18	SENT_180	[p15l709t3059r1261b3144],
21	.	.	O	.	_	0	SENT_180	[p15l709t3059r1261b3144],

1	[	RB	O	[	advmod	17	SENT_181	[p15l709t3059r1261b3144],
2	13	CD	NUMBER	13	num	3	SENT_181	[p15l709t3059r1261b3144],
3	]	CD	NUMBER	]	npadvmod	17	SENT_181	[p15l709t3059r1261b3144],
4	In	IN	O	in	_	0	SENT_181	[p15l1311t3071r1397b3142],
5	the	DT	O	the	det	7	SENT_181	[p15l1443t3069r1573b3143],
6	latter	JJ	O	latter	amod	7	SENT_181	[p15l1620t3069r1843b3143],
7	study	NN	O	study	prep_in	17	SENT_181	[p15l1890t3069r2142b3165],
8	,	,	O	,	_	0	SENT_181	[p15l1890t3069r2142b3165],
9	dosages	NNS	O	dosage	nsubjpass	17	SENT_181	[p15l9t3194r341b3289],
10	of	IN	O	of	_	0	SENT_181	[p15l382t3194r473b3267],
11	bosentan	NN	O	bosentan	prep_of	9	SENT_181	[p15l502t3194r880b3267],
12	up	IN	O	up	advmod	11	SENT_181	[p15l916t3218r1019b3289],
13	to	TO	O	to	_	0	SENT_181	[p15l1057t3205r1136b3267],
14	1000	CD	DATE	1000	num	15	SENT_181	[p15l1184t3195r1383b3268],
15	mg/day	NN	O	mg/day	prep_to	12	SENT_181	[p15l1420t3194r1736b3289],
16	were	VBD	O	be	auxpass	17	SENT_181	[p15l1774t3218r1977b3268],
17	administered	VBN	O	administer	_	0	SENT_181	[p15l2016t3194r2143b3267, p15l8t3318r505b3404],
18	,	,	O	,	_	0	SENT_181	[p15l2016t3194r2143b3267, p15l8t3318r505b3404],
19	indicating	VBG	O	indicate	xcomp	17	SENT_181	[p15l556t3318r1004b3413],
20	that	IN	O	that	complm	32	SENT_181	[p15l1052t3318r1219b3391],
21	the	DT	O	the	det	22	SENT_181	[p15l1266t3318r1397b3391],
22	phenomenon	NN	O	phenomenon	nsubj	32	SENT_181	[p15l1443t3318r2010b3413],
23	of	IN	O	of	_	0	SENT_181	[p15l2059t3318r2152b3391],
24	enzyme	NN	O	enzyme	nn	25	SENT_181	[p15l9t3466r348b3537],
25	induction	NN	O	induction	prep_of	22	SENT_181	[p15l406t3442r833b3515],
26	caused	VBN	O	cause	partmod	25	SENT_181	[p15l892t3442r1195b3515],
27	by	IN	O	by	_	0	SENT_181	[p15l1251t3442r1358b3537],
28	bosentan	NN	O	bosentan	agent	26	SENT_181	[p15l1416t3442r1816b3515],
29	is	VBZ	O	be	cop	32	SENT_181	[p15l1874t3442r1943b3515],
30	not	RB	O	not	neg	32	SENT_181	[p15l2004t3453r2145b3515],
31	dose	NN	O	dose	nn	32	SENT_181	[p15l9t3566r697b3661],
32	—	NN	O	—	ccomp	19	SENT_181	[p15l9t3566r697b3661],
33	dependent	JJ	O	dependent	amod	32	SENT_181	[p15l9t3566r697b3661],
34	in	IN	O	in	_	0	SENT_181	[p15l741t3566r822b3638],
35	the	DT	O	the	det	38	SENT_181	[p15l867t3566r996b3639],
36	range	NN	O	range	nn	38	SENT_181	[p15l1041t3590r1278b3661],
37	250-1000	CD	NUMBER	250-1000	num	38	SENT_181	[p15l1326t3566r1752b3640],
38	mg/day	NN	O	mg/day	prep_in	33	SENT_181	[p15l1798t3566r2141b3661],
39	.	.	O	.	_	0	SENT_181	[p15l1798t3566r2141b3661],

1	Attainment	NN	O	attainment	_	0	SENT_182	[p15l8t3690r504b3763],
2	of	IN	O	of	_	0	SENT_182	[p15l556t3690r648b3763],
3	steady	JJ	O	steady	amod	6	SENT_182	[p15l697t3690r1211b3785],
4	—	JJ	O	—	amod	6	SENT_182	[p15l697t3690r1211b3785],
5	state	NN	O	state	nn	6	SENT_182	[p15l697t3690r1211b3785],
6	conditions	NNS	O	condition	prep_of	1	SENT_182	[p15l1263t3690r1715b3763],
7	within	IN	O	within	_	0	SENT_182	[p15l1769t3690r2046b3764],
8	5	CD	NUMBER	5	prep_within	1	SENT_182	[p15l2099t3690r2142b3764],

1	days	NNS	DURATION	day	nsubj	2	SENT_183	[p16l9t21r198b116],
2	is	VBZ	O	be	_	0	SENT_183	[p16l240t21r305b95],
3	also	RB	O	also	advmod	2	SENT_183	[p16l349t22r515b95],
4	in	IN	O	in	_	0	SENT_183	[p16l555t21r635b94],
5	agreement	NN	O	agreement	prep_in	2	SENT_183	[p16l675t32r1117b116],
6	with	IN	O	with	_	0	SENT_183	[p16l1154t21r1340b95],
7	published	VBN	O	publish	amod	8	SENT_183	[p16l1377t21r1792b116],
8	data	NNS	O	datum	prep_with	2	SENT_183	[p16l1830t21r2006b95],
9	on	IN	O	on	_	0	SENT_183	[p16l2044t45r2146b95],
10	the	DT	O	the	det	11	SENT_183	[p16l8t145r135b219],
11	half-life	NN	O	half-life	prep_on	8	SENT_183	[p16l163t145r506b219],
12	of	IN	O	of	_	0	SENT_183	[p16l535t145r627b219],
13	CYP3A4	NN	O	cyp3a4	prep_of	11	SENT_183	[p16l649t146r1032b219],
14	in	IN	O	in	_	0	SENT_183	[p16l1061t145r1142b218],
15	primary	JJ	O	primary	amod	16	SENT_183	[p16l1168t145r1504b240],
16	cultures	NNS	O	culture	prep_in	13	SENT_183	[p16l1532t145r1865b219],
17	of	IN	O	of	_	0	SENT_183	[p16l1897t145r1988b219],
18	human	JJ	O	human	amod	19	SENT_183	[p16l2008t146r2144b219, p16l8t293r191b343],
19	hepatocytes	NNS	O	hepatocyte	prep_of	16	SENT_183	[p16l245t259r911b365],
20	.	.	O	.	_	0	SENT_183	[p16l245t259r911b365],

1	[	NN	O	[	nsubj	19	SENT_184	[p16l245t259r911b365],
2	23	CD	NUMBER	23	num	5	SENT_184	[p16l245t259r911b365],
3	]	NN	O	]	nn	5	SENT_184	[p16l245t259r911b365],
4	Trough	NN	O	trough	nn	5	SENT_184	[p16l973t269r1294b365],
5	concentrations	NNS	O	concentration	dep	1	SENT_184	[p16l1355t269r1997b343],
6	of	IN	O	of	_	0	SENT_184	[p16l2060t269r2153b343],
7	simvastatin	NN	O	simvastatin	prep_of	5	SENT_184	[p16l12t394r493b468],
8	and	CC	O	and	_	0	SENT_184	[p16l526t394r675b467],
9	its	PRP$	O	its	poss	15	SENT_184	[p16l705t394r801b467],
10	pharmacologically	RB	O	pharmacologically	advmod	11	SENT_184	[p16l833t394r1627b489],
11	active	JJ	O	active	amod	15	SENT_184	[p16l1660t394r1910b467],
12	form	NN	O	form	nn	15	SENT_184	[p16l1942t394r2147b467],
13	[	NN	O	[	nn	15	SENT_184	[p16l13t512r634b614],
14	3-hydroxyacid	JJ	O	3-hydroxyacid	amod	15	SENT_184	[p16l13t512r634b614],
15	simvastatin	NN	O	simvastatin	nsubj	19	SENT_184	[p16l658t518r1140b593],
16	were	VBD	O	be	cop	19	SENT_184	[p16l1162t542r1365b593],
17	also	RB	O	also	advmod	19	SENT_184	[p16l1390t518r1555b592],
18	virtually	RB	O	virtually	advmod	19	SENT_184	[p16l1579t518r1938b614],
19	constant	JJ	O	constant	_	0	SENT_184	[p16l1962t542r2144b592, p16l12t654r209b716],
20	during	IN	O	during	_	0	SENT_184	[p16l241t643r515b738],
21	the	DT	O	the	det	22	SENT_184	[p16l547t643r674b716],
22	study	NN	O	study	prep_during	19	SENT_184	[p16l711t643r935b738],
23	(	CD	NUMBER	(	num	24	SENT_184	[p16l971t643r1180b733],
24	data	NNS	O	datum	npadvmod	25	SENT_184	[p16l971t643r1180b733],
25	not	RB	O	not	neg	26	SENT_184	[p16l1210t654r1345b716],
26	shown	VBN	O	show	partmod	22	SENT_184	[p16l1379t643r1683b733],
27	)	NN	O	)	dobj	26	SENT_184	[p16l1379t643r1683b733],
28	in	IN	O	in	_	0	SENT_184	[p16l1718t643r1799b715],
29	accordance	NN	O	accordance	prep_in	26	SENT_184	[p16l1832t643r2144b716, p16l11t791r200b840],
30	with	IN	O	with	_	0	SENT_184	[p16l229t767r416b841],
31	the	DT	O	the	det	33	SENT_184	[p16l443t767r570b840],
32	short	JJ	O	short	amod	33	SENT_184	[p16l602t767r811b840],
33	t1/ZZ	NN	O	t1/zz	prep_with	26	SENT_184	[p16l837t778r960b865],
34	of	IN	O	of	prep	26	SENT_184	[p16l988t767r1080b840],
35	both	CC	O	both	dep	34	SENT_184	[p16l1099t767r1287b840],
36	compounds	NNS	O	compound	conj	34	SENT_184	[p16l1315t757r1951b863],
37	.	.	O	.	_	0	SENT_184	[p16l1315t757r1951b863],

1	[	NN	O	[	nsubj	23	SENT_185	[p16l1315t757r1951b863],
2	17	CD	NUMBER	17	number	3	SENT_185	[p16l1315t757r1951b863],
3	]	CD	NUMBER	]	dep	1	SENT_185	[p16l1315t757r1951b863],
4	The	DT	O	the	det	6	SENT_185	[p16l1983t767r2145b840],
5	pharmacokinetic	JJ	O	pharmacokinetic	amod	6	SENT_185	[p16l7t892r726b987],
6	parameters	NNS	O	parameter	dep	1	SENT_185	[p16l772t903r1242b987],
7	of	IN	O	of	_	0	SENT_185	[p16l1292t892r1384b965],
8	bosentan	NN	O	bosentan	prep_of	6	SENT_185	[p16l1422t892r1805b965],
9	and	CC	O	and	_	0	SENT_185	[p16l1853t892r2004b965],
10	its	PRP$	O	its	poss	11	SENT_185	[p16l2047t892r2143b965],
11	metabolites	NNS	O	metabolite	conj_and	1	SENT_185	[p16l8t1016r496b1089],
12	following	VBG	O	follow	_	0	SENT_185	[p16l534t1016r945b1111],
13	a	DT	O	a	det	17	SENT_185	[p16l983t1040r1026b1089],
14	multiple	JJ	O	multiple	amod	17	SENT_185	[p16l1059t1016r1644b1111],
15	—	NN	O	—	nn	17	SENT_185	[p16l1059t1016r1644b1111],
16	dose	NN	O	dose	nn	17	SENT_185	[p16l1059t1016r1644b1111],
17	regimen	NN	O	regimen	prep_following	11	SENT_185	[p16l1678t1016r2026b1111],
18	of	IN	O	of	_	0	SENT_185	[p16l2061t1016r2153b1089],
19	125mg	NN	O	125mg	prep_of	17	SENT_185	[p16l18t1140r300b1235],
20	twice	RB	O	twice	advmod	21	SENT_185	[p16l323t1140r551b1214],
21	daily	JJ	SET	daily	advmod	23	SENT_185	[p16l575t1140r785b1235],
22	were	VBD	O	be	cop	23	SENT_185	[p16l808t1164r1011b1214],
23	similar	JJ	O	similar	_	0	SENT_185	[p16l1038t1140r1330b1213],
24	to	TO	O	to	_	0	SENT_185	[p16l1350t1151r1429b1213],
25	those	DT	O	those	prep_to	23	SENT_185	[p16l1452t1140r1674b1213],
26	previously	RB	DATE	previously	advmod	27	SENT_185	[p16l1696t1140r2145b1235],
27	reported	VBN	O	report	partmod	25	SENT_185	[p16l7t1264r363b1360],
28	following	VBG	O	follow	_	0	SENT_185	[p16l395t1264r807b1360],
29	the	DT	O	the	det	31	SENT_185	[p16l841t1264r968b1338],
30	same	JJ	O	same	amod	31	SENT_185	[p16l1006t1288r1217b1338],
31	regimen	NN	O	regimen	prep_following	27	SENT_185	[p16l1249t1254r1746b1360],
32	.	.	O	.	_	0	SENT_185	[p16l1249t1254r1746b1360],

1	[	NN	O	[	nsubjpass	8	SENT_186	[p16l1249t1254r1746b1360],
2	24	CD	NUMBER	24	num	3	SENT_186	[p16l1249t1254r1746b1360],
3	]	CD	NUMBER	]	npadvmod	4	SENT_186	[p16l1249t1254r1746b1360],
4	Only	RB	O	only	advmod	5	SENT_186	[p16l1785t1264r1991b1360],
5	Ro	NN	O	ro	rcmod	1	SENT_186	[p16l2025t1266r2144b1338],
6	48-5033	CD	NUMBER	48-5033	num	5	SENT_186	[p16l8t1389r355b1463],
7	is	VBZ	O	be	auxpass	8	SENT_186	[p16l393t1389r459b1462],
8	known	VBN	O	know	_	0	SENT_186	[p16l493t1389r781b1463],
9	to	TO	O	to	aux	10	SENT_186	[p16l812t1400r891b1462],
10	possess	VB	O	possess	xcomp	8	SENT_186	[p16l923t1413r1239b1484],
11	some	DT	O	some	det	13	SENT_186	[p16l1277t1413r1495b1462],
12	pharmacological	JJ	O	pharmacological	amod	13	SENT_186	[p16l1526t1389r2144b1484, p16l9t1513r129b1586],
13	activity	NN	O	activity	dobj	10	SENT_186	[p16l165t1513r505b1608],
14	,	,	O	,	_	0	SENT_186	[p16l165t1513r505b1608],
15	a	DT	O	a	det	16	SENT_186	[p16l543t1537r586b1586],
16	contribution	NN	O	contribution	appos	13	SENT_186	[p16l619t1513r1139b1586],
17	of	IN	O	of	_	0	SENT_186	[p16l1173t1513r1264b1586],
18	up	RB	O	up	quantmod	20	SENT_186	[p16l1289t1537r1392b1608],
19	to	TO	O	to	dep	20	SENT_186	[p16l1425t1524r1503b1586],
20	20	CD	PERCENT	20	num	21	SENT_186	[p16l1538t1514r1723b1587],
21	%	NN	PERCENT	%	prep_of	16	SENT_186	[p16l1538t1514r1723b1587],
22	to	TO	O	to	_	0	SENT_186	[p16l1761t1524r1839b1586],
23	the	DT	O	the	det	25	SENT_186	[p16l1872t1513r1999b1586],
24	ef	NN	O	ef	nn	25	SENT_186	[p16l2032t1513r2144b1586, p16l10t1801r54b1845],
25	©	NN	O	©	prep_to	10	SENT_186	[p16l2032t1513r2144b1586, p16l10t1801r54b1845],

1	Adis	NNP	ORGANIZATION	Adis	nn	3	SENT_187	[p16l75t1797r198b1845],
2	International	NNP	ORGANIZATION	International	nn	3	SENT_187	[p16l220t1797r594b1845],
3	Limited	NNP	ORGANIZATION	Limited	_	0	SENT_187	[p16l619t1797r843b1845],
4	.	.	O	.	_	0	SENT_187	[p16l619t1797r843b1845],

1	All	DT	O	all	det	2	SENT_188	[p16l865t1797r933b1844],
2	rights	NNS	O	rights	nsubj	3	SENT_188	[p16l957t1797r1109b1857],
3	reserved	VBN	O	reserve	_	0	SENT_188	[p16l1131t1797r1400b1845],
4	.	.	O	.	_	0	SENT_188	[p16l1131t1797r1400b1845],

1	fects	NNS	O	fect	nsubj	2	SENT_189	[p16l8t2056r205b2130],
2	seen	VBN	O	see	_	0	SENT_189	[p16l233t2080r416b2130],
3	following	VBG	O	follow	_	0	SENT_189	[p16l438t2056r849b2152],
4	administration	NN	O	administration	prep_following	2	SENT_189	[p16l874t2056r1488b2130],
5	of	IN	O	of	_	0	SENT_189	[p16l1511t2056r1602b2130],
6	bosentan	NN	O	bosentan	prep_of	4	SENT_189	[p16l1614t2045r2142b2130],
7	.	.	O	.	_	0	SENT_189	[p16l1614t2045r2142b2130],

1	[	NN	O	[	nsubj	14	SENT_190	[p16l1614t2045r2142b2130],
2	25	CD	NUMBER	25	num	3	SENT_190	[p16l1614t2045r2142b2130],
3	]	CD	NUMBER	]	dep	1	SENT_190	[p16l1614t2045r2142b2130],
4	The	DT	O	the	det	7	SENT_190	[p16l8t2185r170b2258],
5	intersubj	NN	O	intersubj	nn	7	SENT_190	[p16l195t2185r561b2280],
6	ect	NN	O	ect	nn	7	SENT_190	[p16l572t2196r695b2258],
7	variability	NN	O	variability	dep	1	SENT_190	[p16l718t2185r1155b2280],
8	in	IN	O	in	_	0	SENT_190	[p16l1180t2185r1261b2257],
9	the	DT	O	the	det	11	SENT_190	[p16l1284t2185r1411b2258],
10	pharmacokinetic	JJ	O	pharmacokinetic	amod	11	SENT_190	[p16l1434t2185r2144b2280],
11	parameters	NNS	O	parameter	prep_in	7	SENT_190	[p16l7t2325r472b2409],
12	of	IN	O	of	_	0	SENT_190	[p16l522t2314r613b2387],
13	bosentan	NN	O	bosentan	prep_of	11	SENT_190	[p16l650t2314r1029b2387],
14	is	VBZ	O	be	_	0	SENT_190	[p16l1074t2314r1140b2387],
15	in	IN	O	in	_	0	SENT_190	[p16l1188t2314r1269b2386],
16	the	DT	O	the	det	19	SENT_190	[p16l1314t2314r1441b2387],
17	range	NN	O	range	nn	19	SENT_190	[p16l1486t2337r1721b2409],
18	30-40	CD	PERCENT	30-40	num	19	SENT_190	[p16l1770t2314r2140b2387],
19	%	NN	PERCENT	%	prep_in	14	SENT_190	[p16l1770t2314r2140b2387],
20	.	.	O	.	_	0	SENT_190	[p16l1770t2314r2140b2387],

1	Concomitant	JJ	O	concomitant	amod	2	SENT_191	[p16l9t2442r559b2516],
2	administration	NN	O	administration	nsubjpass	7	SENT_191	[p16l581t2442r1195b2515],
3	of	IN	O	of	_	0	SENT_191	[p16l1217t2442r1309b2515],
4	simvastatin	NN	O	simvastatin	prep_of	2	SENT_191	[p16l1326t2442r1808b2515],
5	was	VBD	O	be	auxpass	7	SENT_191	[p16l1829t2465r1988b2516],
6	not	RB	O	not	neg	7	SENT_191	[p16l2012t2453r2147b2515],
7	found	VBN	O	find	_	0	SENT_191	[p16l8t2570r255b2643],
8	to	TO	O	to	aux	9	SENT_191	[p16l277t2581r355b2643],
9	exert	VB	O	exert	xcomp	7	SENT_191	[p16l380t2581r592b2643],
10	any	DT	O	any	det	11	SENT_191	[p16l615t2593r763b2665],
11	inﬂuence	NN	O	inﬂuence	dobj	9	SENT_191	[p16l786t2570r1182b2643],
12	on	IN	O	on	_	0	SENT_191	[p16l1205t2593r1308b2643],
13	the	DT	O	the	det	14	SENT_191	[p16l1329t2570r1456b2643],
14	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	9	SENT_191	[p16l1477t2570r2144b2665, p16l8t2697r124b2771],
15	of	IN	O	of	_	0	SENT_191	[p16l174t2697r266b2771],
16	bosentan	NN	O	bosentan	prep_of	14	SENT_191	[p16l304t2697r690b2771],
17	or	CC	O	or	_	0	SENT_191	[p16l738t2721r825b2771],
18	its	PRP$	O	its	poss	19	SENT_191	[p16l869t2697r967b2771],
19	metabolites	NNS	O	metabolite	prep_of	14	SENT_191	[p16l1016t2697r1539b2771],
20	.	.	O	.	_	0	SENT_191	[p16l1016t2697r1539b2771],

1	Indeed	RB	O	indeed	advmod	6	SENT_192	[p16l1591t2697r1908b2784],
2	,	,	O	,	_	0	SENT_192	[p16l1591t2697r1908b2784],
3	simvastatin	NN	O	simvastatin	nsubjpass	6	SENT_192	[p16l1962t2697r2143b2771, p16l8t2826r339b2900],
4	is	VBZ	O	be	auxpass	6	SENT_192	[p16l377t2826r443b2900],
5	not	RB	O	not	neg	6	SENT_192	[p16l483t2837r618b2900],
6	known	VBN	O	know	_	0	SENT_192	[p16l654t2826r941b2900],
7	to	TO	O	to	aux	8	SENT_192	[p16l979t2837r1057b2900],
8	have	VB	O	have	xcomp	6	SENT_192	[p16l1095t2826r1294b2900],
9	inducing	VBG	O	induce	xcomp	8	SENT_192	[p16l1332t2826r1702b2921],
10	or	CC	O	or	_	0	SENT_192	[p16l1742t2850r1829b2900],
11	inhibitory	JJ	O	inhibitory	amod	12	SENT_192	[p16l1864t2826r2144b2900, p16l8t2965r177b3050],
12	effects	NNS	O	effect	conj_or	6	SENT_192	[p16l204t2954r483b3028],
13	on	IN	O	on	_	0	SENT_192	[p16l512t2978r614b3028],
14	the	DT	O	the	det	15	SENT_192	[p16l639t2954r766b3028],
15	metabolism	NN	O	metabolism	prep_on	12	SENT_192	[p16l791t2954r1288b3028],
16	of	IN	O	of	_	0	SENT_192	[p16l1313t2954r1404b3028],
17	other	JJ	O	other	amod	18	SENT_192	[p16l1423t2955r1641b3028],
18	drugs	NNS	O	drug	prep_of	15	SENT_192	[p16l1665t2944r2142b3050],
19	.	.	O	.	_	0	SENT_192	[p16l1665t2944r2142b3050],

1	[	NN	O	[	nn	2	SENT_193	[p16l1665t2944r2142b3050],
2	18v26	NN	O	18v26	nsubjpass	15	SENT_193	[p16l1665t2944r2142b3050],
3	]	CD	NUMBER	]	tmod	2	SENT_193	[p16l1665t2944r2142b3050],
4	Recently	RB	DATE	recently	advmod	3	SENT_193	[p16l8t3084r408b3178],
5	,	,	O	,	_	0	SENT_193	[p16l8t3084r408b3178],
6	simvastatin	NN	O	simvastatin	nn	7	SENT_193	[p16l438t3084r919b3157],
7	(	NN	O	(	appos	2	SENT_193	[p16l944t3084r1057b3173],
8	in	IN	O	in	_	0	SENT_193	[p16l944t3084r1057b3173],
9	its	PRP$	O	its	poss	12	SENT_193	[p16l1079t3084r1174b3157],
10	lactone	NN	O	lactone	nn	12	SENT_193	[p16l1199t3084r1504b3157],
11	form	NN	O	form	nn	12	SENT_193	[p16l1526t3084r1762b3174],
12	)	NN	O	)	prep_in	7	SENT_193	[p16l1526t3084r1762b3174],
13	has	VBZ	O	have	aux	15	SENT_193	[p16l1786t3084r1923b3157],
14	been	VBN	O	be	auxpass	15	SENT_193	[p16l1946t3084r2146b3157],
15	shown	VBN	O	show	_	0	SENT_193	[p16l12t3212r284b3285],
16	to	TO	O	to	aux	20	SENT_193	[p16l320t3222r399b3285],
17	be	VB	O	be	cop	20	SENT_193	[p16l436t3212r534b3285],
18	a	DT	O	a	det	20	SENT_193	[p16l573t3235r616b3285],
19	potent	JJ	O	potent	amod	20	SENT_193	[p16l650t3222r917b3306],
20	inhibitor	NN	O	inhibitor	xcomp	15	SENT_193	[p16l952t3212r1320b3285],
21	of	IN	O	of	_	0	SENT_193	[p16l1356t3212r1447b3285],
22	Pglycoproteinmediated	JJ	O	pglycoproteinmediated	amod	23	SENT_193	[p16l1477t3212r2142b3306, p16l8t3340r398b3414],
23	transport	NN	O	transport	prep_of	20	SENT_193	[p16l443t3329r1064b3435],
24	.	.	O	.	_	0	SENT_193	[p16l443t3329r1064b3435],

1	[	NN	O	[	nn	3	SENT_194	[p16l443t3329r1064b3435],
2	27	CD	NUMBER	27	num	3	SENT_194	[p16l443t3329r1064b3435],
3	’	NN	O	’	nsubj	23	SENT_194	[p16l443t3329r1064b3435],
4	28	CD	NUMBER	28	number	5	SENT_194	[p16l443t3329r1064b3435],
5	]	CD	NUMBER	]	num	7	SENT_194	[p16l443t3329r1064b3435],
6	The	DT	O	the	det	7	SENT_194	[p16l1114t3340r1275b3414],
7	insensitivity	NN	O	insensitivity	npadvmod	18	SENT_194	[p16l1321t3340r1841b3435],
8	of	IN	O	of	_	0	SENT_194	[p16l1889t3340r1980b3414],
9	the	DT	O	the	det	10	SENT_194	[p16l2018t3340r2145b3414],
10	pharmacokinetics	NNS	O	pharmacokinetic	prep_of	7	SENT_194	[p16l7t3469r758b3563],
11	of	IN	O	of	_	0	SENT_194	[p16l805t3469r897b3542],
12	bosentan	NN	O	bosentan	prep_of	10	SENT_194	[p16l932t3469r1310b3542],
13	to	TO	O	to	_	0	SENT_194	[p16l1353t3480r1432b3542],
14	the	DT	O	the	det	15	SENT_194	[p16l1476t3469r1603b3542],
15	presence	NN	O	presence	prep_to	12	SENT_194	[p16l1645t3492r2017b3563],
16	of	IN	O	of	_	0	SENT_194	[p16l2062t3469r2153b3542],
17	simvastatin	NN	O	simvastatin	prep_of	15	SENT_194	[p16l12t3597r493b3670],
18	as	IN	O	as	advmod	19	SENT_194	[p16l524t3620r605b3670],
19	demonstrated	VBN	O	demonstrate	partmod	3	SENT_194	[p16l636t3597r1210b3670],
20	in	IN	O	in	_	0	SENT_194	[p16l1237t3597r1316b3669],
21	this	DT	O	this	det	22	SENT_194	[p16l1344t3597r1494b3670],
22	study	NN	O	study	prep_in	19	SENT_194	[p16l1528t3597r1752b3691],
23	provides	VBZ	O	provide	_	0	SENT_194	[p16l1780t3597r2143b3691],
24	indirect	JJ	O	indirect	amod	25	SENT_194	[p17l8t23r335b97],
25	evidence	NN	O	evidence	dobj	23	SENT_194	[p17l367t23r742b97],
26	that	IN	O	that	complm	32	SENT_194	[p17l777t23r936b97],
27	bosentan	NN	O	bosentan	nsubj	32	SENT_194	[p17l966t23r1345b97],
28	is	VBZ	O	be	cop	32	SENT_194	[p17l1378t23r1443b97],
29	not	RB	O	not	neg	32	SENT_194	[p17l1479t34r1614b97],
30	a	DT	O	a	det	32	SENT_194	[p17l1648t47r1691b97],
31	good	JJ	O	good	amod	32	SENT_194	[p17l1724t24r1933b118],
32	substrate	NN	O	substrate	ccomp	23	SENT_194	[p17l1970t23r2144b97, p17l12t162r246b225],
33	of	IN	O	of	_	0	SENT_194	[p17l304t151r397b225],
34	P-glycoprotein	NN	O	p-glycoprotein	prep_of	32	SENT_194	[p17l444t151r1124b246],
35	.	.	O	.	_	0	SENT_194	[p17l444t151r1124b246],

1	An	DT	O	a	det	3	SENT_195	[p17l1184t152r1313b224],
2	earlier	JJR	O	earlier	amod	3	SENT_195	[p17l1369t151r1650b225],
3	study	NN	O	study	nsubj	5	SENT_195	[p17l1707t152r1937b246],
4	had	VBD	O	have	aux	5	SENT_195	[p17l1992t152r2147b225],
5	shown	VBN	O	show	_	0	SENT_195	[p17l12t281r284b354],
6	that	IN	O	that	complm	11	SENT_195	[p17l316t281r476b354],
7	bosentan	NN	O	bosentan	nsubj	11	SENT_195	[p17l506t281r884b354],
8	itself	PRP	O	itself	advmod	7	SENT_195	[p17l918t281r1137b354],
9	did	VBD	O	do	aux	11	SENT_195	[p17l1164t281r1297b354],
10	not	RB	O	not	neg	11	SENT_195	[p17l1330t292r1465b354],
11	have	VB	O	have	ccomp	5	SENT_195	[p17l1495t281r1693b354],
12	a	DT	O	a	det	14	SENT_195	[p17l1729t305r1772b354],
13	relevant	JJ	O	relevant	amod	14	SENT_195	[p17l1802t281r2147b354],
14	effect	NN	O	effect	dobj	11	SENT_195	[p17l9t409r260b482],
15	on	IN	O	on	_	0	SENT_195	[p17l300t432r404b482],
16	the	DT	O	the	det	17	SENT_195	[p17l444t409r575b482],
17	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	14	SENT_195	[p17l614t409r1393b503],
18	of	IN	O	of	_	0	SENT_195	[p17l1437t409r1530b482],
19	digoxin	NN	O	digoxin	prep_of	17	SENT_195	[p17l1565t409r1923b503],
20	,	,	O	,	_	0	SENT_195	[p17l1565t409r1923b503],
21	a	DT	O	a	det	23	SENT_195	[p17l1969t432r2012b482],
22	Pglycoprotein	NN	O	pglycoprotein	nn	23	SENT_195	[p17l2050t411r2140b481, p17l9t537r553b631],
23	substrate	NN	O	substrate	appos	19	SENT_195	[p17l587t527r1109b610],
24	.	.	O	.	_	0	SENT_195	[p17l587t527r1109b610],

1	[	NN	O	[	_	0	SENT_196	[p17l587t527r1109b610],
2	29	CD	NUMBER	29	num	3	SENT_196	[p17l587t527r1109b610],
3	]	NN	O	]	dep	1	SENT_196	[p17l587t527r1109b610],

1	Simvastatin	NN	O	simvastatin	nsubj	2	SENT_197	[p17l137t665r653b738],
2	shows	VBZ	O	show	_	0	SENT_197	[p17l719t665r982b738],
3	a	DT	O	a	det	9	SENT_197	[p17l1051t688r1094b738],
4	relatively	RB	O	relatively	advmod	5	SENT_197	[p17l1154t665r1569b759],
5	pronounced	JJ	O	pronounced	amod	9	SENT_197	[p17l1631t665r2147b759],
6	intersubject	JJ	O	intersubject	amod	9	SENT_197	[p17l8t793r526b887],
7	variability	NN	O	variability	nn	9	SENT_197	[p17l572t793r1022b887],
8	(	NN	O	(	nn	9	SENT_197	[p17l1073t793r1578b882],
9	coefficient	NN	O	coefficient	dobj	2	SENT_197	[p17l1073t793r1578b882],
10	of	IN	O	of	_	0	SENT_197	[p17l1624t793r1717b866],
11	variation	NN	O	variation	prep_of	9	SENT_197	[p17l1756t793r2145b866],
12	30-70	CD	PERCENT	30-70	num	13	SENT_197	[p17l12t921r419b1010],
13	%	NN	PERCENT	%	dep	11	SENT_197	[p17l12t921r419b1010],
14	)	CD	NUMBER	)	dep	11	SENT_197	[p17l12t921r419b1010],
15	,	,	O	,	_	0	SENT_197	[p17l12t921r419b1010],
16	a	DT	O	a	det	17	SENT_197	[p17l452t944r495b994],
17	phenomenon	NN	O	phenomenon	appos	11	SENT_197	[p17l518t921r1067b1015],
18	that	WDT	O	that	nsubj	20	SENT_197	[p17l1094t921r1252b994],
19	is	VBZ	O	be	cop	20	SENT_197	[p17l1277t921r1342b994],
20	common	JJ	O	common	rcmod	17	SENT_197	[p17l1371t943r1740b994],
21	for	IN	O	for	_	0	SENT_197	[p17l1766t921r1888b994],
22	drugs	NNS	O	drug	prep_for	20	SENT_197	[p17l1913t921r2144b1015],
23	that	WDT	O	that	nsubj	24	SENT_197	[p17l8t1049r169b1122],
24	undergo	VBP	O	undergo	rcmod	22	SENT_197	[p17l213t1048r562b1144],
25	extensive	JJ	O	extensive	amod	29	SENT_197	[p17l610t1048r1014b1123],
26	first	JJ	ORDINAL	first	amod	29	SENT_197	[p17l1061t1048r1451b1144],
27	—	NN	O	—	nn	29	SENT_197	[p17l1061t1048r1451b1144],
28	pass	NN	O	pass	nn	29	SENT_197	[p17l1061t1048r1451b1144],
29	metabolism	NN	O	metabolism	dobj	24	SENT_197	[p17l1498t1038r2142b1122],
30	.	.	O	.	_	0	SENT_197	[p17l1498t1038r2142b1122],

1	[	NN	O	[	nsubj	17	SENT_198	[p17l1498t1038r2142b1122],
2	3	CD	NUMBER	3	num	1	SENT_198	[p17l1498t1038r2142b1122],
3	°	NN	O	°	dep	1	SENT_198	[p17l1498t1038r2142b1122],
4	]	CD	NUMBER	]	num	3	SENT_198	[p17l1498t1038r2142b1122],
5	The	DT	O	the	det	7	SENT_198	[p17l8t1178r173b1251],
6	pharmacokinetic	JJ	O	pharmacokinetic	amod	7	SENT_198	[p17l218t1178r945b1272],
7	parameters	NNS	O	parameter	dep	1	SENT_198	[p17l992t1188r1468b1272],
8	of	IN	O	of	_	0	SENT_198	[p17l1518t1178r1611b1251],
9	simvastatin	NN	O	simvastatin	prep_of	7	SENT_198	[p17l1654t1178r2146b1251],
10	and	CC	O	and	_	0	SENT_198	[p17l11t1306r160b1379],
11	B-hydroxyacid	JJ	O	b-hydroxyacid	amod	16	SENT_198	[p17l190t1300r811b1402],
12	simvastatin	NN	O	simvastatin	nn	16	SENT_198	[p17l840t1306r1322b1380],
13	(	NN	O	(	nn	16	SENT_198	[p17l1352t1306r1787b1396],
14	treatment	NN	O	treatment	nn	16	SENT_198	[p17l1352t1306r1787b1396],
15	B	NN	O	b	nn	16	SENT_198	[p17l1812t1307r1912b1396],
16	)	NN	O	)	prep_of	7	SENT_198	[p17l1812t1307r1912b1396],
17	were	VBD	O	be	_	0	SENT_198	[p17l1942t1329r2144b1380],
18	in	IN	O	in	_	0	SENT_198	[p17l8t1435r89b1507],
19	accordance	NN	O	accordance	prep_in	17	SENT_198	[p17l135t1435r610b1508],
20	with	IN	O	with	_	0	SENT_198	[p17l655t1435r843b1508],
21	values	NNS	O	value	prep_with	17	SENT_198	[p17l886t1435r1154b1508],
22	reported	VBN	O	report	partmod	21	SENT_198	[p17l1199t1435r1555b1529],
23	in	IN	O	in	_	0	SENT_198	[p17l1599t1435r1678b1507],
24	the	DT	O	the	det	25	SENT_198	[p17l1722t1435r1849b1508],
25	literature	NN	O	literature	prep_in	22	SENT_198	[p17l1894t1435r2144b1508, p17l8t1552r510b1637],
26	.	.	O	.	_	0	SENT_198	[p17l1894t1435r2144b1508, p17l8t1552r510b1637],

1	[	NN	O	[	nsubjpass	32	SENT_199	[p17l1894t1435r2144b1508, p17l8t1552r510b1637],
2	19	CD	NUMBER	19	num	1	SENT_199	[p17l1894t1435r2144b1508, p17l8t1552r510b1637],
3	=	JJ	O	=	quantmod	4	SENT_199	[p17l1894t1435r2144b1508, p17l8t1552r510b1637],
4	3	CD	NUMBER	3	num	5	SENT_199	[p17l1894t1435r2144b1508, p17l8t1552r510b1637],
5	°	NN	O	°	npadvmod	6	SENT_199	[p17l1894t1435r2144b1508, p17l8t1552r510b1637],
6	>	JJR	O	>	amod	1	SENT_199	[p17l1894t1435r2144b1508, p17l8t1552r510b1637],
7	31	CD	NUMBER	31	num	8	SENT_199	[p17l1894t1435r2144b1508, p17l8t1552r510b1637],
8	]	NN	O	]	dep	26	SENT_199	[p17l1894t1435r2144b1508, p17l8t1552r510b1637],
9	In	IN	O	in	dep	26	SENT_199	[p17l543t1565r629b1635],
10	the	DT	O	the	det	11	SENT_199	[p17l659t1563r785b1637],
11	presence	NN	O	presence	pobj	9	SENT_199	[p17l815t1586r1186b1658],
12	of	IN	O	of	_	0	SENT_199	[p17l1217t1563r1308b1637],
13	bosentan	NN	O	bosentan	prep_of	11	SENT_199	[p17l1329t1563r1730b1650],
14	,	,	O	,	_	0	SENT_199	[p17l1329t1563r1730b1650],
15	exposure	NN	O	exposure	conj_and	11	SENT_199	[p17l1764t1586r2145b1658],
16	to	TO	O	to	_	0	SENT_199	[p17l8t1703r87b1766],
17	simvastatin	NN	O	simvastatin	prep_to	15	SENT_199	[p17l132t1692r614b1766],
18	and	CC	O	and	_	0	SENT_199	[p17l655t1692r805b1766],
19	[	NN	O	[	nn	22	SENT_199	[p17l849t1686r1469b1788],
20	3	CD	NUMBER	3	num	22	SENT_199	[p17l849t1686r1469b1788],
21	—	NN	O	—	nn	22	SENT_199	[p17l849t1686r1469b1788],
22	hydroXyacid	NN	O	hydroxyacid	conj_and	11	SENT_199	[p17l849t1686r1469b1788],
23	simvastatin	NN	O	simvastatin	dep	22	SENT_199	[p17l1512t1692r2016b1779],
24	,	,	O	,	_	0	SENT_199	[p17l1512t1692r2016b1779],
25	as	IN	O	as	mark	26	SENT_199	[p17l2063t1716r2143b1766],
26	reﬂected	VBN	O	reﬂected	parataxis	32	SENT_199	[p17l7t1821r396b1894],
27	in	IN	O	in	_	0	SENT_199	[p17l435t1821r517b1893],
28	AUC	NN	O	auc	prep_in	26	SENT_199	[p17l557t1821r807b1907],
29	,	,	O	,	_	0	SENT_199	[p17l557t1821r807b1907],
30	was	VBD	O	be	auxpass	32	SENT_199	[p17l851t1844r1015b1894],
31	significantly	RB	O	significantly	advmod	32	SENT_199	[p17l1060t1821r1612b1916],
32	reduced	VBN	O	reduce	_	0	SENT_199	[p17l1651t1821r2000b1894],
33	by	IN	O	by	_	0	SENT_199	[p17l2037t1821r2143b1916],
34	34	CD	NUMBER	34	agent	32	SENT_199	[p17l11t1949r113b2022],
35	and	CC	O	and	_	0	SENT_199	[p17l151t1949r301b2022],
36	46	CD	PERCENT	46	num	37	SENT_199	[p17l333t1949r548b2035],
37	%	NN	PERCENT	%	conj_and	34	SENT_199	[p17l333t1949r548b2035],
38	,	,	O	,	_	0	SENT_199	[p17l333t1949r548b2035],
39	respectively	RB	O	respectively	advmod	32	SENT_199	[p17l585t1949r1122b2044],
40	.	.	O	.	_	0	SENT_199	[p17l585t1949r1122b2044],

1	No	DT	O	no	det	4	SENT_200	[p17l1160t1951r1285b2022],
2	statistically	RB	O	statistically	advmod	3	SENT_200	[p17l1324t1949r1806b2044],
3	significant	JJ	O	significant	amod	4	SENT_200	[p17l1844t1949r2143b2044, p17l9t2086r187b2148],
4	effect	NN	O	effect	nsubjpass	6	SENT_200	[p17l232t2075r477b2148],
5	was	VBD	O	be	auxpass	6	SENT_200	[p17l522t2099r682b2148],
6	observed	VBN	O	observe	_	0	SENT_200	[p17l732t2075r1119b2149],
7	for	IN	O	for	_	0	SENT_200	[p17l1163t2075r1286b2148],
8	Cmax	NN	O	cmax	prep_for	6	SENT_200	[p17l1331t2076r1526b2163],
9	of	IN	O	of	prep	6	SENT_200	[p17l1566t2075r1658b2148],
10	both	CC	O	both	dep	9	SENT_200	[p17l1695t2075r1885b2148],
11	compounds	NNS	O	compound	conj	9	SENT_200	[p17l1932t2099r2143b2148, p17l7t2205r336b2300],
12	,	,	O	,	_	0	SENT_200	[p17l1932t2099r2143b2148, p17l7t2205r336b2300],
13	which	WDT	O	which	nsubj	14	SENT_200	[p17l365t2205r622b2278],
14	suggests	VBZ	O	suggest	rcmod	11	SENT_200	[p17l647t2216r1001b2300],
15	that	IN	O	that	_	0	SENT_200	[p17l1026t2205r1184b2278],
16	the	DT	O	the	det	17	SENT_200	[p17l1205t2205r1332b2278],
17	effects	NNS	O	effect	prep_that	14	SENT_200	[p17l1356t2205r1635b2278],
18	of	IN	O	of	_	0	SENT_200	[p17l1662t2205r1753b2278],
19	bosentan	NN	O	bosentan	prep_of	17	SENT_200	[p17l1767t2205r2146b2278],

1	Clin	NNP	O	Clin	nn	2	SENT_201	[p17l1194t2489r1303b2537],
2	Phormocokinef	NNP	O	Phormocokinef	_	0	SENT_201	[p17l1327t2489r1786b2537],
3	2003	CD	DATE	2003	num	2	SENT_201	[p17l1804t2489r1955b2540],
4	;	:	O	;	_	0	SENT_201	[p17l1804t2489r1955b2540],
5	42	CD	NUMBER	42	number	6	SENT_201	[p17l1976t2489r2042b2536],
6	(	CD	NUMBER	(	dep	2	SENT_201	[p17l2065t2489r2138b2544],
7	3	CD	NUMBER	3	num	8	SENT_201	[p17l2065t2489r2138b2544],
8	)	NN	O	)	dep	6	SENT_201	[p17l2065t2489r2138b2544],

1	Bosentan	NNP	O	Bosentan	_	0	SENT_202	[p17l192t2619r518b2644],
2	.	.	O	.	_	0	SENT_202	[p17l192t2619r518b2644],

1	—	NN	O	—	_	0	SENT_203	[p17l192t2619r518b2644],
2	.	.	O	.	_	0	SENT_203	[p17l192t2619r518b2644],

1	Sirnvastatin	NNP	O	Sirnvastatin	_	0	SENT_204	[p17l192t2619r518b2644],
2	Interactions	NNS	O	interaction	dep	1	SENT_204	[p17l527t2619r701b2644],
3	299	CD	NUMBER	299	dep	1	SENT_204	[p17l1918t2620r1967b2644],

1	O	NN	O	o	nn	2	SENT_205	[p18l273t714r309b767],
2	O	NN	O	o	_	0	SENT_205	[p18l273t1063r309b1117],
3	6	CD	NUMBER	6	num	4	SENT_205	[p18l233t714r268b767],
4	4	CD	NUMBER	4	dep	2	SENT_205	[p18l232t1063r269b1115],

1	:2	NN	O	:2	_	0	SENT_206	[p18l70t487r139b603],
2	.	.	O	.	_	0	SENT_206	[p18l89t630r116b657],

1	3	CD	NUMBER	3	num	2	SENT_207	[p18l70t684r140b780],
2	c	NN	O	c	dep	3	SENT_207	[p18l72t810r125b1164],
3	_	VBD	O	_	_	0	SENT_207	[p18l72t810r125b1164],
4	§	CD	NUMBER	§	number	5	SENT_207	[p18l72t810r125b1164],
5	8	CD	NUMBER	8	npadvmod	6	SENT_207	[p18l72t810r125b1164],
6	>	JJR	O	>	amod	7	SENT_207	[p18l72t810r125b1164],
7	e_m	NN	O	e_m	dobj	3	SENT_207	[p18l72t810r125b1164],
8	52	CD	NUMBER	52	nsubj	3	SENT_207	[p18l70t1187r126b1366],

1	O	NN	O	o	_	0	SENT_208	[p18l273t1412r309b1466],
2	2	CD	NUMBER	2	num	1	SENT_208	[p18l232t1412r268b1464],

1	3E	NN	O	3e	_	0	SENT_209	[p18l70t2286r139b2402],
2	.	.	O	.	_	0	SENT_209	[p18l89t2430r116b2457],

1	me	PRP	O	I	_	0	SENT_210	[p18l70t2484r140b2580],
2	:	:	O	:	_	0	SENT_210	[p18l72t2609r125b2963],
3	_	NN	O	_	dep	1	SENT_210	[p18l72t2609r125b2963],
4	.	.	O	.	_	0	SENT_210	[p18l72t2609r125b2963],

1	.	.	O	.	_	0	SENT_211	[p18l72t2609r125b2963],

1	m.	NN	O	m.	_	0	SENT_212	[p18l72t2609r125b2963],
2	.	.	O	.	_	0	SENT_212	[p18l72t2609r125b2963],

1	mm	NN	O	mm	_	0	SENT_213	[p18l72t2609r125b2963],
2	>	JJR	O	>	amod	3	SENT_213	[p18l72t2609r125b2963],
3	E_m	NN	O	e_m	dep	1	SENT_213	[p18l72t2609r125b2963],
4	_	CD	NUMBER	_	num	5	SENT_213	[p18l70t2989r140b3426],
5	o_om	NN	O	o_om	dep	1	SENT_213	[p18l70t2989r140b3426],
6	>	JJR	O	>	amod	8	SENT_213	[p18l70t2989r140b3426],
7	x9PE-a	NN	O	x9pe-a	nn	8	SENT_213	[p18l70t2989r140b3426],
8	eo	NN	O	eo	dep	5	SENT_213	[p18l70t3451r126b3629],
9	:	:	O	:	_	0	SENT_213	[p18l70t3451r126b3629],
10	<	JJR	O	<	dep	5	SENT_213	[p18l70t3451r126b3629],

1	No	DT	O	no	det	2	SENT_214	[p19l461t42r547b96],
2	bosentan	NN	O	bosentan	_	0	SENT_214	[p19l573t42r863b96],
3	+	CC	O	+	cc	4	SENT_214	[p19l1628t56r1667b95],
4	Bosentan	NN	MISC	bosentan	dep	2	SENT_214	[p19l1693t42r1989b96],

1	Fig	NN	O	fig	_	0	SENT_215	[p19l12t223r131b293],
2	.	.	O	.	_	0	SENT_215	[p19l12t223r131b293],

1	4	LS	NUMBER	4	_	0	SENT_216	[p19l151t224r206b277],
2	.	.	O	.	_	0	SENT_216	[p19l151t224r206b277],

1	Individual	JJ	O	individual	amod	2	SENT_217	[p19l233t220r547b278],
2	values	NNS	O	value	nsubj	9	SENT_217	[p19l569t220r790b278],
3	of	IN	O	of	_	0	SENT_217	[p19l811t219r873b278],
4	area	NN	O	area	prep_of	2	SENT_217	[p19l892t234r1043b278],
5	under	IN	O	under	_	0	SENT_217	[p19l1067t220r1259b278],
6	the	DT	O	the	det	8	SENT_217	[p19l1276t220r1380b278],
7	plasma	NN	O	plasma	nn	8	SENT_217	[p19l1403t220r1648b293],
8	concentrationtime	NN	O	concentrationtime	prep_under	4	SENT_217	[p19l1667t220r2151b278, p19l7t313r151b371],
9	curve	NN	O	curve	_	0	SENT_217	[p19l180t327r364b371],
10	over	IN	O	over	_	0	SENT_217	[p19l394t327r542b371],
11	one	CD	NUMBER	one	num	13	SENT_217	[p19l569t327r693b371],
12	administration	NN	O	administration	nn	13	SENT_217	[p19l723t313r1196b371],
13	interval	NN	O	interval	prep_over	9	SENT_217	[p19l1230t313r1469b371],
14	of	IN	O	of	_	0	SENT_217	[p19l1501t312r1562b371],
15	12	CD	DURATION	12	num	16	SENT_217	[p19l1595t314r1671b370],
16	hours	NNS	NUMBER	hour	prep_of	13	SENT_217	[p19l1704t313r1890b371],
17	(	CD	NUMBER	(	num	19	SENT_217	[p19l1921t312r2149b386],
18	AUCT	NN	O	auct	nn	19	SENT_217	[p19l1921t312r2149b386],
19	)	NN	O	)	dep	29	SENT_217	[p19l1921t312r2149b386],
20	in	IN	O	in	_	0	SENT_217	[p19l12t406r66b463],
21	nine	CD	NUMBER	nine	num	24	SENT_217	[p19l112t406r261b464],
22	healthy	JJ	O	healthy	amod	24	SENT_217	[p19l305t406r570b479],
23	male	JJ	O	male	amod	24	SENT_217	[p19l612t406r784b464],
24	subjects	NNS	O	subject	prep_in	19	SENT_217	[p19l826t406r1128b479],
25	for	IN	O	for	_	0	SENT_217	[p19l1169t405r1264b464],
26	simvastatin	NN	O	simvastatin	prep_for	24	SENT_217	[p19l1304t406r1716b464],
27	(	CD	NUMBER	(	dep	29	SENT_217	[p19l1762t405r1848b479],
28	a	DT	O	a	det	29	SENT_217	[p19l1762t405r1848b479],
29	)	NN	O	)	dep	34	SENT_217	[p19l1762t405r1848b479],
30	and	CC	O	and	_	0	SENT_217	[p19l1903t406r2042b464],
31	Bhydroxyacid	JJ	O	bhydroxyacid	amod	33	SENT_217	[p19l2090t408r2151b479, p19l11t499r416b572],
32	simvastatin	NN	O	simvastatin	nn	33	SENT_217	[p19l456t499r837b557],
33	(	NN	O	(	dep	34	SENT_217	[p19l880t498r969b572],
34	b	NN	O	b	dep	9	SENT_217	[p19l880t498r969b572],
35	)	CD	NUMBER	)	num	34	SENT_217	[p19l880t498r969b572],
36	in	IN	O	in	_	0	SENT_217	[p19l1012t499r1063b556],
37	the	DT	O	the	det	38	SENT_217	[p19l1103t499r1207b557],
38	absence	NN	O	absence	prep_in	9	SENT_217	[p19l1246t499r1536b557],
39	and	CC	O	and	_	0	SENT_217	[p19l1574t499r1697b557],
40	presence	NN	O	presence	prep_in	9	SENT_217	[p19l1739t513r2053b572],
41	of	IN	O	of	_	0	SENT_217	[p19l2092t498r2153b557],
42	bosentan	NN	O	bosentan	prep_of	38	SENT_217	[p19l11t591r340b648],
43	.	.	O	.	_	0	SENT_217	[p19l11t591r340b648],

1	on	IN	O	on	amod	3	SENT_218	[p19l19t859r121b908],
2	the	DT	O	the	det	3	SENT_218	[p19l158t835r284b908],
3	metabolism	NN	O	metabolism	nsubj	8	SENT_218	[p19l322t835r815b908],
4	of	IN	O	of	_	0	SENT_218	[p19l852t835r942b908],
5	simvastatin	NN	O	simvastatin	prep_of	3	SENT_218	[p19l977t835r1455b909],
6	are	VBP	O	be	cop	8	SENT_218	[p19l1494t859r1617b908],
7	mainly	RB	O	mainly	advmod	8	SENT_218	[p19l1655t835r1945b930],
8	due	JJ	O	due	_	0	SENT_218	[p19l1984t835r2132b908],
9	to	TO	O	to	_	0	SENT_218	[p19l18t977r96b1040],
10	interference	NN	O	interference	prep_to	8	SENT_218	[p19l140t967r645b1040],
11	at	IN	O	at	_	0	SENT_218	[p19l690t977r763b1040],
12	the	DT	O	the	det	13	SENT_218	[p19l804t967r930b1040],
13	systemic	JJ	O	systemic	prep_at	8	SENT_218	[p19l976t967r1339b1061],
14	rather	RB	O	rather	_	0	SENT_218	[p19l1381t967r1629b1040],
15	than	IN	O	than	_	0	SENT_218	[p19l1669t967r1849b1040],
16	at	IN	O	at	_	0	SENT_218	[p19l1893t977r1966b1040],
17	the	DT	O	the	det	19	SENT_218	[p19l2006t967r2132b1040],
18	presystemic	JJ	O	presystemic	amod	19	SENT_218	[p19l17t1097r521b1192],
19	level	NN	O	level	prep_at	8	SENT_218	[p19l567t1097r792b1170],
20	.	.	O	.	_	0	SENT_218	[p19l567t1097r792b1170],

1	These	DT	O	these	det	2	SENT_219	[p19l842t1097r1091b1170],
2	findings	NNS	O	finding	nsubj	3	SENT_219	[p19l1136t1097r1479b1192],
3	are	VBP	O	be	_	0	SENT_219	[p19l1528t1120r1651b1170],
4	in	IN	O	in	_	0	SENT_219	[p19l1696t1097r1775b1169],
5	accordance	NN	O	accordance	prep_in	3	SENT_219	[p19l1821t1097r2131b1170, p19l21t1251r214b1301],
6	with	IN	O	with	_	0	SENT_219	[p19l286t1228r476b1301],
7	induction	NN	O	induction	prep_with	3	SENT_219	[p19l547t1228r958b1301],
8	of	IN	O	of	_	0	SENT_219	[p19l1030t1228r1122b1301],
9	hepatic	JJ	O	hepatic	amod	10	SENT_219	[p19l1185t1228r1497b1322],
10	CYP3A4	NN	O	cyp3a4	prep_of	7	SENT_219	[p19l1570t1228r1957b1301],
11	by	IN	O	by	_	0	SENT_219	[p19l2027t1228r2131b1322],
12	bosentan	NN	O	bosentan	prep_by	3	SENT_219	[p19l17t1358r426b1444],
13	,	,	O	,	_	0	SENT_219	[p19l17t1358r426b1444],
14	as	IN	O	as	mark	15	SENT_219	[p19l478t1381r560b1431],
15	observed	VBN	O	observe	dep	12	SENT_219	[p19l609t1358r997b1431],
16	earlier	RBR	O	earlier	advmod	15	SENT_219	[p19l1044t1358r1321b1431],
17	in	IN	O	in	_	0	SENT_219	[p19l1365t1358r1446b1429],
18	the	DT	O	the	det	20	SENT_219	[p19l1492t1358r1621b1431],
19	interaction	NN	O	interaction	nn	20	SENT_219	[p19l1667t1358r2132b1431],
20	study	NN	O	study	prep_in	15	SENT_219	[p19l22t1487r250b1582],
21	between	IN	O	between	_	0	SENT_219	[p19l317t1488r677b1561],
22	warfarin	NN	O	warfarin	prep_between	20	SENT_219	[p19l745t1487r1110b1561],
23	and	CC	O	and	_	0	SENT_219	[p19l1180t1488r1330b1561],
24	higher	JJR	O	higher	amod	25	SENT_219	[p19l1397t1487r1674b1582],
25	doses	NNS	O	dose	prep_in	15	SENT_219	[p19l1741t1487r1975b1561],
26	of	IN	O	of	_	0	SENT_219	[p19l2047t1487r2138b1561],
27	bosentan	NN	O	bosentan	prep_of	25	SENT_219	[p19l17t1608r540b1692],
28	.	.	O	.	_	0	SENT_219	[p19l17t1608r540b1692],

1	[	NN	O	[	_	0	SENT_220	[p19l17t1608r540b1692],
2	16	CD	NUMBER	16	num	3	SENT_220	[p19l17t1608r540b1692],
3	]	NN	O	]	dep	1	SENT_220	[p19l17t1608r540b1692],

1	©	NNP	O	©	nn	4	SENT_221	[p19l18t1883r62b1927],
2	Adis	NNP	PERSON	Adis	nn	4	SENT_221	[p19l83t1879r205b1927],
3	lnternotionoil	NNP	O	lnternotionoil	nn	4	SENT_221	[p19l227t1879r598b1927],
4	Limited	NNP	O	Limited	_	0	SENT_221	[p19l623t1879r845b1927],
5	.	.	O	.	_	0	SENT_221	[p19l623t1879r845b1927],

1	All	DT	O	all	det	2	SENT_222	[p19l868t1879r935b1926],
2	rights	NNS	O	rights	nsubj	3	SENT_222	[p19l958t1879r1110b1939],
3	reserved	VBN	O	reserve	_	0	SENT_222	[p19l1131t1879r1399b1927],
4	.	.	O	.	_	0	SENT_222	[p19l1131t1879r1399b1927],

1	The	DT	O	the	det	4	SENT_223	[p19l133t2128r296b2202],
2	enzyme	NN	O	enzyme	nn	4	SENT_223	[p19l333t2151r661b2223],
3	induction	NN	O	induction	nn	4	SENT_223	[p19l697t2128r1100b2202],
4	potential	NN	O	potential	nsubjpass	9	SENT_223	[p19l1134t2128r1509b2223],
5	of	IN	O	of	_	0	SENT_223	[p19l1545t2128r1637b2202],
6	bosentan	NN	O	bosentan	prep_of	4	SENT_223	[p19l1663t2128r2043b2202],
7	is	VBZ	O	be	auxpass	9	SENT_223	[p19l2077t2128r2143b2202],
8	also	RB	O	also	advmod	9	SENT_223	[p19l10t2259r176b2333],
9	reﬂected	VBN	O	reﬂected	_	0	SENT_223	[p19l213t2259r589b2333],
10	in	IN	O	in	_	0	SENT_223	[p19l625t2259r706b2332],
11	a	DT	O	a	det	13	SENT_223	[p19l745t2283r788b2333],
12	reduced	VBN	O	reduce	amod	13	SENT_223	[p19l822t2259r1160b2333],
13	exposure	NN	O	exposure	prep_in	9	SENT_223	[p19l1197t2283r1580b2355],
14	with	IN	O	with	_	0	SENT_223	[p19l1618t2259r1805b2333],
15	time	NN	O	time	prep_with	13	SENT_223	[p19l1841t2259r2028b2333],
16	to	TO	O	to	aux	17	SENT_223	[p19l2065t2270r2144b2333],
17	bosentan	VB	O	bosentan	infmod	13	SENT_223	[p19l6t2392r386b2466],
18	itself	PRP	O	itself	dobj	17	SENT_223	[p19l428t2392r648b2466],
19	because	IN	O	because	_	0	SENT_223	[p19l682t2392r1019b2466],
20	of	IN	O	of	_	0	SENT_223	[p19l1063t2392r1154b2466],
21	auto-induction	NN	O	auto-induction	nn	23	SENT_223	[p19l1192t2392r1814b2466],
22	(	CD	NUMBER	(	num	23	SENT_223	[p19l1859t2392r2145b2487],
23	figure	NN	O	figure	prep_because_of	17	SENT_223	[p19l1859t2392r2145b2487],
24	1	CD	NUMBER	1	num	25	SENT_223	[p19l17t2524r115b2614],
25	)	NN	O	)	dep	23	SENT_223	[p19l17t2524r115b2614],
26	.	.	O	.	_	0	SENT_223	[p19l17t2524r115b2614],

1	The	DT	O	the	det	2	SENT_224	[p19l162t2523r324b2597],
2	extent	NN	O	extent	nsubj	10	SENT_224	[p19l368t2534r628b2597],
3	of	IN	O	of	_	0	SENT_224	[p19l669t2523r761b2597],
4	auto	NN	O	auto	nn	6	SENT_224	[p19l797t2523r1419b2597],
5	—	NN	O	—	nn	6	SENT_224	[p19l797t2523r1419b2597],
6	induction	NN	O	induction	prep_of	2	SENT_224	[p19l797t2523r1419b2597],
7	is	VBZ	O	be	cop	10	SENT_224	[p19l1460t2523r1526b2597],
8	not	RB	O	not	neg	10	SENT_224	[p19l1569t2534r1704b2597],
9	markedly	RB	O	markedly	advmod	10	SENT_224	[p19l1744t2523r2145b2619],
10	dose-dependent	JJ	O	dose-dependent	_	0	SENT_224	[p19l8t2656r680b2751],
11	and	CC	O	and	_	0	SENT_224	[p19l711t2656r860b2730],
12	is	VBZ	O	be	conj_and	10	SENT_224	[p19l890t2656r956b2730],
13	in	IN	O	in	_	0	SENT_224	[p19l989t2656r1070b2728],
14	the	DT	O	the	det	15	SENT_224	[p19l1099t2656r1226b2730],
15	range	NN	O	range	prep_in	12	SENT_224	[p19l1256t2679r1492b2751],
16	of	IN	O	of	_	0	SENT_224	[p19l1524t2656r1616b2730],
17	30-60	CD	PERCENT	30-60	num	18	SENT_224	[p19l1642t2656r1988b2730],
18	%	NN	PERCENT	%	prep_of	15	SENT_224	[p19l1642t2656r1988b2730],
19	for	IN	O	for	_	0	SENT_224	[p19l2023t2656r2147b2730],
20	regimens	NNS	O	regimen	prep_for	18	SENT_224	[p19l6t2787r395b2883],
21	of	IN	O	of	_	0	SENT_224	[p19l431t2787r522b2861],
22	100-1000	CD	NUMBER	100-1000	num	23	SENT_224	[p19l557t2788r972b2862],
23	mg/day	NN	O	mg/day	prep_of	20	SENT_224	[p19l1004t2777r1471b2883],
24	.	.	O	.	_	0	SENT_224	[p19l1004t2777r1471b2883],

1	[	RB	O	[	advmod	5	SENT_225	[p19l1004t2777r1471b2883],
2	13	CD	NUMBER	13	number	3	SENT_225	[p19l1004t2777r1471b2883],
3	]	CD	NUMBER	]	num	5	SENT_225	[p19l1004t2777r1471b2883],
4	The	DT	O	the	det	5	SENT_225	[p19l1507t2787r1669b2861],
5	reductions	NNS	O	reduction	_	0	SENT_225	[p19l1700t2787r2144b2861],
6	in	IN	O	in	_	0	SENT_225	[p19l7t2918r89b2991],
7	exposure	NN	O	exposure	prep_in	5	SENT_225	[p19l150t2942r545b3014],
8	to	TO	O	to	_	0	SENT_225	[p19l605t2930r686b2992],
9	simvastatin	NN	O	simvastatin	prep_to	7	SENT_225	[p19l750t2918r1248b2992],
10	and	CC	O	and	_	0	SENT_225	[p19l1309t2918r1462b2992],
11	[	NN	O	[	prep_to	7	SENT_225	[p19l1523t2912r2147b3014],
12	3	CD	NUMBER	3	num	15	SENT_225	[p19l1523t2912r2147b3014],
13	—	NN	O	—	nn	15	SENT_225	[p19l1523t2912r2147b3014],
14	hydroxyacid	NN	O	hydroxyacid	nn	15	SENT_225	[p19l1523t2912r2147b3014],
15	simvastatin	NN	O	simvastatin	dep	5	SENT_225	[p19l11t3051r538b3138],
16	,	,	O	,	_	0	SENT_225	[p19l11t3051r538b3138],
17	i.e.	FW	O	i.e.	dep	5	SENT_225	[p19l587t3051r716b3125],
18	34	CD	NUMBER	34	dep	5	SENT_225	[p19l769t3051r870b3125],
19	and	CC	O	and	_	0	SENT_225	[p19l919t3051r1072b3125],
20	46	CD	PERCENT	46	num	21	SENT_225	[p19l1116t3051r1337b3138],
21	%	NN	PERCENT	%	dep	5	SENT_225	[p19l1116t3051r1337b3138],
22	,	,	O	,	_	0	SENT_225	[p19l1116t3051r1337b3138],
23	respectively	RB	O	respectively	advmod	21	SENT_225	[p19l1385t3051r1949b3146],
24	,	,	O	,	_	0	SENT_225	[p19l1385t3051r1949b3146],
25	fall	VB	O	fall	dep	27	SENT_225	[p19l1998t3051r2143b3125],
26	Well	UH	O	well	dep	25	SENT_225	[p19l8t3182r194b3257],
27	within	IN	O	within	appos	5	SENT_225	[p19l228t3182r498b3256],
28	this	DT	O	this	det	29	SENT_225	[p19l528t3182r677b3256],
29	range	NN	O	range	pobj	27	SENT_225	[p19l708t3206r966b3278],
30	.	.	O	.	_	0	SENT_225	[p19l708t3206r966b3278],

1	A	DT	O	a	det	4	SENT_226	[p19l1001t3183r1075b3255],
2	similar	JJ	O	similar	amod	4	SENT_226	[p19l1108t3182r1401b3256],
3	interaction	NN	O	interaction	nn	4	SENT_226	[p19l1429t3182r1887b3256],
4	study	NN	O	study	nsubj	10	SENT_226	[p19l1920t3182r2144b3278],
5	conducted	VBN	O	conduct	partmod	4	SENT_226	[p19l8t3315r446b3389],
6	with	IN	O	with	_	0	SENT_226	[p19l467t3315r655b3389],
7	simvastatin	NN	O	simvastatin	prep_with	5	SENT_226	[p19l679t3315r1163b3389],
8	and	CC	O	and	_	0	SENT_226	[p19l1186t3315r1336b3389],
9	rifampicin	NN	O	rifampicin	conj_and	7	SENT_226	[p19l1355t3315r1801b3410],
10	showed	VBD	O	show	_	0	SENT_226	[p19l1826t3315r2147b3389],
11	a	DT	O	a	det	15	SENT_226	[p19l10t3470r53b3520],
12	much	RB	O	much	advmod	14	SENT_226	[p19l82t3446r316b3520],
13	more	RBR	O	more	advmod	14	SENT_226	[p19l346t3470r562b3520],
14	pronounced	JJ	O	pronounced	amod	15	SENT_226	[p19l592t3447r1097b3542],
15	effect	NN	O	effect	nsubj	19	SENT_226	[p19l1127t3446r1370b3520],
16	of	IN	O	of	_	0	SENT_226	[p19l1400t3446r1492b3520],
17	enzyme	NN	O	enzyme	nn	18	SENT_226	[p19l1516t3470r1844b3542],
18	induction	NN	O	induction	prep_of	15	SENT_226	[p19l1875t3446r2143b3520, p19l7t3579r172b3653],
19	due	JJ	O	due	xcomp	10	SENT_226	[p19l196t3579r346b3653],
20	to	TO	O	to	_	0	SENT_226	[p19l370t3590r449b3653],
21	rifampicin	NN	O	rifampicin	prep_to	19	SENT_226	[p19l474t3579r942b3674],
22	:	:	O	:	_	0	SENT_226	[p19l474t3579r942b3674],
23	exposure	NN	O	exposure	nsubjpass	31	SENT_226	[p19l975t3602r1357b3674],
24	to	TO	O	to	_	0	SENT_226	[p19l1381t3590r1460b3653],
25	simvastatin	NN	O	simvastatin	nn	29	SENT_226	[p19l1488t3579r1972b3653],
26	and	CC	O	and	_	0	SENT_226	[p19l1997t3579r2147b3653],
27	[	NN	O	[	conj_and	25	SENT_226	[p19l12t3705r635b3806],
28	3-hydroxyacid	JJ	O	3-hydroxyacid	amod	29	SENT_226	[p19l12t3705r635b3806],
29	simvastatin	NN	O	simvastatin	prep_to	23	SENT_226	[p19l666t3710r1149b3785],
30	was	VBD	O	be	auxpass	31	SENT_226	[p19l1178t3734r1337b3785],
31	reduced	VBN	O	reduce	parataxis	10	SENT_226	[p19l1367t3711r1705b3784],
32	by	IN	O	by	_	0	SENT_226	[p19l1730t3711r1834b3806],
33	87	CD	NUMBER	87	agent	31	SENT_226	[p19l1867t3711r1963b3785],
34	and	CC	O	and	advmod	31	SENT_226	[p19l1996t3710r2147b3784],

1	93	CD	PERCENT	93	num	2	SENT_227	[p20l9t31r223b117],
2	%	NN	PERCENT	%	_	0	SENT_227	[p20l9t31r223b117],
3	,	,	O	,	_	0	SENT_227	[p20l9t31r223b117],
4	respectiVely	NNP	O	respectiVely	appos	2	SENT_227	[p20l262t19r929b126],
5	.	.	O	.	_	0	SENT_227	[p20l262t19r929b126],

1	[	NN	O	[	nsubjpass	12	SENT_228	[p20l262t19r929b126],
2	32	CD	NUMBER	32	number	3	SENT_228	[p20l262t19r929b126],
3	]	CD	NUMBER	]	dep	1	SENT_228	[p20l262t19r929b126],
4	Interestingly	RB	O	interestingly	advmod	3	SENT_228	[p20l970t30r1535b125],
5	,	,	O	,	_	0	SENT_228	[p20l970t30r1535b125],
6	the	DT	O	the	det	7	SENT_228	[p20l1575t30r1702b103],
7	effects	NNS	O	effect	appos	1	SENT_228	[p20l1740t30r2021b103],
8	of	IN	O	of	_	0	SENT_228	[p20l2061t30r2153b103],
9	rifampicin	NN	O	rifampicin	prep_of	7	SENT_228	[p20l6t161r453b257],
10	were	VBD	O	be	auxpass	12	SENT_228	[p20l484t185r689b236],
11	mainly	RB	O	mainly	advmod	12	SENT_228	[p20l721t161r1014b257],
12	expressed	VBN	O	express	_	0	SENT_228	[p20l1048t161r1468b257],
13	at	IN	O	at	_	0	SENT_228	[p20l1501t172r1574b235],
14	the	DT	O	the	det	18	SENT_228	[p20l1604t161r1732b235],
15	presyste	NN	O	presyste	nn	18	SENT_228	[p20l1762t172r2145b257],
16	—	NN	O	—	nn	18	SENT_228	[p20l1762t172r2145b257],
17	mic	JJ	O	mic	amod	18	SENT_228	[p20l7t293r163b366],
18	level	NN	O	level	prep_at	12	SENT_228	[p20l203t293r432b380],
19	,	,	O	,	_	0	SENT_228	[p20l203t293r432b380],
20	because	IN	O	because	mark	27	SENT_228	[p20l472t293r809b366],
21	the	DT	O	the	det	22	SENT_228	[p20l847t293r975b366],
22	t1/ZZ	NN	O	t1/zz	nsubjpass	27	SENT_228	[p20l1012t304r1136b390],
23	of	IN	O	of	_	0	SENT_228	[p20l1167t293r1259b366],
24	simvastatin	NN	O	simvastatin	prep_of	22	SENT_228	[p20l1292t293r1775b366],
25	was	VBD	O	be	auxpass	27	SENT_228	[p20l1812t316r1972b366],
26	not	RB	O	not	neg	27	SENT_228	[p20l2011t303r2147b366],
27	affected	VBN	O	affect	dep	18	SENT_228	[p20l10t424r372b498],
28	.	.	O	.	_	0	SENT_228	[p20l10t424r372b498],

1	When	WRB	O	when	advmod	2	SENT_229	[p20l400t424r653b498],
2	compared	VBN	O	compare	advcl	10	SENT_229	[p20l677t424r1096b520],
3	with	IN	O	with	_	0	SENT_229	[p20l1119t424r1307b499],
4	compounds	NNS	O	compound	prep_with	2	SENT_229	[p20l1330t424r1818b520],
5	such	JJ	O	such	_	0	SENT_229	[p20l1847t424r2037b498],
6	as	IN	O	as	_	0	SENT_229	[p20l2062t448r2143b498],
7	rifampicin	NN	O	rifampicin	prep_such_as	4	SENT_229	[p20l6t556r475b652],
8	,	,	O	,	_	0	SENT_229	[p20l6t556r475b652],
9	bosentan	NN	O	bosentan	nsubj	10	SENT_229	[p20l510t556r891b630],
10	appears	VBZ	O	appear	_	0	SENT_229	[p20l925t580r1246b652],
11	to	TO	O	to	aux	15	SENT_229	[p20l1281t567r1360b630],
12	be	VB	O	be	cop	15	SENT_229	[p20l1392t556r1491b630],
13	a	DT	O	a	det	15	SENT_229	[p20l1526t580r1570b630],
14	mild	JJ	O	mild	amod	15	SENT_229	[p20l1600t556r1795b630],
15	inducer	NN	O	inducer	xcomp	10	SENT_229	[p20l1826t556r2147b630],
16	of	IN	O	of	_	0	SENT_229	[p20l9t689r101b763],
17	CYP3A4	NN	O	cyp3a4	nn	18	SENT_229	[p20l131t689r517b763],
18	(	NN	O	(	prep_of	15	SENT_229	[p20l558t689r743b780],
19	and	CC	O	and	_	0	SENT_229	[p20l558t689r743b780],
20	CYP2C9	NN	O	cyp2c9	nn	21	SENT_229	[p20l779t689r1218b780],
21	)	NN	O	)	conj_and	18	SENT_229	[p20l779t689r1218b780],
22	.	.	O	.	_	0	SENT_229	[p20l779t689r1218b780],

1	An	DT	O	a	det	3	SENT_230	[p20l1261t690r1388b761],
2	interaction	NN	O	interaction	nn	3	SENT_230	[p20l1424t689r1881b763],
3	study	NN	O	study	nsubj	8	SENT_230	[p20l1920t689r2144b784],
4	between	IN	O	between	_	0	SENT_230	[p20l6t820r362b894],
5	rifampicin	NN	O	rifampicin	prep_between	3	SENT_230	[p20l397t820r843b916],
6	and	CC	O	and	_	0	SENT_230	[p20l881t820r1032b894],
7	warfarin	NN	O	warfarin	prep_between	3	SENT_230	[p20l1067t820r1428b895],
8	showed	VBD	O	show	_	0	SENT_230	[p20l1467t820r1789b894],
9	that	IN	O	that	complm	11	SENT_230	[p20l1823t820r1983b894],
10	the	DT	O	the	det	11	SENT_230	[p20l2017t820r2145b894],
11	exposure	NN	O	exposure	dep	8	SENT_230	[p20l8t976r395b1048],
12	of	IN	O	of	_	0	SENT_230	[p20l442t953r535b1027],
13	the	DT	O	the	det	17	SENT_230	[p20l573t953r701b1027],
14	CYP3A4	NN	O	cyp3a4	nn	17	SENT_230	[p20l749t953r1138b1027],
15	substrate	NN	O	substrate	nn	17	SENT_230	[p20l1189t953r1565b1027],
16	(	CD	NUMBER	(	num	17	SENT_230	[p20l1615t953r2146b1044],
17	R	NN	O	r	prep_of	11	SENT_230	[p20l1615t953r2146b1044],
18	)	SYM	O	)	dep	11	SENT_230	[p20l1615t953r2146b1044],
19	-	:	O	-	_	0	SENT_230	[p20l1615t953r2146b1044],
20	warfarin	NN	O	warfarin	nsubjpass	22	SENT_230	[p20l1615t953r2146b1044],
21	was	VBD	O	be	auxpass	22	SENT_230	[p20l8t1108r168b1159],
22	reduced	VBN	O	reduce	dep	11	SENT_230	[p20l201t1084r540b1158],
23	3-fold	RB	O	3-fold	advmod	22	SENT_230	[p20l574t1084r831b1159],
24	compared	VBN	O	compare	_	0	SENT_230	[p20l864t1084r1283b1180],
25	with	IN	O	with	prepc_compared_with	22	SENT_230	[p20l1314t1084r1502b1159],
26	1.6-fold	RB	O	1.6-fold	advmod	27	SENT_230	[p20l1544t1084r1874b1159],
27	in	IN	O	in	pcomp	22	SENT_230	[p20l1906t1084r1986b1157],
28	the	DT	O	the	det	29	SENT_230	[p20l2017t1084r2145b1158],
29	presence	NN	O	presence	pobj	27	SENT_230	[p20l6t1240r380b1312],
30	of	IN	O	of	_	0	SENT_230	[p20l413t1216r505b1290],
31	bosentan	NN	O	bosentan	prep_of	29	SENT_230	[p20l528t1205r1152b1290],
32	.	.	O	.	_	0	SENT_230	[p20l528t1205r1152b1290],

1	[	RB	O	[	advmod	33	SENT_231	[p20l528t1205r1152b1290],
2	16	CD	NUMBER	16	num	3	SENT_231	[p20l528t1205r1152b1290],
3	’	CD	NUMBER	’	dep	1	SENT_231	[p20l528t1205r1152b1290],
4	33	CD	NUMBER	33	num	5	SENT_231	[p20l528t1205r1152b1290],
5	]	CD	NUMBER	]	dep	1	SENT_231	[p20l528t1205r1152b1290],
6	Whether	IN	O	whether	complm	19	SENT_231	[p20l1185t1216r1554b1290],
7	the	DT	O	the	det	8	SENT_231	[p20l1584t1216r1711b1289],
8	induction	NN	O	induction	nsubj	19	SENT_231	[p20l1743t1216r2146b1289],
9	by	IN	O	by	_	0	SENT_231	[p20l6t1347r110b1443],
10	bosentan	NN	O	bosentan	prep_by	8	SENT_231	[p20l131t1347r511b1421],
11	is	VBZ	O	be	cop	19	SENT_231	[p20l532t1347r598b1421],
12	of	IN	O	of	_	0	SENT_231	[p20l624t1347r715b1421],
13	the	DT	O	the	det	18	SENT_231	[p20l730t1347r857b1421],
14	constitutive	JJ	O	constitutive	amod	18	SENT_231	[p20l879t1347r1377b1421],
15	androstane	NN	O	androstane	nn	18	SENT_231	[p20l1401t1347r1861b1421],
16	receptor	NN	O	receptor	nn	18	SENT_231	[p20l1880t1371r2144b1443, p20l7t1491r126b1554],
17	(	CD	NUMBER	(	num	18	SENT_231	[p20l158t1480r440b1571],
18	CAR	NN	O	car	prep_of	19	SENT_231	[p20l158t1480r440b1571],
19	)	CD	NUMBER	)	dep	1	SENT_231	[p20l158t1480r440b1571],
20	or	CC	O	or	_	0	SENT_231	[p20l476t1503r562b1554],
21	the	DT	O	the	det	26	SENT_231	[p20l591t1480r719b1554],
22	pregnane	NN	O	pregnane	nn	26	SENT_231	[p20l750t1503r1141b1575],
23	X	NN	O	x	nn	26	SENT_231	[p20l1172t1482r1246b1552],
24	receptor	NN	O	receptor	nn	26	SENT_231	[p20l1276t1491r1628b1575],
25	(	NN	O	(	nn	26	SENT_231	[p20l1661t1481r1930b1571],
26	PXR	NN	O	pxr	conj_or	19	SENT_231	[p20l1661t1481r1930b1571],
27	)	CD	NUMBER	)	num	28	SENT_231	[p20l1661t1481r1930b1571],
28	type	NN	O	type	nsubjpass	33	SENT_231	[p20l1964t1491r2146b1575],
29	has	VBZ	O	have	aux	33	SENT_231	[p20l6t1610r145b1684],
30	not	RB	O	not	neg	33	SENT_231	[p20l178t1621r313b1684],
31	yet	RB	O	yet	advmod	33	SENT_231	[p20l342t1622r472b1706],
32	been	VBN	O	be	auxpass	33	SENT_231	[p20l500t1610r700b1684],
33	established	VBN	O	establish	_	0	SENT_231	[p20l732t1599r1451b1684],
34	.	.	O	.	_	0	SENT_231	[p20l732t1599r1451b1684],

1	[	NN	O	[	_	0	SENT_232	[p20l732t1599r1451b1684],
2	34	CD	NUMBER	34	number	3	SENT_232	[p20l732t1599r1451b1684],
3	’	CD	NUMBER	’	dep	1	SENT_232	[p20l732t1599r1451b1684],
4	35	CD	NUMBER	35	num	5	SENT_232	[p20l732t1599r1451b1684],
5	]	NN	O	]	dep	3	SENT_232	[p20l732t1599r1451b1684],

1	When	WRB	O	when	advmod	7	SENT_233	[p20l132t1743r386b1817],
2	the	DT	O	the	det	3	SENT_233	[p20l417t1743r545b1817],
3	metabolism	NN	O	metabolism	nsubjpass	7	SENT_233	[p20l579t1743r1077b1817],
4	of	IN	O	of	_	0	SENT_233	[p20l1110t1743r1201b1817],
5	drugs	NNS	O	drug	prep_of	3	SENT_233	[p20l1228t1743r1459b1838],
6	is	VBZ	O	be	auxpass	7	SENT_233	[p20l1495t1743r1560b1817],
7	induced	VBN	O	induce	advcl	42	SENT_233	[p20l1596t1743r1934b1817],
8	by	IN	O	by	_	0	SENT_233	[p20l1964t1743r2068b1838],
9	a	DT	O	a	det	12	SENT_233	[p20l2104t1766r2147b1817],
10	concomitantly	RB	O	concomitantly	advmod	11	SENT_233	[p20l8t1875r618b1970],
11	administered	VBN	O	administer	amod	12	SENT_233	[p20l664t1875r1215b1949],
12	compound	NN	O	compound	agent	7	SENT_233	[p20l1257t1875r1728b1970],
13	,	,	O	,	_	0	SENT_233	[p20l1257t1875r1728b1970],
14	not	RB	O	not	neg	12	SENT_233	[p20l1776t1886r1911b1949],
15	their	PRP$	O	they	poss	16	SENT_233	[p20l1951t1875r2148b1949],
16	safety	NN	O	safety	dep	12	SENT_233	[p20l11t2005r260b2101],
17	but	CC	O	but	cc	21	SENT_233	[p20l295t2005r431b2079],
18	potentially	RB	O	potentially	advmod	21	SENT_233	[p20l463t2005r921b2101],
19	their	PRP$	O	they	poss	20	SENT_233	[p20l957t2005r1153b2079],
20	efficacy	NN	O	efficacy	nsubj	21	SENT_233	[p20l1187t2005r1529b2101],
21	is	VBZ	O	be	rcmod	16	SENT_233	[p20l1564t2005r1630b2079],
22	at	IN	O	at	_	0	SENT_233	[p20l1668t2016r1742b2079],
23	stal	JJ	O	stal	amod	26	SENT_233	[p20l1778t1994r2142b2079],
24	<	JJR	O	<	dep	23	SENT_233	[p20l1778t1994r2142b2079],
25	e.	FW	O	e.	nn	26	SENT_233	[p20l1778t1994r2142b2079],
26	[	FW	O	[	prep_at	21	SENT_233	[p20l1778t1994r2142b2079],
27	15	CD	NUMBER	15	number	28	SENT_233	[p20l1778t1994r2142b2079],
28	]	CD	NUMBER	]	dep	26	SENT_233	[p20l1778t1994r2142b2079],
29	Theoretically	RB	O	theoretically	advmod	31	SENT_233	[p20l7t2138r601b2233],
30	,	,	O	,	_	0	SENT_233	[p20l7t2138r601b2233],
31	reduced	VBD	O	reduce	dep	21	SENT_233	[p20l629t2138r968b2212],
32	efficacy	NN	O	efficacy	dobj	31	SENT_233	[p20l994t2138r1335b2233],
33	of	IN	O	of	_	0	SENT_233	[p20l1362t2138r1454b2212],
34	compounds	NNS	O	compound	prep_of	32	SENT_233	[p20l1473t2138r1960b2233],
35	that	WDT	O	that	nsubj	37	SENT_233	[p20l1988t2138r2147b2212],
36	are	VBP	O	be	cop	37	SENT_233	[p20l10t2293r135b2342],
37	substrates	NNS	O	substrate	rcmod	34	SENT_233	[p20l185t2269r600b2342],
38	of	IN	O	of	_	0	SENT_233	[p20l649t2269r740b2342],
39	CYP3A4	NN	O	cyp3a4	prep_of	37	SENT_233	[p20l780t2270r1166b2343],
40	should	MD	O	should	aux	42	SENT_233	[p20l1217t2269r1496b2342],
41	be	VB	O	be	auxpass	42	SENT_233	[p20l1540t2269r1638b2342],
42	considered	VBN	O	consider	_	0	SENT_233	[p20l1685t2269r2147b2342],
43	when	WRB	O	when	advmod	44	SENT_233	[p20l8t2401r236b2474],
44	administered	VBN	O	administer	advcl	42	SENT_233	[p20l274t2401r824b2474],
45	in	IN	O	in	_	0	SENT_233	[p20l860t2401r940b2473],
46	combination	NN	O	combination	prep_in	44	SENT_233	[p20l976t2401r1509b2474],
47	with	IN	O	with	_	0	SENT_233	[p20l1545t2401r1732b2474],
48	bosentan	NN	O	bosentan	prep_with	44	SENT_233	[p20l1765t2401r2146b2474],
49	because	IN	O	because	mark	53	SENT_233	[p20l6t2531r343b2605],
50	the	DT	O	the	det	51	SENT_233	[p20l370t2531r498b2605],
51	latter	NN	O	latter	nsubj	53	SENT_233	[p20l525t2531r745b2605],
52	may	MD	O	may	aux	53	SENT_233	[p20l770t2555r950b2627],
53	reduce	VB	O	reduce	advcl	44	SENT_233	[p20l976t2531r1260b2605],
54	their	PRP$	O	they	poss	56	SENT_233	[p20l1286t2531r1483b2605],
55	systemic	JJ	O	systemic	amod	56	SENT_233	[p20l1511t2531r1878b2627],
56	exposure	NN	O	exposure	dobj	53	SENT_233	[p20l1907t2555r2144b2627, p20l11t2687r183b2738],
57	up	IN	O	up	advmod	53	SENT_233	[p20l218t2687r321b2759],
58	to	TO	O	to	_	0	SENT_233	[p20l358t2675r437b2738],
59	2-fold	JJ	O	2-fold	prep_to	57	SENT_233	[p20l475t2664r754b2738],
60	.	.	O	.	_	0	SENT_233	[p20l475t2664r754b2738],

1	Substrates	NNS	O	substrate	_	0	SENT_234	[p20l798t2664r1231b2738],
2	of	IN	O	of	dep	1	SENT_234	[p20l1271t2664r1362b2738],
3	CYP3A4	NN	O	cyp3a4	pobj	2	SENT_234	[p20l1392t2664r1777b2738],
4	have	VBP	O	have	dep	3	SENT_234	[p20l1813t2664r2012b2738],
5	an	DT	O	a	det	8	SENT_234	[p20l2051t2687r2146b2738],
6	inherent	JJ	O	inherent	amod	7	SENT_234	[p20l7t2795r358b2869],
7	marked	JJ	O	marked	amod	8	SENT_234	[p20l379t2795r699b2869],
8	intra	NN	O	intra	dobj	4	SENT_234	[p20l720t2795r947b2869],
9	-	:	O	-	_	0	SENT_234	[p20l720t2795r947b2869],
10	and	CC	O	and	dep	1	SENT_234	[p20l976t2795r1125b2869],
11	inter	SYM	O	inter	dep	14	SENT_234	[p20l1147t2795r1375b2869],
12	-	:	O	-	_	0	SENT_234	[p20l1147t2795r1375b2869],
13	subj	NN	O	subj	nn	14	SENT_234	[p20l1385t2795r1550b2891],
14	ect	NN	O	ect	dep	1	SENT_234	[p20l1561t2806r1684b2869],
15	Variability	NN	O	variability	nsubj	25	SENT_234	[p20l1706t2795r2145b2891],
16	and	CC	O	and	dep	22	SENT_234	[p20l10t2927r182b3014],
17	,	,	O	,	_	0	SENT_234	[p20l10t2927r182b3014],
18	therefore	RB	O	therefore	dep	22	SENT_234	[p20l215t2927r623b3014],
19	,	,	O	,	_	0	SENT_234	[p20l215t2927r623b3014],
20	for	IN	O	for	_	0	SENT_234	[p20l658t2927r782b3000],
21	most	JJS	O	most	prep_for	22	SENT_234	[p20l811t2938r1017b3000],
22	substrates	NNS	O	substrate	dep	15	SENT_234	[p20l1049t2927r1463b3000],
23	the	DT	O	the	det	24	SENT_234	[p20l1496t2927r1622b3000],
24	mild	JJ	O	mild	dep	22	SENT_234	[p20l1653t2927r1847b3000],
25	inducing	VBG	O	induce	rcmod	14	SENT_234	[p20l1876t2927r2144b3000, p20l7t3058r140b3154],
26	effect	NN	O	effect	nsubjpass	31	SENT_234	[p20l185t3058r428b3132],
27	of	IN	O	of	_	0	SENT_234	[p20l470t3058r561b3132],
28	bosentan	NN	O	bosentan	prep_of	26	SENT_234	[p20l595t3058r975b3132],
29	is	VBZ	O	be	auxpass	31	SENT_234	[p20l1018t3058r1083b3132],
30	not	RB	O	not	neg	31	SENT_234	[p20l1128t3070r1264b3132],
31	expected	VBN	O	expect	ccomp	25	SENT_234	[p20l1305t3058r1684b3154],
32	to	TO	O	to	aux	33	SENT_234	[p20l1725t3070r1804b3132],
33	lead	VB	O	lead	xcomp	31	SENT_234	[p20l1848t3058r2024b3132],
34	to	TO	O	to	_	0	SENT_234	[p20l2066t3070r2144b3132],
35	clinically	RB	O	clinically	advmod	36	SENT_234	[p20l8t3191r416b3287],
36	relevant	JJ	O	relevant	amod	38	SENT_234	[p20l462t3191r817b3265],
37	drug	NN	O	drug	nn	38	SENT_234	[p20l863t3191r1057b3287],
38	interactions	NNS	O	interaction	prep_to	33	SENT_234	[p20l1105t3191r1638b3265],
39	.	.	O	.	_	0	SENT_234	[p20l1105t3191r1638b3265],

1	Clinically	RB	O	clinically	advmod	12	SENT_235	[p20l1691t3191r2141b3287],
2	,	,	O	,	_	0	SENT_235	[p20l1691t3191r2141b3287],
3	the	DT	O	the	det	4	SENT_235	[p20l7t3323r135b3396],
4	effects	NNS	O	effect	nsubjpass	12	SENT_235	[p20l179t3323r459b3396],
5	of	IN	O	of	_	0	SENT_235	[p20l506t3323r598b3396],
6	a	DT	O	a	det	8	SENT_235	[p20l636t3347r680b3396],
7	mild	JJ	O	mild	amod	8	SENT_235	[p20l720t3323r915b3396],
8	inducer	NN	O	inducer	prep_of	4	SENT_235	[p20l956t3323r1278b3396],
9	are	VBP	O	be	auxpass	12	SENT_235	[p20l1320t3347r1445b3396],
10	usually	RB	O	usually	advmod	12	SENT_235	[p20l1487t3323r1794b3419],
11	not	RB	O	not	neg	12	SENT_235	[p20l1837t3334r1973b3396],
12	detected	VBN	O	detect	_	0	SENT_235	[p20l2014t3323r2144b3396, p20l7t3454r272b3528],
13	in	IN	O	in	_	0	SENT_235	[p20l322t3454r404b3527],
14	the	DT	O	the	det	15	SENT_235	[p20l455t3454r585b3528],
15	background	NN	O	background	prep_in	12	SENT_235	[p20l634t3454r1152b3550],
16	of	IN	O	of	_	0	SENT_235	[p20l1202t3454r1295b3528],
17	nonspecific	JJ	O	nonspecific	amod	18	SENT_235	[p20l1338t3454r1842b3550],
18	Variation	NN	O	variation	prep_of	15	SENT_235	[p20l1895t3454r2144b3529, p20l7t3576r320b3661],
19	.	.	O	.	_	0	SENT_235	[p20l1895t3454r2144b3529, p20l7t3576r320b3661],

1	[	NN	O	[	nsubjpass	17	SENT_236	[p20l1895t3454r2144b3529, p20l7t3576r320b3661],
2	34	CD	NUMBER	34	num	3	SENT_236	[p20l1895t3454r2144b3529, p20l7t3576r320b3661],
3	]	CD	NUMBER	]	npadvmod	4	SENT_236	[p20l1895t3454r2144b3529, p20l7t3576r320b3661],
4	Only	RB	O	only	advmod	1	SENT_236	[p20l368t3587r575b3682],
5	the	DT	O	the	det	6	SENT_236	[p20l617t3587r744b3661],
6	efficacy	NN	O	efficacy	pobj	4	SENT_236	[p20l788t3587r1129b3682],
7	of	IN	O	of	_	0	SENT_236	[p20l1171t3587r1263b3661],
8	CYP3A4	NN	O	cyp3a4	nn	9	SENT_236	[p20l1298t3587r1684b3661],
9	substrates	NNS	O	substrate	prep_of	1	SENT_236	[p20l1729t3587r2144b3661],
10	with	IN	O	with	_	0	SENT_236	[p21l8t25r195b100],
11	a	DT	O	a	det	14	SENT_236	[p21l225t49r268b99],
12	narrow	JJ	O	narrow	amod	14	SENT_236	[p21l294t49r594b99],
13	therapeutic	JJ	O	therapeutic	amod	14	SENT_236	[p21l623t25r1096b121],
14	margin	NN	O	margin	prep_with	9	SENT_236	[p21l1125t25r1426b121],
15	may	MD	O	may	aux	17	SENT_236	[p21l1453t49r1633b121],
16	be	VB	O	be	auxpass	17	SENT_236	[p21l1660t25r1759b99],
17	compromised	VBN	O	compromise	_	0	SENT_236	[p21l1788t49r2144b121, p21l7t158r282b231],
18	.	.	O	.	_	0	SENT_236	[p21l1788t49r2144b121, p21l7t158r282b231],

1	It	PRP	O	it	nsubjpass	6	SENT_237	[p21l320t160r384b231],
2	can	MD	O	can	aux	6	SENT_237	[p21l416t169r700b231],
3	not	RB	O	not	neg	6	SENT_237	[p21l416t169r700b231],
4	also	RB	O	also	advmod	6	SENT_237	[p21l732t158r898b231],
5	be	VB	O	be	auxpass	6	SENT_237	[p21l930t158r1028b231],
6	excluded	VBN	O	exclude	_	0	SENT_237	[p21l1062t158r1446b231],
7	that	IN	O	that	complm	13	SENT_237	[p21l1477t158r1637b231],
8	in	IN	O	in	dep	13	SENT_237	[p21l1667t158r1747b230],
9	some	DT	O	some	det	11	SENT_237	[p21l1782t181r2001b231],
10	individual	JJ	O	individual	amod	11	SENT_237	[p21l2033t158r2146b230, p21l8t288r357b362],
11	subjects	NNS	O	subject	pobj	8	SENT_237	[p21l401t288r738b384],
12	the	DT	O	the	det	13	SENT_237	[p21l780t288r908b362],
13	extent	NN	O	extent	dep	6	SENT_237	[p21l949t299r1209b362],
14	of	IN	O	of	_	0	SENT_237	[p21l1249t288r1341b362],
15	enzyme	NN	O	enzyme	nn	16	SENT_237	[p21l1374t312r1702b384],
16	induction	NN	O	induction	prep_of	13	SENT_237	[p21l1743t288r2146b362],

1	Clin	NNP	O	Clin	nn	2	SENT_238	[p21l1206t573r1314b622],
2	Phormocokinet	NNP	O	Phormocokinet	_	0	SENT_238	[p21l1339t573r1800b622],
3	2003	CD	DATE	2003	num	2	SENT_238	[p21l1818t573r1969b625],
4	;	:	O	;	_	0	SENT_238	[p21l1818t573r1969b625],
5	42	CD	NUMBER	42	number	6	SENT_238	[p21l1990t573r2056b621],
6	(	CD	NUMBER	(	dep	2	SENT_238	[p21l2080t573r2153b629],
7	3	CD	NUMBER	3	num	8	SENT_238	[p21l2080t573r2153b629],
8	)	NN	O	)	dep	6	SENT_238	[p21l2080t573r2153b629],

1	300	CD	NUMBER	300	num	2	SENT_239	[p21l191t705r240b730],
2	Dingemrmse	NNP	O	Dingemrmse	_	0	SENT_239	[p21l1725t704r1893b738],
3	et	FW	O	et	dep	2	SENT_239	[p21l1902t707r1925b729],
4	111	CD	NUMBER	111	dep	3	SENT_239	[p21l1935t704r1965b729],
5	.	.	O	.	_	0	SENT_239	[p21l1935t704r1965b729],

1	may	MD	O	may	aux	3	SENT_240	[p21l8t975r187b1047],
2	be	VB	O	be	cop	3	SENT_240	[p21l228t952r326b1025],
3	greater	JJR	O	greater	_	0	SENT_240	[p21l369t963r664b1047],
4	than	IN	O	than	_	0	SENT_240	[p21l703t952r884b1025],
5	the	DT	O	the	det	9	SENT_240	[p21l925t952r1052b1025],
6	observed	VBN	O	observe	amod	9	SENT_240	[p21l1095t952r1477b1025],
7	average	JJ	O	average	amod	9	SENT_240	[p21l1519t975r1846b1047],
8	2-fold	JJ	O	2-fold	amod	9	SENT_240	[p21l1889t952r2147b1025],
9	factor	NN	O	factor	prep_than	3	SENT_240	[p21l8t1076r257b1149],
10	in	IN	O	in	_	0	SENT_240	[p21l286t1076r366b1148],
11	the	DT	O	the	det	13	SENT_240	[p21l396t1076r524b1149],
12	present	JJ	DATE	present	amod	13	SENT_240	[p21l553t1087r862b1171],
13	study	NN	O	study	prep_in	9	SENT_240	[p21l895t1076r1142b1171],
14	.	.	O	.	_	0	SENT_240	[p21l895t1076r1142b1171],

1	Conclusion	NN	O	conclusion	_	0	SENT_241	[p21l136t1329r693b1410],

1	The	DT	O	the	det	3	SENT_242	[p21l134t1538r296b1611],
2	present	JJ	DATE	present	amod	3	SENT_242	[p21l331t1549r640b1633],
3	study	NN	O	study	nsubj	5	SENT_242	[p21l679t1538r903b1633],
4	has	VBZ	O	have	aux	5	SENT_242	[p21l939t1538r1076b1611],
5	shown	VBN	O	show	_	0	SENT_242	[p21l1119t1538r1391b1611],
6	that	IN	O	that	complm	8	SENT_242	[p21l1425t1538r1585b1611],
7	bosentan	NN	O	bosentan	nsubj	8	SENT_242	[p21l1618t1538r1996b1611],
8	reduces	VBZ	O	reduce	ccomp	5	SENT_242	[p21l2030t1561r2144b1611, p21l9t1662r246b1736],
9	exposure	NN	O	exposure	iobj	8	SENT_242	[p21l284t1686r666b1758],
10	to	TO	O	to	_	0	SENT_242	[p21l701t1674r780b1736],
11	simvastatin	NN	O	simvastatin	prep_to	9	SENT_242	[p21l820t1662r1301b1736],
12	and	CC	O	and	_	0	SENT_242	[p21l1339t1662r1487b1736],
13	[	NN	O	[	conj_and	11	SENT_242	[p21l1526t1656r2147b1758],
14	3-hydroxyacid	JJ	O	3-hydroxyacid	amod	15	SENT_242	[p21l1526t1656r2147b1758],
15	simvastatin	NN	O	simvastatin	dobj	8	SENT_242	[p21l12t1787r493b1860],
16	by	IN	O	by	_	0	SENT_242	[p21l532t1787r636b1882],
17	approximately	RB	O	approximately	quantmod	18	SENT_242	[p21l680t1787r1292b1882],
18	40	CD	PERCENT	40	num	19	SENT_242	[p21l1333t1788r1520b1860],
19	%	NN	PERCENT	%	prep_by	8	SENT_242	[p21l1333t1788r1520b1860],
20	which	WDT	O	which	nsubjpass	23	SENT_242	[p21l1566t1787r1824b1860],
21	can	MD	O	can	aux	23	SENT_242	[p21l1864t1810r2009b1860],
22	be	VB	O	be	auxpass	23	SENT_242	[p21l2047t1787r2145b1860],
23	explained	VBN	O	explain	rcmod	19	SENT_242	[p21l9t1911r422b2006],
24	by	IN	O	by	_	0	SENT_242	[p21l450t1911r554b2006],
25	induction	NN	O	induction	agent	23	SENT_242	[p21l585t1911r986b1984],
26	of	IN	O	of	_	0	SENT_242	[p21l1017t1911r1109b1984],
27	CYP3A4	NN	O	cyp3a4	nn	29	SENT_242	[p21l1133t1911r1517b1984],
28	enzyme	NN	O	enzyme	nn	29	SENT_242	[p21l1549t1934r1876b2006],
29	activity	NN	O	activity	prep_of	25	SENT_242	[p21l1908t1911r2144b1984, p21l8t2034r146b2129],
30	.	.	O	.	_	0	SENT_242	[p21l1908t1911r2144b1984, p21l8t2034r146b2129],

1	Lovastatin	NNP	O	Lovastatin	nsubjpass	14	SENT_243	[p21l206t2034r669b2108],
2	and	CC	O	and	_	0	SENT_243	[p21l727t2034r879b2107],
3	atorvastatin	NN	O	atorvastatin	nsubjpass	14	SENT_243	[p21l935t2034r1470b2120],
4	,	,	O	,	_	0	SENT_243	[p21l935t2034r1470b2120],
5	in	IN	O	in	_	0	SENT_243	[p21l1529t2034r1610b2106],
6	contrast	NN	O	contrast	prep_in	14	SENT_243	[p21l1666t2045r2012b2107],
7	to	TO	O	to	_	0	SENT_243	[p21l2065t2045r2145b2107],
8	ﬂuvastatin	NN	O	ﬂuvastatin	prep_to	6	SENT_243	[p21l9t2158r477b2232],
9	and	CC	O	and	_	0	SENT_243	[p21l541t2158r694b2231],
10	pravastatin	NN	O	pravastatin	prep_to	6	SENT_243	[p21l754t2158r1266b2253],
11	,	,	O	,	_	0	SENT_243	[p21l754t2158r1266b2253],
12	are	VBP	O	be	auxpass	14	SENT_243	[p21l1334t2182r1462b2231],
13	also	RB	O	also	advmod	14	SENT_243	[p21l1527t2158r1697b2231],
14	biotransformed	VBN	O	biotransform	_	0	SENT_243	[p21l1758t2158r2143b2231, p21l8t2282r314b2356],
15	primarily	RB	O	primarily	advmod	14	SENT_243	[p21l334t2282r730b2378],
16	by	IN	O	by	_	0	SENT_243	[p21l751t2282r854b2378],
17	CYP3A4	NN	O	cyp3a4	agent	14	SENT_243	[p21l878t2271r1384b2357],
18	[	CD	NUMBER	[	num	17	SENT_243	[p21l878t2271r1384b2357],
19	31	CD	NUMBER	31	num	20	SENT_243	[p21l878t2271r1384b2357],
20	]	NN	O	]	dep	17	SENT_243	[p21l878t2271r1384b2357],
21	and	CC	O	and	_	0	SENT_243	[p21l1413t2282r1562b2356],
22	will	MD	O	will	aux	25	SENT_243	[p21l1584t2282r1746b2356],
23	probably	RB	O	probably	advmod	25	SENT_243	[p21l1767t2282r2145b2378],
24	be	VB	O	be	auxpass	25	SENT_243	[p21l7t2408r105b2481],
25	inﬂuenced	VBN	O	inﬂuenced	conj_and	14	SENT_243	[p21l135t2408r585b2481],
26	to	TO	O	to	_	0	SENT_243	[p21l615t2419r693b2481],
27	a	DT	O	a	det	29	SENT_243	[p21l727t2431r770b2481],
28	similar	JJ	O	similar	amod	29	SENT_243	[p21l802t2408r1095b2481],
29	extent	NN	O	extent	prep_to	25	SENT_243	[p21l1124t2419r1383b2481],
30	as	IN	O	as	_	0	SENT_243	[p21l1414t2431r1495b2481],
31	simvastatin	NN	O	simvastatin	prep_as	29	SENT_243	[p21l1531t2408r2012b2481],
32	by	IN	O	by	_	0	SENT_243	[p21l2041t2408r2144b2503],
33	concomitant	JJ	O	concomitant	amod	34	SENT_243	[p21l9t2533r535b2606],
34	administration	NN	O	administration	agent	25	SENT_243	[p21l567t2533r1181b2606],
35	of	IN	O	of	_	0	SENT_243	[p21l1213t2533r1304b2606],
36	bosentan	NN	O	bosentan	prep_of	34	SENT_243	[p21l1326t2533r1726b2606],
37	.	.	O	.	_	0	SENT_243	[p21l1326t2533r1726b2606],

1	Acknowledgements	NNS	O	acknowledgement	_	0	SENT_244	[p21l134t2789r1149b2891],

1	Actelion	NNP	ORGANIZATION	Actelion	nn	3	SENT_245	[p21l134t2991r439b3053],
2	Pharmaceuticals	NNPS	ORGANIZATION	Pharmaceuticals	nn	3	SENT_245	[p21l469t2991r1050b3053],
3	Ltd	NNP	ORGANIZATION	Ltd	nsubj	5	SENT_245	[p21l1081t2991r1203b3053],
4	financially	RB	O	financially	advmod	5	SENT_245	[p21l1232t2991r1611b3071],
5	supported	VBD	O	support	_	0	SENT_245	[p21l1643t2991r1991b3071],
6	this	DT	O	this	det	7	SENT_245	[p21l2019t2991r2144b3053],
7	study	NN	O	study	dobj	5	SENT_245	[p21l11t3094r217b3174],
8	.	.	O	.	_	0	SENT_245	[p21l11t3094r217b3174],

1	The	DT	O	the	det	2	SENT_246	[p21l241t3094r376b3156],
2	authors	NNS	O	author	nsubj	4	SENT_246	[p21l397t3094r654b3156],
3	have	VBP	O	have	aux	4	SENT_246	[p21l674t3094r840b3157],
4	provided	VBN	O	provide	_	0	SENT_246	[p21l858t3094r1175b3174],
5	no	DT	O	no	det	6	SENT_246	[p21l1193t3114r1278b3156],
6	information	NN	O	information	nsubj	12	SENT_246	[p21l1298t3094r1717b3156],
7	on	IN	O	on	_	0	SENT_246	[p21l1737t3114r1822b3156],
8	conﬂicts	NNS	O	conﬂicts	prep_on	6	SENT_246	[p21l1841t3094r2144b3156],
9	of	IN	O	of	_	0	SENT_246	[p21l9t3198r86b3259],
10	interest	NN	O	interest	prep_of	8	SENT_246	[p21l105t3198r368b3259],
11	directly	RB	O	directly	advmod	12	SENT_246	[p21l394t3198r663b3278],
12	relevant	JJ	O	relevant	xcomp	4	SENT_246	[p21l688t3198r976b3259],
13	to	TO	O	to	_	0	SENT_246	[p21l1001t3207r1066b3259],
14	the	DT	O	the	det	15	SENT_246	[p21l1093t3198r1199b3259],
15	content	NN	O	content	prep_to	12	SENT_246	[p21l1226t3208r1487b3259],
16	of	IN	O	of	_	0	SENT_246	[p21l1513t3198r1589b3259],
17	this	DT	O	this	det	18	SENT_246	[p21l1609t3198r1734b3259],
18	study	NN	O	study	prep_of	15	SENT_246	[p21l1764t3198r1971b3278],
19	.	.	O	.	_	0	SENT_246	[p21l1764t3198r1971b3278],

1	References	NNS	O	reference	_	0	SENT_247	[p21l171t3432r727b3514],

1	1	LS	NUMBER	1	_	0	SENT_248	[p21l86t3552r132b3606],
2	.	.	O	.	_	0	SENT_248	[p21l86t3552r132b3606],

1	Yanagisawa	NNP	PERSON	Yanagisawa	nn	2	SENT_249	[p21l166t3552r551b3622],
2	M	NNP	O	M	_	0	SENT_249	[p21l580t3553r664b3616],
3	,	,	O	,	_	0	SENT_249	[p21l580t3553r664b3616],
4	Kurihara	NNP	PERSON	Kurihara	nn	5	SENT_249	[p21l699t3552r978b3606],
5	H	NNP	PERSON	H	appos	2	SENT_249	[p21l1007t3553r1079b3616],
6	,	,	O	,	_	0	SENT_249	[p21l1007t3553r1079b3616],
7	Kimura	NNP	PERSON	Kimura	nn	8	SENT_249	[p21l1113t3552r1352b3606],
8	S	NNP	PERSON	S	appos	2	SENT_249	[p21l1383t3552r1440b3616],
9	,	,	O	,	_	0	SENT_249	[p21l1383t3552r1440b3616],
10	et	FW	O	et	nn	11	SENT_249	[p21l1473t3560r1529b3606],
11	al.	FW	O	al.	appos	2	SENT_249	[p21l1560t3552r1628b3606],
12	.	.	O	.	_	0	SENT_249	[p21l1560t3552r1628b3606],

1	A	DT	O	a	det	5	SENT_250	[p21l1663t3552r1717b3606],
2	novel	JJ	O	novel	amod	5	SENT_250	[p21l1747t3552r1921b3607],
3	potent	JJ	O	potent	amod	5	SENT_250	[p21l1950t3560r2148b3622],
4	vasoconstrictor	NN	O	vasoconstrictor	nn	5	SENT_250	[p21l228t3640r728b3694],
5	peptide	NN	O	peptide	nsubj	6	SENT_250	[p21l761t3640r1000b3710],
6	produced	VBN	O	produce	_	0	SENT_250	[p21l1034t3640r1338b3710],
7	by	IN	O	by	_	0	SENT_250	[p21l1370t3640r1449b3710],
8	vascular	JJ	O	vascular	amod	10	SENT_250	[p21l1485t3640r1756b3694],
9	endothelial	JJ	O	endothelial	amod	10	SENT_250	[p21l1791t3640r2147b3694],
10	cells	NNS	O	cell	prep_by	6	SENT_250	[p21l228t3728r387b3782],
11	.	.	O	.	_	0	SENT_250	[p21l228t3728r387b3782],

1	Nature	NNP	O	Nature	_	0	SENT_251	[p21l413t3729r626b3782],
2	1988	CD	DATE	1988	num	1	SENT_251	[p21l657t3728r824b3792],
3	;	:	O	;	_	0	SENT_251	[p21l657t3728r824b3792],
4	332	CD	NUMBER	332	num	6	SENT_251	[p21l852t3728r983b3783],
5	:	:	O	:	_	0	SENT_251	[p21l852t3728r983b3783],
6	411-5	CD	NUMBER	411-5	dep	1	SENT_251	[p21l1011t3728r1190b3783],

1	2	LS	NUMBER	2	_	0	SENT_252	[p22l80t20r132b75],
2	.	.	O	.	_	0	SENT_252	[p22l80t20r132b75],

1	Ray	NNP	MISC	Ray	nn	2	SENT_253	[p22l165t21r290b91],
2	A	NNP	MISC	A	_	0	SENT_253	[p22l315t20r387b85],
3	,	,	O	,	_	0	SENT_253	[p22l315t20r387b85],
4	Hegde	NNP	ORGANIZATION	Hegde	nn	5	SENT_253	[p22l414t19r618b91],
5	LG	NNP	ORGANIZATION	LG	appos	2	SENT_253	[p22l641t20r761b85],
6	,	,	O	,	_	0	SENT_253	[p22l641t20r761b85],
7	Chugh	NNP	PERSON	Chugh	nn	8	SENT_253	[p22l789t19r997b91],
8	A	NNP	O	A	appos	2	SENT_253	[p22l1021t20r1093b85],
9	,	,	O	,	_	0	SENT_253	[p22l1021t20r1093b85],
10	et	FW	O	et	nn	11	SENT_253	[p22l1120t28r1175b75],
11	al.	FW	O	al.	appos	2	SENT_253	[p22l1199t19r1269b75],
12	.	.	O	.	_	0	SENT_253	[p22l1199t19r1269b75],

1	Endothelin	JJ	O	endothelin	amod	4	SENT_254	[p22l1296t19r1929b91],
2	—	NN	O	—	nn	4	SENT_254	[p22l1296t19r1929b91],
3	receptor	NN	O	receptor	nn	4	SENT_254	[p22l1296t19r1929b91],
4	antagonists	NNS	O	antagonist	_	0	SENT_254	[p22l1953t28r2145b91, p22l229t108r427b164],
5	:	:	O	:	_	0	SENT_254	[p22l1953t28r2145b91, p22l229t108r427b164],
6	current	JJ	DATE	current	amod	9	SENT_254	[p22l463t117r685b164],
7	and	CC	O	and	_	0	SENT_254	[p22l715t108r826b164],
8	future	JJ	DATE	future	amod	9	SENT_254	[p22l854t108r1041b164],
9	perspectives	NNS	O	perspective	dep	4	SENT_254	[p22l1069t108r1475b180],
10	.	.	O	.	_	0	SENT_254	[p22l1069t108r1475b180],

1	Drug	NN	O	drug	nn	3	SENT_255	[p22l1507t110r1667b180],
2	Discov	NNP	O	Discov	nn	3	SENT_255	[p22l1697t108r1918b164],
3	Today	NNP	DATE	Today	_	0	SENT_255	[p22l1947t108r2146b180],
4	2000	CD	DATE	2000	num	3	SENT_255	[p22l229t196r403b260],
5	;	:	O	;	_	0	SENT_255	[p22l229t196r403b260],
6	5	CD	NUMBER	5	num	8	SENT_255	[p22l429t195r482b250],
7	:	:	O	:	_	0	SENT_255	[p22l429t195r482b250],
8	455-64	CD	NUMBER	455-64	dep	3	SENT_255	[p22l510t195r732b250],

1	3	LS	NUMBER	3	_	0	SENT_256	[p22l81t284r132b339],
2	.	.	O	.	_	0	SENT_256	[p22l81t284r132b339],

1	Wu	NNP	MISC	Wu	nn	2	SENT_257	[p22l164t285r276b339],
2	C.	NNP	MISC	C.	_	0	SENT_257	[p22l299t284r364b339],
3	Recent	JJ	MISC	recent	amod	4	SENT_257	[p22l390t285r608b338],
4	discovery	NN	O	discovery	dep	2	SENT_257	[p22l629t284r933b354],
5	and	CC	O	and	_	0	SENT_257	[p22l957t284r1068b338],
6	development	NN	O	development	dep	2	SENT_257	[p22l1089t284r1495b354],
7	of	IN	O	of	_	0	SENT_257	[p22l1516t284r1584b338],
8	endothelin	NN	O	endothelin	nn	9	SENT_257	[p22l1600t284r1931b338],
9	receptor	NN	O	receptor	prep_of	4	SENT_257	[p22l1951t301r2144b354, p22l228t380r315b426],

1	antagonists	NNS	O	antagonist	_	0	SENT_258	[p22l338t372r706b442],
2	.	.	O	.	_	0	SENT_258	[p22l338t372r706b442],

1	Exp	NNP	O	Exp	nn	4	SENT_259	[p22l732t373r857b442],
2	Opin	NNP	O	Opin	nn	4	SENT_259	[p22l881t372r1036b442],
3	Ther	NNP	O	Ther	nn	4	SENT_259	[p22l1059t372r1207b426],
4	Patents	NNP	O	Patents	_	0	SENT_259	[p22l1228t373r1452b426],
5	2000	CD	DATE	2000	num	4	SENT_259	[p22l1478t372r1652b436],
6	;	:	O	;	_	0	SENT_259	[p22l1478t372r1652b436],
7	10	CD	NUMBER	10	num	9	SENT_259	[p22l1685t372r1771b427],
8	:	:	O	:	_	0	SENT_259	[p22l1685t372r1771b427],
9	1653-68	CD	NUMBER	1653-68	dep	4	SENT_259	[p22l1806t372r2058b427],

1	4	LS	NUMBER	4	_	0	SENT_260	[p22l79t462r132b517],
2	.	.	O	.	_	0	SENT_260	[p22l79t462r132b517],

1	Giannessi	NN	PERSON	giannessus	nn	2	SENT_261	[p22l166t461r480b517],
2	D	NN	PERSON	d	_	0	SENT_261	[p22l500t463r573b527],
3	,	,	O	,	_	0	SENT_261	[p22l500t463r573b527],
4	Del	NNP	PERSON	Del	nn	6	SENT_261	[p22l595t461r708b517],
5	Ry	NNP	PERSON	Ry	nn	6	SENT_261	[p22l728t463r819b533],
6	S	NN	PERSON	s	appos	2	SENT_261	[p22l841t462r898b527],
7	,	,	O	,	_	0	SENT_261	[p22l841t462r898b527],
8	Vitale	NNP	PERSON	Vitale	nn	9	SENT_261	[p22l921t461r1115b517],
9	RL	NNP	O	RL	appos	6	SENT_261	[p22l1135t463r1251b517],
10	.	.	O	.	_	0	SENT_261	[p22l1135t463r1251b517],

1	The	DT	O	the	det	2	SENT_262	[p22l1275t461r1397b517],
2	role	NN	O	role	_	0	SENT_262	[p22l1416t461r1540b517],
3	of	IN	O	of	_	0	SENT_262	[p22l1561t461r1629b517],
4	endothelins	NNS	O	endothelin	prep_of	2	SENT_262	[p22l1645t461r2011b517],
5	and	CC	O	and	_	0	SENT_262	[p22l2035t461r2147b517],
6	their	PRP$	O	they	poss	7	SENT_262	[p22l228t550r379b606],
7	receptors	NNS	O	receptor	conj_and	4	SENT_262	[p22l415t559r711b622],
8	in	IN	O	in	_	0	SENT_262	[p22l748t550r809b605],
9	heart	NN	O	heart	nn	10	SENT_262	[p22l844t550r1004b606],
10	failure	NN	O	failure	prep_in	2	SENT_262	[p22l1038t550r1262b606],
11	.	.	O	.	_	0	SENT_262	[p22l1038t550r1262b606],

1	Pharmacol	NNP	O	Pharmacol	nn	2	SENT_263	[p22l1301t550r1643b606],
2	Res	NNP	O	Res	_	0	SENT_263	[p22l1678t552r1794b606],
3	2001	CD	DATE	2001	num	2	SENT_263	[p22l1831t551r2007b616],
4	;	:	O	;	_	0	SENT_263	[p22l1831t551r2007b616],
5	43	CD	NUMBER	43	num	7	SENT_263	[p22l2046t551r2141b606],
6	:	:	O	:	_	0	SENT_263	[p22l2046t551r2141b606],
7	11-126	CD	NUMBER	11-126	dep	2	SENT_263	[p22l236t638r452b693],

1	5	CD	NUMBER	5	_	0	SENT_264	[p22l80t726r132b781],
2	.	.	O	.	_	0	SENT_264	[p22l80t726r132b781],

1	Liischer	JJ	PERSON	liischer	amod	3	SENT_265	[p22l165t726r419b780],
2	T	NN	PERSON	t	nn	3	SENT_265	[p22l452t727r498b780],
3	F	NN	PERSON	f	_	0	SENT_265	[p22l500t727r559b790],
4	,	,	O	,	_	0	SENT_265	[p22l500t727r559b790],
5	Barton	NNP	PERSON	Barton	nn	7	SENT_265	[p22l596t727r810b780],
6	M.	NNP	PERSON	M.	nn	7	SENT_265	[p22l844t727r928b780],
7	Endothelins	NNP	PERSON	Endothelins	conj_and	3	SENT_265	[p22l966t726r1340b780],
8	and	CC	O	and	_	0	SENT_265	[p22l1379t726r1490b780],
9	endothelin	NN	O	endothelin	nn	11	SENT_265	[p22l1524t726r1855b780],
10	receptor	NN	O	receptor	nn	11	SENT_265	[p22l1889t734r2148b796],
11	antagonists	NNS	O	antagonist	conj_and	3	SENT_265	[p22l229t814r599b884],
12	:	:	O	:	_	0	SENT_265	[p22l229t814r599b884],
13	therapeutic	JJ	O	therapeutic	amod	14	SENT_265	[p22l636t814r985b884],
14	considerations	NNS	O	consideration	dep	3	SENT_265	[p22l1019t814r1472b868],
15	for	IN	O	for	_	0	SENT_265	[p22l1506t814r1598b868],
16	a	DT	O	a	det	18	SENT_265	[p22l1630t831r1663b868],
17	novel	JJ	O	novel	amod	18	SENT_265	[p22l1694t814r1867b869],
18	class	NN	O	class	prep_for	14	SENT_265	[p22l1900t814r2050b868],
19	of	IN	O	of	_	0	SENT_265	[p22l2085t814r2153b868],
20	cardiovascular	JJ	O	cardiovascular	amod	21	SENT_265	[p22l228t902r689b957],
21	drugs	NNS	O	drug	prep_of	18	SENT_265	[p22l711t902r899b972],
22	.	.	O	.	_	0	SENT_265	[p22l711t902r899b972],

1	Circulation	NN	O	circulation	_	0	SENT_266	[p22l927t902r1280b957],
2	2000	CD	DATE	2000	num	1	SENT_266	[p22l1304t902r1477b966],
3	;	:	O	;	_	0	SENT_266	[p22l1304t902r1477b966],
4	102	CD	NUMBER	102	num	6	SENT_266	[p22l1511t902r1636b957],
5	:	:	O	:	_	0	SENT_266	[p22l1511t902r1636b957],
6	2434-40	CD	NUMBER	2434-40	dep	1	SENT_266	[p22l1665t902r1925b957],

1	6	CD	NUMBER	6	_	0	SENT_267	[p22l81t991r132b1047],
2	.	.	O	.	_	0	SENT_267	[p22l81t991r132b1047],

1	Chakrabarti	NNP	PERSON	Chakrabarti	nn	2	SENT_268	[p22l166t991r536b1047],
2	S	NNP	O	S	_	0	SENT_268	[p22l569t992r625b1057],
3	,	,	O	,	_	0	SENT_268	[p22l569t992r625b1057],
4	Cukiernik	NNP	O	Cukiernik	nn	5	SENT_268	[p22l659t991r975b1047],
5	M	NNP	O	M	appos	2	SENT_268	[p22l1003t993r1088b1057],
6	,	,	O	,	_	0	SENT_268	[p22l1003t993r1088b1057],
7	Mukherjee	NNP	PERSON	Mukherjee	nn	8	SENT_268	[p22l1120t991r1461b1063],
8	S	NNP	O	S	appos	2	SENT_268	[p22l1493t992r1550b1057],
9	,	,	O	,	_	0	SENT_268	[p22l1493t992r1550b1057],
10	et	FW	O	et	nn	11	SENT_268	[p22l1583t1000r1638b1047],
11	al.	FW	O	al.	appos	2	SENT_268	[p22l1668t992r1737b1047],
12	.	.	O	.	_	0	SENT_268	[p22l1668t992r1737b1047],

1	Therapeutic	JJ	O	therapeutic	amod	2	SENT_269	[p22l1771t991r2146b1063],
2	potential	NN	O	potential	_	0	SENT_269	[p22l227t1080r502b1152],
3	of	IN	O	of	_	0	SENT_269	[p22l531t1080r599b1136],
4	endothelin	NN	O	endothelin	nn	6	SENT_269	[p22l622t1080r953b1136],
5	receptor	NN	O	receptor	nn	6	SENT_269	[p22l980t1089r1240b1152],
6	antagonists	NNS	O	antagonist	prep_of	2	SENT_269	[p22l1267t1080r1617b1152],
7	in	IN	O	in	_	0	SENT_269	[p22l1645t1080r1705b1135],
8	diabetes	NN	O	diabetes	prep_in	2	SENT_269	[p22l1733t1080r2005b1136],
9	.	.	O	.	_	0	SENT_269	[p22l1733t1080r2005b1136],

1	EXpert	NN	O	expert	_	0	SENT_270	[p22l2035t1082r2145b1135, p22l227t1176r350b1238],
2	Opin	NNP	O	Opin	nn	4	SENT_270	[p22l373t1168r527b1238],
3	Investig	NNP	O	Investig	nn	4	SENT_270	[p22l550t1168r801b1238],
4	Drugs	NNPS	O	Drugs	dep	1	SENT_270	[p22l825t1169r1014b1238],
5	2000	CD	DATE	2000	dep	4	SENT_270	[p22l1040t1168r1213b1232],
6	;	:	O	;	_	0	SENT_270	[p22l1040t1168r1213b1232],
7	9	CD	NUMBER	9	num	9	SENT_270	[p22l1240t1168r1293b1223],
8	:	:	O	:	_	0	SENT_270	[p22l1240t1168r1293b1223],
9	2873-88	CD	NUMBER	2873-88	dep	4	SENT_270	[p22l1322t1168r1579b1223],

1	7	CD	NUMBER	7	_	0	SENT_271	[p22l80t1257r132b1310],
2	.	.	O	.	_	0	SENT_271	[p22l80t1257r132b1310],

1	Clozel	NNP	O	Clozel	nn	2	SENT_272	[p22l166t1256r369b1311],
2	M	NNP	O	M	_	0	SENT_272	[p22l401t1257r487b1320],
3	,	,	O	,	_	0	SENT_272	[p22l401t1257r487b1320],
4	Breu	NNP	PERSON	Breu	nn	5	SENT_272	[p22l522t1257r673b1310],
5	V	NNP	PERSON	V	appos	2	SENT_272	[p22l705t1257r776b1320],
6	,	,	O	,	_	0	SENT_272	[p22l705t1257r776b1320],
7	Gray	NNP	PERSON	Gray	nn	8	SENT_272	[p22l812t1256r966b1326],
8	GA	NNP	O	GA	appos	2	SENT_272	[p22l1001t1256r1128b1320],
9	,	,	O	,	_	0	SENT_272	[p22l1001t1256r1128b1320],
10	et	FW	O	et	nn	11	SENT_272	[p22l1163t1264r1219b1310],
11	al.	FW	O	al.	appos	2	SENT_272	[p22l1251t1256r1320b1310],
12	.	.	O	.	_	0	SENT_272	[p22l1251t1256r1320b1310],

1	Pharmacological	JJ	O	pharmacological	amod	2	SENT_273	[p22l1355t1256r1884b1326],
2	characterization	NN	O	characterization	_	0	SENT_273	[p22l1917t1256r2145b1310, p22l228t1344r525b1398],
3	of	IN	O	of	_	0	SENT_273	[p22l549t1344r617b1398],
4	bosentan	NN	O	bosentan	prep_of	2	SENT_273	[p22l634t1344r931b1408],
5	,	,	O	,	_	0	SENT_273	[p22l634t1344r931b1408],
6	a	DT	O	a	det	12	SENT_273	[p22l958t1361r991b1398],
7	new	JJ	O	new	amod	12	SENT_273	[p22l1013t1361r1141b1399],
8	potent	JJ	O	potent	amod	12	SENT_273	[p22l1164t1352r1362b1414],
9	orally	RB	O	orally	advmod	10	SENT_273	[p22l1384t1344r1565b1414],
10	active	JJ	O	active	amod	12	SENT_273	[p22l1590t1344r1775b1399],
11	nonpeptide	JJ	O	nonpeptide	amod	12	SENT_273	[p22l1798t1344r2147b1414],
12	endothelin	NN	O	endothelin	appos	2	SENT_273	[p22l228t1433r560b1489],
13	receptor	NN	O	receptor	nn	14	SENT_273	[p22l584t1442r844b1505],
14	antagonist	NN	O	antagonist	dep	12	SENT_273	[p22l869t1433r1206b1505],
15	.	.	O	.	_	0	SENT_273	[p22l869t1433r1206b1505],

1	J	NNP	O	J	nn	4	SENT_274	[p22l1234t1435r1263b1489],
2	Pharmacol	NNP	O	Pharmacol	nn	4	SENT_274	[p22l1287t1433r1623b1489],
3	Exp	NNP	O	Exp	nn	4	SENT_274	[p22l1648t1435r1772b1505],
4	Ther	NNP	O	Ther	_	0	SENT_274	[p22l1797t1433r1946b1489],
5	1994	CD	DATE	1994	num	4	SENT_274	[p22l1977t1434r2143b1499],
6	;	:	O	;	_	0	SENT_274	[p22l1977t1434r2143b1499],
7	270	CD	NUMBER	270	num	9	SENT_274	[p22l229t1522r361b1576],
8	:	:	O	:	_	0	SENT_274	[p22l229t1522r361b1576],
9	228-35	CD	NUMBER	228-35	dep	4	SENT_274	[p22l390t1521r608b1576],

1	8	CD	NUMBER	8	_	0	SENT_275	[p22l82t1610r132b1664],
2	.	.	O	.	_	0	SENT_275	[p22l82t1610r132b1664],

1	Weber	NNP	PERSON	Weber	nn	2	SENT_276	[p22l164t1609r375b1664],
2	C	NNP	O	C	_	0	SENT_276	[p22l395t1610r462b1674],
3	,	,	O	,	_	0	SENT_276	[p22l395t1610r462b1674],
4	Schmitt	NNP	PERSON	Schmitt	nn	5	SENT_276	[p22l487t1609r731b1664],
5	R	NNP	PERSON	R	appos	2	SENT_276	[p22l750t1611r817b1674],
6	,	,	O	,	_	0	SENT_276	[p22l750t1611r817b1674],
7	Birnboeck	NNP	O	Birnboeck	nn	8	SENT_276	[p22l841t1609r1170b1664],
8	H	NNP	O	H	appos	2	SENT_276	[p22l1189t1611r1261b1674],
9	,	,	O	,	_	0	SENT_276	[p22l1189t1611r1261b1674],
10	et	FW	O	et	nn	11	SENT_276	[p22l1285t1618r1340b1664],
11	al.	FW	O	al.	appos	2	SENT_276	[p22l1361t1609r1430b1664],
12	.	.	O	.	_	0	SENT_276	[p22l1361t1609r1430b1664],

1	Pharmacokinetics	NNS	O	pharmacokinetic	_	0	SENT_277	[p22l1454t1609r2013b1664],
2	and	CC	O	and	_	0	SENT_277	[p22l2036t1609r2147b1664],
3	pharmacodynamics	NNS	O	pharmacodynamic	conj_and	1	SENT_277	[p22l227t1697r853b1767],
4	of	IN	O	of	_	0	SENT_277	[p22l898t1697r967b1751],
5	the	DT	O	the	det	8	SENT_277	[p22l1004t1697r1099b1751],
6	endothelin-receptor	JJ	O	endothelin-receptor	amod	8	SENT_277	[p22l1143t1697r1775b1767],
7	antagonist	NN	O	antagonist	nn	8	SENT_277	[p22l1817t1697r2147b1767],
8	bosentan	NN	O	bosentan	prep_of	1	SENT_277	[p22l227t1785r512b1839],
9	in	IN	O	in	_	0	SENT_277	[p22l546t1785r606b1839],
10	healthy	JJ	O	healthy	amod	12	SENT_277	[p22l640t1785r874b1855],
11	human	JJ	O	human	amod	12	SENT_277	[p22l909t1785r1122b1839],
12	subjects	NNS	O	subject	prep_in	1	SENT_277	[p22l1159t1785r1424b1855],
13	.	.	O	.	_	0	SENT_277	[p22l1159t1785r1424b1855],

1	Clin	NNP	O	Clin	nn	3	SENT_278	[p22l1463t1785r1596b1840],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_278	[p22l1630t1785r1966b1839],
3	Ther	NNP	O	Ther	_	0	SENT_278	[p22l2001t1785r2149b1839],
4	1996	CD	DATE	1996	num	3	SENT_278	[p22l236t1873r403b1938],
5	;	:	O	;	_	0	SENT_278	[p22l236t1873r403b1938],
6	60	CD	NUMBER	60	num	8	SENT_278	[p22l430t1873r522b1928],
7	:	:	O	:	_	0	SENT_278	[p22l430t1873r522b1928],
8	124-37	CD	NUMBER	124-37	dep	3	SENT_278	[p22l557t1874r770b1928],

1	9	CD	NUMBER	9	_	0	SENT_279	[p22l80t1963r132b2019],
2	.	.	O	.	_	0	SENT_279	[p22l80t1963r132b2019],

1	Roux	NNP	PERSON	Roux	nn	2	SENT_280	[p22l165t1964r334b2018],
2	S	NNP	O	S	_	0	SENT_280	[p22l367t1963r424b2028],
3	,	,	O	,	_	0	SENT_280	[p22l367t1963r424b2028],
4	Breu	NNP	PERSON	Breu	nn	5	SENT_280	[p22l458t1964r610b2018],
5	V	NNP	PERSON	V	appos	2	SENT_280	[p22l641t1964r713b2028],
6	,	,	O	,	_	0	SENT_280	[p22l641t1964r713b2028],
7	Ertel	NNP	ORGANIZATION	Ertel	nn	8	SENT_280	[p22l747t1962r898b2018],
8	SI	NNP	ORGANIZATION	SI	appos	2	SENT_280	[p22l932t1963r1015b2028],
9	,	,	O	,	_	0	SENT_280	[p22l932t1963r1015b2028],
10	et	FW	O	et	nn	11	SENT_280	[p22l1049t1971r1104b2018],
11	al.	FW	O	al.	appos	2	SENT_280	[p22l1135t1962r1204b2018],
12	.	.	O	.	_	0	SENT_280	[p22l1135t1962r1204b2018],

1	Endothelin	JJ	O	endothelin	amod	2	SENT_281	[p22l1238t1962r1585b2018],
2	antagonism	NN	O	antagonism	_	0	SENT_281	[p22l1616t1962r1979b2034],
3	with	IN	O	with	_	0	SENT_281	[p22l2008t1962r2147b2018],
4	bosentan	NN	O	bosentan	prep_with	2	SENT_281	[p22l227t2051r524b2107],
5	:	:	O	:	_	0	SENT_281	[p22l227t2051r524b2107],
6	a	DT	O	a	det	7	SENT_281	[p22l548t2069r580b2107],
7	review	NN	O	review	dep	2	SENT_281	[p22l596t2051r809b2107],
8	of	IN	O	of	_	0	SENT_281	[p22l828t2051r896b2107],
9	potential	JJ	O	potential	amod	10	SENT_281	[p22l908t2051r1183b2123],
10	applications	NNS	O	application	prep_of	7	SENT_281	[p22l1203t2051r1597b2123],
11	.	.	O	.	_	0	SENT_281	[p22l1203t2051r1597b2123],

1	J	NN	O	j	nn	3	SENT_282	[p22l1617t2053r1646b2107],
2	Mol	NNP	O	Mol	nn	3	SENT_282	[p22l1663t2051r1792b2107],
3	Med	NNP	O	Med	_	0	SENT_282	[p22l1809t2051r1952b2107],
4	1999	CD	DATE	1999	num	3	SENT_282	[p22l1976t2052r2143b2117],
5	;	:	O	;	_	0	SENT_282	[p22l1976t2052r2143b2117],
6	77	CD	NUMBER	77	num	8	SENT_282	[p22l228t2140r321b2193],
7	:	:	O	:	_	0	SENT_282	[p22l228t2140r321b2193],
8	364-76	CD	NUMBER	364-76	dep	3	SENT_282	[p22l351t2139r570b2194],

1	10	CD	NUMBER	10	_	0	SENT_283	[p22l47t2227r132b2282],
2	.	.	O	.	_	0	SENT_283	[p22l47t2227r132b2282],

1	Channick	NNP	PERSON	Channick	nn	2	SENT_284	[p22l166t2227r468b2282],
2	RN	NNP	O	RN	_	0	SENT_284	[p22l485t2228r609b2291],
3	,	,	O	,	_	0	SENT_284	[p22l485t2228r609b2291],
4	Simonneau	NNP	PERSON	Simonneau	nn	5	SENT_284	[p22l633t2227r984b2282],
5	G	NNP	PERSON	G	appos	2	SENT_284	[p22l1004t2227r1075b2291],
6	,	,	O	,	_	0	SENT_284	[p22l1004t2227r1075b2291],
7	Sitbon	NNP	PERSON	Sitbon	nn	8	SENT_284	[p22l1099t2227r1301b2282],
8	O	NNP	O	O	appos	2	SENT_284	[p22l1321t2227r1391b2291],
9	,	,	O	,	_	0	SENT_284	[p22l1321t2227r1391b2291],
10	et	FW	O	et	nn	11	SENT_284	[p22l1413t2235r1468b2281],
11	al.	FW	O	al.	appos	2	SENT_284	[p22l1487t2227r1556b2281],
12	.	.	O	.	_	0	SENT_284	[p22l1487t2227r1556b2281],

1	Effects	NNS	O	effect	_	0	SENT_285	[p22l1578t2227r1798b2281],
2	of	IN	O	of	_	0	SENT_285	[p22l1819t2227r1887b2281],
3	the	DT	O	the	det	7	SENT_285	[p22l1900t2227r1994b2281],
4	dual	JJ	O	dual	amod	7	SENT_285	[p22l2013t2227r2147b2281],
5	endothelin-receptor	JJ	O	endothelin-receptor	amod	7	SENT_285	[p22l228t2315r846b2385],
6	antagonist	NN	O	antagonist	nn	7	SENT_285	[p22l869t2315r1192b2385],
7	bosentan	NN	O	bosentan	prep_of	1	SENT_285	[p22l1212t2315r1492b2369],
8	in	IN	O	in	_	0	SENT_285	[p22l1514t2315r1573b2369],
9	patients	NNS	O	patient	prep_in	7	SENT_285	[p22l1594t2315r1838b2385],
10	with	IN	O	with	_	0	SENT_285	[p22l1862t2315r2000b2370],
11	pulmonary	JJ	O	pulmonary	amod	12	SENT_285	[p22l2021t2315r2145b2385, p22l228t2422r471b2476],
12	hypertension	NN	O	hypertension	prep_with	9	SENT_285	[p22l528t2404r961b2476],
13	:	:	O	:	_	0	SENT_285	[p22l528t2404r961b2476],
14	a	DT	O	a	det	17	SENT_285	[p22l1025t2422r1058b2460],
15	randomised	JJ	O	randomised	amod	17	SENT_285	[p22l1111t2404r1487b2460],
16	placebo	NN	O	placebo	nn	17	SENT_285	[p22l1542t2404r2147b2476],
17	—	NN	O	—	dep	1	SENT_285	[p22l1542t2404r2147b2476],
18	controlled	JJ	O	controlled	amod	19	SENT_285	[p22l1542t2404r2147b2476],
19	study	NN	O	study	dep	17	SENT_285	[p22l230t2493r413b2565],
20	.	.	O	.	_	0	SENT_285	[p22l230t2493r413b2565],

1	Lancet	NNP	O	Lancet	_	0	SENT_286	[p22l439t2495r654b2549],
2	2001	CD	DATE	2001	num	1	SENT_286	[p22l676t2494r850b2559],
3	;	:	O	;	_	0	SENT_286	[p22l676t2494r850b2559],
4	358	CD	NUMBER	358	num	6	SENT_286	[p22l878t2493r1009b2549],
5	:	:	O	:	_	0	SENT_286	[p22l878t2493r1009b2549],
6	1119-23	CD	NUMBER	1119-23	dep	1	SENT_286	[p22l1045t2494r1294b2550],

1	11	CD	NUMBER	11	_	0	SENT_287	[p22l47t2581r132b2635],
2	.	.	O	.	_	0	SENT_287	[p22l47t2581r132b2635],

1	Kiowski	NNP	PERSON	Kiowski	nn	2	SENT_288	[p22l166t2581r438b2635],
2	W	NNP	PERSON	W	_	0	SENT_288	[p22l470t2582r561b2645],
3	,	,	O	,	_	0	SENT_288	[p22l470t2582r561b2645],
4	Suetsch	NNP	O	Suetsch	nn	5	SENT_288	[p22l597t2581r847b2636],
5	G	NNP	O	G	appos	2	SENT_288	[p22l879t2581r951b2645],
6	,	,	O	,	_	0	SENT_288	[p22l879t2581r951b2645],
7	Hunziker	NNP	PERSON	Hunziker	nn	8	SENT_288	[p22l986t2581r1288b2635],
8	P	NN	O	p	appos	2	SENT_288	[p22l1318t2582r1378b2645],
9	,	,	O	,	_	0	SENT_288	[p22l1318t2582r1378b2645],
10	et	FW	O	et	nn	11	SENT_288	[p22l1413t2589r1470b2635],
11	al.	FW	O	al.	appos	2	SENT_288	[p22l1501t2581r1573b2635],
12	.	.	O	.	_	0	SENT_288	[p22l1501t2581r1573b2635],

1	Evidence	NN	O	evidence	nsubj	4	SENT_289	[p22l1608t2581r1908b2635],
2	of	IN	O	of	_	0	SENT_289	[p22l1942t2581r2011b2635],
3	endothelin-1	NN	O	endothelin-1	prep_of	1	SENT_289	[p22l2041t2598r2145b2635, p22l229t2669r544b2723],
4	mediated	VBD	O	mediate	_	0	SENT_289	[p22l575t2669r863b2723],
5	vasoconstriction	NN	O	vasoconstriction	dobj	4	SENT_289	[p22l887t2669r1403b2723],
6	in	IN	O	in	_	0	SENT_289	[p22l1427t2669r1486b2723],
7	severe	JJ	O	severe	amod	10	SENT_289	[p22l1512t2686r1709b2724],
8	chronic	JJ	O	chronic	amod	10	SENT_289	[p22l1733t2669r1966b2723],
9	heart	NN	O	heart	nn	10	SENT_289	[p22l1990t2669r2148b2723],
10	failure	NN	O	failure	prep_in	4	SENT_289	[p22l228t2757r448b2811],
11	.	.	O	.	_	0	SENT_289	[p22l228t2757r448b2811],

1	Lancet	NNP	O	Lancet	_	0	SENT_290	[p22l475t2758r689b2811],
2	1995	CD	DATE	1995	num	1	SENT_290	[p22l718t2757r885b2821],
3	;	:	O	;	_	0	SENT_290	[p22l718t2757r885b2821],
4	346	CD	NUMBER	346	num	6	SENT_290	[p22l913t2757r1044b2812],
5	:	:	O	:	_	0	SENT_290	[p22l913t2757r1044b2812],
6	732-6	CD	NUMBER	732-6	dep	1	SENT_290	[p22l1073t2757r1253b2812],

1	©	NNP	O	©	nn	4	SENT_291	[p22l10t3015r54b3059],
2	Adis	NNP	O	Adis	nn	4	SENT_291	[p22l74t3010r198b3058],
3	Internoitioncil	NNP	O	Internoitioncil	nn	4	SENT_291	[p22l220t3010r594b3058],
4	Limited	NNP	O	Limited	_	0	SENT_291	[p22l619t3010r843b3058],
5	.	.	O	.	_	0	SENT_291	[p22l619t3010r843b3058],

1	All	DT	O	all	det	2	SENT_292	[p22l865t3010r933b3058],
2	rights	NNS	O	rights	nsubj	3	SENT_292	[p22l957t3010r1109b3071],
3	reserved	VBN	O	reserve	_	0	SENT_292	[p22l1131t3010r1400b3058],
4	.	.	O	.	_	0	SENT_292	[p22l1131t3010r1400b3058],

1	12	CD	NUMBER	12	_	0	SENT_293	[p22l12t3098r99b3154],
2	.	.	O	.	_	0	SENT_293	[p22l12t3098r99b3154],

1	Suetsch	NNP	O	Suetsch	nn	2	SENT_294	[p22l135t3097r382b3154],
2	G	NNP	O	G	_	0	SENT_294	[p22l403t3098r474b3164],
3	,	,	O	,	_	0	SENT_294	[p22l403t3098r474b3164],
4	Kiowski	NNP	PERSON	Kiowski	nn	5	SENT_294	[p22l498t3097r767b3154],
5	W	NNP	PERSON	W	appos	2	SENT_294	[p22l787t3099r878b3164],
6	,	,	O	,	_	0	SENT_294	[p22l787t3099r878b3164],
7	Yan	NNP	PERSON	Yan	nn	8	SENT_294	[p22l901t3099r1033b3154],
8	X-W	NNP	O	X-W	appos	2	SENT_294	[p22l1050t3099r1227b3164],
9	,	,	O	,	_	0	SENT_294	[p22l1050t3099r1227b3164],
10	et	FW	O	et	nn	11	SENT_294	[p22l1250t3106r1306b3154],
11	al.	FW	O	al.	appos	2	SENT_294	[p22l1326t3097r1396b3154],
12	.	.	O	.	_	0	SENT_294	[p22l1326t3097r1396b3154],

1	Short-term	JJ	O	short-term	amod	4	SENT_295	[p22l1422t3097r1768b3154],
2	endothelinreceptor	NN	O	endothelinreceptor	nn	4	SENT_295	[p22l1787t3097r2149b3154, p22l195t3200r460b3264],
3	antagonist	NN	O	antagonist	nn	4	SENT_295	[p22l481t3191r809b3264],
4	therapy	NN	O	therapy	nsubj	7	SENT_295	[p22l828t3191r1067b3264],
5	in	IN	O	in	prep	4	SENT_295	[p22l1088t3191r1149b3246],
6	conventionally	RB	O	conventionally	pcomp	5	SENT_295	[p22l1170t3191r1646b3264],
7	treated	VBN	O	treat	_	0	SENT_295	[p22l1666t3191r1884b3247],
8	patients	NNS	O	patient	dobj	7	SENT_295	[p22l1902t3191r2150b3264],
9	with	IN	O	with	_	0	SENT_295	[p22l197t3285r338b3342],
10	symptomatic	JJ	O	symptomatic	amod	14	SENT_295	[p22l376t3285r786b3358],
11	severe	JJ	O	severe	amod	14	SENT_295	[p22l825t3303r1025b3342],
12	chronic	JJ	O	chronic	amod	14	SENT_295	[p22l1062t3285r1299b3341],
13	heart	NN	O	heart	nn	14	SENT_295	[p22l1335t3285r1495b3341],
14	failure	NN	O	failure	prep_with	7	SENT_295	[p22l1529t3285r1753b3342],
15	.	.	O	.	_	0	SENT_295	[p22l1529t3285r1753b3342],

1	Circulation	NN	O	circulation	_	0	SENT_296	[p22l1793t3285r2153b3342],
2	1998	CD	DATE	1998	num	1	SENT_296	[p22l204t3380r375b3446],
3	;	:	O	;	_	0	SENT_296	[p22l204t3380r375b3446],
4	98	CD	NUMBER	98	num	6	SENT_296	[p22l402t3380r496b3437],
5	:	:	O	:	_	0	SENT_296	[p22l402t3380r496b3437],
6	2262-8	CD	NUMBER	2262-8	dep	1	SENT_296	[p22l526t3379r747b3436],

1	13	CD	NUMBER	13	_	0	SENT_297	[p22l12t3474r99b3530],
2	.	.	O	.	_	0	SENT_297	[p22l12t3474r99b3530],

1	Weber	NNP	PERSON	Weber	nn	2	SENT_298	[p22l131t3473r347b3530],
2	C	NNP	O	C	_	0	SENT_298	[p22l375t3474r442b3540],
3	,	,	O	,	_	0	SENT_298	[p22l375t3474r442b3540],
4	Schmitt	NNP	PERSON	Schmitt	nn	5	SENT_298	[p22l476t3473r723b3530],
5	R	NNP	PERSON	R	appos	2	SENT_298	[p22l751t3475r820b3540],
6	,	,	O	,	_	0	SENT_298	[p22l751t3475r820b3540],
7	Bimboeck	NNP	O	Bimboeck	nn	8	SENT_298	[p22l851t3473r1187b3529],
8	H	NNP	O	H	appos	2	SENT_298	[p22l1213t3475r1286b3540],
9	,	,	O	,	_	0	SENT_298	[p22l1213t3475r1286b3540],
10	et	FW	O	et	nn	11	SENT_298	[p22l1318t3482r1374b3529],
11	al.	FW	O	al.	appos	2	SENT_298	[p22l1403t3473r1473b3530],
12	.	.	O	.	_	0	SENT_298	[p22l1403t3473r1473b3530],

1	Multiple-dose	JJ	O	multiple-dose	amod	2	SENT_299	[p22l1505t3473r1955b3546],
2	pharmacokinetics	NNS	O	pharmacokinetic	_	0	SENT_299	[p22l1983t3473r2149b3546, p22l197t3567r637b3634],
3	,	,	O	,	_	0	SENT_299	[p22l1983t3473r2149b3546, p22l197t3567r637b3634],
4	safety	NN	O	safety	conj_and	2	SENT_299	[p22l673t3567r878b3640],
5	,	,	O	,	_	0	SENT_299	[p22l673t3567r878b3640],
6	and	CC	O	and	_	0	SENT_299	[p22l913t3567r1026b3623],
7	tolerability	NN	O	tolerability	conj_and	2	SENT_299	[p22l1056t3567r1407b3640],
8	of	IN	O	of	_	0	SENT_299	[p22l1439t3567r1508b3623],
9	bosentan	NN	O	bosentan	prep_of	7	SENT_299	[p22l1532t3567r1834b3634],
10	,	,	O	,	_	0	SENT_299	[p22l1532t3567r1834b3634],
11	an	DT	O	a	det	14	SENT_299	[p22l1869t3585r1941b3623],
12	endothelin	NN	O	endothelin	nn	14	SENT_299	[p22l1971t3567r2150b3623, p22l197t3661r379b3717],
13	receptor	NN	O	receptor	nn	14	SENT_299	[p22l401t3670r666b3734],
14	antagonist	NN	O	antagonist	conj_and	2	SENT_299	[p22l690t3661r1035b3734],
15	,	,	O	,	_	0	SENT_299	[p22l690t3661r1035b3734],
16	in	IN	O	in	conj_and	2	SENT_299	[p22l1062t3661r1123b3716],
17	healthy	JJ	O	healthy	amod	19	SENT_299	[p22l1146t3661r1381b3734],
18	male	JJ	O	male	amod	19	SENT_299	[p22l1405t3661r1559b3718],
19	volunteers	NNS	O	volunteer	pobj	16	SENT_299	[p22l1584t3661r1934b3718],
20	.	.	O	.	_	0	SENT_299	[p22l1584t3661r1934b3718],

1	J	NNP	O	J	nn	2	SENT_300	[p22l1962t3663r1991b3718],
2	Clin	NNP	O	Clin	_	0	SENT_300	[p22l2016t3661r2152b3718],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_301	[p23l197t17r539b74],
2	1999	CD	DATE	1999	num	1	SENT_301	[p23l570t18r740b84],
3	;	:	O	;	_	0	SENT_301	[p23l570t18r740b84],
4	39	CD	NUMBER	39	num	6	SENT_301	[p23l769t18r861b75],
5	:	:	O	:	_	0	SENT_301	[p23l769t18r861b75],
6	703-14	CD	NUMBER	703-14	dep	1	SENT_301	[p23l890t18r1116b74],

1	Weber	NNP	PERSON	Weber	nn	2	SENT_302	[p23l131t111r347b168],
2	C	NNP	O	C	_	0	SENT_302	[p23l367t112r435b178],
3	,	,	O	,	_	0	SENT_302	[p23l367t112r435b178],
4	Gasser	NNP	PERSON	Gasser	nn	5	SENT_302	[p23l460t112r677b168],
5	R	NNP	PERSON	R	conj_and	2	SENT_302	[p23l696t113r765b178],
6	,	,	O	,	_	0	SENT_302	[p23l696t113r765b178],
7	Hopfgartner	NNP	PERSON	Hopfgartner	nn	9	SENT_302	[p23l788t111r1182b184],
8	G.	NNP	PERSON	G.	nn	9	SENT_302	[p23l1202t112r1273b168],
9	Absorption	NNP	PERSON	Absorption	conj_and	2	SENT_302	[p23l1297t111r1676b184],
10	,	,	O	,	_	0	SENT_302	[p23l1297t111r1676b184],
11	excretion	NN	O	excretion	conj_and	2	SENT_302	[p23l1700t111r2015b178],
12	,	,	O	,	_	0	SENT_302	[p23l1700t111r2015b178],
13	and	CC	O	and	_	0	SENT_302	[p23l2039t111r2153b167],
14	metabolism	NN	O	metabolism	conj_and	2	SENT_302	[p23l197t205r572b262],
15	of	IN	O	of	_	0	SENT_302	[p23l592t205r662b261],
16	the	DT	O	the	det	18	SENT_302	[p23l677t205r773b261],
17	endothelin	NN	O	endothelin	nn	18	SENT_302	[p23l796t205r1133b261],
18	receptor	NN	O	receptor	prep_of	14	SENT_302	[p23l1153t214r1417b278],
19	antagonist	NN	O	antagonist	nn	20	SENT_302	[p23l1438t205r1767b278],
20	bosentan	NN	O	bosentan	dep	2	SENT_302	[p23l1785t205r2071b262],
21	in	IN	O	in	_	0	SENT_302	[p23l2091t205r2152b260],
22	healthy	JJ	O	healthy	amod	24	SENT_302	[p23l196t299r431b372],
23	male	JJ	O	male	amod	24	SENT_302	[p23l455t299r609b356],
24	subjects	NNS	O	subject	prep_in	20	SENT_302	[p23l635t299r906b372],
25	.	.	O	.	_	0	SENT_302	[p23l635t299r906b372],

1	Drug	NN	O	drug	nn	3	SENT_303	[p23l933t301r1096b372],
2	Metab	NNP	O	Metab	nn	3	SENT_303	[p23l1118t299r1322b356],
3	Dispos	NNP	O	Dispos	_	0	SENT_303	[p23l1346t299r1566b372],
4	1999	CD	DATE	1999	num	3	SENT_303	[p23l1598t300r1769b366],
5	;	:	O	;	_	0	SENT_303	[p23l1598t300r1769b366],
6	27	CD	NUMBER	27	num	8	SENT_303	[p23l1796t300r1890b355],
7	:	:	O	:	_	0	SENT_303	[p23l1796t300r1890b355],
8	810-5	CD	NUMBER	810-5	dep	3	SENT_303	[p23l1921t299r2101b356],

1	Smith	NNP	PERSON	Smith	nn	2	SENT_304	[p23l135t393r323b450],
2	DA	NNP	O	DA	_	0	SENT_304	[p23l350t393r480b449],
3	.	.	O	.	_	0	SENT_304	[p23l350t393r480b449],

1	Induction	NN	O	induction	_	0	SENT_305	[p23l512t393r819b449],
2	and	CC	O	and	_	0	SENT_305	[p23l847t393r960b449],
3	drug	NN	O	drug	conj_and	1	SENT_305	[p23l987t393r1130b465],
4	development	NN	O	development	dep	1	SENT_305	[p23l1159t393r1589b465],
5	.	.	O	.	_	0	SENT_305	[p23l1159t393r1589b465],

1	Eur	NNP	O	Eur	nn	4	SENT_306	[p23l1619t394r1735b449],
2	J	NNP	O	J	nn	4	SENT_306	[p23l1760t394r1789b449],
3	Pharm	NNP	O	Pharm	nn	4	SENT_306	[p23l1816t393r2025b449],
4	Sci	NNP	O	Sci	_	0	SENT_306	[p23l2053t393r2151b449],

1	Weber	NNP	PERSON	Weber	nn	2	SENT_307	[p23l131t581r352b638],
2	C	NNP	O	C	_	0	SENT_307	[p23l387t582r456b648],
3	,	,	O	,	_	0	SENT_307	[p23l387t582r456b648],
4	Banken	NNP	PERSON	Banken	nn	5	SENT_307	[p23l495t581r746b638],
5	L	NNP	PERSON	L	appos	2	SENT_307	[p23l780t583r846b648],
6	,	,	O	,	_	0	SENT_307	[p23l780t583r846b648],
7	Birnboeck	NNP	O	Birnboeck	nn	8	SENT_307	[p23l885t581r1231b638],
8	H	NNP	O	H	appos	2	SENT_307	[p23l1265t583r1339b648],
9	,	,	O	,	_	0	SENT_307	[p23l1265t583r1339b648],
10	et	FW	O	et	nn	11	SENT_307	[p23l1378t590r1436b638],
11	al.	FW	O	al.	appos	2	SENT_307	[p23l1473t581r1546b638],
12	.	.	O	.	_	0	SENT_307	[p23l1473t581r1546b638],

1	Effect	NN	O	effect	_	0	SENT_308	[p23l1585t581r1784b638],
2	of	IN	O	of	_	0	SENT_308	[p23l1819t581r1889b638],
3	the	DT	O	the	det	6	SENT_308	[p23l1919t581r2016b638],
4	endothelin-receptor	JJ	O	endothelin-receptor	amod	6	SENT_308	[p23l2052t599r2151b638, p23l198t675r751b747],
5	antagonist	NN	O	antagonist	nn	6	SENT_308	[p23l774t675r1102b747],
6	bosentan	NN	O	bosentan	prep_of	1	SENT_308	[p23l1122t675r1408b731],
7	on	IN	O	on	_	0	SENT_308	[p23l1431t693r1509b731],
8	the	DT	O	the	det	9	SENT_308	[p23l1532t675r1627b731],
9	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	1	SENT_308	[p23l1648t675r2150b747, p23l197t769r283b825],
10	and	CC	O	and	_	0	SENT_308	[p23l322t769r436b825],
11	pharmacodynamics	NNS	O	pharmacodynamic	prep_on	1	SENT_308	[p23l469t769r1102b842],
12	of	IN	O	of	_	0	SENT_308	[p23l1139t769r1209b825],
13	warfarin	NN	O	warfarin	prep_of	9	SENT_308	[p23l1239t769r1530b826],
14	.	.	O	.	_	0	SENT_308	[p23l1239t769r1530b826],

1	J	NNP	O	J	nn	3	SENT_309	[p23l1569t771r1598b826],
2	Clin	NNP	O	Clin	nn	3	SENT_309	[p23l1634t769r1772b826],
3	Pharmacol	NNP	O	Pharmacol	_	0	SENT_309	[p23l1806t769r2152b826],
4	1999	CD	DATE	1999	num	3	SENT_309	[p23l204t862r375b927],
5	;	:	O	;	_	0	SENT_309	[p23l204t862r375b927],
6	39	CD	NUMBER	39	num	8	SENT_309	[p23l403t862r496b918],
7	:	:	O	:	_	0	SENT_309	[p23l403t862r496b918],
8	847-54	CD	NUMBER	847-54	dep	3	SENT_309	[p23l528t862r750b918],

1	Lennemas	NN	O	lennema	nn	2	SENT_310	[p23l132t958r465b1013],
2	H	NN	O	h	_	0	SENT_310	[p23l485t958r558b1023],
3	,	,	O	,	_	0	SENT_310	[p23l485t958r558b1023],
4	F	NN	O	f	nn	7	SENT_310	[p23l577t958r621b1011],
5	ager	NN	O	ager	nn	7	SENT_310	[p23l624t974r761b1029],
6	G.	NNP	PERSON	G.	nn	7	SENT_310	[p23l779t957r849b1013],
7	Pharmacodynamics	NNP	PERSON	Pharmacodynamics	conj_and	2	SENT_310	[p23l870t956r1498b1029],
8	and	CC	O	and	_	0	SENT_310	[p23l1519t956r1632b1013],
9	pharmacokinetics	NNS	O	pharmacokinetic	conj_and	2	SENT_310	[p23l1647t956r2150b1029, p23l197t1050r282b1106],
10	of	IN	O	of	_	0	SENT_310	[p23l319t1050r389b1106],
11	the	DT	O	the	det	14	SENT_310	[p23l418t1050r513b1106],
12	HMG-CoA	NN	O	hmg-coa	nn	14	SENT_310	[p23l549t1051r913b1106],
13	reductase	NN	O	reductase	nn	14	SENT_310	[p23l946t1050r1249b1106],
14	inhibitors	NNS	O	inhibitor	prep_of	9	SENT_310	[p23l1284t1050r1608b1106],
15	:	:	O	:	_	0	SENT_310	[p23l1284t1050r1608b1106],
16	similarities	NNS	O	similarity	dep	2	SENT_310	[p23l1650t1050r2002b1106],
17	and	CC	O	and	_	0	SENT_310	[p23l2040t1051r2153b1106],
18	differences	NNS	O	difference	conj_and	16	SENT_310	[p23l198t1143r569b1200],
19	.	.	O	.	_	0	SENT_310	[p23l198t1143r569b1200],

1	Clin	NNP	O	Clin	nn	2	SENT_311	[p23l597t1143r733b1200],
2	Pharmacokinet	NNP	O	Pharmacokinet	_	0	SENT_311	[p23l756t1143r1238b1200],
3	1997	CD	DATE	1997	num	2	SENT_311	[p23l1268t1144r1438b1210],
4	;	:	O	;	_	0	SENT_311	[p23l1268t1144r1438b1210],
5	32	CD	NUMBER	32	num	7	SENT_311	[p23l1467t1144r1560b1200],
6	:	:	O	:	_	0	SENT_311	[p23l1467t1144r1560b1200],
7	403-25	CD	NUMBER	403-25	dep	2	SENT_311	[p23l1588t1143r1810b1200],

1	Prueksaritanont	JJ	O	prueksaritanont	amod	2	SENT_312	[p23l133t1237r638b1294],
2	T	NN	O	t	_	0	SENT_312	[p23l671t1239r735b1304],
3	,	,	O	,	_	0	SENT_312	[p23l671t1239r735b1304],
4	Gorham	NNP	ORGANIZATION	Gorham	nn	5	SENT_312	[p23l773t1237r1034b1294],
5	LM	NNP	ORGANIZATION	LM	appos	2	SENT_312	[p23l1067t1239r1203b1304],
6	,	,	O	,	_	0	SENT_312	[p23l1067t1239r1203b1304],
7	Bennett	NNP	PERSON	Bennett	nn	8	SENT_312	[p23l1240t1239r1490b1294],
8	MA	NNP	PERSON	MA	appos	2	SENT_312	[p23l1522t1238r1667b1304],
9	,	,	O	,	_	0	SENT_312	[p23l1522t1238r1667b1304],
10	et	FW	O	et	nn	11	SENT_312	[p23l1704t1246r1760b1294],
11	al.	FW	O	al.	appos	2	SENT_312	[p23l1795t1237r1865b1294],
12	.	.	O	.	_	0	SENT_312	[p23l1795t1237r1865b1294],

1	In	FW	O	in	nn	3	SENT_313	[p23l1903t1239r1969b1293],
2	vitro	FW	O	vitro	nn	3	SENT_313	[p23l2002t1237r2151b1294],
3	metabolism	NN	O	metabolism	_	0	SENT_313	[p23l197t1331r572b1387],
4	of	IN	O	of	_	0	SENT_313	[p23l592t1331r662b1387],
5	simvastatin	NN	O	simvastatin	prep_of	3	SENT_313	[p23l680t1331r1042b1387],
6	in	IN	O	in	_	0	SENT_313	[p23l1063t1331r1124b1386],
7	humans	NNS	O	human	prep_in	5	SENT_313	[p23l1144t1331r1409b1387],
8	:	:	O	:	_	0	SENT_313	[p23l1144t1331r1409b1387],
9	identification	NN	O	identification	dep	3	SENT_313	[p23l1436t1331r1865b1387],
10	of	IN	O	of	_	0	SENT_313	[p23l1887t1331r1956b1387],
11	metabolizing	VBG	O	metabolize	amod	12	SENT_313	[p23l1971t1340r2150b1387, p23l195t1424r458b1497],
12	enzymes	NNS	O	enzyme	prep_of	9	SENT_313	[p23l492t1442r769b1497],
13	and	CC	O	and	_	0	SENT_313	[p23l804t1424r917b1481],
14	effect	NN	O	effect	conj_and	12	SENT_313	[p23l949t1424r1131b1481],
15	of	IN	O	of	_	0	SENT_313	[p23l1163t1424r1232b1480],
16	the	DT	O	the	det	17	SENT_313	[p23l1258t1424r1354b1480],
17	drug	NN	O	drug	prep_of	14	SENT_313	[p23l1387t1424r1531b1497],
18	on	IN	O	on	_	0	SENT_313	[p23l1565t1442r1642b1480],
19	hepatic	JJ	O	hepatic	amod	20	SENT_313	[p23l1674t1424r1903b1497],
20	P450s	NNS	O	p450	prep_on	17	SENT_313	[p23l1936t1424r2147b1481],
21	.	.	O	.	_	0	SENT_313	[p23l1936t1424r2147b1481],

1	Drug	NN	O	drug	nn	3	SENT_314	[p23l196t1520r359b1591],
2	Metab	NNP	O	Metab	nn	3	SENT_314	[p23l382t1518r585b1575],
3	Dispos	NNP	O	Dispos	_	0	SENT_314	[p23l609t1518r829b1591],
4	1997	CD	DATE	1997	num	3	SENT_314	[p23l861t1519r1032b1585],
5	;	:	O	;	_	0	SENT_314	[p23l861t1519r1032b1585],
6	25	CD	NUMBER	25	num	8	SENT_314	[p23l1059t1518r1153b1575],
7	:	:	O	:	_	0	SENT_314	[p23l1059t1518r1153b1575],
8	1191-9	CD	NUMBER	1191-9	dep	3	SENT_314	[p23l1190t1519r1406b1576],

1	Mauro	NNP	PERSON	Mauro	nn	2	SENT_315	[p23l133t1614r346b1669],
2	VF	NNP	O	VF	_	0	SENT_315	[p23l381t1614r499b1669],
3	.	.	O	.	_	0	SENT_315	[p23l381t1614r499b1669],

1	Clinical	JJ	O	clinical	amod	2	SENT_316	[p23l540t1612r794b1669],
2	pharmacokinetics	NNS	O	pharmacokinetic	_	0	SENT_316	[p23l828t1612r1396b1685],
3	and	CC	O	and	_	0	SENT_316	[p23l1435t1612r1548b1669],
4	practical	JJ	O	practical	amod	5	SENT_316	[p23l1581t1612r1859b1685],
5	applications	NNS	O	application	conj_and	2	SENT_316	[p23l1895t1612r2149b1685, p23l196t1706r349b1763],
6	of	IN	O	of	_	0	SENT_316	[p23l375t1706r444b1763],
7	simvastatin	NN	O	simvastatin	prep_of	5	SENT_316	[p23l465t1706r843b1763],
8	.	.	O	.	_	0	SENT_316	[p23l465t1706r843b1763],

1	Clin	NNP	O	Clin	nn	2	SENT_317	[p23l871t1706r1007b1763],
2	Pharmacokinet	NNP	O	Pharmacokinet	_	0	SENT_317	[p23l1030t1706r1512b1763],
3	1993	CD	DATE	1993	num	5	SENT_317	[p23l1542t1707r1712b1773],
4	;	:	O	;	_	0	SENT_317	[p23l1542t1707r1712b1773],
5	24	CD	NUMBER	24	dep	2	SENT_317	[p23l1739t1707r1834b1763],
6	:	:	O	:	_	0	SENT_317	[p23l1739t1707r1834b1763],
7	195-202	CD	NUMBER	195-202	num	9	SENT_317	[p23l1870t1706r2128b1764],
8	Tucker	NNP	ORGANIZATION	Tucker	nn	9	SENT_317	[p23l133t1800r361b1856],
9	GT	NN	ORGANIZATION	gt	dep	2	SENT_317	[p23l387t1801r508b1867],
10	,	,	O	,	_	0	SENT_317	[p23l387t1801r508b1867],
11	Houston	NNP	LOCATION	Houston	nn	12	SENT_317	[p23l538t1802r810b1857],
12	JB	NNP	O	JB	appos	9	SENT_317	[p23l835t1802r936b1867],
13	,	,	O	,	_	0	SENT_317	[p23l835t1802r936b1867],
14	Huang	NNP	PERSON	Huang	nn	15	SENT_317	[p23l966t1802r1178b1873],
15	S-M	NNP	O	S-M	appos	9	SENT_317	[p23l1207t1801r1362b1857],
16	.	.	O	.	_	0	SENT_317	[p23l1207t1801r1362b1857],

1	Optimising	VBG	O	optimise	dep	5	SENT_318	[p23l1395t1800r1753b1873],
2	drug	NN	O	drug	nn	3	SENT_318	[p23l1782t1800r1925b1873],
3	development	NN	O	development	dobj	1	SENT_318	[p23l1954t1800r2150b1857, p23l198t1902r453b1966],
4	:	:	O	:	_	0	SENT_318	[p23l1954t1800r2150b1857, p23l198t1902r453b1966],
5	strategies	NNS	O	strategy	_	0	SENT_318	[p23l488t1894r786b1966],
6	to	TO	O	to	aux	7	SENT_318	[p23l815t1903r874b1950],
7	assess	VB	O	assess	infmod	5	SENT_318	[p23l902t1912r1093b1950],
8	drug	NN	O	drug	nn	11	SENT_318	[p23l1122t1894r1266b1966],
9	metabolism/transporter	NN	O	metabolism/transporter	nn	11	SENT_318	[p23l1293t1894r2040b1966],
10	interaction	NN	O	interaction	nn	11	SENT_318	[p23l2065t1894r2150b1949, p23l197t1988r477b2045],
11	potential	NN	O	potential	dep	7	SENT_318	[p23l492t1988r790b2061],
12	:	:	O	:	_	0	SENT_318	[p23l492t1988r790b2061],
13	towards	IN	O	towards	dep	11	SENT_318	[p23l812t1988r1064b2045],
14	a	DT	O	a	det	15	SENT_318	[p23l1083t2006r1116b2045],
15	consensus	NN	O	consensus	pobj	13	SENT_318	[p23l1131t2006r1471b2045],
16	.	.	O	.	_	0	SENT_318	[p23l1131t2006r1471b2045],

1	Clin	NNP	O	Clin	nn	3	SENT_319	[p23l1492t1988r1628b2045],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_319	[p23l1643t1988r1986b2045],
3	Ther	NNP	O	Ther	_	0	SENT_319	[p23l2002t1988r2153b2045],
4	2001	CD	DATE	2001	num	3	SENT_319	[p23l198t2083r375b2148],
5	;	:	O	;	_	0	SENT_319	[p23l198t2083r375b2148],
6	70	CD	NUMBER	70	num	8	SENT_319	[p23l401t2083r496b2138],
7	:	:	O	:	_	0	SENT_319	[p23l401t2083r496b2138],
8	103-14	CD	NUMBER	103-14	dep	3	SENT_319	[p23l532t2083r750b2138],

1	Lausecker	NN	O	lausecker	nn	2	SENT_320	[p23l133t2174r463b2229],
2	B	NN	O	b	_	0	SENT_320	[p23l490t2175r558b2239],
3	,	,	O	,	_	0	SENT_320	[p23l490t2175r558b2239],
4	Hess	NNP	PERSON	Hess	nn	5	SENT_320	[p23l588t2175r740b2229],
5	B	NNP	O	B	appos	2	SENT_320	[p23l769t2175r837b2239],
6	,	,	O	,	_	0	SENT_320	[p23l769t2175r837b2239],
7	Fischer	NNP	PERSON	Fischer	nn	8	SENT_320	[p23l866t2174r1103b2229],
8	G	NNP	O	G	appos	2	SENT_320	[p23l1130t2174r1202b2239],
9	,	,	O	,	_	0	SENT_320	[p23l1130t2174r1202b2239],
10	et	FW	O	et	nn	11	SENT_320	[p23l1232t2183r1289b2229],
11	al.	FW	O	al.	appos	2	SENT_320	[p23l1316t2174r1386b2229],
12	.	.	O	.	_	0	SENT_320	[p23l1316t2174r1386b2229],

1	Simultaneous	JJ	O	simultaneous	amod	2	SENT_321	[p23l1420t2174r1852b2230],
2	determination	NN	O	determination	nsubj	18	SENT_321	[p23l1882t2174r2150b2229, p23l197t2268r396b2325],
3	of	IN	O	of	_	0	SENT_321	[p23l421t2268r490b2324],
4	bosentan	NN	O	bosentan	prep_of	2	SENT_321	[p23l506t2268r792b2325],
5	and	CC	O	and	_	0	SENT_321	[p23l817t2268r930b2324],
6	its	PRP$	O	its	poss	9	SENT_321	[p23l953t2268r1025b2325],
7	three	CD	NUMBER	three	num	9	SENT_321	[p23l1051t2268r1209b2324],
8	major	JJ	O	major	amod	9	SENT_321	[p23l1232t2268r1420b2341],
9	metabolites	NNS	O	metabolite	nsubj	18	SENT_321	[p23l1441t2268r1809b2324],
10	in	IN	O	in	_	0	SENT_321	[p23l1833t2268r1894b2323],
11	various	JJ	O	various	amod	13	SENT_321	[p23l1917t2268r2150b2325],
12	biological	JJ	O	biological	amod	13	SENT_321	[p23l195t2362r516b2434],
13	matrices	NNS	O	matrix	prep_in	9	SENT_321	[p23l533t2362r801b2418],
14	and	CC	O	and	_	0	SENT_321	[p23l821t2362r934b2418],
15	species	NNS	O	species	conj_and	13	SENT_321	[p23l952t2362r1178b2434],
16	using	VBG	O	use	partmod	13	SENT_321	[p23l1195t2362r1367b2434],
17	narrow	JJ	O	narrow	acomp	16	SENT_321	[p23l1384t2380r1609b2418],
18	bore	VBD	O	bear	_	0	SENT_321	[p23l1624t2362r1765b2418],
19	liquid	JJ	O	liquid	amod	20	SENT_321	[p23l1783t2362r1969b2434],
20	chromatography	NN	O	chromatography	dobj	18	SENT_321	[p23l1985t2362r2149b2418, p23l197t2456r578b2529],
21	with	IN	O	with	_	0	SENT_321	[p23l599t2456r740b2513],
22	ion	NN	O	ion	nn	23	SENT_321	[p23l759t2456r860b2512],
23	spray	NN	O	spray	prep_with	18	SENT_321	[p23l881t2474r1050b2529],
24	tandem	JJ	O	tandem	amod	27	SENT_321	[p23l1070t2456r1306b2513],
25	mass	NN	O	mass	nn	27	SENT_321	[p23l1323t2474r1481b2513],
26	spectrometric	JJ	O	spectrometric	amod	27	SENT_321	[p23l1504t2456r1937b2529],
27	detection	NN	O	detection	dep	23	SENT_321	[p23l1958t2456r2150b2513, p23l197t2550r336b2606],
28	.	.	O	.	_	0	SENT_321	[p23l1958t2456r2150b2513, p23l197t2550r336b2606],

1	J	NN	O	j	nn	3	SENT_322	[p23l363t2551r392b2606],
2	Chromatogr	NN	O	chromatogr	nn	3	SENT_322	[p23l416t2550r804b2622],
3	B	NN	O	b	_	0	SENT_322	[p23l825t2551r872b2605],
4	Biomed	NNP	O	Biomed	nn	6	SENT_322	[p23l900t2550r1153b2606],
5	Sci	NNP	O	Sci	nn	6	SENT_322	[p23l1177t2550r1276b2606],
6	Appl	NNP	O	Appl	dep	3	SENT_322	[p23l1299t2550r1458b2622],
7	2000	CD	DATE	2000	num	6	SENT_322	[p23l1482t2550r1659b2616],
8	;	:	O	;	_	0	SENT_322	[p23l1482t2550r1659b2616],
9	749	CD	NUMBER	749	dep	3	SENT_322	[p23l1686t2550r1820b2607],
10	:	:	O	:	_	0	SENT_322	[p23l1686t2550r1820b2607],
11	67-83	CD	NUMBER	67-83	dep	9	SENT_322	[p23l1851t2550r2031b2606],

1	Gibaldi	NNP	MISC	Gibaldi	nn	2	SENT_323	[p23l134t2644r372b2701],
2	M	NNP	O	M	_	0	SENT_323	[p23l405t2646r491b2711],
3	,	,	O	,	_	0	SENT_323	[p23l405t2646r491b2711],
4	Perrier	NNP	ORGANIZATION	Perrier	nn	6	SENT_323	[p23l527t2644r746b2701],
5	D.	NNP	ORGANIZATION	D.	nn	6	SENT_323	[p23l776t2646r848b2701],
6	Pharmacokinetics	NNP	ORGANIZATION	Pharmacokinetics	appos	2	SENT_323	[p23l884t2644r1472b2701],
7	.	.	O	.	_	0	SENT_323	[p23l884t2644r1472b2701],

1	2nd	JJ	ORDINAL	2nd	nsubj	2	SENT_324	[p23l1509t2644r1627b2701],
2	ed	VBN	O	ed	_	0	SENT_324	[p23l1660t2644r1749b2701],
3	.	.	O	.	_	0	SENT_324	[p23l1660t2644r1749b2701],

1	New	NNP	LOCATION	New	nn	2	SENT_325	[p23l1784t2646r1934b2701],
2	York	NNP	LOCATION	York	_	0	SENT_325	[p23l1967t2644r2147b2701],
3	:	:	O	:	_	0	SENT_325	[p23l1967t2644r2147b2701],

1	Marcel	NNP	PERSON	Marcel	nn	3	SENT_326	[p23l196t2738r422b2795],
2	Dekker	NNP	PERSON	Dekker	nn	3	SENT_326	[p23l446t2738r682b2795],
3	Inc	NNP	PERSON	Inc	_	0	SENT_326	[p23l704t2740r822b2805],
4	,	,	O	,	_	0	SENT_326	[p23l704t2740r822b2805],
5	1982	CD	DATE	1982	appos	3	SENT_326	[p23l856t2739r1006b2796],

1	Pichard	NN	PERSON	pichard	nn	2	SENT_327	[p23l132t2832r377b2889],
2	L	NN	PERSON	l	_	0	SENT_327	[p23l398t2834r462b2899],
3	,	,	O	,	_	0	SENT_327	[p23l398t2834r462b2899],
4	Fabre	NN	PERSON	fabre	nn	5	SENT_327	[p23l486t2832r668b2889],
5	I	NN	O	i	appos	2	SENT_327	[p23l690t2834r732b2899],
6	,	,	O	,	_	0	SENT_327	[p23l690t2834r732b2899],
7	Dauj	NN	PERSON	dauj	appos	2	SENT_327	[p23l756t2832r905b2905],
8	at	IN	O	at	_	0	SENT_327	[p23l915t2841r970b2889],
9	M	NN	O	m	prep_at	7	SENT_327	[p23l990t2834r1077b2899],
10	,	,	O	,	_	0	SENT_327	[p23l990t2834r1077b2899],
11	et	FW	O	et	nn	12	SENT_327	[p23l1103t2841r1159b2888],
12	al.	FW	O	al.	appos	2	SENT_327	[p23l1181t2832r1252b2889],
13	.	.	O	.	_	0	SENT_327	[p23l1181t2832r1252b2889],

1	Effect	NN	O	effect	_	0	SENT_328	[p23l1277t2832r1473b2889],
2	of	IN	O	of	_	0	SENT_328	[p23l1495t2832r1564b2888],
3	corticosteroids	NNS	O	corticosteroid	prep_of	1	SENT_328	[p23l1581t2832r2051b2889],
4	on	IN	O	on	_	0	SENT_328	[p23l2075t2850r2152b2888],
5	the	DT	O	the	det	6	SENT_328	[p23l197t2926r293b2983],
6	expression	NN	O	expression	prep_on	3	SENT_328	[p23l326t2926r668b2999],
7	of	IN	O	of	_	0	SENT_328	[p23l701t2926r771b2982],
8	cytochromes	NNS	O	cytochrome	nn	9	SENT_328	[p23l798t2926r1205b2999],
9	P450	NN	O	p450	prep_of	6	SENT_328	[p23l1239t2926r1402b2983],
10	and	CC	O	and	_	0	SENT_328	[p23l1436t2926r1549b2983],
11	on	IN	O	on	_	0	SENT_328	[p23l1581t2944r1658b2982],
12	cyclosporin	NN	O	cyclosporin	nn	15	SENT_328	[p23l1691t2926r2064b2999],
13	A	NN	O	a	nn	15	SENT_328	[p23l2095t2927r2152b2981],
14	oxidase	NN	O	oxidase	nn	15	SENT_328	[p23l198t3020r440b3077],
15	activity	NN	O	activity	prep_on	3	SENT_328	[p23l475t3020r712b3093],
16	in	IN	O	in	_	0	SENT_328	[p23l746t3020r806b3075],
17	primary	JJ	O	primary	amod	18	SENT_328	[p23l837t3020r1090b3093],
18	cultures	NNS	O	culture	prep_in	15	SENT_328	[p23l1123t3020r1373b3077],
19	of	IN	O	of	_	0	SENT_328	[p23l1409t3020r1477b3076],
20	human	JJ	O	human	amod	21	SENT_328	[p23l1504t3020r1722b3077],
21	hepatocytes	NNS	O	hepatocyte	prep_of	1	SENT_328	[p23l1752t3020r2147b3093],
22	.	.	O	.	_	0	SENT_328	[p23l1752t3020r2147b3093],

1	MolPharmaco1	NN	O	molpharmaco1	_	0	SENT_329	[p23l197t3113r693b3168],
2	1992	CD	DATE	1992	num	1	SENT_329	[p23l724t3113r895b3178],
3	;	:	O	;	_	0	SENT_329	[p23l724t3113r895b3178],
4	41	CD	NUMBER	41	num	6	SENT_329	[p23l921t3113r1016b3168],
5	:	:	O	:	_	0	SENT_329	[p23l921t3113r1016b3168],
6	1047-55	CD	NUMBER	1047-55	dep	1	SENT_329	[p23l1052t3113r1308b3169],

1	Van	NNP	PERSON	Van	nn	3	SENT_330	[p23l133t3209r265b3264],
2	Giersbergen	NNP	PERSON	Giersbergen	nn	3	SENT_330	[p23l288t3207r679b3280],
3	PLM	NNP	ORGANIZATION	PLM	_	0	SENT_330	[p23l701t3209r882b3274],
4	,	,	O	,	_	0	SENT_330	[p23l701t3209r882b3274],
5	T	NN	O	t	nn	7	SENT_330	[p23l906t3209r953b3262],
6	reiber	NN	O	reiber	nn	7	SENT_330	[p23l955t3207r1143b3263],
7	A	NN	O	a	appos	3	SENT_330	[p23l1164t3208r1237b3274],
8	,	,	O	,	_	0	SENT_330	[p23l1164t3208r1237b3274],
9	Clozel	NN	O	clozel	nn	10	SENT_330	[p23l1263t3207r1471b3264],
10	M	NN	O	m	appos	3	SENT_330	[p23l1492t3209r1578b3274],
11	,	,	O	,	_	0	SENT_330	[p23l1492t3209r1578b3274],
12	et	FW	O	et	nn	13	SENT_330	[p23l1604t3216r1660b3263],
13	al.	FW	O	al.	appos	3	SENT_330	[p23l1683t3207r1753b3264],
14	.	.	O	.	_	0	SENT_330	[p23l1683t3207r1753b3264],

1	In	FW	O	in	nn	2	SENT_331	[p23l1779t3209r1844b3262],
2	vitro	FW	O	vitro	dep	6	SENT_331	[p23l1866t3207r2015b3264],
3	and	CC	O	and	_	0	SENT_331	[p23l2039t3207r2152b3263],
4	in	FW	O	in	conj_and	2	SENT_331	[p23l197t3301r257b3356],
5	vivo	FW	O	vivo	pobj	4	SENT_331	[p23l279t3301r418b3358],
6	studies	NNS	O	study	_	0	SENT_331	[p23l444t3301r661b3357],
7	exploring	VBG	O	explore	partmod	6	SENT_331	[p23l686t3301r991b3374],
8	the	DT	O	the	det	10	SENT_331	[p23l1013t3301r1109b3357],
9	pharrnacokinetic	JJ	O	pharrnacokinetic	amod	10	SENT_331	[p23l1130t3301r1664b3374],
10	interaction	NN	O	interaction	dobj	7	SENT_331	[p23l1687t3301r2030b3358],
11	between	IN	O	between	_	0	SENT_331	[p23l2050t3301r2150b3357, p23l197t3404r387b3451],
12	bosentan	NN	O	bosentan	prep_between	10	SENT_331	[p23l418t3395r721b3462],
13	,	,	O	,	_	0	SENT_331	[p23l418t3395r721b3462],
14	a	DT	O	a	det	18	SENT_331	[p23l758t3413r791b3451],
15	dual	JJ	O	dual	amod	18	SENT_331	[p23l824t3395r959b3451],
16	endothelin	NN	O	endothelin	nn	18	SENT_331	[p23l992t3395r1330b3451],
17	receptor	NN	O	receptor	nn	18	SENT_331	[p23l1362t3404r1626b3468],
18	antagonist	NN	O	antagonist	conj_and	12	SENT_331	[p23l1658t3395r2003b3468],
19	,	,	O	,	_	0	SENT_331	[p23l1658t3395r2003b3468],
20	and	CC	O	and	_	0	SENT_331	[p23l2039t3395r2153b3451],
21	glyburide	NN	O	glyburide	prep_between	10	SENT_331	[p23l198t3489r520b3562],
22	.	.	O	.	_	0	SENT_331	[p23l198t3489r520b3562],

1	Clin	NNP	O	Clin	nn	3	SENT_332	[p23l547t3489r683b3546],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_332	[p23l706t3489r1048b3546],
3	Ther	NNP	O	Ther	_	0	SENT_332	[p23l1072t3489r1223b3545],
4	2002	CD	DATE	2002	num	3	SENT_332	[p23l1245t3490r1422b3556],
5	;	:	O	;	_	0	SENT_332	[p23l1245t3490r1422b3556],
6	71	CD	NUMBER	71	num	8	SENT_332	[p23l1449t3490r1544b3545],
7	:	:	O	:	_	0	SENT_332	[p23l1449t3490r1544b3545],
8	253-62	CD	NUMBER	253-62	dep	3	SENT_332	[p23l1573t3489r1797b3546],

1	Dingemanse	JJ	O	dingemanse	amod	2	SENT_333	[p23l133t3583r533b3656],
2	J	NN	O	j	_	0	SENT_333	[p23l552t3585r581b3640],
3	,	,	O	,	_	0	SENT_333	[p23l587t3630r599b3650],
4	Bodin	NNP	PERSON	Bodin	nn	5	SENT_333	[p23l621t3583r816b3639],
5	F	NN	O	f	appos	2	SENT_333	[p23l834t3585r895b3650],
6	,	,	O	,	_	0	SENT_333	[p23l834t3585r895b3650],
7	Weidekamm	NNP	O	Weidekamm	nn	8	SENT_333	[p23l916t3583r1327b3640],
8	E	NNP	O	E	appos	2	SENT_333	[p23l1345t3585r1409b3650],
9	,	,	O	,	_	0	SENT_333	[p23l1345t3585r1409b3650],
10	et	FW	O	et	nn	11	SENT_333	[p23l1432t3592r1489b3639],
11	al.	FW	O	al.	appos	2	SENT_333	[p23l1508t3583r1578b3640],
12	.	.	O	.	_	0	SENT_333	[p23l1508t3583r1578b3640],

1	Inﬂuence	NN	O	inﬂuence	_	0	SENT_334	[p23l1602t3583r1904b3639],
2	of	IN	O	of	_	0	SENT_334	[p23l1924t3583r1993b3639],
3	food	NN	O	food	nn	4	SENT_334	[p23l2007t3583r2153b3639],
4	intake	NN	O	intake	prep_of	1	SENT_334	[p23l197t3677r391b3733],
5	and	CC	O	and	_	0	SENT_334	[p23l415t3677r527b3733],
6	formulation	NN	O	formulation	prep_of	1	SENT_334	[p23l549t3677r928b3733],
7	on	IN	O	on	_	0	SENT_334	[p23l950t3695r1028b3733],
8	the	DT	O	the	det	9	SENT_334	[p23l1049t3677r1144b3733],
9	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	1	SENT_334	[p23l1166t3677r1731b3750],
10	and	CC	O	and	_	0	SENT_334	[p23l1756t3677r1869b3734],
11	metabolism	NN	O	metabolism	prep_on	1	SENT_334	[p23l1890t3677r2150b3734, p24l197t17r334b73],

1	of	IN	O	of	_	0	SENT_335	[p24l353t17r422b73],
2	bosentan	NN	O	bosentan	pobj	1	SENT_335	[p24l434t17r736b83],
3	,	,	O	,	_	0	SENT_335	[p24l434t17r736b83],
4	a	DT	O	a	det	8	SENT_335	[p24l760t35r792b73],
5	dual	JJ	O	dual	amod	8	SENT_335	[p24l811t17r946b73],
6	endothelin	NN	O	endothelin	nn	8	SENT_335	[p24l965t17r1303b73],
7	receptor	NN	O	receptor	nn	8	SENT_335	[p24l1321t26r1585b89],
8	antagonist	NN	O	antagonist	appos	2	SENT_335	[p24l1603t17r1947b89],
9	.	.	O	.	_	0	SENT_335	[p24l1603t17r1947b89],

1	J	NNP	O	J	nn	3	SENT_336	[p24l1968t18r1997b73],
2	Clin	NNP	O	Clin	nn	3	SENT_336	[p24l2016t17r2152b73],
3	Pharmacol	NNP	O	Pharmacol	_	0	SENT_336	[p24l197t110r539b165],
4	2002	CD	DATE	2002	num	3	SENT_336	[p24l563t110r740b175],
5	;	:	O	;	_	0	SENT_336	[p24l563t110r740b175],
6	42	CD	NUMBER	42	num	8	SENT_336	[p24l766t110r862b165],
7	:	:	O	:	_	0	SENT_336	[p24l766t110r862b165],
8	283-9	CD	NUMBER	283-9	dep	3	SENT_336	[p24l892t110r1074b166],

1	26	CD	NUMBER	26	_	0	SENT_337	[p24l6t204r99b261],
2	.	.	O	.	_	0	SENT_337	[p24l6t204r99b261],

1	Prueksaritanont	JJ	O	prueksaritanont	amod	2	SENT_338	[p24l133t204r639b261],
2	T	NN	O	t	_	0	SENT_338	[p24l656t206r720b271],
3	,	,	O	,	_	0	SENT_338	[p24l656t206r720b271],
4	Vega	NNP	PERSON	Vega	nn	6	SENT_338	[p24l742t206r911b277],
5	J	NNP	O	J	nn	6	SENT_338	[p24l929t206r958b261],
6	M	NN	O	m	appos	2	SENT_338	[p24l960t206r1047b271],
7	,	,	O	,	_	0	SENT_338	[p24l960t206r1047b271],
8	Rogers	NNP	ORGANIZATION	Rogers	nn	9	SENT_338	[p24l1068t206r1293b277],
9	JD	NNP	ORGANIZATION	JD	appos	2	SENT_338	[p24l1313t206r1418b271],
10	,	,	O	,	_	0	SENT_338	[p24l1313t206r1418b271],
11	et	FW	O	et	nn	12	SENT_338	[p24l1441t213r1497b260],
12	al.	FW	O	al.	appos	2	SENT_338	[p24l1516t204r1586b261],
13	.	.	O	.	_	0	SENT_338	[p24l1516t204r1586b261],

1	Simvastatin	NNP	O	Simvastatin	nsubj	4	SENT_339	[p24l1611t204r1988b261],
2	does	VBZ	O	do	aux	4	SENT_339	[p24l2007t204r2150b261],
3	not	RB	O	not	neg	4	SENT_339	[p24l197t306r298b354],
4	affect	VB	O	affect	_	0	SENT_339	[p24l332t298r513b354],
5	CYP3A	NN	O	cyp3a	nn	6	SENT_339	[p24l546t298r797b354],
6	activity	NN	O	activity	dobj	4	SENT_339	[p24l832t298r1088b370],
7	,	,	O	,	_	0	SENT_339	[p24l832t298r1088b370],
8	quantified	VBN	O	quantify	partmod	6	SENT_339	[p24l1123t298r1448b370],
9	by	IN	O	by	_	0	SENT_339	[p24l1479t298r1558b370],
10	the	DT	O	the	det	13	SENT_339	[p24l1591t298r1687b354],
11	erythromycin	NN	O	erythromycin	nn	13	SENT_339	[p24l1720t298r2152b370],
12	breath	NN	O	breath	nn	13	SENT_339	[p24l195t392r396b449],
13	test	NN	O	test	agent	8	SENT_339	[p24l421t401r532b448],
14	and	CC	O	and	_	0	SENT_339	[p24l558t392r670b448],
15	oral	JJ	O	oral	amod	17	SENT_339	[p24l695t392r817b449],
16	midazolam	NN	O	midazolam	nn	17	SENT_339	[p24l841t392r1198b449],
17	pharmacokinetics	NNS	O	pharmacokinetic	agent	8	SENT_339	[p24l1220t392r1805b465],
18	,	,	O	,	_	0	SENT_339	[p24l1220t392r1805b465],
19	in	IN	O	in	_	0	SENT_339	[p24l1833t392r1893b447],
20	healthy	JJ	O	healthy	amod	22	SENT_339	[p24l1916t392r2152b465],
21	male	JJ	O	male	amod	22	SENT_339	[p24l197t486r350b542],
22	subjects	NNS	O	subject	prep_in	6	SENT_339	[p24l377t486r648b558],
23	.	.	O	.	_	0	SENT_339	[p24l377t486r648b558],

1	J	NNP	O	J	nn	3	SENT_340	[p24l674t487r704b542],
2	Clin	NNP	O	Clin	nn	3	SENT_340	[p24l728t486r864b542],
3	Pharmacol	NNP	O	Pharmacol	_	0	SENT_340	[p24l887t486r1228b542],
4	2000	CD	DATE	2000	num	3	SENT_340	[p24l1253t486r1430b552],
5	;	:	O	;	_	0	SENT_340	[p24l1253t486r1430b552],
6	40	CD	NUMBER	40	num	8	SENT_340	[p24l1455t486r1551b542],
7	:	:	O	:	_	0	SENT_340	[p24l1455t486r1551b542],
8	1274-9	CD	NUMBER	1274-9	dep	3	SENT_340	[p24l1587t486r1804b543],

1	27	CD	NUMBER	27	_	0	SENT_341	[p24l6t580r99b636],
2	.	.	O	.	_	0	SENT_341	[p24l6t580r99b636],

1	Bogman	NNP	PERSON	Bogman	nn	2	SENT_342	[p24l133t581r404b652],
2	K	NNP	PERSON	K	_	0	SENT_342	[p24l436t581r508b646],
3	,	,	O	,	_	0	SENT_342	[p24l436t581r508b646],
4	Peyer	NNP	ORGANIZATION	Peyer	nn	5	SENT_342	[p24l541t581r724b652],
5	AK	NNP	ORGANIZATION	AK	appos	2	SENT_342	[p24l753t580r884b646],
6	,	,	O	,	_	0	SENT_342	[p24l753t580r884b646],
7	Torok	NNP	PERSON	Torok	nn	8	SENT_342	[p24l918t580r1115b636],
8	M	NNP	O	M	appos	2	SENT_342	[p24l1143t581r1229b646],
9	,	,	O	,	_	0	SENT_342	[p24l1143t581r1229b646],
10	et	FW	O	et	nn	11	SENT_342	[p24l1263t588r1320b636],
11	al.	FW	O	al.	appos	2	SENT_342	[p24l1350t580r1420b636],
12	.	.	O	.	_	0	SENT_342	[p24l1350t580r1420b636],

1	HMG-CoA	JJ	O	hmg-coa	amod	2	SENT_343	[p24l1455t580r1819b636],
2	reductase	NN	O	reductase	_	0	SENT_343	[p24l1848t580r2151b636],
3	inhibitors	NNS	O	inhibitor	dep	2	SENT_343	[p24l197t674r505b730],
4	and	CC	O	and	_	0	SENT_343	[p24l543t674r657b730],
5	P-glycoprotein	NN	O	p-glycoprotein	nn	6	SENT_343	[p24l691t674r1173b747],
6	modulation	NN	O	modulation	dep	2	SENT_343	[p24l1207t674r1591b731],
7	.	.	O	.	_	0	SENT_343	[p24l1207t674r1591b731],

1	Br	NN	O	br	nn	3	SENT_344	[p24l1630t676r1710b729],
2	J	NN	O	j	nn	3	SENT_344	[p24l1743t676r1772b731],
3	Pharmacol	NN	O	pharmacol	_	0	SENT_344	[p24l1806t674r2152b731],
4	2001	CD	DATE	2001	dep	3	SENT_344	[p24l198t767r375b832],
5	;	:	O	;	_	0	SENT_344	[p24l198t767r375b832],
6	132	CD	NUMBER	132	dep	3	SENT_344	[p24l408t767r536b823],
7	:	:	O	:	_	0	SENT_344	[p24l408t767r536b823],
8	1183-92	CD	NUMBER	1183-92	dep	6	SENT_344	[p24l572t767r831b823],

1	28	CD	NUMBER	28	_	0	SENT_345	[p24l6t861r99b917],
2	.	.	O	.	_	0	SENT_345	[p24l6t861r99b917],

1	Wang	NNP	PERSON	Wang	nn	2	SENT_346	[p24l132t862r322b933],
2	E	NNP	PERSON	E	_	0	SENT_346	[p24l340t862r404b927],
3	,	,	O	,	_	0	SENT_346	[p24l340t862r404b927],
4	Casciano	NNP	O	Casciano	nn	5	SENT_346	[p24l426t861r717b917],
5	CN	NN	O	cn	appos	2	SENT_346	[p24l736t861r862b927],
6	,	,	O	,	_	0	SENT_346	[p24l736t861r862b927],
7	Clement	NNP	ORGANIZATION	Clement	nn	8	SENT_346	[p24l883t861r1155b917],
8	RP	NNP	ORGANIZATION	RP	appos	2	SENT_346	[p24l1170t862r1283b927],
9	,	,	O	,	_	0	SENT_346	[p24l1170t862r1283b927],
10	et	FW	O	et	nn	11	SENT_346	[p24l1304t869r1360b917],
11	al.	FW	O	al.	appos	2	SENT_346	[p24l1377t861r1448b917],
12	.	.	O	.	_	0	SENT_346	[p24l1377t861r1448b917],

1	HMG-CoA	JJ	O	hmg-coa	amod	3	SENT_347	[p24l1468t861r1833b917],
2	reductase	NN	O	reductase	nn	3	SENT_347	[p24l1848t861r2152b917],
3	inhibitors	NNS	O	inhibitor	nsubj	4	SENT_347	[p24l197t955r513b1011],
4	(	VBP	O	(	_	0	SENT_347	[p24l549t955r812b1024],
5	statins	NNS	O	statin	nsubj	7	SENT_347	[p24l549t955r812b1024],
6	)	JJ	O	)	dep	7	SENT_347	[p24l549t955r812b1024],
7	characterized	VBN	O	characterize	xcomp	4	SENT_347	[p24l846t955r1289b1011],
8	as	IN	O	as	_	0	SENT_347	[p24l1321t973r1384b1011],
9	direct	JJ	O	direct	amod	10	SENT_347	[p24l1417t955r1605b1011],
10	inhibitors	NNS	O	inhibitor	prep_as	7	SENT_347	[p24l1634t955r1951b1011],
11	of	IN	O	of	_	0	SENT_347	[p24l1984t955r2055b1011],
12	Pglycoprotein	NN	LOCATION	pglycoprotein	prep_of	10	SENT_347	[p24l2080t957r2148b1010, p24l198t1049r622b1121],
13	.	.	O	.	_	0	SENT_347	[p24l2080t957r2148b1010, p24l198t1049r622b1121],

1	Pharm	NNP	O	Pharm	nn	2	SENT_348	[p24l649t1049r859b1105],
2	Res	NNP	O	Res	_	0	SENT_348	[p24l880t1050r997b1105],
3	2001	CD	DATE	2001	num	2	SENT_348	[p24l1023t1049r1200b1115],
4	;	:	O	;	_	0	SENT_348	[p24l1023t1049r1200b1115],
5	18	CD	NUMBER	18	num	7	SENT_348	[p24l1234t1049r1321b1105],
6	:	:	O	:	_	0	SENT_348	[p24l1234t1049r1321b1105],
7	800-6	CD	NUMBER	800-6	dep	2	SENT_348	[p24l1353t1049r1535b1105],

1	29	CD	NUMBER	29	_	0	SENT_349	[p24l6t1144r99b1201],
2	.	.	O	.	_	0	SENT_349	[p24l6t1144r99b1201],

1	Weber	NNP	PERSON	Weber	nn	2	SENT_350	[p24l131t1143r347b1200],
2	C	NNP	O	C	_	0	SENT_350	[p24l367t1144r435b1210],
3	,	,	O	,	_	0	SENT_350	[p24l367t1144r435b1210],
4	Banken	NNP	PERSON	Banken	nn	5	SENT_350	[p24l459t1143r703b1200],
5	L	NNP	PERSON	L	appos	2	SENT_350	[p24l723t1145r788b1210],
6	,	,	O	,	_	0	SENT_350	[p24l723t1145r788b1210],
7	Birnboeck	NNP	O	Birnboeck	nn	8	SENT_350	[p24l811t1143r1147b1200],
8	H	NNP	O	H	appos	2	SENT_350	[p24l1167t1145r1239b1210],
9	,	,	O	,	_	0	SENT_350	[p24l1167t1145r1239b1210],
10	et	FW	O	et	nn	11	SENT_350	[p24l1264t1152r1320b1200],
11	al.	FW	O	al.	appos	2	SENT_350	[p24l1341t1143r1412b1200],
12	.	.	O	.	_	0	SENT_350	[p24l1341t1143r1412b1200],

1	The	DT	O	the	det	2	SENT_351	[p24l1436t1143r1559b1200],
2	effect	NN	O	effect	_	0	SENT_351	[p24l1581t1143r1763b1200],
3	of	IN	O	of	_	0	SENT_351	[p24l1783t1143r1852b1200],
4	bosentan	NN	O	bosentan	prep_of	2	SENT_351	[p24l1866t1143r2152b1200],
5	on	IN	O	on	_	0	SENT_351	[p24l198t1255r275b1293],
6	the	DT	O	the	det	7	SENT_351	[p24l297t1237r393b1293],
7	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	2	SENT_351	[p24l415t1237r980b1310],
8	of	IN	O	of	_	0	SENT_351	[p24l1005t1237r1074b1293],
9	digoxin	NN	O	digoxin	prep_of	7	SENT_351	[p24l1093t1237r1335b1310],
10	in	IN	O	in	_	0	SENT_351	[p24l1358t1237r1418b1292],
11	healthy	JJ	O	healthy	amod	13	SENT_351	[p24l1440t1237r1675b1310],
12	male	JJ	O	male	amod	13	SENT_351	[p24l1698t1237r1851b1293],
13	subjects	NNS	O	subject	prep_in	2	SENT_351	[p24l1876t1237r2147b1310],
14	.	.	O	.	_	0	SENT_351	[p24l1876t1237r2147b1310],

1	Br	NN	O	br	nn	4	SENT_352	[p24l197t1331r276b1385],
2	J	NN	O	j	nn	4	SENT_352	[p24l297t1331r326b1386],
3	Clin	NN	O	clin	nn	4	SENT_352	[p24l350t1330r486b1386],
4	Pharmacol	NN	O	pharmacol	_	0	SENT_352	[p24l509t1330r851b1385],
5	1999	CD	DATE	1999	dep	4	SENT_352	[p24l882t1330r1052b1395],
6	;	:	O	;	_	0	SENT_352	[p24l882t1330r1052b1395],
7	47	CD	NUMBER	47	num	9	SENT_352	[p24l1078t1330r1174b1385],
8	:	:	O	:	_	0	SENT_352	[p24l1078t1330r1174b1385],
9	701-6	CD	NUMBER	701-6	dep	5	SENT_352	[p24l1203t1330r1387b1386],

1	Clin	NNP	O	Clin	nn	2	SENT_353	[p24l1181t1587r1292b1636],
2	Phorrmocokinet	NNP	O	Phorrmocokinet	_	0	SENT_353	[p24l1317t1587r1784b1636],
3	2003	CD	DATE	2003	num	2	SENT_353	[p24l1802t1587r1956b1639],
4	;	:	O	;	_	0	SENT_353	[p24l1802t1587r1956b1639],
5	42	CD	NUMBER	42	number	6	SENT_353	[p24l1977t1587r2045b1635],
6	(	CD	NUMBER	(	dep	2	SENT_353	[p24l2068t1587r2143b1643],
7	3	CD	NUMBER	3	num	8	SENT_353	[p24l2068t1587r2143b1643],
8	)	NN	O	)	dep	6	SENT_353	[p24l2068t1587r2143b1643],

1	Bosentan	NNP	O	Bosentan	_	0	SENT_354	[p24l192t1718r518b1743],
2	.	.	O	.	_	0	SENT_354	[p24l192t1718r518b1743],

1	—	NN	O	—	_	0	SENT_355	[p24l192t1718r518b1743],
2	.	.	O	.	_	0	SENT_355	[p24l192t1718r518b1743],

1	Simvastatin	NNP	O	Simvastatin	_	0	SENT_356	[p24l192t1718r518b1743],
2	Interactions	NNS	O	interaction	dep	1	SENT_356	[p24l527t1719r701b1743],
3	301	CD	NUMBER	301	dep	1	SENT_356	[p24l1918t1719r1965b1743],

1	30	CD	NUMBER	30	_	0	SENT_357	[p24l33t1967r123b2022],
2	.	.	O	.	_	0	SENT_357	[p24l33t1967r123b2022],

1	Desager	NNP	O	Desager	nn	2	SENT_358	[p24l164t1968r430b2038],
2	JP	NNP	O	JP	_	0	SENT_358	[p24l466t1968r558b2032],
3	,	,	O	,	_	0	SENT_358	[p24l466t1968r558b2032],
4	Horsmans	NNP	O	Horsmans	nn	7	SENT_358	[p24l600t1968r923b2022],
5	Y.	NNP	O	Y.	nn	7	SENT_358	[p24l964t1968r1035b2022],
6	Clinical	JJ	O	clinical	amod	7	SENT_358	[p24l1079t1966r1332b2022],
7	pharmacokinetics	NNS	O	pharmacokinetic	appos	2	SENT_358	[p24l1371t1966r1939b2038],
8	of	IN	O	of	_	0	SENT_358	[p24l1980t1966r2049b2022],
9	3hydroXy	NN	O	3hydroxy	prep_of	7	SENT_358	[p24l2084t1967r2144b2022, p24l227t2064r1399b2136],
10	—	CD	NUMBER	—	num	9	SENT_358	[p24l2084t1967r2144b2022, p24l227t2064r1399b2136],
11	3	CD	NUMBER	3	num	18	SENT_358	[p24l2084t1967r2144b2022, p24l227t2064r1399b2136],
12	—	NN	O	—	nn	18	SENT_358	[p24l2084t1967r2144b2022, p24l227t2064r1399b2136],
13	methylglutaryl	NN	O	methylglutaryl	nn	18	SENT_358	[p24l2084t1967r2144b2022, p24l227t2064r1399b2136],
14	—	NN	O	—	nn	18	SENT_358	[p24l2084t1967r2144b2022, p24l227t2064r1399b2136],
15	coenzyme	NN	O	coenzyme	nn	18	SENT_358	[p24l2084t1967r2144b2022, p24l227t2064r1399b2136],
16	A	NN	O	a	nn	18	SENT_358	[p24l1423t2065r1478b2119],
17	reductase	NN	O	reductase	nn	18	SENT_358	[p24l1501t2064r1800b2120],
18	inhibitors	NNS	O	inhibitor	dep	7	SENT_358	[p24l1824t2064r2142b2120],
19	.	.	O	.	_	0	SENT_358	[p24l1824t2064r2142b2120],

1	Clin	NNP	O	Clin	nn	2	SENT_359	[p24l229t2162r363b2218],
2	Pharmacokinet	NNP	O	Pharmacokinet	_	0	SENT_359	[p24l385t2162r860b2218],
3	1996	CD	DATE	1996	num	2	SENT_359	[p24l890t2162r1057b2228],
4	;	:	O	;	_	0	SENT_359	[p24l890t2162r1057b2228],
5	31	CD	NUMBER	31	num	7	SENT_359	[p24l1085t2163r1177b2218],
6	:	:	O	:	_	0	SENT_359	[p24l1085t2163r1177b2218],
7	348-71	CD	NUMBER	348-71	dep	2	SENT_359	[p24l1208t2163r1421b2218],

1	31	CD	NUMBER	31	_	0	SENT_360	[p24l33t2260r123b2316],
2	.	.	O	.	_	0	SENT_360	[p24l33t2260r123b2316],

1	Corsini	NNP	PERSON	Corsini	nn	2	SENT_361	[p24l166t2260r396b2316],
2	A	NNP	O	A	_	0	SENT_361	[p24l428t2260r499b2325],
3	,	,	O	,	_	0	SENT_361	[p24l428t2260r499b2325],
4	Bellosta	NNP	PERSON	Bellosta	nn	5	SENT_361	[p24l534t2260r793b2315],
5	S	NNP	O	S	appos	2	SENT_361	[p24l826t2260r883b2325],
6	,	,	O	,	_	0	SENT_361	[p24l826t2260r883b2325],
7	Baetta	NNP	PERSON	Baetta	nn	8	SENT_361	[p24l917t2261r1119b2315],
8	R	NNP	PERSON	R	appos	2	SENT_361	[p24l1150t2261r1217b2325],
9	,	,	O	,	_	0	SENT_361	[p24l1150t2261r1217b2325],
10	et	FW	O	et	nn	11	SENT_361	[p24l1252t2268r1308b2315],
11	al.	FW	O	al.	appos	2	SENT_361	[p24l1339t2260r1409b2315],
12	.	.	O	.	_	0	SENT_361	[p24l1339t2260r1409b2315],

1	New	NNP	O	New	nn	2	SENT_362	[p24l1444t2261r1590b2315],
2	insights	NNS	O	insight	_	0	SENT_362	[p24l1623t2260r1867b2331],
3	into	IN	O	into	_	0	SENT_362	[p24l1900t2260r2020b2315],
4	the	DT	O	the	det	8	SENT_362	[p24l2052t2260r2147b2315],
5	pharmacodynamic	JJ	O	pharmacodynamic	amod	8	SENT_362	[p24l226t2358r810b2430],
6	and	CC	O	and	_	0	SENT_362	[p24l832t2358r943b2414],
7	pharmacokinetic	JJ	O	pharmacokinetic	conj_and	5	SENT_362	[p24l961t2358r1487b2430],
8	properties	NNS	O	property	prep_into	2	SENT_362	[p24l1507t2358r1821b2430],
9	of	IN	O	of	_	0	SENT_362	[p24l1843t2358r1911b2414],
10	statins	NNS	O	statin	prep_of	2	SENT_362	[p24l1927t2358r2142b2414],
11	.	.	O	.	_	0	SENT_362	[p24l1927t2358r2142b2414],

1	Pharmacol	NNP	O	Pharmacol	nn	2	SENT_363	[p24l228t2456r565b2512],
2	Ther	NNP	O	Ther	_	0	SENT_363	[p24l588t2456r737b2512],
3	1999	CD	DATE	1999	num	2	SENT_363	[p24l766t2457r933b2522],
4	;	:	O	;	_	0	SENT_363	[p24l766t2457r933b2522],
5	84	CD	NUMBER	84	num	7	SENT_363	[p24l963t2457r1053b2512],
6	:	:	O	:	_	0	SENT_363	[p24l963t2457r1053b2512],
7	413-28	CD	NUMBER	413-28	dep	2	SENT_363	[p24l1081t2457r1301b2512],

1	32	CD	NUMBER	32	_	0	SENT_364	[p24l33t2554r123b2610],
2	.	.	O	.	_	0	SENT_364	[p24l33t2554r123b2610],

1	Kyrklund	NN	O	kyrklund	nn	2	SENT_365	[p24l166t2554r468b2625],
2	C	NN	O	c	_	0	SENT_365	[p24l491t2554r558b2619],
3	,	,	O	,	_	0	SENT_365	[p24l491t2554r558b2619],
4	Backman	NNP	PERSON	Backman	nn	6	SENT_365	[p24l586t2554r883b2609],
5	J	NNP	PERSON	J	nn	6	SENT_365	[p24l906t2555r935b2610],
6	T	NN	PERSON	t	appos	2	SENT_365	[p24l938t2555r1001b2619],
7	,	,	O	,	_	0	SENT_365	[p24l938t2555r1001b2619],
8	Kivisto	NNP	PERSON	Kivisto	nn	9	SENT_365	[p24l1029t2554r1259b2609],
9	KT	NNP	O	KT	appos	2	SENT_365	[p24l1285t2555r1404b2619],
10	,	,	O	,	_	0	SENT_365	[p24l1285t2555r1404b2619],
11	et	FW	O	et	nn	12	SENT_365	[p24l1431t2562r1487b2609],
12	al.	FW	O	al.	appos	2	SENT_365	[p24l1510t2554r1579b2609],
13	.	.	O	.	_	0	SENT_365	[p24l1510t2554r1579b2609],

1	Rifampin	NNP	O	Rifampin	nsubj	3	SENT_366	[p24l1607t2554r1905b2625],
2	greatly	RB	O	greatly	advmod	3	SENT_366	[p24l1929t2554r2146b2625],
3	reduces	VBZ	O	reduce	_	0	SENT_366	[p24l227t2652r466b2707],
4	plasma	NN	O	plasma	nn	5	SENT_366	[p24l494t2652r719b2723],
5	simvastatin	NN	O	simvastatin	dobj	3	SENT_366	[p24l747t2652r1105b2707],
6	and	CC	O	and	_	0	SENT_366	[p24l1133t2652r1245b2707],
7	simvastatin	NN	O	simvastatin	nn	9	SENT_366	[p24l1273t2652r1631b2707],
8	acid	NN	O	acid	nn	9	SENT_366	[p24l1660t2652r1789b2707],
9	concentrations	NNS	O	concentration	dobj	3	SENT_366	[p24l1815t2660r2145b2707, p24l228t2750r396b2806],
10	.	.	O	.	_	0	SENT_366	[p24l1815t2660r2145b2707, p24l228t2750r396b2806],

1	Clin	NNP	O	Clin	nn	3	SENT_367	[p24l423t2750r557b2806],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_367	[p24l580t2750r917b2806],
3	Ther	NNP	O	Ther	_	0	SENT_367	[p24l940t2750r1089b2806],
4	2000	CD	DATE	2000	num	3	SENT_367	[p24l1111t2751r1285b2816],
5	;	:	O	;	_	0	SENT_367	[p24l1111t2751r1285b2816],
6	68	CD	NUMBER	68	num	8	SENT_367	[p24l1313t2750r1405b2806],
7	:	:	O	:	_	0	SENT_367	[p24l1313t2750r1405b2806],
8	592-7	CD	NUMBER	592-7	dep	3	SENT_367	[p24l1435t2750r1614b2807],

1	33	CD	NUMBER	33	_	0	SENT_368	[p24l33t2848r123b2904],
2	.	.	O	.	_	0	SENT_368	[p24l33t2848r123b2904],

1	Heimark	NNP	O	Heimark	nn	2	SENT_369	[p24l165t2848r442b2903],
2	LD	NNP	O	LD	_	0	SENT_369	[p24l464t2849r585b2913],
3	,	,	O	,	_	0	SENT_369	[p24l464t2849r585b2913],
4	Gibaldi	NNP	PERSON	Gibaldi	nn	5	SENT_369	[p24l613t2848r847b2904],
5	M	NNP	O	M	appos	2	SENT_369	[p24l871t2849r957b2913],
6	,	,	O	,	_	0	SENT_369	[p24l871t2849r957b2913],
7	Trager	NNP	PERSON	Trager	nn	8	SENT_369	[p24l984t2849r1195b2919],
8	WF	NNP	PERSON	WF	appos	2	SENT_369	[p24l1217t2849r1351b2913],
9	,	,	O	,	_	0	SENT_369	[p24l1217t2849r1351b2913],
10	et	FW	O	et	nn	11	SENT_369	[p24l1379t2856r1434b2903],
11	al.	FW	O	al.	appos	2	SENT_369	[p24l1459t2848r1529b2903],
12	.	.	O	.	_	0	SENT_369	[p24l1459t2848r1529b2903],

1	The	DT	O	the	det	2	SENT_370	[p24l1556t2848r1676b2903],
2	mechanism	NN	O	mechanism	_	0	SENT_370	[p24l1700t2848r2061b2903],
3	of	IN	O	of	_	0	SENT_370	[p24l2084t2848r2152b2903],
4	the	DT	O	the	det	7	SENT_370	[p24l228t2946r322b3001],
5	warfarin-rifampin	NN	O	warfarin-rifampin	nn	7	SENT_370	[p24l344t2946r911b3017],
6	drug	NN	O	drug	nn	7	SENT_370	[p24l933t2946r1074b3017],
7	interaction	NN	O	interaction	prep_of	2	SENT_370	[p24l1097t2946r1435b3001],
8	in	IN	O	in	_	0	SENT_370	[p24l1456t2946r1516b3001],
9	humans	NNS	O	human	prep_in	2	SENT_370	[p24l1536t2946r1797b3001],
10	.	.	O	.	_	0	SENT_370	[p24l1536t2946r1797b3001],

1	Clin	NNP	O	Clin	nn	3	SENT_371	[p24l1823t2946r1956b3002],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_371	[p24l1977t2946r2145b3001, p24l228t3043r419b3097],
3	Ther	NNP	O	Ther	_	0	SENT_371	[p24l442t3043r591b3097],
4	1987	CD	DATE	1987	num	3	SENT_371	[p24l620t3043r788b3107],
5	;	:	O	;	_	0	SENT_371	[p24l620t3043r788b3107],
6	42	CD	NUMBER	42	num	8	SENT_371	[p24l813t3043r908b3097],
7	:	:	O	:	_	0	SENT_371	[p24l813t3043r908b3097],
8	388-94	CD	NUMBER	388-94	dep	3	SENT_371	[p24l938t3043r1158b3098],

1	©	NN	O	©	_	0	SENT_372	[p24l7t3301r51b3345],
2	Adis	NNP	O	Adis	nn	4	SENT_372	[p24l72t3296r196b3344],
3	International	NNP	O	International	nn	4	SENT_372	[p24l219t3296r594b3344],
4	Limited	NNP	O	Limited	dep	1	SENT_372	[p24l619t3296r843b3344],
5	.	.	O	.	_	0	SENT_372	[p24l619t3296r843b3344],

1	All	DT	O	all	det	2	SENT_373	[p24l866t3296r934b3344],
2	rights	NNS	O	rights	nsubj	3	SENT_373	[p24l958t3296r1111b3357],
3	reserved	VBN	O	reserve	_	0	SENT_373	[p24l1133t3296r1404b3344],
4	.	.	O	.	_	0	SENT_373	[p24l1133t3296r1404b3344],

1	34	CD	NUMBER	34	_	0	SENT_374	[p24l33t3380r124b3435],
2	.	.	O	.	_	0	SENT_374	[p24l33t3380r124b3435],

1	Fuhr	NNP	PERSON	Fuhr	nn	3	SENT_375	[p24l164t3380r314b3435],
2	U.	NNP	PERSON	U.	nn	3	SENT_375	[p24l333t3381r404b3435],
3	Induction	NN	PERSON	induction	_	0	SENT_375	[p24l429t3379r732b3435],
4	of	IN	O	of	_	0	SENT_375	[p24l753t3379r821b3435],
5	drug	NN	O	drug	nn	7	SENT_375	[p24l837t3379r979b3451],
6	metabolising	NN	O	metabolising	nn	7	SENT_375	[p24l1001t3379r1408b3451],
7	enzymes	NNS	O	enzyme	prep_of	3	SENT_375	[p24l1430t3397r1722b3451],
8	:	:	O	:	_	0	SENT_375	[p24l1430t3397r1722b3451],
9	pharmacoki	NNS	O	pharmacokus	nsubj	10	SENT_375	[p24l1747t3379r2145b3451],
10	—	VBP	O	—	dep	3	SENT_375	[p24l1747t3379r2145b3451],
11	netic	JJ	O	netic	amod	14	SENT_375	[p24l228t3468r378b3523],
12	and	CC	O	and	_	0	SENT_375	[p24l407t3468r519b3523],
13	toxicological	JJ	O	toxicological	amod	14	SENT_375	[p24l544t3468r956b3539],
14	consequences	NNS	O	consequence	dobj	10	SENT_375	[p24l983t3485r1415b3539],
15	in	IN	O	in	_	0	SENT_375	[p24l1443t3468r1502b3523],
16	humans	NNS	O	human	prep_in	14	SENT_375	[p24l1527t3468r1788b3523],
17	.	.	O	.	_	0	SENT_375	[p24l1527t3468r1788b3523],

1	Clin	NNP	O	Clin	nn	2	SENT_376	[p24l1818t3468r1952b3524],
2	Pharmacokinet	NNP	O	Pharmacokinet	_	0	SENT_376	[p24l1977t3468r2145b3523, p24l228t3556r558b3610],
3	2000	CD	DATE	2000	num	2	SENT_376	[p24l580t3556r754b3620],
4	;	:	O	;	_	0	SENT_376	[p24l580t3556r754b3620],
5	38	CD	NUMBER	38	num	7	SENT_376	[p24l783t3556r874b3611],
6	:	:	O	:	_	0	SENT_376	[p24l783t3556r874b3611],
7	493-504	CD	NUMBER	493-504	dep	2	SENT_376	[p24l902t3556r1164b3611],

1	35	CD	NUMBER	35	_	0	SENT_377	[p25l33t19r124b75],
2	.	.	O	.	_	0	SENT_377	[p25l33t19r124b75],

1	Quattrochi	NNP	PERSON	Quattrochi	nn	2	SENT_378	[p25l166t19r502b88],
2	LC	NNP	O	LC	_	0	SENT_378	[p25l521t19r638b84],
3	,	,	O	,	_	0	SENT_378	[p25l521t19r638b84],
4	Guzelian	NNP	PERSON	Guzelian	nn	5	SENT_378	[p25l660t19r944b75],
5	PS	NNP	O	PS	appos	2	SENT_378	[p25l962t19r1065b75],
6	.	.	O	.	_	0	SENT_378	[p25l962t19r1065b75],

1	CYP3A	NN	O	cyp3a	nn	2	SENT_379	[p25l1088t19r1336b75],
2	regulation	NN	O	regulation	_	0	SENT_379	[p25l1353t19r1691b90],
3	:	:	O	:	_	0	SENT_379	[p25l1353t19r1691b90],
4	from	IN	O	from	_	0	SENT_379	[p25l1714t19r1868b74],
5	pharmacology	NN	O	pharmacology	prep_from	2	SENT_379	[p25l1883t19r2144b90, p25l228t108r441b179],
6	to	TO	O	to	_	0	SENT_379	[p25l473t116r532b163],
7	nuclear	JJ	O	nuclear	amod	8	SENT_379	[p25l563t108r797b163],
8	receptors	NNS	O	receptor	prep_to	5	SENT_379	[p25l825t116r1131b179],
9	.	.	O	.	_	0	SENT_379	[p25l825t116r1131b179],

1	Drug	NN	O	drug	nn	3	SENT_380	[p25l1165t109r1326b179],
2	Metab	NNP	O	Metab	nn	3	SENT_380	[p25l1357t108r1557b163],
3	Dispos	NNP	O	Dispos	_	0	SENT_380	[p25l1589t108r1805b179],
4	2001	CD	DATE	2001	num	3	SENT_380	[p25l1839t108r2013b173],
5	;	:	O	;	_	0	SENT_380	[p25l1839t108r2013b173],
6	29	CD	NUMBER	29	num	8	SENT_380	[p25l2048t108r2141b164],
7	:	:	O	:	_	0	SENT_380	[p25l2048t108r2141b164],
8	615-22	CD	NUMBER	615-22	dep	3	SENT_380	[p25l229t197r450b253],

1	Correspondence	NN	O	correspondence	_	0	SENT_381	[p25l7t491r610b577],
2	and	CC	O	and	_	0	SENT_381	[p25l644t491r782b554],
3	offprints	NNS	O	offprint	conj_and	1	SENT_381	[p25l816t491r1148b576],
4	:	:	O	:	_	0	SENT_381	[p25l816t491r1148b576],
5	Dr	NNP	O	Dr	nn	7	SENT_381	[p25l1185t494r1280b553],
6	Iasper	NNP	PERSON	Iasper	nn	7	SENT_381	[p25l1307t494r1514b576],
7	Dingemanse	NNP	PERSON	Dingemanse	dep	1	SENT_381	[p25l1546t492r1984b576],
8	,	,	O	,	_	0	SENT_381	[p25l1546t492r1984b576],
9	Department	NNP	ORGANIZATION	Department	appos	1	SENT_381	[p25l2017t494r2147b554, p25l6t604r347b681],
10	of	IN	ORGANIZATION	of	_	0	SENT_381	[p25l367t595r439b658],
11	Clinical	JJ	ORGANIZATION	clinical	amod	12	SENT_381	[p25l456t595r737b658],
12	Pharmacology	NN	ORGANIZATION	pharmacology	prep_of	9	SENT_381	[p25l756t595r1307b681],
13	,	,	O	,	_	0	SENT_381	[p25l756t595r1307b681],
14	Actelion	NNP	ORGANIZATION	Actelion	nn	16	SENT_381	[p25l1327t595r1637b658],
15	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	nn	16	SENT_381	[p25l1656t595r2147b658, p25l8t699r142b762],
16	Ltd	NNP	ORGANIZATION	Ltd	appos	1	SENT_381	[p25l167t699r313b773],
17	,	,	O	,	_	0	SENT_381	[p25l167t699r313b773],
18	Gewerbestrasse	NNP	O	Gewerbestrasse	appos	1	SENT_381	[p25l338t699r914b762],
19	18	CD	NUMBER	18	num	18	SENT_381	[p25l942t701r1038b772],
20	,	,	O	,	_	0	SENT_381	[p25l942t701r1038b772],
21	4123	CD	NUMBER	4123	num	18	SENT_381	[p25l1062t701r1226b762],
22	Allschwil	NNP	O	Allschwil	nn	24	SENT_381	[p25l1250t699r1620b773],
23	,	,	O	,	_	0	SENT_381	[p25l1250t699r1620b773],
24	Switzerland	NNP	LOCATION	Switzerland	dep	18	SENT_381	[p25l1644t699r2103b762],
25	.	.	O	.	_	0	SENT_381	[p25l1644t699r2103b762],

1	E-mail	NN	O	e-mail	_	0	SENT_382	[p25l7t802r265b865],
2	:	:	O	:	_	0	SENT_382	[p25l7t802r265b865],
3	jasper.dingemanse@actelion.com	NNP	O	jasper.dingemanse@actelion.com	dep	1	SENT_382	[p25l287t802r1507b888],

1	Clin	NNP	O	Clin	nn	2	SENT_383	[p25l1205t1077r1314b1126],
2	Phormocokinet	NNP	O	Phormocokinet	_	0	SENT_383	[p25l1339t1077r1800b1126],
3	2003	CD	DATE	2003	num	2	SENT_383	[p25l1818t1077r1969b1129],
4	;	:	O	;	_	0	SENT_383	[p25l1818t1077r1969b1129],
5	42	CD	NUMBER	42	number	6	SENT_383	[p25l1990t1077r2057b1125],
6	(	CD	NUMBER	(	dep	2	SENT_383	[p25l2079t1077r2153b1133],
7	3	CD	NUMBER	3	num	8	SENT_383	[p25l2079t1077r2153b1133],
8	)	NN	O	)	dep	6	SENT_383	[p25l2079t1077r2153b1133],

